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Abstract
Animal venoms are essentially diverse libraries of compounds evolved to have both 
high affinity and high specificity, making them ideal targets for bioprospecting. Despite 
advances in antivenom therapy, envenomations remain clinically significant, accounting 
for numerous human fatalities.
The Indian red scorpion (Mesobuthus famulus) is a serious threat to life in India, but its 
venom is poorly characterised. This study examines antigenic and proteomic variability 
of Mesob. famulus venoms obtained in two geographical regions with distinct biotopes. 
In addition to highlighting general venomic differences between the two populations, 
the study identified a peptide of 2947Da that may prove diagnostic between the venom 
types. As an aid to the future isolation of specific peptides, particularly those initially 
identified via their DNA sequences, a mass profile of fractionated, commercially 
available venom was also generated.
Scorpion short insectotoxins may have importance as chloride channel blockers and in 
cancer therapeutics. Only a few such molecules have been isolated and in general, 
relatively little is known about their properties. Analysis of a Mesob. famulus telson 
cDNA library, using probes based upon the signal peptide sequence of a known short 
insectotoxin (Bml2 from Buthus martensii), yielded two novel “short-insectotoxin” 
sequences, BtChll and BtChl2. Mass spectrometry-guided isolation has been used to 
purify a corresponding peptide from the venom, based upon its calculated mass. 
Additional studies using the same cDNA revealed evidence supporting the amidation of 
tamulustoxin (a potassium channel toxin found in the venom of this species), and 
evidence to suggest the existence of a novel long-chain potassium channel toxin.
Toxins also play an important role as molecular probes for the dissection of ion channel 
structure. The structure-function relationships of apamin (a calcium-activated potassium 
channel toxin from the honey bee, Apis mellifera) were examined by investigating the 
effect of addition of a fluorescent label, non-native disulphide pairings, and disruption 
of the P-tum on the toxin’s affinity for its receptor on rat brain membranes.
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1.1 Significance of Natural Toxins
Plant extracts have been used medicinally for thousands of years and are the origin of 
many well-known drugs, e.g. cardiac glycosides (from Digitalis species) and quinine 
(from Cichona species). Approximately 50% of the world’s best selling pharmaceuticals 
were originally derived from natural sources (for reviews on the use of natural products 
in the pharmaceutical and agrochemical industry see Harvey 1993; Clark, 1996; Tulp 
and Bohlin, 2004). Research has generally focussed in two areas, the study of plant 
compounds and the study of natural toxins, including bacterial and fungal toxins and 
animal venoms. In particular, natural toxins make attractive targets for bioprospecting. 
There are three key features of natural toxins that make them ideal for drug screening. 
Natural toxins are very diverse and are evolved to recognise specific pharmacological 
targets. In general, they recognise these targets with high specificity and affinity 
(Rappuoli and Montecucco, 1997).
Many drugs derived from, or modelled on, natural toxins are in clinical trials or already 
in use. These include Clostridium botulinum toxin (for which novel clinical uses are 
constantly being proposed), derivatives of epibatidine (an alkaloid from frog skin, 
which causes analgesia via its action on nicotinic receptors) and a large number of 
snake-derived compounds, which include the ACE (angiotensin-converting enzyme) 
inhibitors and anticoagulants such as tirofiban.
These toxins are also important tools in the study of a number of physiological 
processes and disease states, allowing the study of their receptors at the molecular, 
biochemical and behavioural level, and providing a means of receptor purification (for a 
review of the use of toxins in cell biology see Rappuoli and Montecucco, 1997).
This study will focus on a group of naturally derived toxins, specifically ion channel 
toxins from bee and scorpion venoms.
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1.2 Ion Channels
An ion-impermeable extracellular membrane allows cells to maintain differential intra- 
and extra-cellular ion concentrations. Ions can pass across this membrane by virtue of 
ATP-driven active transport systems, or passively through ion channels, driven by their 
electrochemical gradient. Most cells at rest maintain an increased concentration of 
potassium and organic anions in their cytoplasm, whilst [Na+] and [Cf] are higher 
extracellularly. When open, ion channels provide an aqueous environment through 
which ions can rapidly cross hydrophobic membranes. This rapid transfer of charged 
molecules generates membrane currents and also enables rapid changes in 
concentrations of key ions important for cellular signalling.
Ion channels are ubiquitous and vital for normal cellular function. In animals they form 
the basis of excitability of nerve and muscle and are also involved in non-neuronal 
processes. In plants, like animals, ion channels are required for control of membrane 
potential, cell volume and signal transduction, and play an additional role in large scale 
transport systems such as in the phloem (Zimmermann and Sentenac, 1999; 
Schachtman, 2000). Ion channels are also present in viruses (Fischer and Sansom, 2002) 
and in prokaryotic organisms. Ion channels of bacteria have proved especially important 
in recent years, providing structural data from which properties of their eukaryotic 
counterparts can be inferred (Booth et al., 2003).
The importance of ion channels is best demonstrated by the role they play in the 
nervous system, where they are involved in the entire neuronal process, i.e. maintaining 
resting potential, sensory signal transduction, synaptic transmission, and muscle 
contraction. They are crucial to the propagation of impulses via action and inhibitory 
potentials. Hodgkin and Huxley, 1952, first demonstrated that the action potential (AP) 
was produced by coordinated opening of K+ and Na+ channels (see fig 1.1). Ion 
channels have numerous roles in non-neuronal systems, for instance cellular regulation 
and signalling, endocrine, secretory and absorptive processes.
Structurally, ion channels are oligomers containing pore forming a-subunits and 
accessory modulatory subunits (which have many functions including altering gating 
kinetics and regulation of channel expression, Trimmer, 1998). Generally, a single pore 
spans the membrane and often shows selectivity for different ions (for reviews on
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selectivity and permeation of ion channels see Imoto, 1993; Sather et al., 1994). The 
first channel structure to be determined was that of KcsA, a K+ channel from 
Streptomyces lividans, fig 1.2 (Doyle et al., 1998; Zhou et al., 2001). The data from this 
and subsequent bacterial channel structures (e.g. Chang et al., 1998; Jiang et al., 2002; 
Bass et al., 2002; Dutzler et al., 2002) have been used to model the pore-forming 
regions of a number of voltage-gated channels (Giorgetti and Carloni, 2003).
Opening and closing of a channel is an all or nothing event with spontaneous switching 
between the states, the overall conductance being determined by the number of channels 
open at any time. However, in order for a channel to be capable of passing ions, it must 
first be activated. In a phenomenon known as gating, an electrical, chemical or 
mechanical stimulus causes a conformational change in the ion channel, allowing the 
passage of ions through the pore (for a discussion of models for structural changes 
during gating by different stimuli see Beckstein et al., 2003; Doyle, 2004; Ahem and 
Horn, 2004). In many channels, after a period of activation, a second structurally- 
distinct conformational change occurs (deactivation), restricting ion-flow.
a-Subunits of voltage-gated channels contain a region sensitive to membrane potential 
and responsible for channel gating. The pore forming subunits of most voltage-gated 
channels form a superfamily of evolutionary related proteins, with similar sequence, 
structural and functional properties. In sodium and calcium channels the pore region is 
contained within a single polypeptide, whereas the potassium channel (regarded as the 
ancestral voltage-gated ion channel) is a tetramer of similar, but not necessarily 
identical, subunits (see fig 1.3). Voltage-sensitive ion channels have been reviewed by 
Catterall, 1988; Catterall, 1995; and Conley and Brammer, 1999, and their accessory 
subunits reviewed by Adelman, 1995. Excitation and signalling in excitable tissues is 
almost exclusively determined by voltage-gated channels with Na+, K+, Ca2+ or Cl" 
permeability and these same channels are the target of a large number of venom 
neurotoxins.
The ligand- or transmitter-gated channel groups contain a large number of important 
channels, responsible for coupling chemical and electrical signalling. The ligands 
themselves may be intracellular, e.g. cAMP, cGMP, G-proteins, or extracellular, e.g. 
neurotransmitters. In vertebrate skeletal muscle and the peripheral nervous system, 
nicotinic acetylcholine receptors (AChRs) (Lindstrom, 1995) are the major excitatory
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ligand-gated channel. In the CNS, glutamate receptors (Sprengel and Seeburg, 1995) 
dominate, a distribution that is reversed in insects. The anion selective glycine 
(Langosch, 1995) and GAB A (y-aminobutyrate) receptors (Tyndale et al., 1995) are the 
primary channels responsible for receptor-mediated hyperpolarisation, increasing the 
threshold required to trigger an action potential. Glycine predominates in the brain stem 
and spine, GABA being utilized in the cerebellum and cortex. For a review on the 
permeation and selectivity of ligand-gated ion channels, see Sather et al., 1994. The 
torpedo electric organ AChR was one of the first ion channels studied, due both to the 
availability of specific toxins (i.e. a-bungarotoxin and cobratoxin) and its high tissue 
abundance. Ligand-gated ion channels are thought to be the sites of action of a number 
of drugs, including nicotine (AChRs), barbiturates (GABA receptor type A, GABAa) 
and ethanol (GABAa).
Relatively little is known about mechano-gated channels, which convert membrane 
deformation into an electrical signal, either directly or via secondary messengers 
controlled by mechanosensitive enzymes. They have a variety of ion permeabilities and 
may be selective for K+, Cf or cations, or be non-selective. The mechanical signal may 
prompt channel activation or inactivation, and sensitivities vary from those found in the 
hair cells of the inner ear, to those that respond to stimulation above the threshold for 
cellular damage. See Garcia-Anoveros and Corey, 1997; Patel et al., 2001; Pivetti et al., 
2003 for reviews on mechano-gated channels.
Ion channels include a large number of proteins, with approx. 140 members in the 
voltage-gated family alone. Only those on which apamin, or scorpion venom toxins are 
active will be discussed further. Data on the genetic, molecular and functional properties 
of known receptor- and voltage-gated channels can be found on the International Union 
of Pharmacology website (www.iuphar-db.org/iuphar-rd and www.iuphar- 
db.org/iuphar-ic respectively).
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Fig 1.1 The Action Potential
In a resting neuron, the ionic gradients maintained by the Na+/K+ ATPase pump ensure 
that the interior of the cell has a high potassium ion concentration and a low sodium ion 
concentration relative to the cell exterior. In this resting state the membrane is more 
permeable to potassium ions than to sodium ions. The resting membrane potential is 
therefore largely determined by the electrochemical gradient of K+. The generation of a 
nerve impulse in a neuron is predominantly the result of large changes in the 
permeability of the axon membrane to sodium and potassium ions.
A) Initiation of the action potential. Localised depolarisation of the membrane leads 
to opening of voltage-gated Na+ channels. Since the action potential is an all-or-nothing 
response, a depolarisation threshold of -55mV must be reached before the action 
potential is propagated. Below this value, the outward flow of K+ channels prevents 
further depolarisation. Above the threshold, sufficient Na+ channels are open that the 
inward Na+ flow exceeds the outward K+ flow. The resulting depolarisation in turn 
opens more Na+ channels and the depolarisation becomes self-propagating.
B) Towards the peak of the action potential, Na+ channels are beginning to 
inactivate and the Na+ conductance starts to fall. At the same time, K+ channels (also 
gated by the membrane depolarisation, but which activate more slowly than the sodium 
channels (delayed rectifiers)) begin to open and K+ flows out of the cell.
C) At the peak of the action potential, outward K+ flow begins to exceed inward 
Na+ flow and the membrane begins to repolarise.
D) In many cells, elevated K+ conductance through both voltage- and calcium-gated 
K+ channels leads to the after-hyperpolarisation (AHP). This AHP, in conjunction with 
residual inactivation of the Na+ channels, accounts for the refractory period. During this 
time a greater than usual depolarisation is required to reach threshold value, allowing 
for the spacing of neuronal signals and accounting for desensitisation.
Only a small proportion of the total potassium and sodium ions in the cell participate in 
action potential generation.
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Fig 1.1 The Action Potential (From Aidley, 1989)
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Fig 1.3 Membrane Topology of Voltage-Gated Na+, Ca2+ and K* channel a-
Subunits
A) Subunit structure of the voltage-gated sodium channels (see 1.2.1). The 
extracellular domains of the (31 and 02 subunits are shown as immunoglobulin- 
like folds. Picture taken from Catterall et al., 2003a.
B) Subunit structure of Cavl voltage-gated calcium channels (see 1.2 .2) purified 
from skeletal muscle. Picture taken from Catterall et al 2003.
C-F) The subunit structure of the four main classes of potassium channel a-subunits.
Refer to 1.2.4 for details. Picture taken from Choe, 2002.
C) 2TM/P channels e.g. inward rectifiers and KcsA (see 1.2.4). Subunits assemble 
as tetramers.
D) 6TM/P channels e.g. Kv (see 1.2.4.1) and Kca (see 1.2.4.2) channels. Subunits 
assemble as tetramers.
E) 8TM/2P channels. Found in yeast. Subunits assemble as dimers.
F) 4TM/2P channels. E.g. TWDC and TREK (see 1.2.4). Subunits assemble as 
dimers.
In all cases a-helical segments are represented by cylinders. In A and B, P indicates
sites of demonstrated phosphorylation by protein kinase.
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Fig 1.3 Membrane Topology of Voltage-Gated Na+, Ca2+ and K* channel a-
Subunits
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Fig 1.3 Membrane Topology of Voltage-Gated Na+, Ca2+ and K+ channel a-Subunits 
C-F) K+ channels
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1.2.1 Voltage-Gated Sodium Channels (VGSC)
Voltage-gated Na+ channels (VGSC) (Goldin, 2001) are present in the membranes of 
most excitable cells and are responsible for the depolarising phase of action potentials in 
these tissues (see fig 1.1). They are highly selective for sodium ions and show rapid 
voltage-dependent activation and inactivation.
Much of the early work on channel structure was carried out on sodium channels (for 
comprehensive reviews see Catterall, 1992, Catterall, 1995). One of the reasons for the 
ease of their study was the availability of specific blockers (e.g. tetrodotoxin (TTX) 
isolated from the puffer fish).
VGSCs were traditionally classified based on tissue and species (e.g. eel electroplax 
sodium channel [eNal], Noda et al., 1984), the channels from different tissues having 
distinct physiological and pharmacological properties. The subunit composition of 
voltage-gated sodium channels differs from tissue to tissue, e.g. mammalian heart (one 
a-subunit), skeletal muscle (one a- and one pi-like subunit) and brain (one a-subunit, 
one pi-subunit and one P2 -subunit).
The a-subunit (see fig 1.3) forms the pore itself and is composed of four domains, each 
with a similar primary sequence and containing six transmembrane (TM) domains. One 
of these TM domains (S4) is highly charged and has been identified as the voltage 
sensor. Another important feature of this subunit is the intracellular loop between 
domains in and IV, which is thought to act as the inactivation gate and produces the 
refractory period of the channel. The actual pore is lined by the residues between the S5 
and S6 segments. The selectivity filter is located at a narrowing of the channel and is 
thought to contain negatively charged ion binding sites (Imoto, 1993). To date nine 
mammalian a-subunit genes have been identified and are classified Navl.l-Nav1.9 
(Catterall et al., 2003a). Expression of an a-subunit alone is sufficient to produce 
sodium currents (Noda et al., 1986), but the p-subunits are required for native gating 
and kinetics (Patton et al., 1994). These p-subunits may also play a role in localising the 
channels at specific cellular locations (Srinivasan et al., 1998).
A number of sodium channel modulators have been identified. Briefly, these fall into 
six classes grouped according to their binding site on the channel. Tetrodotoxin and p-
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conotoxins bind to site 1, causing channel block. Toxins binding to site 2 (e.g. 
veratridine, batrachotoxin) alter the kinetics of activation and inhibit inactivation; site 3 
toxins (e.g. sea anemone toxins, a-scorpion toxins) also block inactivation. Other 
scorpion toxins (p-toxins) bind to site 4, altering either voltage-dependence of activation 
and inactivation, or that of activation alone. Site 5 toxins (e.g. brevotoxins) and site 6 
modulators (e.g. pyrethroid insecticides) also affect kinetics of activation and 
inactivation, but by interaction with different binding sites.
Some voltage-gated sodium channels play a role in nociception and it is speculated that 
they play a role in neuropathy, inflammation and acute and chronic pain. Classic local 
anaesthetics such as lidocaine are sodium channel blockers, and the channels represent 
viable targets for novel analgesics.
1.2.2 Calcium Channels
Intracellular calcium concentration plays a major role in cellular signalling; therefore 
calcium channels have a direct effect on membrane excitability and are also involved in 
signalling pathways. Influx of Ca2+ through these channels, together with the release of 
stored intracellular calcium acts as an important secondary messenger involved in 
processes such as activation of other ion channels, neurotransmission, synapse 
formation, exocytosis, cell division and gene activation and a number of Ca2+-dependent 
enzyme mediated effects.
Voltage-gated Ca2+ channels (Brammar, 1999; Yamakage and Naniki, 2002; Catterall et 
al., 2003) are ubiquitous in excitable membranes. VGCCs open in response to 
membrane depolarisation and, in general, produce long depolarising pulses since they 
do not show fast inactivation. This property is important in sustained contractions of 
heart and smooth muscle, and in maintaining secretion. At high [Ca2+] they are highly 
selective (Ca2+: Na+ 1000:1), but at low [Ca2+], this selectivity is lost (McKlesky 1994).
Like voltage gated Na+ channels, native VGCCs consist of a single pore-forming a- 
subunit (ai) in complex with auxiliary subunits (one isoform each of: - <*25, p, and y). 
As with VGSCs, the a-subunits contain four homologous domains, each with 6TM 
regions (including an S4 voltage sensor, and a pore forming loop) (see fig 1.3). The 0C2
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and 8-subunits are expressed as a single polypeptide, the mature forms resulting from 
posttranslational processing (Dejongh et al., 1990). The mature transmembrane 8- 
subunit anchors the extracellular ct2-subunit to the membrane via a disulphide bond 
(Campbell et al., 1988, Catterall, 1988). The 8/ct2-subunit influences activation and 
inactivation. The P-subunits are intracellular and direct membrane trafficking of the ai- 
subunits to specific cellular compartments. They also affect open time, activation and 
inactivation, and modulation by other proteins. The y-subunit, initially thought to be 
specific to skeletal muscle, has four TM segments and seems to have a general role in 
the regulation of surface expression of a number of receptors and ion channels 
(Chetkovich et al., 2000). Ten a-subunit genes have been identified and each auxiliary 
subunit has several gene variants. A number of these subunit genes provide several 
splice variants, further increasing channel and current diversity. For a discussion of 
VGCC auxiliary subunits see Adelman, 1995.
There are at least six classes of voltage-gated calcium channels, distinguished by their 
differential location, pharmacology, structure and electrophysiology. T- type (transient) 
channels (important in pacemaker activity of cardiac muscle) are the most distinctive, 
needing only small depolarisations for activation, and showing rapid voltage-dependent 
deactivation. By lowering the action potential threshold in neurons and cardiac cells 
during periods of hyperpolarized resting potential, they stimulate repetitive firing. In 
contrast, much higher depolarising voltages are required for activation of the other 
channel types (L, N, P, Q and R-types).
Voltage-gated calcium channels are sensitive to a number of venom toxins, N-, P-, and 
Q-type channels showing sensitivity to spider and/ or molluscian venom peptides. These 
toxins are being investigated for their neuroprotectant properties, since a high 
intracellular free calcium concentration is toxic and a primary cause of ischemic brain 
damage.
Intracellular calcium concentration in a resting eukaryotic cell is maintained at a low 
concentration by active Ca2+ transport both out of the cell and into intracellular stores. 
Various stimuli provoke release of calcium from the intracellular stores, causing a rapid 
increase in intracellular free calcium ion concentration ([Ca2+]i). This stored calcium 
release is largely modulated by the InsP3 and the ryanodine receptor (RyR) families.
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The ryanodine receptors (Fill and Copello, 2002) are multimeric proteins comprised of 
four large (approx. 5000 amino acids) and four small (100 amino acids) subunits and are 
localised on the sarcoplasmic reticulum. They are gated by voltage-induced 
conformational changes in the dihydropyridine receptors of the T-tubule plasma 
membrane. RyRs are regulated by a wide variety of intracellular signals, one of the most 
important of which is Ca2+ itself (Ca2+-induced Ca2+ release). They show far less Ca2+ 
selectivity than do plasma membrane Ca2+ channels. This is permitted by the fact that 
selective passage of Ca2+ into the intracellular stores is provided by the Ca2+ pump, 
making selective release superfluous. Ryanodine, the ligand after which the ryanodine 
receptor was named, is a plant alkaloid from Ryania speciosa that binds with high 
affinity to the open state of the channel.
1.2.3 Chloride Channels
The Cl' channels form a large and very diverse group, but we have limited knowledge of 
their specific functions compared to that of Na+, K+ and Ca2+ channels. Although in 
most cases, intracellular [Cf] is less than extracellular [C1‘]; intracellular [Cf] is 
maintained at levels close to electrochemical equilibrium. Cf fluxes are rarely involved 
in electrical excitation; instead, they generally suppress it. Opening of these channels 
holds the membrane potential at its resting value, or at a hyperpolarized value, making it 
more difficult to depolarise the membrane and hence excite the cell. They are therefore 
important in neurons and in muscle, where they contribute to resting conductance and 
dampen down electrical excitability. Probably present in the plasma membrane of all 
eukaryotic cells, chloride channels also have roles in cell volume regulation, secretion, 
and sensory signal transduction.
A large number of genes for functional chloride channels have been cloned (Jentsch et 
al., 1995; Jentsch, 1996; Frings et al., 2000), but the structure and functional properties 
of most of these are unclear. There are many different types of chloride channel; these 
include those gated by extracellular ligands, intracellular calcium, voltage and cell 
volume.
The first voltage gated Cf channel to be cloned was C1C-0 from the electric organ of 
Torpedo (Jentsch et al., 1990). Since then, nine human C1C channels have been
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identified (Jentsch et al., 2002; Dutzler, 2004; Dutzler, 2004a). C1C-1 modulates resting 
potential in skeletal muscle, C1C-2 has a similar function in some neurons, and C1C 3, 4, 
6  and 7 are involved in acidification, as is kidney-localised C1C-5. CICKa and CICKb 
are also localised in the kidney and are responsible for trans-epithelial Cf transport in 
the renal inner medulla (Matsumara et al., 1999). C1C channels have two pores; one 
located on each of two homodimeric subunits (see fig 1.4 a-d).
The calcium-activated chloride channels (CaCC, Frings et al., 2000) may be localised to 
specific regions of the cell where their activity depends upon local Cf equilibrium 
potential and Ca2+ concentrations. Neuronal CaCCs participate in sensory signal 
processing of some somatic senses, as well as vision, olfaction and taste, and are also 
present in non-sensory neurons in the CNS (central nervous system) and PNS 
(peripheral nervous system). They have a wide non-neuronal distribution including 
epithelia, muscle, blood and endocrine cells, and a wide range of functions. In striated 
muscle, for example, they contribute to the initial phase of repolarisation during the 
action potential.
GABA and glycine are responsible for fast inhibitory transmission in the mammalian 
central nervous system. GABAa, GABAc, and glycine receptors (see Chebib and 
Johnston, 2000; Whiting, 2003; Colquhoun and Sivilotti, 2004) mediate these inhibitory 
Cf currents. One such example is the production of the inhibitory postsynaptic potential 
(IPSP) in the direct inhibitory pathway of muscles. These channels are members of the 
ligand-gated ion channel superfamily (see fig 1.4 f).
Expressed in the epithelium and the heart, and of great clinical importance, the cystic 
fibrosis transmembrane conductance regulator (CFTR, McAuley and Elbom, 2000) 
gene was identified and cloned by Riordan et al., 1989. It is expressed in the apical 
membrane in many epithelial tissues e.g. in the airways, pancreas, sweat ducts and the 
intestine. A variant is also found in cardiac muscle. Although functionally an ion 
channel responsible for the I ci (cam p) current, structurally it belongs to the traffic 
ATPase superfamily (see fig 1.4 e for membrane topology). It may have a regulatory as 
well as ion channel function, and interacts with the epithelial sodium channel. Inhibitors 
of the channel are important in the study of cystic fibrosis and have been proposed as 
therapeutics for secretory diarrhoeas e.g. cholera.
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Figure 1.4 Chloride Channel Topology
a-d) C1C channel structure. (Based upon that of the E. coli C1‘ channel EcClC. See 
Dutzler, 2004, 2004a for a review of C1C structure), (a) The C1C protein is composed of 
17 a-helices (A-R) many of which do not fully span the membrane (helix A is not 
inserted in the membrane). Each subunit consists of two domains (blue and green 
regions). The helices in each of these domains are tilted in opposite directions, with the 
pore located between the domains (b). Early electrophysiological data on C1C-0 
suggested a ‘double-barrelled’ structure for C1C channels (c). In this model the channels 
are dimers, with each subunit contributing a pore. These pores can be gated 
individually, or both pores closed by a common gate. The structure of EcClC (viewed 
from the extracellular side) confirmed this dimeric architecture, both of the identical 
subunits contributing a pore (d). Pictures taken from Jentsch et al., 2002 and Dutzler, 
2004.
e) Membrane topology of CFTR. The CFTR protein is divided into two 6TM 
regions separated by a cytoplasmic region. The regulatory domain (R-domain) and the 
first of two nucleotide-binding folds (NBF) are located in this intracellular segment. A 
second NBF is located close to the C-terminus. It is currently unclear if CFTR is a 
monomer or a dimer. Picture taken from Jentsch et al., 2002.
f) Membrane topology of a ligand-gated anion channel subunit. GABA and 
Glycine receptors are members of the ligand-gated ion channel superfamily (which also 
contains the nicotinic acetylcholine receptors). These receptors share sequence and 
structural homology and are believed to have evolved from a common ancestral receptor 
subunit. The channels are homo- and hetero-pentamers of 4TM subunits. Picture taken 
from Jentsch et al., 2002.
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Figure 1.4 Chloride Channel Topology
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1.2.4 Potassium Channels
Potassium channels are the largest and most diverse family of ion channels. They have a 
range of functions including: setting resting membrane potential; shaping action 
potentials and determining their frequency; cell volume control; and secretion of salt, 
hormones and transmitters. Although they may be voltage-, ligand-, or mechano-gated, 
only those activated by changes in membrane potential, and their relatives (the voltage- 
gated potassium channel gene family), are considered in this section. K+ channels have 
a near-perfect selectivity for potassium (K+: Na+ > 1000:1), which is achieved at 
conductance rates approaching the diffusion limit. All of these channels contain a highly 
conserved K+ channel signature sequence (Heginbotham et al., 1994) that forms the 
selectivity filter. These channels, their classification and the mechanisms determining 
their selectivity have been reviewed by a number of authors (Miller, 2000; Choe, 2002; 
MacKinnon, 2003; Gutman et al., 2003).
Primarily due to lack of specific probes, the early studies of voltage-gated potassium 
channels lagged behind that of their sodium channel counterparts and it was not until 
the advent of molecular cloning techniques, and discovery of natural ligands, that 
detailed study was possible.
A wide variety of functionally and pharmacologically different K+ currents have been 
recorded in vivo. The last fifteen years have seen a rapidly increasing family of K+ 
channels emerge, identified via cloning. These K+ channels can be classified into four 
groups according to the membrane topology of their pore-forming subunits (see fig 1.3).
In the first group, a single pore is surrounded by four subunits with two TM domains 
and a pore loop each (2TM7P, a motif that essentially forms the basic unit of the K+ 
channel family). This group includes the inward rectifiers (Kir) and the bacterial 
channel KcsA. The large family of Kirs tend to open at membrane potentials near to, or 
more negative than, the resting potential (Reimann and Ashcroft, 1999; Loussouam et 
al., 2002). They are homo- or heteromeric and are involved in maintenance of the 
resting membrane potential and regulation of the action potential. They also have a role 
in electrolyte processing in the kidney. The KcsA channel from Streptomyces lividans 
is of particular significance as the first ion channel to have its 3D structure determined
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(Doyle et al., 1998), providing important information on the structure and function of 
the K+ channel pore.
The largest group is comprised of channels containing four 6TM segment subunits 
surrounding a single pore (6TMZP). Four TM regions, including an S4 voltage sensor, 
precede the 2TM/P motif This topology is shared by the Shaker voltage-gated 
potassium channel family (Kv), calcium-activated potassium channels (although the 
slopoke subfamily has an extra transmembrane segment close to the extracellular C- 
terminus), the eag {ether-a-go-go)-like gene family (including EAG {ether-a-go-go gene 
potassium channel), ERG {ether-a-go-go-re\ated gene potassium channel), and ELK 
(ether-a-go-go-like potassium channel); showing inward rectification and of particular 
importance in the heart (Cooper and Jan, 1999; Karle and Kiehn, 2002), KCNQ 
channels (responsible for the M-Type potassium currents, which activate near the 
threshold for action potential generation and regulate neuronal excitability, Jentsch, 
2000; Robbins, 2001) and the CNGs (cyclic nucleotide-gated cation channels).
In 1995 a yeast channel was identified containing two tandemly arranged pore-like 
domains (Ketchum et al., 1995). The dimeric 8TM/2P subunits have a 6TM7P motif and 
a 2TMZP region arranged in tandem.
The last group contains proteins with 2x 4TM subunits and two pore domains (4TM/2P, 
consisting of two 2TM/P repeats). These include the TWDCs (tandem of P domains in 
weak inward rectifier K+ channels), TREKs (TWIK-related K+ channels), TRAAKs 
(TWIK-Related arachidonic acid-stimulated K+ channels), TASKs (TWIK-related acid- 
sensitive K+ channels), THIKs (halothene-inhibited 2P domain K+ channels) and 
TALKs (alkaline-activated background K+ channels). The two-pore potassium channels 
include a number of mechano-gated and lipid sensitive channels. They tend to be 
constitutively active, may mediate background K+ currents and are the targets of many 
anaesthetics (Lesage and Lazdunski, 2000; Patel et al., 2001).
Potassium channels are generally homo- or hetero-multimers of pore-forming a- 
subunits. Alternative gene splicing creates further diversity (Pongs 1992) and accessory 
p-subunits may also be present, regulating channel targeting or modulating function 
(McManus et al., 1995; Fink et al., 1996; Mangubat et al., 2003).
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Drugs that alter K+ channel activity are in development for a variety of conditions (e.g. 
diabetes, cardiac arrhythmias, hypertension, angina). The great diversity of K+ channels, 
however, creates problems in the development of selective drugs. Also, different 
physiological channels may be structurally related, so a drug often acts on multiple 
channel types.
1.2.4.1 Kv Channels
The first ion channel to be cloned was the Shaker channel a  subunit from Drosophila 
(Temple et al., 1987), followed by three related genes (Shab, Shaw, and Shat) (Butler, 
et al., 1989). Seventeen mammalian homologues have been found and grouped into 
Kvl-4, related to Shaker, Shab, Shaw and Shal respectively. These mammalian 
counterparts share 50-82% homology with the Drosophila genes but, unlike the 
Drosophila channels, are encoded on separate, intronless genes.
Kv subunits and (associated (3 subunits) are found in neuronal and non-neuronal cells, 
and form delayed rectifiers (which activate a short while after membrane depolarisation, 
inactivate slowly, or not at all, and are involved in the falling phase of the action 
potential) and A-type channels (which activate and inactivate rapidly on initial 
depolarisation producing a brief outward current thus buffering depolarisations below 
threshold value and inserting a gap between successive action potentials). Kv a- 
subunits form homotetramers, or hetrotetramers within and between Kv subfamilies. 
Functional channels are often dependent on co-expression with |3- or y-subunits 
(Robertson, 1997).
Kv channels are the most characterised of potassium channels and much of what is now 
known about K+ channel structure (from KscA, and more recent structural studies) had 
previously been postulated, based upon studies on Kv channels. The channels are the 
targets of a number of naturally-derived inhibitors from scorpion, snake and sea 
anemone venoms, for example, and from plants (e.g. correolide from Spachea correa) 
(see Kaczorowski and Garcia, 1999 for details). Not only do these inhibitors show 
potential in the design of therapeutic drugs but they have also been used extensively in 
channel characterisation. As an example, studies using charybdotoxin led to the
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characterisation of the outer vestibule of the Shaker channel as a shallow hole approx. 
30A wide (Miller, 1995).
1.2.4.2 Calcium-Activated Potassium Channels (Kca)
Change in intracellular free calcium concentration is a ubiquitous signalling mechanism. 
This calcium may be released from cytostolic stores or may enter the cell, via voltage- 
activated calcium channels, during an action potential. This [Ca2+]i is coupled to 
membrane potential by a group of potassium channels that are activated by local 
increases in cytostolic calcium concentration. Opening of these calcium-activated 
potassium channels leads to potassium ion efflux and membrane hyperpolarisation.
Kca channels have a number of functions. They generate membrane potential 
oscillations and are the predominant channel involved in spike frequency adaptation. 
The prolonged afterhyperpolarisation seen after the action potential is due to the slow 
inactivation kinetics of a Kca channel. These channels also play a role in hormone 
secretion (Montiel et al., 1995).
An intracellular-calcium linked potassium permeability was first noted by Gardos, 1958 
in human erythrocytes and later a Kca current was identified in Aplysia neurons (Meech 
and Strumwasser, 1970). A number of different calcium activated currents have since 
been distinguished on the basis of pharmacology and kinetics, and at the molecular level 
several channel proteins have been identified. These have been divided into three 
groups according to the rate of conductance and are termed SK, IK and BK (small 
conductance, intermediate conductance and large (big) conductance calcium-activated 
potassium channels respectively).
Kca channels represent targets for the development of therapeutics for asthma, 
hypertension, psychoses, depression, memory disorders, convulsions, ischemic stroke 
and traumatic brain injury (Kaczorowski and Garcia, 1999; Faber and Sah, 2003).
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Large Conductance Calcium-Activated Potassium Channels (BK or maxi-K)
BK channels have a single channel conductance of 100-250pS, open rapidly on increase 
of [Ca2+]i, and close rapidly when the calcium is removed. The Kd of the channel for 
calcium is voltage-sensitive. The greater affinity for calcium at more positive potentials 
translates to a greater open probability under these conditions. The channels are highly 
expressed in smooth muscle and are also found in the brain, inner ear, kidney, human T- 
cells (Deutsch et al., 1991) and endocrine and exocrine epithelium. They have a number 
of functions, including regulation of smooth muscle contraction, the duration of the 
action potential and quantity of neurotransmitter release. In the chicken cochlea, they 
adjust the oscillation frequency in individual hair cells (Rosenblatt et al., 1997).
BK channels contain a combination of a- and P-subunits. The alpha subunit is unusual 
amongst the voltage-activated potassium channel superfamily in having seven 
transmembrane domains. The extra transmembrane segment (SO) means that the N- 
terminus has an extracellular location. Despite this, the channel retains sensitivity to 
TEA+ (tetraethylammonium cation, 0.5-lmM) and charybdotoxin, suggesting the pore 
structure is similar to that of voltage gated channels and has the distinctive S4 voltage 
sensor. The different forms of this subunit are encoded by a single gene (Tseng-Crank et 
al., 1994; Lagrutta et al., 1994). Splice variants give rise to channels with different 
voltage and calcium sensitivities.
For recent general reviews on BK channels, see Gribkoff et al., 2001 and Weigner et al., 
2002.
Intermediate Conductance Calcium-Activated Potassium Channels (IK)
The intermediate conductance (20-80 pS) IK channels are six transmembrane domain 
proteins and are often grouped with the SK channels (IK1 is sometimes referred to as 
SK4). The IK channels are voltage-insensitive, being gated by [Ca2+]j to which they are 
more sensitive than are BK channels. This calcium sensitivity is mediated by 
calmodulin (Fanger, 1999). The channels can also be activated by cell swelling and are 
pH sensitive.
43
The channel is expressed in many non-neuronal tissue types. In red blood cells DC forms 
the Gardos channel (Maher and Kuchel, 2003). This channel is sensitive to clotrimazole, 
which is in clinical trials for sickle cell anaemia. By blocking potassium loss through 
erythrocyte DC channels, the drug may help prevent water loss and hence cell sickling 
(Brugnara et al., 1996). In the colon the DC is essential for acetylcholine-mediated 
secretion (Warth and Bleich, 2000). They may be responsible for the effects of 
bradykinin in kidney capillary cells. The channels are generally not considered 
neuronal, although one group has reported the associated currents in rat supraoptic 
nuclear neurons (Greflrath et al., 1998).
Small Conductance Calcium-Activated Potassium Channels (SK)
As their name suggests, the small conductance calcium-activated potassium channels 
have only a small single channel conductance (2-20pS) and are activated by an increase 
in intracellular calcium, as is seen during an action potential. The potassium current 
produced causes membrane depolarisation. This hyperpolarisation is long-lasting due to 
the slow decrease in [Ca2+]i after the action potential. The current is the slow 
afterhyperpolarisation, and limits the firing frequency of action potentials. This sAHP 
can be divided into two pharmacologically distinct currents, which vary according to 
their sensitivity to apamin, and their activation and inactivation properties.
The gene family responsible for the apamin-sensitive current has been identified (SK1- 
3, Kohler et al., 1996), although, as discussed by Faber and Sah, 2003, the precise 
channel responsible for the apamin insensitive current is unclear. All three subtypes are 
sensitive to apamin, though in the case of SKI the affinity is much lower. Early reports 
indicated SKI was insensitive to the toxin (Kohler et al., 1996), but subsequent studies 
in a different expression system revealed that this was not the case (Strobaek et al., 
2000).
These expressed SK channels seem to be able, in themselves, to produce functional 
pores, and they are capable of forming functional homo- and heteromers (Kohler et al., 
1996; Ishii et al., 1997a). They are voltage insensitive but respond rapidly to small 
changes in free calcium (Kd < lpM) (Hirschberg et al., 1998). The channels co- 
assemble with calmodulin. Calcium ions do not bind directly to the a-subunit. Instead,
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gating is regulated by Ca2+ binding to the calmodulin moiety, which in turn produces 
conformational changes in the channel itself (Xia et al., 1998; Maylie et al., 2004).
SK mRNAs are found throughout the CNS (although the subtypes have differential 
distributions, Stocker and Pedarzani et al., 2000) and are also found in many non­
neuronal cell types. The SKI gene has eight exons, and over 30 predicted transcripts, of 
which 20 have been detected in the brain (Shmukler, et al., 2001).
The importance of these channels in the CNS is demonstrated by the effects of apamin 
(see 1.4.1) and they play important roles in learning and memory (Faber and Sah, 2003). 
Aside from their neuronal functions, calcium activated potassium channels provide an 
important link between metabolism and membrane potential. SK channels appear to 
have roles in endocrine mechanisms and have been implicated in regulating the release 
of adrenaline from chromaffin cells (Monteil et al., 1995).
1.2.5 Clinical Relevance of Ion Channels
Not surprisingly, disorders of ion channels result in hyper- or hypo-activity of cells. Ion 
channel defects underlie a number of clinical disorders, of which the channelopathies 
are the most extensively studied. Channelopathy refers to a disorder caused by 
mutations in the genes encoding various proteins that together form functional ion 
channels. Naturally arising channelopathies, together with knockout gene studies, can 
provide valuable information on the role of specific ion channel proteins. The gene 
products involved in such genetic disorders and relevant recent reviews are summarised 
in table 1.1.
Considering the wide diversity of ion channels, it is perhaps surprising that more 
pathological ion channel mutations have not been recognised. It is thought that most 
mutations of key ion channels lead to non-viability or early mortality and are, therefore, 
not maintained within the gene pool. There is, however, a degree of functional 
redundancy provided by the large number of subtypes of the ion channels and many 
mutations may produce only mild, or periodic, symptoms. Mutations in a single gene 
can give rise to different disorders and a single disorder can arise from mutations in 
genes encoding different ion-channel families.
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Several ion channel diseases are caused by defects in trafficking. Spinocerebellar ataxia 
(SCA6) is a polyglutamine disease caused by the expansion of a CAG repeat in a single 
splice variant of Ca a-subunit a lA . It is postulated that this expansion results in the 
protein forming aggregates in the cytoplasm of Purkinje cells (Ishikawa et al., 1999), 
although researchers disagree as to whether the pathology seen with this disorder is due 
to these aggregates or to loss of channel function (Frontali, 2001). The SK3 gene 
[KCNN3] also contains polymorphic CAG repeats. There has been controversy over the 
role that this polymorphism may play in schizophrenia (e.g. Bowen et al., 1996; Li et 
al., 1998; Cardno et al., 1999). The role of trinucleotide repeats in this disorder is 
discussed by Vaswani and Kapur, 2001.
A large number of ion channel defects are acquired. These include ion channel 
autoimmune disorders (Vincent et al., 2000), of which myasthenia gravis, affecting the 
nicotinic AChR in skeletal muscle (Hoedemaekers et al., 1997), is the most common. 
Other ion channel autoimmune diseases include Rasmussen’s encephalitis (affecting the 
GluR3 glutamate receptor subunit, Granata, 2003), acquired neuromyotonia (voltage- 
gated potassium channels, Vincent et al., 1998) and Lambert-Eaton myasthenic 
syndrome (P- and Q-type voltage-gated calcium channels, Takamori et al., 2000). Ion 
channels may also play a role in certain demyelinating autoimmune diseases. For 
example, relapses commonly seen in multiple sclerosis have been blamed on 
endogenous substances reversibly blocking sodium channels (Brinkmeier et al., 2000).
Recently, transcriptional ion channel disorders have been the subject of investigation 
(Waxman, 2001). One of the most studied of these is peripheral nerve injury, which 
causes a change in expression levels of sodium channel genes (both up- and down- 
regulation) leading to hyperexcitability of spinal sensory neurons and to neuropathic 
pain (Dib-Hajj et al., 1996).
Ion channels are the therapeutic targets for a number of classes of drugs, including local 
anaesthetics (Na+, Ca2+), neuroprotectants (Na+, Ca2+), antihypertensives (K4), 
immunosuppressants (K4), analgesics (Ca24), anticonvulsants (GABA), antiepileptics 
(glutamate); neuromuscular blockers (ACh), antidepressants (GABA), cardioprotectants 
(K4), antidysrhythmias (Ca24, K4), hypoglycaemics (K4) and drugs for treating 
neurodegeneration (ACh, glutamate). For many of these pharmacological agents, the 
site of action has only been elucidated relatively recently. Knowledge of the structure
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and function of the ion channels involved is leading to a new generation of specific 
drugs.
Action on ion channels has also been shown to underlie some of the unwanted side 
effects of many pharmaceuticals. One such example is the production of cataracts by 
tamoxifen, a potent blocker of volume-activated outwardly rectifying Cl" currents, used 
in the treatment of breast cancer. Aside from its cancer cell target, the drug also blocks a 
lens Cl' channel involved in volume and hydration of the lens, and hence its 
transparency (Zhang et al., 1994). The use of a wide range of drugs (including 
antihistamines, antimicrobials and antipsychotics) has been associated with increased 
risk of torsade de pointes, via interactions with the HERG K+ channel (Redfern et al., 
2003). Polymorphisms in ion channel genes may have important effects on 
susceptibilities to certain drugs. For example a SCN5A sodium channel variant found in 
African races, unproblematic under normal conditions, may provoke a long QT 
syndrome in the presence of Ikr blockers (Splawski et al., 2002). Such unwanted actions 
of many existing ion channel drugs, and genetic variation in susceptibility, highlight the 
need for increased knowledge regarding the precise therapeutic targets of these 
compounds and the development of modulators with a heightened specificity.
Increasing knowledge of the structure and function of ion channels, has highlighted 
them as targets for novel therapeutics. In sickle cell anaemia, dehydration of 
erythrocytes leads to polymerisation of haemoglobin, which produces the sickling 
effect. The calcium activated K+ efflux (via the Gardos pathway) is accompanied by 
further water loss and dehydration, and increased sickling. A number of inhibitors of the 
IK channel that carries this current have been identified, of which Clotrimazole has 
undergone clinical trails in humans (Brugnara et al., 1995). Research is now focussing 
on finding compounds with a higher specificity (Jensen et al., 2001). A number of ion 
channels may provide targets for anti cancer drugs. ERG1, for example, is expressed in 
several tumour types and is responsible for the inward rectifier current which maintains 
the resting potential at a depolarised value necessary for unlimited tumour growth 
(Bianchi et al., 1998). The much-publicised discovery of the CatSper ion channels in 
sperm may provide a target for contraceptives (Ren et al., 2001).
47
Table 1.1 Human Channelopathies
Type of 
disorder
Disorder Channel [gene] Recent reviews
Skeletal
muscle
Hyperkalemic Periodic Paralysis Na a  subunit [SCN4A] Krause and McNamara, 1995; Dworakowska 
and Dolowy, 2000; Gargus, 2003
Paramyotonia Na a  subunit [SCN4A] Krause and McNamara, 1995; Weinreich and 
Jentsch, 2000; Dworakowska and Dolowy, 
2000
Hypokalemic Periodic Paralysis L-type Ca channel a l  subunit 
(Dihydropyridine Receptor) [CACNA1S]; 
Na channel a  subunit
Weinreich and Jentsch, 2000; Dworakowska 
and Dolowy, 2000; Gargus, 2003,
Potassium sensitive myotonia 
(myotonia fluctuans; myotonia 
permanens)
Na channel a  subunit [SCN4A] Cannon, 1997; Dworakowska and Dolowy, 
2000; Gargus, 2003
Myotonia (Thomsens; Beckers) Cl channel [CLCN1] Dworakowska and Dolowy, 2000; Pusch, 
2002; Gargus, 2003
Malignant hyperthermia (central 
core disease; King-Denborough 
syndrome)
Na channel a  subunit [SCN4A]; L-type 
Ca a l  or a2 subunits [CACNA1S] 
[CACNL2A]; ryanodine receptor [RYR1]
Dworakowska and Dolowy, 2000; Wappler, 
2001; Gargus, 2003
Congenital myasthenia ACh receptor subunits [CHRNA1 ] 
rCHRNBll [CHRNE1
Dworakowska and Dolowy, 2000; Lindstrom, 
2000; Gargus, 2003
Nervous
system
Episodic ataxia type 1 (Myokymia) Potassium a  subunit Kv 1.1 
[KCNA11
Krause and McNamara, 1995; Shiehet al., 
2000; Dworakowska and Dolowy, 2000
Episodic ataxia type 2 Ca a  subunit [CACNA1 A] Jen, 1999; Weinreich and Jentsch, 2000; 
Dworakowska and Dolowy, 2000
Hyperekplexia (familial startle 
disease)
Glycine receptor a l  subunit [GLRA1] Krause and McNamara, 1995; Rajendra et al., 
1997; Dworakowska and Dolowy, 2000
Spinocerebellar ataxia type 6 Ca a  subunit [CACNA1 A] Jen, 1999; Weinreich and Jentsch, 2000; 
Pietrobon, 2002
Heart Long QT type 3 syndrome [KCNQ1], cardiac Na channel [SCN5A] Weinreich and Jentsch, 2000; Jentsch, 2000; 
Head and Gardiner, 2003,
Long QT type 2 syndrome [HERG] heart K+ channel Weinreich and Jentsch, 2000; Shieh et al., 
2000; Dworakowska and Dolowy, 2000
Long QT type 5 syndrome [KCNE1] K* channel p subunit minK 
(IsK)
Weinreich and Jentsch, 2000; Shieh et al., 
2000; Dworakowska and Dolowy, 2000
Cardiac arrhythmia [KCNE2] MiRPl which associates with 
HERG channels
Weinreich and Jentsch, 2000; Dworakowska 
and Dolowy, 2000; Gargus, 2003
Familial idiopathic ventricular 
fibrillation
[SCN5A] cardiac Na channel Dworakowska and Dolowy, 2000; Gargus, 
2003; Head and Gardiner, 2003
Brain Benign familial neonatal 
convulsions
Volt gated K+ a  subunits [KCNQ2], 
[KCNQ3]
Steinlein and Nobel, 2000; Shieh et al., 2000; 
Steinlein, 2002,
Generalised epilepsy with febrile 
seizures ‘plus’
Na channel subunits [SCN1B], [SCN1 A], 
[SCN2A]; GABAa receptor subunit 
[GABRG21
Weinreich and Jentsch, 2000; Steinlein, 2002; 
Gargus, 2003
Familial hemiplegic migraine Brian P/Q type Ca a  subunit 
rCACNAlAl
Weinreich and Jentsch, 2000; Dworakowska 
and Dolowy, 2000; Carrerra et al., 2001,
Familial nocturnal frontal lobe 
epilepsy (Autosomal dominant 
nocturnal frontal lobe epilepsy)
Neuronal nicotinic ACh receptor 
[CHRNA4], [CHRNB], [CHRNB2]
Weinreich and Jentsch, 2000; Steinlein, 2002; 
Gargus, 2003
Severe myoclonic epilepsy of 
infancy
[SCN1 A] sodium channel Head and Gardiner, 2003; Gargus, 2003; 
Mulley et al., 2003
Sensory DFNA2 (Hereditary hearing loss, 
nonsyndromic dominant deafness)
[KCNQ4]Kf a  subunit Weinreich and Jentsch, 2000; Shieh et al., 
2000; Jentsch, 2000
Congenital stationary night 
blindness type 2
Retina-specific Ca channel a  subunit Ca 
1.4 [CACNA1F1
Dworakowska and Dolowy, 2000; Celesia, 
2001; Pietrobon, 2002
Colour blindness Cone photoreceptor CNG channels 
ICNGA31
Dworakowska and Dolowy, 2000; Kaupp and 
Seifer, 2002
Renal Bartters syndrome Kir 1.1 [KCNJ1] CLC-Kb Shieh et al., 2000; Dworakowska and 
Dolowy, 2000; Thakker, 2000
X-linked recessive nephrolithiasis 
(Dents disease)
Chloride channel [CLC-5] Dworakowska and Dolowy, 2000; Thakker, 
2000; Yu, 2001
Secretory Cystic fibrosis Epithelial chloride channel [CFTR] * Dworakowska and Dolowy, 2000; Rubin, 
2003; Ratjen and Doring, 2003
Metabolic Familial Persistent 
Hyperinsulinemic Hypoglycaemia 
of Infancy
Sulfonylurea receptor 1 of ATP-sensitive 
potassium channel. [SUR1]
Shieh et al., 2000; Dworakowska and 
Dolowy, 2000; Foumet and Junien, 2003
This table shows some of the naturally occurring human channelopathies. A large 
number have also been identified in mice.
*It should be noted that although the CFTR is functionally a chloride channel, structurally it forms part of 
the ABC (ATP-binding cassette) transporter family and therefore its classification as a true ion channel is 
controversial
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1.3 Venoms
There are over 1000 species of venomous animals from a wide variety of phyla, 
including arthropods, cniderea, nematodes, echinoderms, molluscs and chordates, which 
use their venoms for prey capture, defence from predators and to deter competitors. The 
distinction between poisonous and venomous species is the possession of specialised 
delivery apparatus. This distinction becomes blurred when considering some frogs, for 
example, which have specialised glands under the skin for venom storage (Terreni et al., 
2003). Delivery, however, is via nothing more than expulsion of the ‘venom’ onto the 
skin as a predator deterrent. Frog ‘venom’ is therefore better classified as a toxic 
secretion.
A wide variety of venom delivery systems have evolved. In some fish the venom 
apparatus is little more than venom secreting cells associated with a modified spine. 
Venom release is entirely involuntary (the direct result of mechanical pressure on the 
spine) and is therefore used solely for defensive purposes (Church and Hodgson, 2002). 
In contrast, scorpions not only control the timing and quantity of venom release, but 
may also be able to control its composition. Other organisms use modified teeth, the 
most obvious of these being the snakes. In the gila monster (Heloderma suspectum), the 
venom is not injected via fangs, but venomous saliva is chewed into the victim using 
grooved teeth (Raufman, 1996). One of the most sophisticated of envenomation devices 
is that of the cnidaria, and consists of specific organelles, or nematocysts (Tardent, 
1997).
Similarly, there is much variation in the venom itself. In some cases this is synthesised 
de novo (e.g. in spiders, Escoubas and Rash, 2004); in other species (e.g. the blue ringed 
octopus), the toxins are produced by a symbiotic bacteria contained within the venom 
glands. Venom may be a highly complex mixture of proteins, such as in cone snails 
(McIntosh and Jones, 2001), or largely comprised of alkaloids, as is the case in some 
ant venoms. In some cases, e.g. snakes, the lethal components are largely enzymes, 
whilst in scorpions, for example, the lethal components are small neurotoxic peptides.
Many venoms (e.g. those of fire ants and bees) contain histamine or histamine-releasing 
factors, producing pain, itching and burning sensations at the site of the sting. Spreading 
factors such as hyaluronidase are also common components (e.g. in venoms from lizard
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and snake), catalysing the breakdown of connective tissue and increasing the diffusion 
and absorption of the venom. Venoms often contain cytolytic peptides, e.g. lycotoxins 
in spider venom (Yan and Adams, 1998) and anoplin in wasp venom (Konno et al., 
2 0 0 1a), which may have both offensive and immunodefensive uses.
The bee and scorpion envenomation systems discussed in this study share two features 
that set them apart from those of snakes. Whereas snakes have an envenomation system 
modified from existing salivary glands, both scorpions and bees have developed 
independent highly specialised venom delivery apparatus. Whilst snake venoms contain 
large numbers of enzymes, again thought to be adapted from those present in the 
digestive system, the scorpion and hymenoptera venoms have a small number of 
enzymes, in conjunction with basic, pharmacologically active peptides. It is possible 
that scorpion toxins are derived from components of the arthropod innate immune 
system.
In summary, animal venoms contain a cocktail of pharmacologically active components, 
each highly evolved to a specific target, making them ideal libraries in the screening of 
novel therapeutics. The venoms are also of great clinical importance in their own right, 
with a significant number of human fatalities arising from various envenomations.
1.3.1 Disulphide Bond Motifs
Multiple paired cystines are common in venom peptides, particularly those active on ion 
channels. They are believed to account for the high stability of these molecules and their 
resistance to proteolytic digestion, and may have a role in directing the folding process. 
Upon analysis of these peptides, several common patterns of cysteine distribution and 
disulphide pairing have been noted. Two of these, the cystine- stabilised-a-helix (CSH) 
and the cystine knot, will be discussed.
The CSH Motif
In finalising the 3D structure of the scorpion potassium channel toxin charybdotoxin, 
Bontems et al., (1991 and 1991a) noted that there were common structural elements
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shared between long- and short-chain scorpion toxins and insect defensins, which 
showed identical pairings'of three disulphide bonds. A similar observation was made by 
Tamaoki et al., (1991), who proposed the cystine stabilised a-helix motif (CSH) 
(Kobayashi et al., 1991). The group noted a consensus pattern of Cys-X-X-X-Cys 
disulphide-bonded to a second conserved motif, Cys-X-Cys in scorpion- and honeybee- 
ion channel toxins, producing a parallel alignment of the peptide backbones in these 
regions. These consensus sequences were also conserved in mammalian endothelins and 
snake sarafotoxin, with the exception that the cystine pairings were reversed, generating 
antiparallel alignment of the backbones. The Cys-X-X-X-Cys motif was contained 
within an a-helical segment whilst Cys-X-Cys was located on an extended p-strand. A 
search of protein databases (Tamaoki et al., 1998) showed that this cysteine framework 
was present in a number of additional proteins, including serine proteinase inhibitors, 
insect and plant defensins, and members of the growth factor family. In all proteins 
containing this cysteine pattern, and which had known 3D structures, the CSH motif 
was preserved, with the exception of the cystine knot growth factor super family (in 
which a third disulphide penetrates the cyclic structure formed by the CSH disulphides, 
disrupting the orientation of an a-helix). In peptides containing different cysteine 
spacing, no conformational preferences linked with the formation of an a-helix were 
observed. This disulphide pattern was proposed to be critical for the correct folding of 
CSH-containing peptides.
It has been noted that plant y-thionins, human endothelins, snake sarafotoxins, insect 
and scorpion defensins, short and long chain scorpion neurotoxins, and the bee venom 
toxins apamin and mast cell degranulating (MCD) peptide are all basic peptides which 
alter membrane permeability. Despite different mechanisms of action, they share high 
affinity of binding to their relative receptors (Froy and Gurevitz, 1998). The authors 
speculate as to the evolutionary origins of the CSH motif, which could have arisen 
through divergent evolution of a common ancestor, or have arisen independently on one 
or more occasions.
The CSH motif connecting an a-helix to a double or triple stranded P-sheet, as 
commonly seen in scorpion toxins, is often referred to as the (cysteine-stabilised) oc/p 
fold.
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The Cystine Knot
The conserved cystine framework of the CSH motif is also present in the cystine knot 
motif. Members of this family possess an additional disulphide bond, which penetrates 
the ring structure formed by the other four cystines, forming a ten membered cystine 
knot (McDonald and Hendrickson, 1993). This motif occurs in growth factor cystine 
knot proteins (Isaacs, 1995 and Sun and Davies 1995), the cycleotides (Craik et al., 
1999), and in the small inhibitor cystine knot proteins (Pallaghy et al., 1994). In a 
growth factor cystine knot, the penetrating disulphide is Cysl-Cys4. In the cases of the 
inhibitor cystine knot and the cyclic cystine knot, the ring is formed by the first 2  bonds 
(1-4 and 2-5) and the third disulphide (3-6) passes through this (Pallaghy et al., 1994). 
The inhibitor cystine knot (IKC) is common in toxic and inhibitory peptides including 
some conotoxins and spider toxins (Qu et al., 1997) and appears to be able to support 
various pharmacological activities.
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1.4 Bee Venom
Much of the early work on bee venom has been discussed by Habermann, 1972; for a 
more recent review see Strong and Wadsworth, 2 0 0 0 . Of relatively simple composition 
when compared to many other venoms, that of the honey bee (Apis mellifera) contains 
approx. 70% protein (dry weight), with lesser quantities of carbohydrates, amino acids 
(Nelson and O’Connor, 1968) and phospholipids. A number of biogenic amines, 
predominately histamine, are present and may contribute to the initial pain felt 
following a bee sting. Dopamine and noradrenaline are also present (Owen, 1971), their 
concentrations varying according to age and season (Owen and Bridges 1982).
The major enzymatic components are phospholipase A2 (PLA2) and hyaluronidase 
(Habermann, 1972 and references therein), which act as spreading factors. Acid 
phosphomonoesterase, glycosidase and lysophospholipase activities are also present 
(Shkenderov and Koburova, 1979) in lower quantities. The PLA2 acts as an indirect 
lytic agent, causing the release of lysolecithin from lecithin (Habermann, 1972 and 
references therein). Interestingly, the phospholipase is found exclusively in worker bee 
venom, and is almost absent in that of queen bees (Kuchler et al., 1989).
PLA2 would appear to act in synergy with another cell membrane lytic factor, melittin, 
which has a direct cytolytic effect. Melittin (Habermann, 1972 and references therein) is 
the main constituent of bee venom. Its amphipathic nature gives the peptide detergent­
like properties. As a result of its general lytic action, melittin brings about a wide range 
of pharmacological effects. This peptide is an inhibitor of a number protein kinases 
(Dudkin et al., 1983; Raynor et al., 1991) and is a potent anti-inflammatory agent. To 
protect the bee from the lytic effects of melittin, the peptide is secreted into the venom 
sac as a propeptide (Kreil and Bachmayer, 1971; Kindas-Mugge, 1979) before being 
cleaved to form the mature peptide (Kreil et al., 1980). Two other forms of the peptide 
are present, a N-terminal formylated variant (Lubke et al., 1971) and a smaller quantity 
of a partially degraded melittin known as melittin F (Gauldie et al., 1976, 1978).
Aside from melittin, several small, basic, neurotoxic peptides are contained in the 
venom. Apamin, mast cell degranulating peptide, tertiapin and secapin are disulphide- 
bridged peptides sharing a similar structure of a p-tum covalently linked to an a-helix 
by one or two disulphide bonds (Hider and Ragnarsson, 1981). The first of these,
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apamin, is an 18 residue highly basic C-terminally amidated neurotoxin, containing two 
disulphide bonds, and is an inhibitor of small conductance calcium-activated potassium 
channels. This peptide will be discussed in more detail later.
MCD peptide (mast cell degranulating peptide or peptide 401) (Breithaupt and 
Habermann, 1968) is even more basic than apamin and was named for its ability to 
release histamine from mast cells, which occurs without cell lysis (Fredholm, 1966; 
Jasani et al., 1979). The peptide has also been shown to have potent anti-inflammatory 
action (Winter et al., 1962; Hanson et al., 1972; Billingham et al., 1973). Of particular 
note was its anti inflammatory effects in a rat model of arthritis, a condition which 
apitherapy has long been claimed to alleviate (Newbould, 1963). Like apamin, MCD 
peptide is a centrally acting neurotoxin (Habermann, 1977; Bidard et al., 1987; 
Gandolfo et al., 1989). These neurotoxic effects can be attributed to its ability to 
suppress the activity ofK vl.l channels (Stuhmer, et al., 1988).
Tertiapin was first isolated 30 years ago (Gauldie et al., 1976). It has been shown to 
have presynaptic activity (Ovchinnikov et al, 1980), originally suggested to be due to 
its binding to calmodulin (Dudkin et al., 1983). More recently, the peptide’s ability to 
block inwardly rectifying potassium channels (discriminating between GIRK1/4 
/ROMK and IRK1) (Jin and Lu, 1998) and to selectively inhibit muscarinic potassium 
channels (KAch)in cardiac monocytes, (Kitamura et al., 2000) have been demonstrated.
Unlike the other bee venom neurotoxins, secapin (Gauldie et al., 1976) contains only a 
single disulphide bridge and little is known about its pharmacology. Interestingly, the 
peptide is far more abundant in the venom of queen bees than in that of the workers 
(Vlasak and Kreil, 1984), raising intriguing questions as to secapin’s functional role.
Adolapin, a larger (approx 11100-11500 Da) basic polypeptide with anti-inflammatory 
and analgesic properties has also been isolated from honey bee venom (Shkenderov and 
Koburova, 1982; Koburova et al., 1985). Although other peptides, procamine A, 
procamine B and minimine (named for its ability to produce miniature flies from 
Drosophila larvae) have been reported (Nelson and O’Connor, 1968; Lowy et al., 
1971), subsequent studies have failed to repeat these findings (Gauldie et al., 1976).
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In humans, the pharmacological effects of envenomation are generally local ones. 
Histamine acts upon nerve endings and small blood vessels, causing pain and swelling; 
hyaluronidase permeabilises connective tissue, acting as a spreading factor; MCD 
peptide releases more histamine; phospholipase increases capillary permeability and 
produces lytic agents, which in conjunction with melittin, cause general tissue damage 
and liberate further active substances, e.g. potassium, histamine and serotonin.
Hymenoptera are, however, responsible for more deaths than any other venomous 
creature (Gueron et al., 2000). This is not a direct effect of the venoms, but due to 
hyperimmunity leading to anaphylactic shock in hypersensitive individuals. Multiple 
allergens would appear to be present, IgE from hypersensitive patients recognising 
several venom proteins. Opinions vary as to which is the major allergen, with patients 
showing varying reactivity, although PLA2, hyaluronidase, acid phosphatase and 
melittin would all appear to play a significant role (Shkenderov, 1974; Hoffman and 
Shipman, 1976; Light et al., 1976; Sobotka et al., 1976; Hoffman et al., 1977; Pauli et 
al., 1977; Kemney et al., 1984; Kettner et al., 1999). Further components, e.g. Api m 6 , 
allergen B and allergen C (Hoffman, 1977; Kettner et al., 2001), have been isolated on 
the basis of their immunogenic properties. It has been postulated that some of these 
allergens are not components of the venom per se, but are proteolytic fragments from 
larger structural and membrane proteins.
Research into bee venom thus has three main foci. As demonstrated by recent progress 
in identifying ion channel targets of tertiapin, despite 30 years of research the venom is 
still yielding novel pharmacological tools. Continuing progress is being made in the 
identification and synthesis of bee venom antigens required for effective venom 
immunotherapy. Finally, apitherapy has long been associated with alleviation of 
symptoms of a number of autoimmune conditions. More research is required into the 
validity of such treatment, and into the components responsible for its effects, in order 
to provide synthetic and recombinant alternatives, and to reduce the risk of anaphylactic 
side effects.
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1.4.1 Apamin
Apamin is an 18 amino acid toxin and a minor active component of A  mellifera venom. 
Apamin intoxication seems to produce symptoms specific to the central nervous system. 
When purified apamin was injected into mice, it led to convulsions, followed by 
respiratory distress and death (mouse LDso ~ 2.05 mg/Kg i.p.) within 2-4 hours 
(Shipolini et al., 1967; Lallement et al., 1995). Sub-lethal doses gave rise to 
hyperexcitable mice over a 24hr period. Direct injection into the spinal cord gave 
similar, but local effects. In general, the toxin has an excitatory effect on the CNS and is 
the only toxin known to be able to pass through the blood-brain barrier.
Nanomolar concentrations of apamin specifically block a potassium current, activated 
by an increase in free intracellular calcium concentration, in a variety of cell types. This 
includes currents in neuronal and in non-neuronal cells (Cook et al., 1983). The toxin 
acts on the external side of the channel carrying these currents, disassociating when 
internal potassium concentration is high, suggesting the block is via a simple plugging 
mechanism.
Apamin was successfully radiolabelled by Habermann and Fischer, 1979 and purified 
mono [125I]apamin was characterised by Hugues et al., 1982c. The radiolabelled toxin 
was initially used to look at the distribution of acceptors in whole organisms, showing a 
concentration of acceptors in the spinal cord (Vincent et al., 1975). Later, 
autoradiographic studies using the toxin showed the acceptor to be heterogeneously 
distributed in the brain. Areas containing a large proportion of glial cells showed low 
levels of labelling (Mourre et al., 1986), suggesting that, in the brain, receptors are 
located primarily on neurons within the cerebellum.
A specific binding site for radiolabelled apamin was identified on rat skeletal muscle 
cells (Hugues et al., 1982a; Hugues et al., 1982c); and apamin binding sites were 
identified on membranes, whole cells and cultured cell lines prepared from a wide range 
of both neuronal and non-neuronal tissues (refer to table 4.1). These studies strongly 
implied that the apamin acceptor was a component of the SK channel, since binding 
occurred at a single class of binding sites on tissues expressing these channels.
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Apamin was the first specific probe for a potassium channel. It binds specifically tp 
SKI, SK2 and SK3 (although it has far lesser affinity for SKI: - Kd hSKl = 390pM; Kd 
hSK2 = 4pM; KdrSK3 = llpM, Grunnet et al., 2001; Finlayson et al., 2001) and has no 
effect on BK or DC. The identification of apamin as a ligand of the SK channel has 
provided valuable information on the quantity and distribution of these channels and 
provided a ligand to aid in their purification (Schmid-Antomarchi et al., 1984; 
Lazdunski et al., 1985; Seagar et al., 1987; Sokol et al., 1994).
Studies using apamin have also provided structural information on the channel. For 
example, apamin cross-linking studies proved the channel to be a heteroligomer and 
suggested the presence of SK channel (3-subunits. Apamin binding assays, and 
radioimmunoassays using anti-apamin antibodies were used to suggest the presence of 
an endogenous apamin-like factor in mammalian (porcine) brain (Fosset et al., 1984). 
They have helped to identify additional SK channel ligands, e.g. P05 (Sabatier et al., 
1993), scyllatoxin (Sabatier et al., 1994), T sk  (Legros et al., 1996), BmP05 (Romi- 
Lebrun et al., 1997), maurotoxin (Kharrat et al., 1997), Pil (Fajloun et al., 2000c) and 
tamapin (Pedarzani et al., 2002). Strong and Evans, 1987, used internalisation of 
radiolabelled apamin into liver endosomal membranes to provide evidence for receptor- 
mediated endocytosis of toxins. Apamin has notable effects on behaviour. It improves 
cognition, memory and learning in mice (Messier et al., 1991; Deschaux et al., 1997; 
Deschaux and Bizot, 1997; Ikonen et al., 1998; Van der Staay et al., 1999; Fournier et 
al., 2001) and decreases their appetite (Ghelardini et al., 1997). The toxin is therefore 
used as tool in the study of these behaviours and in the understanding of, and 
development of treatment for, various behavioural, psychiatric and memory disorders.
The sequence of apamin was determined by two independent groups (Shiponlini et al., 
1967; Callewaert, 1968 and also Haux et al., 1967). The peptide is highly basic, with 
only one hydrophobic amino acid and a net charge of three, and the C-terminal carboxyl 
group is amidated (Gauldie et al., 1976).
H-Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2
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Analysis of the primary sequence, circular dichroism (CD) conformational studies and 
nuclear magnetic resonance (NMR) studies (Busetta, 1980; Bystrov et al., 1980; 
Freeman et al., 1986; Pease and Wemmer, 1988) predicted a tertiary structure (fig 1.5) 
containing a CSH motif. This structure, an a-helical core and two p-tum regions linked 
by Cysl- Cysll and Cys3 - Cysl5 disulphide bonds, is very resistant to changes in 
solvent polarity, pH, addition of denaturants and even chemical modification of side 
chains. The compactness and thermodynamic stability of the peptide have led to its use 
as a model, e.g. to examine structure-antigenicity relationships (Defendini et al., 1990), 
for analysis of disulphide linkages (Gray, 1993) and in the testing of structural 
algorithms (Sun 1995).
Two residues, Argl3 and Argl4, seem crucial for activity (Vincent et al., 1975; 
Albericio et al, 1984). Substitution of one of these residues by lysine maintains 80% of 
biological activity (Granier et al., 1978). Activity is lost, however, on substitution by 
ornithine or homoarginine (Cosland and Merrifield, 1977), the distance between the 
positive charges being critical (Granier et al., 1978). Bisquatemary neuromuscular 
blocking agents, e.g. tubocurarine, gallamine and decamethonium compete for apamin 
binding sites. All of these molecules contain two positively charged nitrogens separated 
by approx 11 A, comparable to Argl3 and Argl4 in apamin (Cook and Haylett, 1985). 
This motif has been proposed as the SK-channel pharmacophore (Cook and Haylett, 
1985; Galanakis et al., 1995, 1996, 2004). These positive residues are thought to 
interact with complementary negative residues on the apamin receptor, the binding 
augmented by hydrophobic interactions between the receptor and the side chains of 
these residues (Demonchaux et al., 1991; Labbe-Jullie et al., 1991). The single 
negatively charged residue of apamin (Glu7) is located on the opposite side of the 
molecule. This produces a high dipole moment, which may contribute to the precise 
positioning of the toxin in the receptor (Ciechanowicz-Rutkowska et al., 2003). The 
differences in sensitivity of the SK channels to apamin have been shown to be 
influenced by residues in the pore region (Ishii et al., 1997a).
The apamin cDNA precursor has been identified (Gmachl and Kreil 1995). This 
precursor (preproapamin) has both a signal peptide (19 amino acids) and a propeptide (8 
amino acids) preceding the mature peptide sequence. As would be expected from the 
amidation of the C-terminal His, an additional Gly is present at the C-terminus of the 
precursor. This signal peptide and propeptide region is identical to that of MCD peptide,
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and the cDNA sequences of this region and the 5’untranslated region (UTR) show 85% 
identity. The 35 ends are completely identical. This is because the two toxins reside in 
tandem on a single gene. This gene has six exons in the following order: three exons of 
the MCD precursor, two exons of the apamin precursor and a final exon common to the 
mRNA for both toxins. This final exon represents the final six residues of apamin and 
3’UTRs for both toxins (see fig 1.6).
For reviews on apamin and its relationship with SK channels, see Habermann, 1984; 
Lazdunski et al., 1985; Castle et al., 1989 and Strong, 1990.
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Fig 1.5 Structure of Apamin
A)
NH
B)
ARQ13
ARG14
ASN2
YS4
ARGli
ARG14
ASN2
YS4
A) Ribbon structure (Freeman et al., 1986).
B) Stereoview of apamin, showing positions of the two arginines critical for 
binding. Image was created, using the coordinates of Pease and Wemmer, 1988, 
in Protein Explorer (http://molvis.sdsc.edu/protexpl/frntdoor.htmy
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Fig 1.6 Apamin Gene Structure
<
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introns as lines. For the RNA sequences the mature toxin sequence is in a solid box, the signal and pro- peptide regions are shaded and the UTRs 
are solid lines. Figure derived from the data of Gmachl and Kreil, 1995.
1.5 Scorpion Venom
Scorpions (class arachnida) are the oldest living arthropods, evolved over 400 million 
years. The largest scorpion species (e.g. genus Pandinus) may be 20cm in length, 
although the majority of scorpions are much smaller. Their bodies are composed of 18 
segments terminating in a teardrop shaped telson that contains the venom glands, which 
produce potent pharmacologically active peptides. Scorpions also possess two anterior 
pincer-like pedipalps. In general terms, the bigger the pedipalps, the less dangerous the 
sting.
Scorpions are very robust. They can withstand desert or freezing conditions for weeks 
and months of starvation. Generally, scorpions are nocturnal opportunistic predators. 
Their diet is mostly comprised of insects and other arthropods, although they also eat 
isopods and gastropods, and the larger species may feed on small reptiles and mammals 
(Keegan, 1998). Cannibalism has been noted in scorpions kept in close confinement 
under laboratory conditions.
All known scorpion species possess venom, which is used both defensively and to 
attack and immobilise prey. Of approximately 1500 scorpion species only about 25 
(mostly in the Buthidae family) are capable of causing human fatalities. Those 
scorpions considered to be of medical importance have been described by Keegan, 
1998, and include Androctonus australis in North Africa, Leiurus quinquestriatus in 
North Africa and West Asia, Parabuthus spp in South Africa, Tityus bahiensis and 
Tityus serrulatus in South America, Centruroides limpidus and Centruroides suffuses in 
Central America, Centruroides sculpturatus in North America and Mesobuthus tamulus 
in Asia.
1.5.1 Scorpion Sting
The scorpion telson consists of two portions, the swollen ampulla and the slightly 
upturned sharp hollow spine or sting. When the scorpion is in defensive/offensive pose, 
the abdomen is curved back over body, so that the sting points forward. Towards the tip 
of the spine are two oval openings (aculeus) for venom release. Each opening has its 
own venom duct leading from one of a pair of venom glands located, either side of the
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mid-line, in the ampulla. Each gland is covered in a sheet of muscle (the compressor 
muscle) on its dorsal and medial sides, which squeezes the venom through the ducts and 
out of the aculeus. This contraction, and the extent of the contraction, is entirely under 
the voluntary control of the scorpion. The structure of the venom glands of 
Heterometrus longimans has been studied in detail by Gopalakrishnakone, 1995 (see fig 
1.7).
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Fig 1.7 Scorpion 
A)
A) Spine with opening of venom duct, scanning electron micrograph xlOO.
B) Scanning electron micrograph of cross section of telson (xllO). The venom glands 
(V) are surrounded by the cuticle (C) and the skeletal compressor muscle (S). The 
venom glands are lined with glandular epithelia. Despite great differences in the effect 
of the sting, the microscopic structure o f the telson and venom gland tissue appears 
almost identical between species. The lumen o f the venom gland, however, ranges from 
smooth to highly folded, depending upon species.
Venom Apparatus, (from Gopalakrishnakone, 1995)
64
1.5.1.1 Symptoms of Scorpion Sting
Scorpion venoms can be toxic to insects, amphibians, crustaceans and mammals. 
Scorpion envenomation is a common and life threatening public health problem in 
many parts of the world, particularly Africa, Asia and South and Central America. In 
Mexico there are over 200,000 cases of scorpionism annually, and approximately 700 
deaths (Dehesa-Davila and Possani, 1994). Brazil records 10,000 cases per annum 
(Alvarenga et al., 2002) and, in Tunisia, 30,000 to 45,000 incidents are reported 
annually, of which 1000 are severe and 35-105 fatal (Krifi et al., 1996). Indeed, in some 
regions more deaths are caused by scorpion sting than by snakebite.
Symptoms of scorpion envenomation vary widely depending on offending species, but 
can broadly be divided into two categories. The sting of most scorpions is harmless and 
less painful than a bee sting. In the severest of cases in this category, discolouration, 
severe pain, oedema and sweating may last for several days. These symptoms remain 
localised to the site of the sting, however, and severe pain is often an indicator of a good 
clinical prognosis. Envenomations in the second category also produce initial pain at the 
site of the sting. These local symptoms are mild and short lived, however, being rapidly 
replaced by the systemic effects characteristic of severe envenomation and possibly 
leading to death. There is a broad spectrum of severity within these two categories. The 
effects of the sting depend upon scorpion species, season of sting, age of scorpion and 
victim, and size of victim. Children are particularly vulnerable to severe prognosis.
The effect of clinical and experimental envenomation by a wide range of scorpions has 
been reviewed in detail by Ismail, 1995. The severe symptoms affect many systems and 
include both hyper- and hypo-tension, increased activity of the secretory glands 
(sweating, hypersalivation, lacrimation), CNS effects (hyperirritability, focal and 
generalised seizures, hemiplegia, hyperthermia and hypothermia, shivering, 
hyperirritability), cardiac arrhythmia, cyanosis and renal failure. Fatality is usually due 
to cardiac or respiratory failure complicated by pulmonary oedema. These symptoms 
are characteristic of a generalised stimulation of both the sympathetic and 
parasympathetic nervous system, with the sympathetic effects dominating. Hassan and 
Mohammed, 1940, first proposed that the effects of scorpion envenomation were due to 
powerful stimulation of the autonomic nervous system. This is via a massive rise in 
circulating catecholamines and acetylcholine in a process termed ‘autonomic storm’.
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Ismail, 1995 also noted that changes in serum electrolyte concentration (hyponatremia, 
hyperkalemia, hypocalcaemia and hypomagnesaemia) contributed to the cardiac effects 
of the venom. This was concluded to be partly due to catecholamines causing release of 
potassium from the liver (and possibly due to high K+ levels in prevenom, Inceoglu et 
al., 2003), but also associated with opening of Na+channels and block of Kca.
In mild but painful stings, localised pain is caused by liberation of serotonin and kinins 
causing continuous stimulation of C-fibres, and also by direct stimulation of nerves by 
the venom. The absence of local pain at the site of the sting in severe envenomations is 
due to peripheral vasoconstriction and hypoxia due to elevated circulating 
catecholamines.
Antivenoms are available for many scorpion venoms, although their effectiveness is 
debated. Treatment is often a combination of antivenom therapy and symptomatic 
treatments, although the recommended treatments vary according to species.
1.5.2 Scorpion Venom Composition
Scorpion venom is a tasteless, odourless, slightly acidic liquid. The initial drops are 
colourless (prevenom), the subsequent ones translucent (venom) (Caius and Mhaskar, 
1932). The venoms are typically a mixture of mucus, inorganic salts, oligopeptides, 
nucleotides, amino acids, low molecular weight organic molecules and a number of 
proteins, but as the symptoms of scorpion sting vary widely between scorpion species, 
so does the composition.
The venoms with high toxicities are the most widely studied. Unlike snake venoms, for 
example, most of the high-toxicity scorpion venoms lack, or have only low, enzyme 
activity. A few enzymes have been isolated, however, e.g. hyaluronidases from T. 
serrulatus (Pessini et al., 2001). These scorpion venoms alter neuronal action potentials 
and cause release of neurotransmitters from cholinergic and adrenergic neurons. This is 
due to the presence of low molecular weight, basic, neurotoxic peptides that act upon 
ion channels and have pre-junctional effects on synaptic transmission. Most of the 
neurotoxins are selective for voltage-activated sodium channels of excitable cells,
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prolonging action potentials and causing spontaneous neuronal firing. In addition, minor 
components act selectively on voltage-gated or calcium-activated potassium channels.
A few studies have been carried out on black scorpions belonging to the scorpionidae. 
These scorpions are generally formidable looking, with large pincers, but their sting is 
not fatal, instead producing intense localised pain. Of this type of scorpion, the Venoms 
from Heterometrus scaber (Nair and Kurup, 1975), H  longimcms and Heterometrus 
spinifer (Gwee et al., 1993, 1996, 2003; Nirthanan et al., 2002) are the most studied. 
These venoms have a direct, post-junctional, agonist effect on muscarinic M3 
cholinoceptors and a-adrenoceptors. The venoms appear to lack significant sodium or 
potassium channel blocking activity. Instead, noradrenaline and/or acetylcholine are the 
major venom components, accounting for the direct noradrenergic and cholinergic 
agonistic effects of the venoms when applied to rat muscle. It is proposed that the 
acetylcholine acts as an algesic, and noradrenaline is responsible for the potent 
vasoconstrictive effects of these venoms, helping to localise and intensify the effects of 
the algesics. Histamine has been isolated from Heterometrus gravimanus, adding to the 
symptoms of pain, burning and itching (Ismail et al., 1995). Unlike in the more toxic 
scorpions, these less dangerous species have significant enzyme activities. PLA2 is a 
major component of the venom from Heterometrus fulvipes (Ramanaiah et al., 1990), 
and H. scaber venom contains significant quantities of acid phosphatase, 5’- 
nucleotidase, phospholipase A2, acetylcholine esterase and the spreading factor 
hyaluronidase.
Sometimes identical peptides may be present in venoms from different, but closely 
related, species of scorpion, e.g. kurtoxin from Parabuthus granulatus and Parabuthus 
transvaalicus (Olamendi-Portugal et al., 2002); butantoxin from T. serrulatus, T. 
bahiensis and Tityus stigmurus (Holaday et al., 2000).
1.5.3 Scorpion Venom Ion Channel Neurotoxins
The main pharmacological components, and hence the majority of those identified, are 
small peptides acting on ion channels, or peptides with sequence homology to known 
ion channel toxins. The venoms contain multiple classes of ion channel toxins specific 
for different targets. This specificity is twofold. Most of the toxins are highly specific
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for a particular class of ion channel (e.g. sodium channel selective) and often a 
particular channel subtype. Scorpion toxins also show a large degree of host specificity, 
with different toxins targeting mammals, insects and crustaceans found in a single 
venom.
All known scorpion ion channel toxins are single-chain polypeptides, between 23 and 
80 residues in length, and bridged by two to four disulphide bonds. Most known 
examples contain the CSH motif (see 1.3.1). Their primary targets are voltage-gated 
sodium channels (generally modifying the gating kinetics), and potassium channels, Kv 
and Kca in particular (usually by a direct block of the pore). Although abundant in 
spider and cone snail venoms, calcium channel toxins are rare in scorpions and are of 
variable size. Toxins affecting chloride currents exist in scorpion venoms, but their 
mode of action is poorly characterised.
Scorpion neurotoxins are often divided into two groups based on molecular weight* The 
short-chain toxins contain 23-41 amino acids cross-linked by two, three or four 
disulphide bridges, and are active on a wide range of channel types (K+, Cf and some 
Ca2+ channel toxins fall into this category). The sodium channel toxins (and a few 
recently discovered K+ channel toxins) are contained within the long-chain scorpion 
toxins. These peptides are between 60 and 80 residues in length and have four 
disulphide bonds.
Together, the neurotoxins act to prolong the action potential and cause repetitive firing. 
They are generally of higher toxicity than snake neurotoxins. Scorpion ion channel 
toxins have been classified and reviewed by Possani et al., 2000. The authors divided 
the scorpion ion channel toxins into 26 families, although for the sake of simplicity a 
less complex classification has been adopted in this work.
1.5.3.1 Sodium Channel Toxins
Much of the toxicity of scorpion venoms has been attributed to their action on sodium 
channels. For this reason, and due to their often-high abundance in the venom, scorpion 
sodium channel toxins are well studied (Gurevitz et al., 1998; Possani et al., 1999; and 
Martin-Eauclaire and Rochat, 2000). These toxins are 60-76 amino acid peptides
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containing four disulphide bridges and exert their pharmacological effect by altering the 
opening or closing of the voltage-gated sodium channel responsible for the depolarising 
phase of the action potential in nerve, muscle and heart. The scorpion Na+ channel 
toxins have traditionally been grouped according to host specificity: those active on 
vertebrates (mammalian Na+ channel toxins) and those active on invertebrates (insect 
Na+ channel toxins). For a more detailed classification, based upon sequence homology, 
host specificity and mode of action, refer to Possani et al., 1999.
The ‘mammalian5 toxins all increase Na+ influx into cells. Two groups (a-and P) are 
distinguished by their site of action on the sodium channel. These toxins share a similar 
structure of a short a-helical segment and a three-stranded antiparallel p-sheet. Two 
disulphides link the secondary structure, a third bridge links the N-terminus and the C- 
terminus, and the final bridge links the loops. It has been proposed that differences in 
these loop regions determine the differences in a- and P-toxin activities (Fontecilla- 
Camps et al., 1980), and a hydrophobic region on one face of the toxin has been 
implicated in the high-affinity binding of the toxins to their targets (Fontecilla-Camps et 
al., 1980). Although initially characterised as mammalian toxins, some members of the 
a- and P-toxin families show insect activity.
a-Scorpion toxins were the first to be purified and characterised (Miranda et al., 1970). 
They are the main toxic components of the venoms of ‘Old World5 scorpions from 
Africa and Asia (e.g. Androctonus, Buthus and Leiurus species). Four such toxins 
(AaHI-AaHTV) together account for 90% of A. australis venom mammalian toxicity, 
but represent only 3% of the composition (Martin and Rochat, 1986). a-Toxins have 
also been isolated from New World scorpions, e.g. T. serrulatus (Barhanin et al., 1982; 
Vijerberg et al., 1984), though they are present at far lower abundance and have a lower 
affinity for their receptors. a-Toxins prolong the action potential by slowing sodium 
channel inactivation (Jover et al., 1980; Catterall, 1988; Kirsch et al., 1989). They exert 
this action via receptor site 3 of the Na+ channel a-subunit, specifically a site formed by 
the extracellular S3-S4 loops of domains I and IV (Tejedor and Catterall, 1988; 
Thomsen and Catterall, 1989; Rogers et al., 1996), in a voltage dependent manner 
(Catterall, 1979; Jover et al., 1980).
Since these early studies, a number of toxins (a-like toxins) have been isolated with a- 
toxin-like primary sequence and insect toxicity (Gordon et al., 1996; Possani et al.,
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1999). They-too slow Na+ channel inactivation, characterised by a contractile paralysis 
in the insect, and bind to similar, but non-identical, sites on Na+ channels of insects and 
mammals (Eitan et al., 1990; Borchani et al., 1996). The selectivity of a- (and a-like) 
toxins for insect or mammalian receptors, and for distinct mammalian Na+ channel 
subtypes, have been reviewed by Gordon and Gurevitz, 2003.
The main components responsible for mammalian toxicity in the venoms of ‘New 
World scorpions’ (e.g. Centruroides and Tityus species) are also sodium channel toxins, 
increasing Na+ influx. These (3-toxins exert their effect by shifting the voltage- 
dependence of activation to more negative potentials (Cahalan, 1975; Couraud et al., 
1982; Yatani, et al., 1988), leading to spontaneous and repetitive firing of action 
potentials. They bind to a different sodium channel receptor site from that of a-toxins 
(Couraud et al., 1982) in a voltage-independent manner. This binding region (receptor 
site 4) is located on the S3-S4 extracellular loop in domain II of the Na+ channel a - 
subunit (Cestele et al., 1998). Like a-toxins, p-toxins do not act exclusively on 
mammalian channels. The main toxic component of T. serrulatus (Tsy or TsW , 
Possani et al., 1981; Ceard et al., 1992) additionally binds to the insect sodium channel 
with high affinity (Pauron et al., 1985; De Lima et al., 1986, 1989), possibly because of 
its high structural flexibility (Loret et al., 1990). A toxin that is active against 
crustaceans and has a P-like sequence has been isolated from Centruroides noxius 
(Garcia et al., 1997). The differences between this and an archetypal P-toxin are 
concentrated on a surface region that is hence proposed to be involved in species 
specificity.
The potency of scorpion venoms in insects is largely due to Na+ channel toxins, which, 
unlike the ‘mammalian’ toxins, are exclusively selective for insects. These toxins are 
structurally distinct from their mammalian-active counterparts and can essentially be 
classified according to their opposing paralytic effects.
Zlotkin et al., 1972 described the first scorpion insect toxin (AaHIT, A. australis), 
reporting an immediate contractile paralysis caused by repetitive firing of insect 
motomeurons, and due to a shift in the voltage-dependence of activation and a reduction 
in deactivation of the Na+ channel (Walther et al., 1976; Lester et al., 1982; Pelhate and 
Zlotkin, 1982). The binding of this ‘excitatory insect toxin’ is non-voltage dependent 
and shows high selectivity for insect over mammalian sodium channels (Gordon et al.,
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1984). This specificity may be due to the rigid structure of the toxin, imparted by a 
different disulphide pairing to that seen in the mammalian toxins (Darbon et al., 1982; 
Loret et al., 1990). Structural studies on excitatory insect toxins have led to the proposal 
that the C-terminus region forms part of a putative bioactive surface important for insect 
specificity (Darbon et al., 1991; Froy et al., 1999a).
The depressant insect toxins (e.g. Bj IT2, Bothotus judaicus, Lester et al., 1982) share 
their disulphide pairing with the mammalian Na+ channel toxins and are reviewed by 
Zlotkin et al., 1993. They are specific for insects and block action potentials, causing a 
slow flaccid paralysis (Zlotkin, 1983; Zlotkin et al., 1985). This paralysis is preceded by 
a transient contraction, similar to that seen with the excitatory toxins (Zlotkin et al., 
1991; Benkhalifa, 1997). The excitatory and depressant toxins bind to distinct binding 
sites, in close proximity to one another on the extracellular loops of domains I, in, and 
IV of the insect sodium channel (Goudet et al., 2002).
In 1991, Loret et al., isolated AaHiT4 from A. australis Hector. This toxin competes for 
binding sites with both a- and p-type mammalian scorpion toxins and also insect Na+ 
channel scorpion toxins, and is proposed to be an ancestral scorpion toxin.
1.5.3.2 Scorpion Potassium Channel Toxins (KTx).
The other well-studied group of scorpion venom components is the potassium channel 
toxins (KTx) (Garcia et al., 1995; Harvey et al., 1995; Rodriguez de la Vega and 
Possani, 2004). They are minor venom components (each having a far lower abundance 
than the Na+ channel toxins) that increase cell excitability by potassium channel block. 
These molecules are basic peptides containing three or four disulphide bridges. 
Although most known scorpion KTx are 30-40 amino acids in length, long-chain 
scorpion potassium channel toxins (approx 60-65 amino acids) and peptides as small as 
22 amino acids (Srinivasan et al., 2002) have been isolated in more recent years.
The first scorpion potassium channel toxin to be purified was noxiustoxin from C. 
noxius venom (Carbone et al., 1982; Possani et al., 1982). This toxin inhibited 
potassium currents in the squid giant axon, in a voltage-independent manner, without 
altering the gating kinetics. In the ensuing years, several homologous scorpion venom
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peptides were isolated that blocked either voltage-gated (Kv) or calcium-activated (Kca) 
potassium channels. Miller, 1995 grouped the known scorpion KTx peptides in a single 
family (a-KTx) divided into three subfamilies based upon sequence similarity (a- 
KTxl-3, containing charybdotoxin-like, noxiustoxin-like and kaliotoxin-like sequences 
respectively). The last decade has seen a dramatic increase in the a-KTx family and the 
nomenclature was expanded by Tytgat et al., 1999; Goudet et al., 2002 and Batista et 
al., 2002, to include a total of eighteen subfamilies, currently encompassing about 75 
peptides active on Kv, or SK, IK, or BK subtypes of Kca channels.
Since 1995, three further families have been added to the nomenclature. The P-KTx 
family consists of the long-chain potassium channel toxins, of which four have been 
identified (Legros et al, 1998; Zhu, 1999). They contain 60-64 amino acids but only 
three-disulphide bridges.
The y-KTx family contains the ergtoxins, active on the ether-a-go-go-related gene 
(ERG) potassium channels (Gurrola, 1999a). Twenty-six such peptides have been 
identified to date. It is hoped that, in the same way that a-KTx have been beneficial in 
the study of Kv and Kca channels, the ergtoxins will prove vital tools in the 
understanding of their associated channels and in therapeutic drug design.
A potassium channel toxin that became the founding member of the k-KTX family has 
recently been identified in H. Julvipes (Srinivasan et al., 2002). K-Hefixtoxin differs from 
previously identified KTx peptides. It does not share the common CSH motif, but has 
two antiparallel a-helixes joined by a loop region and linked by two disulphide bonds. 
Regions of (3-sheet structure appear to be absent. In common with other KTx, the action 
of k-hefutoxin on Kvl.3 and Kvl.2 appears to be via occlusion of the pore. However, 
unlike other KTxs, this toxin is also able to alter the gating of Kvl.3 currents, slowing 
the kinetics of activation. Since this is the first potassium channel toxin identified in a 
Heterometrus species, it is unclear whether this toxin family is present in all scorpions 
or if it is characteristic to the venom from this non-lethal scorpion family.
The traditional model of potassium channel toxin binding was based on the interactions 
of charybdotoxin, iberiotoxin and noxiustoxin with their targets. It predicted the toxins 
fitting snugly in the rim of the pore and physically plugging the mouth of the selectivity 
filter. The minimum requirement for functional block of K+ channels was proposed to
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be a ‘functional diad’ of a lysine and an aromatic residue 6.6A apart (Dauplais et al.,
1997). Further studies on the interactions of various KTx and their acceptors showed 
that this model was not applicable in all cases. For a detailed discussion of these studies, 
and recent proposals on the interactions of KTx with their targets, see Rodriguez de la 
Vega et al., 2003; Xu et al., 2003; and Rodriguez de la Vega and Possani, 2004. 
Although all these toxins (aside from K-hefutoxin) appear to produce functional block 
by physically occluding the channel pore, the precise nature of this block, and the 
toxin’s orientation in the channel outer vestibule appear to vary (see fig 1.8).
See Rodriguez de la Vega and Possani, 2004, for a list of the known and putative 
scorpion K+ channel scorpion toxins identified to date.
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Fig 1.8 Models for KTx-channel Interactions
This figure is adapted from recent models of KTx-channel interactions presented by 
Rodriguez de la Vega et al, 2003 and Xu et al., 2003. The approximate locations of 
residues critical for the interaction are marked in red (O), and the position of the toxin 
p-tum region is marked in blue (X).
A) Pore block. The interaction of residues on the P-hairpin containing surface of toxins 
in a-KTx 1-3 subfamilies, with residues located close to the selectivity filters of their 
respective targets (Kvl.x and K call), is firmly established (Goldstein et al., 1994). In 
this model, the toxin sits inside the outer vestibule, with its a-helix facing away from 
the pore. Surface interactions involve residues in the channel’s selectivity filter, pore 
helix, and in the ‘turret’ region (the S5-S6 extracellular loop). The interaction between 
a-KTx 3.2 and the Shaker channel is illustrated.
B) Intermediate-type block. In this model, the toxin sits slightly further out of the 
channel mouth, with its alpha-helix orientated towards the channel. Surface interactions 
involve residues at the base of the outer vestibule and in the ‘turret’ region of the 
channel, and residues in the a-helix of the toxin, (as opposed to the P-tum). This type of 
interaction is seen in the binding the a-KTx5 subfamily and a-KTx 4.2 to Kca2.x 
channels (Auguste et al., 1992; Lecomte, et al, 1999; Shakkottai, 2001; Cui et al., 2002). 
The interaction between a-KTx5.3 and Kca2.2 is illustrated.
C) Turret block. The HERG channel appears to contain an extra a-helix in the S5-pore 
linker (Liu et al., 2002; Pardo-Lopez et al., 2002, 2002a), producing an extended 
‘turret’. Ergtoxins are thought to interact with a more external region of the channel 
than seen in the other models. The toxin is proposed to have ‘two heads’, a hydrophobic 
and a hydrophilic patch in separate regions of the toxin, which interact with the turret a- 
helix and the channel vestibule respectively. This block of the outer region of the pore 
allows the flow of residual current. The illustrated interaction is based upon a docking 
model of the interaction between ergtoxin (y-KTxl. 1) and HERG (Xu, et al., 2003).
D) The structures of the selectivity filter (# )  and outer vestibule (< ) of two of the pore 
forming KcsA subunits are illustrated for orientation purposes.
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Fig 1.8 Models for KTx-Channel Interactions
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1.5.3.3 The Short Insectotoxins
In the late 1970s and early 1980s, a group of toxins were isolated from the scorpion 
Buthus eupeus that were active on insects, but smaller than the already well-documented 
long-chain insect sodium channel blockers (Ovchinnikov, 1984 and references therein). 
The toxins were named ‘short’ insectotoxins and related protein or cDNA sequences 
have since been isolated from five other scorpion species. Compared to the long-chain 
insectotoxins, this group of molecules is poorly characterized. Less than 15 have been 
identified to date, including toxin variants: chlorotoxin from Leiurus quinquestriatus 
quinquestriatus (Debin and Strichartz, 1991; Debin et al., 1993) (and cDNA sequence 
variants from Leiurus quinquestriatus hebraeus, Froy et al., 1999); Lqh-8/6 from the 
same venom (Adjadj et al., 1996, 1997); Bs 8, Bs 14 (Ali et al., 1998) and peptide 1 
(Fazal et al., 1989) from Buthus sindicus; Be 15A and Bell from Buthus eupeus 
(Grishin, 1978; Lomize et al., 1991); AmmP2 from Androctonus mauretanicus 
mauretanicus (Rochat et al., 1979); PBITxl from Parabuthus schlechteri (Tytgat et al.,
1998); and Bm-12 (Wu et al., 2000) and BmKCT (Zeng et al., 2000) from Buthus 
martensii Karsch.
The short insectotoxins are basic polypeptides (net charge +2 to +5) of 34-38 residues, 
cross-linked by four disulphide bridges. The cysteine positions are highly conserved 
(consensus sequence ...CX2CX10CX2CCX5.7CX3-4CXCX,,) and, as in the excitatory 
insect toxins, the fourth and fifth cysteine residues are adjacent. NMR structures have 
been determined for 15A (Arseniev et al., 1984), chlorotoxin (Lippens et al., 1995) and 
Lqh-8/6 (Adjadje et al., 1997). Disulphide bridges are formed between Cysl-Cys4, 
Cys2-Cys6, Cys3-Cys7, Cys5-Cys8 and cross-link one a-helix and three p-sheets. The 
extra disulphide bridge, when compared to K+ channel toxins, joins the free N-terminal 
P-sheet to the rest of the molecule.
The most studied of the short insectotoxins is chlorotoxin, which has been reported to 
block colonic epithelial and glioma-specific chloride ion channels (Debin and 
Strichartz, 1991; Debin et al., 1993; Ullrich et al., 1995). Gelatinase A (Matrix 
metalloproteinase 2, MMP-2) activity has also been demonstrated for this toxin 
(Deshane, et al., 2003). These epithelial and glioma chloride channels are unlikely to be 
chlorotoxin’s natural target, however. The group of peptides is neurotoxic to 
crustaceans and insects, although this insecticidal activity is weak when compared to
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long-chain counterparts (Rosso and Rochat, 1985). Indeed, only one short insectotoxin 
has had its natural target investigated; BeIT5A is believed to be active on the insect 
postsynaptic glutamate receptor (Grishin et al., 1980, 1982).
1.5.3.4 Toxins Active on Ca2+ Channels
Although they have been discovered more recently than Na+, K+, and Cl" toxins, a few 
scorpion peptides active upon Ca2+ channels have been reported. Three types of toxin 
affect ryanodine receptors, whilst a fourth type is active on voltage-gated calcium 
channels.
The ryanodine receptor is involved in excitation-contraction coupling in skeletal muscle 
and forms part of a complex with the L-type voltage-dependent calcium channel 
(dihydropyridine receptor, DHPR). Ryanodine is a plant alkaloid that binds specifically 
to the open state of the lyanodine receptor.
Imperatoxin A from Pandinus imperator (IpTxA, Valdiva et al., 1992; Zamudio, 1997) 
and maurocalcine from Scorpio maurus palmatus (MCa, Fajloun et al., 2000a), are 
highly homologous (82%), 33 amino acid, basic peptides which affect ryanodine 
receptors. Three ryanodine receptors have been identified which differ in their 
sensitivity to IpTxA. Maximum IpTxA sensitivity is seen for RyRl, with RyR3 being 
less sensitive. In contrast, RyR2 is not significantly affected by the toxin (Simeoni et al., 
2001; Nabhani et al., 2002). Both toxins increase ryanodine binding to the ryanodine 
receptor (presumably via their ability to stabilise the channel into long lasting, voltage- 
and concentration dependent, subconductance states, Tripathy et al., 1998; Eteve et al., 
2003), increase the rate and amplitude of Ca2+ release in developing skeletal muscle and 
promote Ca2+ release from SR vesicles (Valdiva et al., 1992; El-Hayek et al., 1995; 
Gurrola et al., 1999; Samso et al, 1999; Nabhani et al., 2002; Chen et al., 2003). MCa 
appears to alter the Ca2+ sensitivity of the channel, since the toxin increases the 
sensitivity of ryanodine binding to low (stimulatory) levels of Ca2+ and decreases the 
sensitivity of binding to high (inhibitory) Ca2+ levels.
Single site image analysis revealed that IpTxA binds distal to the channel pore, 
supporting an allosteric mode of action (Samso et al, 1999). Both IpTxA and MCa
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contain a cluster of basic peptides (KKCKRR) also present in domain A (IM I loop) of 
the voltage-sensor subunit (Cava l.l)  of DHPR. The exact role of this domain is unclear, 
but it seems to be essential for the physical coupling to RyRl and also enhances 
ryanodine binding. Arg24 of maurocalcine, contained within this conserved region, is 
critical for MCa-RyR interaction (Esteve et al., 2003). Gurrola et al., 1999 showed that 
domain A and IPTxA activate RyRs in a similar manner and would appear to compete 
for a common binding site on the channel. It has been proposed that the 3D surface of 
the two toxins mimics that of DHPR domain A (Green et al., 2003). However, MCa and 
domain A have different effects on channel gating, suggesting different mechanisms of 
channel modification (Chen et al., 2003).
MCa is the first scorpion toxin to show the inhibitor cystine knot motif, also present in a 
number of other non-scorpion toxins active on voltage gated calcium channels (0 - 
conotoxins and p-agitoxins) (Mosbah et al., 2000). Projecting from this compact core is 
a double-stranded antiparallel p-sheet, with an extended strand perpendicular to the p- 
sheet. Given the high sequence homology of MCa and IpTxA, it is likely that they have 
similar overall structure. However, despite the sequence homology of the two toxins, 
they do not produce identical effects, since they have distinct subconductance states 
(Gurrola et al., 1999; Simeoni et al., 2001). Therefore minor structural differences in 
the toxins may give rise to them stabilising slightly different channel conformations. 
Both of these toxins represent useful tools in the study of the ryanodine receptor, and of 
excitation-contraction coupling.
Imperatoxin I (Zamudio et al., 1997a), also from Pandinus imperator, is a heterodimer 
of ~12kDa and ~3kDa, linked by a disulphide bond. It inhibits ryanodine binding and 
blocks the RyR channel. The larger subunit has phospholipase A2 activity and it is likely 
that the toxin’s effect on the Ca2+ channel is an indirect effect due to liberation of fatty 
acid.
BmK-PL from B. martensii Karsch also seems to exert its effects on the RyR by an 
indirect mechanism (Kuniyashi et al., 1999). Stimulation of RyR activity and an 
increase in ryanodine binding was seen with partially purified, but not with purified, 
ryanodine receptors. The authors suggest triadine, an associated molecule in the 
receptor complex, to be the site of BmK-PL action.
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Chuang et al., 1998 screened scorpion venom for activity directed against aicT-type 
calcium channels expressed in Xenopus oocytes and identified kurtoxin from Parab. 
trcmsvaalicus. The primary sequence classified kurtoxin as an a-scorpion toxin and the 
peptide showed a-toxin activity, binding to sodium channels and slowing their 
inactivation. Subsequent studies revealed the toxin to modify the gating of native P- 
type, N-type and L-type Ca2+ currents, in addition to T-type currents (Sidach and Mintz, 
2002). The nature of these gating modifications was specific to channel type. An 
identical peptide has been isolated from the related scorpion Parab. granulatus (KLII, 
kurtoxin-like II), together with KLI, which differs by 6 amino acids (Olamendi- 
Portugal., et al 2002). Both toxins bind to T-type Ca2+-channels and cardiac Na+- 
channels.
1.5.4 Other Scorpion Venom Peptides
Insect defensins are antimicrobial peptides found in the haemolymph, which interact 
with lipid bilayers or proteins in them, altering the membrane permeability and causing 
cell death. These peptides share the CSH motif with scorpion toxins. The presence of 
this structural motif in insect defensins led to the proposal that insect defensins and 
scorpion toxins could derive from a common ancestor. 4kDa homologues of insect 
defensins (scorpion defensins), with antibacterial properties, have been found in the 
haemolymph of L. quinquestriatus (Cociancich et al., 1993). Further evidence for an 
evolutionary relationship between the two classes of compounds was provided by the 
isolation of a cDNA encoding a scorpion defensin-like peptide from the venom gland of 
B. martensii (Zhu et al., 2000). In terms of primary sequence, cysteine pattern and RNA 
structure, the scorpion defensins show similarity to the scorpion long-chain potassium 
channel toxins.
A second group of scorpion venom antimicrobials are the scorpines (Conde et al., 2000; 
Zhu and Tytgat, 2004). Like the scorpion defensins, they have three disulphide bridges, 
but are significantly longer (75 amino acids). They appear to be hybrid molecules; the 
N-terminal segment resembles some cecropins, whilst the C-terminal region resembles 
some defensins.
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A number of scorpion venom antimicrobial and antifimgal peptides that do not contain 
disulphide bridges have been isolated, e.g. pandinin 1 and 2 (P. imperator, Corzo et al.,
2001), IsCT {Opisthacanthus madagascariensis, Dai et al., 2001), parabutoporin, and 
opistoporinl and 2 {Parab. schlechteri and Opistophtalmus carinatus, Moerman et al.,
2002). They are polycationic, a-helical, pore-forming peptides and have been likened to 
the magainins (antimicrobial peptides from frog skin, Zasloff, 1987). Although they all 
demonstrate antimicrobial activity, these scorpion peptides vary markedly in their size 
and primary structures.
Other linear pharmacological peptides isolated from scorpion venoms include the 
bradykinin-potentiating peptides, e.g. peptide K12 {Buthus occitanus, Meki et al., 1995), 
believed to act via ACE (angiotensin-converting enzyme) inhibition, and peptide T {T. 
serrulatus, Ferreira, et al., 1993), which is only 13 amino acids long. Even smaller are 
the tetrapandins, tetrapeptides isolated from P. imperator venom via their ability to 
inhibit store-operated Ca2+ entry in human embryonic kidney cells (Shalabi et al., 2004).
There are a number of ‘orphan’ scorpion venom peptides. These are either native 
peptides with no-known function (e.g. Pi7, P. imperator, Delepierre, 1999, and BmKnl, 
B. martensii, Zeng et al., 2001a) or peptides which have been deduced from cDNA 
sequences, but show little sequence homology to known scorpion venom components 
(e.g. BmAPl, B. martensii Zeng et al., 2002, Zhu and Li, 2002). In the case of the 
native peptides, these may have an, as yet undefined, function or they may prove to be 
the degradation products of larger bioactive components (as is the case with IsCTf, 
Opisthacanthus madagascariensis, Dai et al., 2002).
1.5.5 Scorpion Venom cDNA and Genes
Scorpion toxin cDNAs typically encode a single precursor containing the mature 
peptide and a signal peptide of approx. 18-28 amino acids, which is removed by post- 
translational processing. This signal peptide is often highly conserved within groups of 
related toxins. The C-terminal also often undergoes C-terminal modification, involving 
the removal of one or two residues from the C-terminus with, or without, amidation of 
the new terminal residue. Scorpion defensins, the long-chain potassium channel toxins
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and the bradykinin potentiating peptide BmKbpp all contain a short propeptide between 
the signal peptide and the mature toxin (Zhu et al., 1999; Zeng et al., 2000a).
The first complete scorpion toxin genomic sequence to be reported was that of T. 
serrulatus toxin gamma (Becerril et al., 1993). The data from this, and the subsequent 
sequencing of other scorpion toxin genes, led to the proposal of a universal scorpion 
toxin gene structure (Becerril et al., 1995; Corona et al., 1996). This model describes a 
gene comprised of one intron and two exons. Exon 1 includes the 5’ non-coding region 
and the region encoding the first two-thirds of the signal peptide. An intron splits a 
cordon in the signal peptide sequence and the second exon encodes the final third of the 
signal peptide, the mature toxin and the 3’ non-coding region. The size of the intron 
varies from approx. 80-100bp in the short chain toxins to over 400bp in the long chain 
toxins.
Although most known scorpion venom peptides conform to this model, a few 
exceptions have been noted. Scorpion defensin genes and those encoding the ryanodine 
receptor toxins BmKAs and BmKASl are intronless (Zhu et al., 1999; Lan et al., 1999). 
The scorpine gene family has two large introns, the first in the 5’ UTR and the second at 
the boundary of the mature-peptide coding region (Zhu and Tytgat 2004a). The long- 
chain potassium channel toxin BmKTxP also contains two large introns. The first is 
>997bp and is located in the signal peptide sequence, the second (886bp) is located in 
the mature peptide sequence (Xiao et al., 2003).
1.5.6 Significance of Scorpion Venom Components
There would appear to be much redundancy in scorpion venom toxins. Why do 
scorpions need both Na+ channel and K+ channel toxins, when both cause membrane 
depolarisation? Why are there several examples of toxins having a very similar site and 
mechanism of action, e.g. several sodium channel a-toxins, in a single scorpion venom? 
The work of Miller, 1995 and of Inceoglu et al., 2003 presented possible answers to the 
former question.
It has been postulated (Miller, 1995) that K+ and Na+ channel toxins work cooperatively 
to produce a depolarised state. The author proposed that since the K+ channel toxins are
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non voltage-dependent, initial block of repolarising potassium currents promotes a 
depolarised state conducive to the voltage-dependent binding of the Na+ channel toxins, 
which are then the primary cause of catastrophic effects of envenomation.
It has long been documented that the first few drops of scorpion venom (prevenom) are 
different in appearance to the main venom and that this change from a transparent, to an 
opaque and viscous, secretion occurs in successive stings. Recently Inceoglu et al., 2003 
showed this prevenom to have a different composition to the main venom. The study 
revealed prevenom to be rich in potassium salts and almost totally devoid of the sodium 
channel toxins that account for the majority of the lethality of the main venom. The 
authors propose the conservative use of the metabolically expensive venom by 
scorpions. In this hypothesis the prevenom is used when the scorpion is not in a life- 
threatening situation, to deter predators or immobilise small prey. It is envisaged that 
the high extracellular K+ causes significant long lasting pain due to localised 
depolarisation. This effect is potentiated by the block of voltage-gated potassium 
channels delaying recovery of the membrane potential. Only when necessary does the 
scorpion inject the metabolically expensive venom, containing the highly toxic sodium 
channel blockers.
Much of our knowledge of K+ channels is the result of a combination of the use of high- 
affinity probes isolated from animal venoms, particularly those from scorpions, and the 
molecular cloning and expression of these channels. Scorpion toxins were essential for 
the determination of the tetrameric nature of voltage-activated potassium channels 
(MacKinnon, 1991) and charybdotoxin was vital to the identification of the pore region 
(MacKinnon and Miller, 1989). Pardo-Lopez et al., 2002, used ergotoxinl and site 
directed mutagenesis of HERG to deduce the presence of a previously unknown 
segment of a-helix in the channel. Scorpion toxins are useful in the purification of 
native ion channels, and in determining subunit composition, molecular structure, and 
the functional role of ion channels. The role of scorpion toxins in the study of ion 
channels is discussed by Garcia and colleagues (Garcia et al., 1998, 2001). Due to their 
compact, well-defined structure, scorpion peptides also make ideal model peptides in 
the study of peptide folding (e.g. Khandelwal et al., 2000).
Studies using toxin chimeras show that different sequences can be attached to the basic 
scorpion toxin CSH scaffold, altering functional properties whilst maintaining structural
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integrity. There is, therefore, the potential to engineer biologically active sites onto this 
stable scaffold, with implications for de novo drug design. This principle was tested by 
Vita et al., 1995. The group were able to engineer a functional metal binding site onto a 
charybdotoxin scaffold. Peptides engineered in this way may be more resistant to 
degradation than those without the scorpion toxin core.
AaH IT is highly potent and highly specific for insect sodium channels. There has been 
much interest in the use of this toxin, and other insect-selective scorpion toxins, as 
biodegradable, selective insecticides that are non-toxic to mammals. Studies on AalT 
and similar toxins, and their potential as an aid to pesticide design have been reviewed 
(Gurevitz et al., 1998; Zlotkin et al., 2000).
Several scorpion sodium channel peptides have been reported to have anti-nociceptive 
effects in animals. The therapeutic potential of such peptides and their promise as tools 
for the study of pain have been discussed (Goudet et al., 2002). Traditional Chinese 
medicine used scorpion stings for relief of paralysis and spasms. Scorpion ion channel 
toxins therefore have potential use not only in the design of novel therapeutics, but also 
in the investigation of the underlying causes of ion channel disorders.
Venom components, other than ion channel toxins, may also have therapeutic potential. 
Bradykinin-potentiating peptides may prove useful models in the design of 
antihypertensive agents. With increasing antibiotic resistance there is an urgent need for 
novel antimicrobials. The defensins and the linear antimicrobial peptides present in both 
the venom and in the haemolymph of scorpions have therefore generated much interest, 
as templates for the next generation of antibiotics. The antimalerial property of such 
peptides has also generated interest. Possani et al., 2002, have assessed their potential 
use in the creation of transgenic, malaria-resistant, mosquitoes.
Less than 1% of the estimated 100,000 peptides believed to be present in the combined 
venoms of all scorpion species have been identified (Possani et al., 2002). The main 
focus of studies to date has been the identification and characterisation of the major 
toxic components and in particular those components active on ion channels. More 
recently peptides with novel pharmacological properties have been discovered and it is 
envisaged that these minor, non-ion channel blocking agents will be the focus of a 
rapidly expanding field of research in the next decade.
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1.6 Mesobuthus famulus (formally Buthus famulus or Buthotus famulus)
There are 86 scorpion species in India, of which two are of medical note, the Asian 
giant forest scorpion Heterometrus swammerdami (also found throughout South East 
Asia) and the Indian red scorpion Mesobuthus tamulus (Mahaddevan, 2000). Mesob. 
famulus (fig 1.9) is a small (65-90mm) scorpion, with insignificant pedipalps and one of 
the most poisonous venoms known (mouse LD50 = 3.65 mg/kg, Ramachandran et al., 
1986). Left untreated, stings from this species are often lethal and there is no effective 
anti-venom (Kankonkar et al., 1998).
There are approximately 12 reported cases of red scorpion envenomation per month in 
India, with reports of 1-5% fatality, increasing to 15% in children (Bawaskar, 1982, 
1999; Bawaskar and Bawaskar, 2003). The fatalities occur predominately in the state of 
Maharashtra. Most stings are reported at night and incidence of stings is seasonal, 
dramatically increasing in summer months.
Like that of all dangerous scorpions, the venom of Mesob. tamulus is a potent stimulator 
of the autonomic nervous system causing a rise in circulating catecholamines. It slows 
down the inactivation of sodium currents and induces repetitive firing of action 
potentials (Siemen and Vogel, 1983; Rowan and Harvey, 1996). A number of studies 
have investigated specific physiological effects of the venom in animal models (Murthy 
and Hossein, 1986; Murthy et al., 1988; Murthy and Medh, 1989; Murthy et al., 1991; 
Deshpande et al., 1999).
The currently recommended treatment of scorpion sting in India is nifedipine (a slow 
calcium-channel blocker which uncouples excitation-contraction, causing smooth 
muscle relaxation, and relieving the pressure on the heart and lungs) plus prazosin (a 
selective inhibitor of post-synaptic a-adrenergic receptors, blocking the action of 
catecholamines), a treatment that is readily available, cheap and effective (Bawaskar, 
1999; Bawaskar and Bawaskar, 2003). Sodium nitroprusside, hydralazine, captopril, 
and digoxin are also administered as vasodilators. Since most victims are stung in rural 
locations, by the time medical treatment is obtained, symptoms have often progressed 
past the stage where antiserum treatment, if available, would be effective. Bawaskar, 
1999, has reported a decrease in scorpion sting fatality from 30% (1977) to 1% (1993)
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with advances in treatment and provided an extensive review of clinical and 
pharmacological aspects of the venom of this scorpion.
Scorpion venom has already been shown to contain large numbers of specific toxins 
acting on a wide range of sodium and potassium channels. Compared to those of 
American and African species, the toxins produced by Asian scorpions are poorly 
investigated (with the exception of B. martensii from which over 80 peptides have been 
isolated Goudet et al., 2002). Chhatwal and Habermann, (1981) identified the presence 
of three distinct neurotoxic components of MW ~ 4400Da, ~7500Da and ~8000Da in 
Mesob. tamulus venom and in 1994, Lala and Narayanan partially sequenced a sodium 
channel toxin, neurotoxin Bt-II.
A few potassium channel toxins have been identified in this species. The most notable 
Mesob. tamulus toxin characterised is iberiotoxin (Galvez et al., 1990), a highly specific 
blocker of high-conductance calcium-activated potassium channels, which binds to the 
channel’s outer vestibule. It belongs to the aKTx 1.x subfamily, and is structurally 
related to charybdotoxin. Tamapin (Pedarzani et al., 2002) targets SK channels, and 
demonstrates high selectivity for SK2 over SKI and SK3. Indeed, it is the most potent 
inhibitor of SK2 identified to date, and was the founding member of subfamily 16 of 
aKTx. A toxin isoform (tamapin-2) differing in a single C-terminal residue has also 
been isolated from Mesob. tamulus venom. Tamulustoxin (Strong et al., 2001) and 
BTK-2 (Dhawan et al., 2003) are both Kv channel blockers. Tamulustoxin inhibits 
currents through Kvl.6 channels expressed in HEK293 cells. Although members of the 
aKTx family, tamulustoxin and its isoform tamulustoxin-2 (which differs by a single 
amino acid) are yet to be assigned a Ktx subfamily or a systematic number (Rodriguez 
de la Vega and Possani, 2004). BTK-2 falls into aKTx subfamily nine but, unlike other 
members of this subfamily (which are either non-toxic, or show weak SK channel 
activity), it is a weak blocker ofK vl.l.
In addition, a number of enzyme activities are present the venom, including 
phospholipase and hyaluronidase, although these activities are considerably lower than 
seen in Heterometrus bengalensis (Achyuthan et al., 1982). Indian red scorpion venom 
also contains at least four histamine releasing factors and one protease inhibitor 
(Chhatwal and Habermann, 1981).
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Fig 1.9 Mesobuthus tamulus
Photograph taken by Prof. P. Strong.
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1.7 Aims and Objectives
There were three main aims of the work presented.
a) Characterisation of the Mesob. tamulus venome, particularly with reference to small 
peptide components. The objective was twofold: -firstly to utilise immunological and 
mass spectrometric techniques to investigate possible regional differences in the venom 
composition of this scorpion species; and secondly to construct a mass profile of 
commercially available Mesob tamulus venom as a tool to aid in future isolation of 
specific venom components.
b) Use of molecular biology to identify short insectotoxin cDNA sequences derived 
from the telson of Mesobuthus tamulus. Mass spectrometry-guided purification would 
then be used to isolate one of the corresponding gene products from the venom itself. It 
was also envisaged that a similar molecular biology protocol would be used to provide 
evidence of the amidation status of the known Mesob tamulus venom peptide 
tamulustoxin.
c) Study of the functional implications of modifications to the well-characterised bee 
venom peptide apamin. Radioligand binding assays would be used to study the effects 
of an Asp2Ala substitution, and a consequential non-native disulphide bridged isoform 
on the interaction of the toxin with its acceptors on rat brain membranes. The same 
techniques would be used to examine the effects of labelling apamin with Alexa Fluor 
488.
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Chapter 2
VStudies on the Mesobuthus tamulus Venome, and Possible Regional
Variation Within it.
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2.1 Introduction
The proteomic analysis of venoms is increasingly seen as a useful tool in taxonomic 
analysis and has been proposed as a complementary method to morphology and 
behavioural characteristics for species and ultimately sub-species discrimination. The 
concept of the venome was described by Pimenta et al., 2003. Since venom contains a 
mixture of peptides and proteins secreted by a specific gland, analysis of venom 
components can produce a fingerprint that can be used as a reference for identification 
and classification of related specimens. Conversely, it can also be used to identify 
specimens that do not conform to this fingerprint and study the factors that affect venom 
variability.
Composition of animal venoms has previously been studied by a variety of methods 
including electrofocussing, gel electrophoresis, and liquid chromatography (Meier, 
1986; Williams, et al., 1988; Mendoza et al., 1992; Otero et al., 1998; Francischetti et 
al., 2000; Binford, 2001). Development of sensitive mass spectrometry techniques and 
advances in data processing capabilities (enabling the characterisation of complex 
mixtures of biomolecules) has, however, revolutionised the study of animal venoms and 
toxins. Mass spectrometry is now the tool of choice for venom profiling (e.g. Sweetman 
et al., 1992; Stocklin and Savoy, 1994; Jones et al., 1996; Roda et al., 1997; Escoubas et 
al., 2002; Dyason et al., 2002; Pimenta et al., 2003), having the advantages of increased 
accuracy, sensitivity and speed. The techniques require only small samples and, unlike 
some traditional taxonomic methods allow the use of live specimens.
In this study, we have chosen to investigate the venom fingerprint and composition of 
the Indian red scorpion Mesobuthus tamulus. Mesob. tamulus is present in West Bengal 
(Dasgupta et al., 1989), parts of Karnataka, Andhara Pradesh, and Tamil Nadu 
(Mahadevan, 2000; Bawaskar and Bawaskar 2003). This scorpion is also common in 
the state of Maharashtra. Kankonkar et al., 1998, showed differences in toxicity and 
neutralisation by antisera of commercial Mesob. tamulus venom obtained from HITRT 
(Haffkine Institute for Training, Research and Testing, Mumbai) and that obtained from 
ISCICS, (Irula Snake Catchers Industrial Co-operative Society Ltd., Madras), 
suggesting geographical variation. There is also evidence to suggest that Indian red 
scorpions found in different regions of the state of Maharashtra (fig 2.1) differ in respect 
to their venom (Kulkarni, D.G.; Haffkine Bio-pharmaceutical Corporation Limited
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(HBPCL), Pimpri, Pune, India. Personal communication). Antiserum raised against 
scorpions from Aurangabad does not effectively neutralise venom from scorpions of the 
Konkan coastal region. This Konkan venom is of considerably higher toxicity and 
antigenicity than the venom of Aurangabad individuals. This is reflected clinically with 
Bawaskar, 1999, reporting that, within the state of Maharashtra, fatal scorpion 
envenomations occur only in the Konkan region.
Geographical and individual variability in venom composition is important on a number 
of levels. Clinically it is crucial in the production of antivenom, in ascertaining a 
suitable dose and in understanding variation in clinical symptoms. There are obvious 
implications in taxonomy and venom research. With increasing numbers of studies on 
venom components, it is becoming increasingly important to accurately identify the 
venom of origin. Work presented in this chapter examines both the immunological- and 
protein- fingerprints of venom from individual scorpions collected from the two regions 
as an initial study on possible compositional differences.
Mesob. tamulus venom is not one of the most studied scorpion venoms, and no mass 
spectrometric studies have been carried out (although the masses of some purified 
toxins have been determined). A combination of chromatography and mass 
spectrometry was also used to examine the peptide mass profile of commercially 
available Mesob. tamulus venom. Identification of the masses present will aid in the 
detection of components with novel pharmacology and in The purification of existing 
toxins. Toxin-like molecules are increasingly being identified by cloning techniques; 
without the native protein, however, these molecules remain putative venom toxin 
components and cleavage sites from precursor peptides remain theoretical. A venom 
mass profile can provide evidence suggesting expression of the component, support 
proposed cleavage site locations and, by pinpointing appropriate masses to specific 
venom fractions, aid in the purification of the active molecule. The latter is of particular 
use in the absence of a suitable functional assay.
The aim of the work presented in this chapter was thus twofold. Firstly, it was intended 
as a preliminary study investigating possible differences in the immunology and 
composition of Mesob. tamulus venom collected from two geographical regions. 
Secondly, it was intended to use chromatographic and mass spectrometric techniques to 
construct a profile of the mass composition of Mesob. tamulus venom and the
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chromatographic distribution of the components. For ease of understanding, the studies 
on the different venoms will be referred to as mass fingerprinting, whilst the more 
thorough dissection of pooled venom will be referred to as venom profiling.
91
Fig 2.1 Location of the Two Mesobuthus tamulus Populations Studied
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Map of India showing location of Maharashtra state and (expanded view) Aurangabad 
district and the Konkan coastal region (incorporating Thane, Raigad, Ratnagiri and 
Sindhugurg districts). The Konkan region is a narrow strip just above sea level. It is 
hilly, with a tropical climate, and is separated from the semi-arid and rocky Deccan 
plateau (300-600m), on which Aurangabad is located, by the Sahyadri mountains 
(Western Ghats).
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2.2 Materials and Methods
2.2.1 Materials
Commercial pooled Mesob. tamulus venom was supplied by Haffkine Institute, 
Mumbai, India; antiserum was supplied by Haffkine Bio-pharmaceutical Corporation 
Limited (HBPCL), Pimpri, Pune, India. Leiurus quinquestriatus hebraeus (Lqh) and 
Pandinus imperator venoms were obtained from Latoxan, Paris, France. Solvents used 
for high performance liquid chromatography and mass spectrometry (acetonitrile, 
trifluoroacetic acid (TFA) and formic acid) were all of analytical grade or better and 
were filtered (0.45pm membrane filter) and degassed prior to use. For LC-MS, solvents 
were degassed on-line using helium. Water for HPLC was purified on an Elga system 
and, for LC-MS, HPLC grade water (Sigma-Aldrich, UK) was used. Standard peptide 
solution was a partially purified synthetic peptide supplied by Hallam Biotech, Sheffield 
Hallam University.
2.2.2 Harvesting and Preparation of Venom Samples
Red scorpions were collected from Ratnagiri and Chiplun (Konkan coastal region) and 
Aurangabad, in the state of Maharashtra, India. They were electrically milked and 
individual venom samples collected and freeze-dried. Single specimens of another 
Indian species (Heterometrus fulvipes) were obtained in a similar fashion.
Samples were extracted for lhr with lOOpl de-ionised water (acidified to pH3.0 with 
acetic acid), centrifuged at 12,500 xg for 30min to remove insoluble material and the 
supernatant retained. A further three extractions were performed on the pellet in further 
aliquots of lOOpl sterile acidified water, stored overnight at 4°C, and centrifuged as 
above. Extracts showing absorbance at 280nm were pooled for each individual. The 
final protein concentration was determined by the BCA assay, using BSA as standard, 
as described 4.2.2.3. Pooled freeze-dried venoms from Mesobuthus tamulus and the 
African species Pandinus imperator and Leiurus quinquestriatus hebraeus were also 
used. These venoms were extracted as above, using 20pl acidified water per mg venom 
in the initial extraction, aliquotted and stored at -20°C prior to use.
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2.2.3 Venom Fingerprinting
2.2.3.1 Development of an ELISA (Enzyme-Linked Immunosorbent Assay) Using 
Mesob. tamulus Antivenom and Assessing its Ability to Recognize Different Venom 
Extracts
Mesob. tamulus antivenom raised in horse, against a mixture of Aurangabad and 
Konkan scorpion venom, was used to perform a direct ELISA on Mesob. tamulus 
venom.
Initial experiments optimised the ELISA in terms of primary and secondary antibody 
concentrations using a range of pooled control venom concentrations. The final assay 
was carried out as follows: Venom was diluted to the appropriate concentration in 
carbonate/bicarbonate buffer (15mM NaCCV 35mM NaHCC>2, pH9.6) and lOOpl 
diluted venom per well was adsorbed onto a 96-well polystyrene microtitre plate 
(Falcon, Becton Dickinson, USA) overnight at 4°C. After washing once in phosphate 
buffered saline (Sigma-Aldrich, Poole) containing 0.1% Tween-20 (PBS-T), each well 
was blocked with 200pl PBS-T/ 5% foetal calf serum (FCS) for 2hr at 37°C and washed 
again with PBS-T. A 1:50 dilution (in PBS-T/ 5% FCS) of the antivenom was added 
(lOOpl per well), and incubated for lhr at 37°C before washing x3 in PBS-T. A HRP 
(horseradish peroxidase)-conjugated secondary antibody (rabbit a-horse whole 
molecule IgG affinity isolated peroxidase conjugate (Sigma)) was diluted 1:3000 in 
PBS-T/ 5% FCS and applied at lOOpl per well. After lhr at 37°C the plate was again 
washed 3 times in PBS-T. 3,3’, 5,5’-tetramethyl benzidine (TMB, Sigma) (50pl) was 
added to each well and allowed to develop in the dark (25min), before addition of stop 
reagent (Sigma) according to manufacturer’s instructions. The absorbance was read at 
450nm on a microtitre plate reader.
A standard curve was created using pooled control venom between 50ng/ml-10mg/ml in 
triplicate. A non-venom control was used as a blank, and this absorbance reading was 
subtracted from the other values before plotting. From this curve, a concentration of 
individual venom samples suitable for use in the assay could be determined.
In order to compare the ability of the antiserum to recognise the different individual 
scorpion venom extracts, lpg (lOOpl of lOjig/ml) of individual samples were adsorbed
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to an ELISA plate and probed as above. For comparison, the venom of a single 
individual of H. fulvipes, and commercially available L. quinquestriatus hebraeus 
venom, were also tested. As above, samples were tested in triplicate and a non-venom 
blank used, its absorbance value subtracted from that of the samples. The results were 
normalized against a Mesob. tamulus pooled venom control and plotted both 
individually, and pooled by scorpion type.
2.2.3.2 SDS-PAGE (Sodium Dodecyl Sulphate -  Polyacrylamide Gel 
Electrophoresis) and Western Blotting of Individual Venom Samples
SDS-PAGE and Western blotting (using the HBPCL antiserum) were performed on 
venom extracts from individual scorpions. A representative Konkan scorpion (K), 
Aurangabad scorpion (A), and a single individual of H. fulvipes (H) were used, as well 
as pooled commercially available L. quinquestriatus hebraeus (LQ) venom. Samples 
were run on both 4-20% Bis-Tris and 16% Tricine non-reducing gels, and the proteins 
visualized by Coomassie staining, silver staining and by Western blotting using the 
Mesob. tamulus antiserum used for the ELISA. Test gels were run in order to determine 
suitable quantities of sample required for each method (Bis-Tris silver: 0.2pg, 0.5pg, 
lpg K and A; 0.5jig LQ. Bis-Tris Coomassie: 5pg, 15|ig, 30pg K and A; 4pg, 15pg LQ. 
Bis-Tris Western blotting: 0.5pg, 2jig, 5pg K and A; 2pg LQ; 2pg H. Tricine silver: 
lpg, 5pg, 10jig K and A; 5jig, 10jig LQ. Tricine Coomassie: 5pg, lOpg, 20pg K, A and 
LQ. Tricine blotting: lpg, 5pg, lOpg K and A; 5pg, lOpg LQ; lpg H). Due to limited 
venom quantity, not all gels contained a H. fulvipes sample.
Bis-Tris [Bis (2-hydroxy ethyl) imino-tris (hydroxy methyl) methane-HCl] 
NuPAGE®
The NuPAGE® Bis-Tris discontinuous buffer system runs at neutral pH (c.f. pH8.8 for 
Laemmli system, Laemmli, 1970) which provides better stability of gel matrix and 
proteins resulting in a longer shelf life and better band resolution (Moos et al., 1988). 
Samples were prepared by heating in NuPAGE® LDS (Lithium dodecyl sulphate) 
sample buffer (106mM Tris-HCl, 141mM Tris Base/ 2% LDS/ 10% glycerol/ 0.5ImM 
EDTA/ 0.22mM SERVA® blue G250/ 0.175mM Phenol Red/ pH 8.5) at 70°C for
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lOmins prior to loading on a pre-cast Novex NuPAGE® 1 x 80 x 80mm Bis-Tris 4-12% 
acrylamide gel (Invitrogen, CA, USA). The gel was run in MES [2-(N- (N-morpholino) 
ethane sulphonic acid)] SDS running buffer (50mM MES/ 50mM Tris-Base/ 0.1% SDS/ 
ImM EDTA/ pH7.3) using an Xcell SureLock mini-cell system (Invitrogen) at 200V 
constant for 35min.
To allow molecular weight estimation, Markl2 unstained molecular weight standards 
(Invitrogen) were used. The components and apparent molecular weights were as 
follows: myosin (apparent MW 200 kDa), p-galactosidase (116.3 kDa), phosphorylase 
B (97.4 kDa), bovine serum albumin (66.3 kDa), glutamic dehydrogenase (55.4 kDa), 
lactate dehydrogenase (36.5 kDa), carbonic anhydrase (31 kDa), trypsin inhibitor (21.5 
kDa), lysozyme (14.4 kDa), aprotinin (6 kDa), insulin B chain (3.5 kDa) and insulin A 
chain (2.5 kDa).
Tricine SDS-PAGE
To allow for better separation of the small molecular weight peptides, venom samples 
were run using a modification of the Tris-glycine discontinuous buffer system 
(Laemmli, 1970) which substitutes Tricine for glycine in the running buffer (Schaegger 
and Von Jagow, 1987). Samples were heated for 2min at 85°C in Tricine SDS sample 
buffer (450mM Tris-HCl/ 12% glycerol/ 4% SDS/ 0.0025% Coomassie® blue G/
0.0025% phenol red/ pH8.45). These samples and a Mark-12 molecular weight standard 
(see above) were then run using Tricine SDS running buffer (lOOmM Tris Base/ 
lOOmM Tricine/ 0.1% SDS/ pH8.3) on a pre-cast Novex 1 x 80 x 80mm, 16% 
acrylamide Tricine gel (Invitrogen) at 125 V (constant) for 90min.
Staining Gels for Protein
Following separation by SDS-PAGE, venom proteins were stained using either a 
colloidal Coomassie blue stain (Gelcode colloidal blue stain reagent, Pierce, IL, USA) 
or a Silver staining kit (silver xpress staining kit, Invitrogen).
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Western Blotting of Venom Proteins
Venom proteins were separated by Bis-Tris or by Tricine SDS-PAGE as described 
above, and for each gel format the blotting protocol was optimised with regards to 
protein concentration, transfer time, and concentrations of both primary and secondary 
antibodies. The final optimised protocols are described. When running gels to be 
visualised by Western blotting procedures, SeeBlue^Ph^ pre-stained standards 
(Invitrogen) were used. The components and their apparent molecular weights in 
NuPAGE MES/ and Tricine buffer systems were as follows: myosin (188/ 210 kDa); 
phosphorylase B (98/ 105 kDa); bovine serum albumin (62/ 78 kDa); glutamic 
dehydrogenase (49/ 55 kDa); alcohol dehydrogenase (38/ 45 kDa); carbonic anhydrase 
(28/ 34 kDa); myoglobin (17/ 17 kDa); lysozyme (14/ 16 kDa); aprotinin (6/ 7 kDa); 
insulin (3/ 4 kDa).
For NuPAGE Bis-Tris gels: 0.45pm PVDF (polyvinylidine difluoride) membranes 
(Invitrogen) were pre-wetted for 30secs in methanol and rinsed in deionised water prior 
to equilibration in Bis-Tris transfer buffer (25mM bicine/ 25nM Bis-Tris free base/ 
ImM EDTA/ pH7.2) containing 10% methanol per gel. Proteins were transferred using 
an Xblot mini-cell system (Invitrogen) for lhr at 30V constant in the above transfer 
buffer. Transfer conditions for Tricine gels were 25V constant for l!4hr, using a Tris- 
glycine transfer buffer (12mM Tris base/ 96mM glycine/ pH8.3) containing 20% 
methanol.
Transferred membranes were blocked in 2% fat-free dried milk in PBS-T (50ml 
blocking solution per membrane) for 30-40mins with agitation. Primary antiserum 
(Mesob. tamulus antivenom from HBPCL, Pune, India) diluted in blocking solution 
(1:2500 dilution for blots from NuPAGE gels, 1:1500 for Tricine gel blots) was added 
to the membranes for lhr with agitation. After washing x4 in PBS-T (lOmin per wash) 
secondary antibody (rabbit a-horse whole molecule IgG affinity isolated peroxidase 
conjugate, Sigma-Aldrich) diluted 1:2000 (Bis-Tris) or 1:2500 (Tricine) in blocking 
buffer was added and the membranes agitated for lhr at RT. Excess antibody was 
removed by washing in PBS-T (four lOmin washes) and an enzyme chemoluminescent 
substrate (ECL+ plus Western blotting detection system, Amersham-Pharmacia, UK) 
added as per manufacturer’s protocol. Light emission was visualised using a UVP 
imager (UVP, UK) and the image captured using Labworks software (UVP, UK).
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2.2.3.3 Analysis of Individual Venom Samples by SELDI-TOF Mass Spectrometry
SELDI-TOF (surface-enhanced laser desorption ionisation-time of flight) mass 
spectrometry is a variation on the MALDI-TOF (matrix-assisted laser desorption 
ionisation - time of flight) technique. In its most common form (surface-enhanced 
affinity capture, SEAC), SELDI utilises chemically engineered chips to differentially 
capture proteins, prior to MALDI analysis. A variety of surfaces (e.g. hydrophilic, 
hydrophobic, metal affinity, cationic, anionic, antibody, DNA, enzyme, receptor) are 
available. The H50 protein chip binds proteins through a reverse phase or hydrophobic 
interaction mechanism and has binding properties similar to C6-C12 reverse phase 
resins. The NP20 chip has properties similar to normal phase chromatographic media
i.e. it primarily retains hydrophilic compounds. The sample is directly applied to this 
surface, and after a short incubation period, unbound sample washed away. A matrix 
solution (or EAM, Energy Absorbing Molecule) is applied and the sample analysed by 
the traditional MALDI-TOF technique.
Mass spectrometry is a three-step process which generally takes place under high 
vacuum. Sample molecules are ionised (in an ion source) to form ions, which are 
repelled out of the ion source and accelerated into the mass analyser, where they 
separate based on their mass-to-charge ratios (m/z). The path of the ions through the 
analyser is bent by a magnetic field, focussing ions of interest onto the detector. The 
ions strike the detector, where they are converted to an electrical signal.
Many types of ion source and mass analyser are available. Dependent upon the mode of 
ionisation, sample is applied in the gas phase, or converted either before, or during, the 
ionisation process. In the case of MALDI, desorption (conversion to the gas phase) and 
ionisation occur simultaneously. Sample and matrix are combined on the target and as 
the solvent evaporates, the matrix co-crystallises with the analyte. The matrix has two 
important properties. The first is its ability to form these composite crystals and the 
second is its ability to absorb energy at the wavelength of the laser. Upon laser 
illumination, analyte molecules are both vaporised and ionised (usually by protonation 
or deprotonation). The exact process by which this occurs remains unknown.
With a TOF (Time-of-Flight) mass analyser, the ions are accelerated by a pulsed 
potential into a field-free tube (drift region) where they move towards the detector. The
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ion’s velocity through this drift region is determined by its m/z value. Ions of a lower 
m/z ratio will have a higher velocity and reach the detector first. Thus, m/z can be 
determined by calculating the ‘time-of -flight’.
In collaboration with Dr Arun Armugam, National University of Singapore (NUS), 
SELDI-TOF protein profiling samples were run by a service facility at NUS. Briefly, 
venom extracts from individual Konkan (K) and Aurangabad (A) Mesob. tamulus 
specimens were examined by protein profiling on SELDI-TOF Proteinchip System II 
(Ciphergen, USA) using both a H50 hydrophobic chip and a NP20 hydrophilic chip 
(Ciphergen, USA). Single specimens of another Indian species (H. fulvipes) and of the 
African species P. imperator (P) were used as comparisons.
Samples (5pg) and standards (Protein MW Standards Kit, Ciphergen, USA) were 
spotted onto proteinchips, and incubated in a humid chamber for 30-40min before 
washing with PBS. Spots were air dried prior to addition of lpl matrix (saturated 
solution of sinapinic acid in 50% acetonitrile/ 0.1% TFA). This was air-dried, and the 
chips inserted into the instrument for analysis. Instrument parameters were as follows: 
NP20 chips- focus mass 10500Da; calibration set lOOppm; intensity 185V; sensitivity 
9V. H20 chips- focus mass 16000Da; calibration set lOOppm; intensity 195V; 
sensitivity 9V.
Mass fingerprints were determined using the software supplied by the manufacturers.
2.2.3.4 LC- Electrospray Ionisation Mass Spectrometry (LC/ESI MS) on 
Individual Venom Samples
ESI (Electrospray Ionisation) is another desorption/ionisation technique. The ionisation 
is produced by spraying a sample solution through a conducting capillary tube at a high 
potential. The spray results from the high voltage potential between the electrospray 
needle and the counter-electrode in the ion source housing, and is composed of 
multiply-charged droplets containing the sample. In ‘ion spray’ this spray is enhanced 
by nitrogen gas forced over the outer surface of the needle. Unlike in MALDI the 
ionisation occurs at atmospheric pressure and the ions pass through a series of reduced 
pressure chambers before entering the analyser. The ions generated are often multiply-
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charged, bringing larger proteins well within the m/z detection range. It is also a very 
gentle ionisation technique, producing little fragmentation of molecules. However, 
compared to MALDI, ESI is much more sensitive to salts, detergents, etc. Unlike 
MALDI, the ionisation is continuous, allowing ESI to be coupled to separation 
techniques such as capillary electrophoresis and HPLC.
LC/MS (Liquid Chromatography/Mass Spectrometry) links the effluent from a liquid 
chromatographic system (usually HPLC) to a mass spectrometer (normally with an ESI 
ion source). The technique allows on-line separation of complex mixtures prior to mass 
spectrometry. The chromatographic process can also allow for pre-concentration and 
removal of salts that would otherwise interfere with ESI. LC/MS can be used to look at 
a wide variety of biologically important compounds including peptides, proteins, 
oligonucleotides and lipids.
In order to minimise sample variation, ‘average’ Aurangabad (A) and Konkan (K) 
regional Mesob. famulus venom samples were created. Resulting A and K venom 
samples were comprised of equal quantities of all available individual venoms for each 
type (n=10, (K); n =6, (A)) made to a final protein concentration of O.lmgmf1. Lqh 
venom was also diluted to O.lmgml'1. To enable relative quantitative analysis, venoms 
were spiked with 0.01 mgmf1 of a standard peptide solution. To identify masses arising 
from this standard and from possible solvent contamination, 0.01 mgmf1 peptide 
standard and a sample-blank were analysed.
Direct on-line analysis of venom LC samples using an electrospray ion source and a 
quadrupole time-of-flight hybrid mass analyser was carried out. An Ultimate LC system 
(LC packings, Amsterdam) controlled by Chromeleon client software (Dionex) coupled 
on-line to an API QSTAR pulsarl (Applied biosystems) LCMS/MS system controlled 
by Analyst QS software (Applied biosystems) was used. 6pl samples were separated on 
a Dionex C l8, 3pm, 100A 1mm x 15cm Pepmap column (LC packings) at a flow rate of 
30pl min*1 using a 5-42% gradient of acetonitrile in 0.1% formic acid over 80min. 
Separation was followed using uv detection at 280nm and eluate introduced directly 
into the electrospray ion source. The mass spectrometer was operated in positive 
ionisation mode at 5000V, scanning over a mass range of 500-4000m/z. The ion source 
and curtain gas were at 40 and 25 respectively. The instrument was calibrated on
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service, and the calibration checked prior to sample run using a test solution of apamin 
(>0.01% accuracy).
2.2.3.5 LC-MS Data Analysis
All analysis was carried out using Analyst-QS software. Total ion current (TIC) 
chromatograms were produced for the sample run over m/z range 500-4000. The LC- 
MS peak reconstruct program, which uses isotopic and charge series from each scan to 
calculate component masses and their elution window, was applied to the data. A mass 
tolerance of 0.01% and a final mass range of 2000-10000 was used. The signal-to-noise 
ratio was set to 10, an intermediate value enabling the detection of nearly all chemical 
species in MS data, with virtually no false positives.
Data for components with a mass and elution time corresponding to those contained 
within the peptide standard sample were removed, and the remaining peak areas 
standardised against that of the main peptide standard component ([M+H]+ = 2463.7). 
Masses differing by -IDa were assumed to be products of either amidation or oxidation 
and, as such, their relative areas combined with that of the higher mass. Masses possibly 
representing adducts were noted, but retained. Relative areas of calculated masses were 
plotted to give mass fingerprints. Differences in A and K venoms were plotted by 
subtracting the relative area in K from the relative area in A for each mass.
2.2.4 Venom Profiling
Commercially available Me sob. tamulus venom was extracted, and fractionated by size- 
exclusion, ion exchange and reverse-phase chromatography. At each stage venom 
samples were tested by MALDI-TOF and/or LC-ESI mass spectrometry.
2.2.4.1 Size Exclusion Chromatography
2ml venom extract was loaded onto a 75ml Sephadex G50 column equilibrated in 
50mM ammonium formate, and run at ~40ml hr'1. 1ml fractions were collected,
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absorbance measured at 215 and 280nm, dried in a rotary evaporator and stored at 
-20°C. Prior to use, samples were reconstituted and pooled in the following groups: - 
lead peak (fractions 11-18), main peak (19-38), and trailing peak (39-55). ‘Main peak’ 
samples to be analysed by mass spectrometry were desalted using a C18-ziptip 
(Millipore) as per manufacturer’s instructions.
2.2.4.2 Cation Exchange Chromatography
The reconstituted, pooled, main peak from the size exclusion column was diluted until it 
had a conductivity approximating that of lOOmM ammonium acetate pH4.8. Ion 
exchange chromatography was performed at 1ml min'1 using a Pharmacia FPLC 
system. 20mg protein was filtered and loaded onto a Hiload 16/10 SP-sepharose fast 
flow 10cm x 1.6cm cation exchange column (Pharmacia) pre-equilibrated in the above 
buffer. A segmented gradient of 0-1M NaCl in lOOmM NaAc, pH4.8, was run as 
follows: 0-0.5M over 300ml, 0.5-0.7M over 40ml and 0.7-1M over 30 ml. The 
absorbance was followed at 280nm, and 2ml fractions collected. The profile was 
divided into eight sections, the fractions pooled within each section and stored frozen.
For illustrative purposes a 2mg sample was run on an AKTA HPLC system 
(Amersham-Pharmacia) using the column and conditions described above.
Samples to be analysed by mass spectrometry were desalted using Sep-Pak cartridges 
(Waters, Millipore), pre-conditioned as per manufacturer’s instructions and eluted with 
75% acetonitrile/ 0.1% TFA.
2.2.4.3 Reversed Phase HPLC
Ion exchange samples were fractionated by reverse-phase HPLC prior to mass 
spectrometric analysis. Separation was carried out on an AKTA system (Amersham- 
Pharmacia) using a Dynamax C18, 300A, 250 x 4.6mm, 5pm column at a flow rate of 
0.5ml min'1. 0.5mg non-desalted ion exchange samples were filtered through a 0.45pm 
membrane filter and injected onto the column, which was pre-equilibrated in solvent A 
(0.1% TFA). The column was washed until absorbance returned to baseline, and flow
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through and column wash pooled and retained for subsequent analysis. Samples were 
eluted using a linear gradient of solvent B (90% acetonitrile/ 0.1% TFA) i.e. 0-50% over 
12 column volumes. Effluent was monitored at 218 and 280nm and 1ml fractions 
collected and stored at 4°C. After testing by MALDI-TOF MS, remaining sample was 
frozen at -20°C to allow for possible future analysis.
2.2.4.4 Matrix-Assisted Laser Desorption/Ionisation Time-of-Flight Mass 
Spectrometry (MALDI-TOF MS)
Several sample preparation techniques and matrix solutions were tested. The best results 
were obtained using a saturated (lOmgml*1) solution of aCHCA (a-cyano-4- 
hydroxycinnamic acid) in 60% acetonitrile/ 0.3% TFA and the preparation techniques 
described below.
For size exclusion and ion exchange samples: lpl desalted fraction was diluted in lOjil 
matrix solution, 0.5pl spotted onto target and air-dried. Insulin and apamin standard 
solutions were prepared in an identical fashion using an initial concentration of 
lmgml'1.
For reverse phase samples: 50-200pl fractions were evaporated to dryness in a rotary 
evaporator (volume required was estimated from UV signal, and adjusted if poor 
ionisation obtained with MALDI). The sample was redissolved in lOpl matrix solution, 
0.5pi spotted onto target and air-dried.
For all samples, triplicate spots were analysed.
MALDI-MS analysis was carried out on a SAI LaserTOF LT1500 mass spectrometer 
(Scientific Analysis Instruments Ltd, Manchester, UK) with a 337nm nitrogen laser 
operated in the positive-ionisation mode under the control of LaserTOF (SAI Ltd.) 
software. Optimal results were obtained using a 20KV accelerating voltage, time 
delayed pulse extraction, a focus mass of 8500 and a data transfer rate of 1-0.8 sec. To 
obtain good spectra the laser power was automatically adjusted to near threshold for 
ionisation. The instrument was calibrated using porcine insulin (pVI+H]+=5773.6), data 
was collected in the range 2000-10000Da and the spectra averaged over 25 laser shots
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to overcome shot-shot variability. 5 spectra were collected for each sample. Since 
apamin has a similar structure to scorpion toxins and known mass within the range 
studied, a control apamin sample was run, which produced an accurate mass (+/- 0.1%).
MALDI peaks were assigned by eye with a clear inflection point on curve used as 
indication of a separate peak. The software calculated the mass at maximum peak height 
and these masses were noted. Masses from different spectra and samples were deemed 
to represent the same component if the variation was <0.1% and a mean mass was 
taken. Masses observed in less than three spectra from two different sample spots were 
discarded.
2.2.4.5 LC-MS
Samples were diluted to O.lmgml"1 protein and LC-MS was carried out as described 
previously (2.2.3.4), but without the addition of peptide standard solution. TIC spectra 
were created and peak reconstruction carried out as described (2.2.3.5). Masses 
differing by -IDa were assumed to be products of amidation and as such their relative 
areas combined with that of the higher mass.
2.2.4.6 Data Analysis
Some isomasses were observed eluting at different times or in different fractions. Where 
there was fraction separation (off-line MALDI-TOF analysis) or elution window 
separation (LC-MS), these masses were considered separate components. Where masses 
were collected in successive fractions the masses were averaged and pooled. In MALDI 
and LC-MS data a large number of putative adducts were observed i.e. representing 
addition ofNa (+22), K (+38), Na+K (+60), loss of C02 (-44), NH3 (-17), H20  (-16), 
mono and di oxidation (+16, +32), matrix adduct (+188). These masses, along with ones 
corresponding to +74 and +104 (unknown adducts observed in scorpion venoms by 
Pimenta et al., 2001), were removed from the final dataset.
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2.3 Results
2.3.1 Ability of Mesob. tamulus Antivenom to Recognise Venom Extracts by ELISA
The ability of the antiserum to recognise venom extracts was assessed by direct ELISA. 
Venom extracts were adsorbed to a microtitre plate and probed using Mesob. tamulus 
antivenom. A typical curve using pooled control Mesob. tamulus venom is shown (fig 
2.2), the data fitted to a sigmoidal curve using Prism (graphpad software, San Diego 
USA). lOpg venom with no primary-, and another with no secondary- antibody were 
used as controls and produced signals less than that of a venom negative sample. The 
standard curve showed that there was a concentration-dependent sigmoidal relationship 
between venom concentration and ELISA signal. Although further optimisation would 
probably increase the sensitivity, lOpgml'1 venom corresponded to the most sensitive 
region of the curve and allowed a lpg sample to be utilised, sufficient for the purpose 
required.
lpg of individual venom extracts from regional Mesob. tamulus specimens, and a single 
individual of H. fulvipes were tested alongside a sample of commercially available L. 
quinquestriatus hebraeus venom using the ELISA described. Resulting absorbances are 
shown standardised against commercial control Mesob. tamulus venom in fig 2.3a. The 
data suggests considerable venom variability between individuals and between species.
Fig 2.3b illustrates the same data grouped according to geographical region, statistical 
analysis shows significant differences in the ability of the antiserum to recognise 
Mesob. tamulus venom from the Konkan and Aurangabad regions (2-tailed student t- 
test, a=0.05), likely to reflect differences in the venom composition in individuals from 
the two regions. The two reference venoms showed opposing results. There is slight 
recognition and therefore cross reactivity with Heterometrus venom. Lqh venom gave a 
high signal, suggesting more cross reactivity with this venom than with that of some 
individuals of the species against which the antiserum was raised.
The differences above do not necessarily reflect the neutralisation abilities of the 
venom, since the ELISA gives no indication of the types of molecules responsible for 
the antigenicity. In order to further analyse the venom components responsible for the 
differences, the venoms were separated electrophoretically. A1 and K3 individuals
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appeared to be suitable representatives for further investigation of antigenicity by 
Western blotting.
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Fig 2.2 Typical ELISA Profile using Mesob. tamulus Control Venom
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The ability of Mesob. tamulus venom antiserum to recognise venom extracts was 
assessed by direct ELISA. Venom extracts were adsorbed to a microtitre plate and 
probed using 1:50 dilution of Haffkine antiserum, followed by an anti-horse HRP 
conjugate. A typical profile using varying concentrations (as determined by protein 
concentration) of pooled control venom is shown. Data shown is mean +/- SD of 
triplicate samples, corrected for blank (ho venom). In the above figure Prism (graphpad 
software, San Diego USA) has been used to fit a sigmoidal curve to the data.
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Fig 2.3 ELISA on Individual Mesob. tamulus Venom from Different Regions
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lpg of individual Konkan (Kl-10) and Aurangabad (Al-10) venom extracts were 
adsorbed to an ELISA plate and probed with 1:50 dilution o f Mesob. tamulus venom 
antiserum (Haffkine institute), followed by an anti-horse HRP-conjugated secondary 
antibody. Antibody complexes were visualised by the addition o f a TMB substrate 
solution and quantified by A450nm. Resulting absorbances (mean +/- SD from triplicate 
samples) are shown standardised against that of pooled control Mesob. tamulus venom 
(S) (a). Values for a single individual o f H. fulvipes (H) and for commercially available 
Leiurus quinquestriatus hebraeus (L) venom (Latoxan, France) are also shown, (b) 
Illustrates the same data pooled by scorpion type.
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2.3.2 SDS PAGE and Western Blotting on Individual Venoms
SDS-PAGE and Western blotting were carried out on venom from a single Konkan 
scorpion (K3) and from an Aurangabad scorpion (Al). For comparison, venom from a 
single individual of H. fulvipes and commercially available Leiurus quinquestriatus 
hebraeus venom were also used. In order to achieve good resolution for both high and 
low molecular-weight proteins, samples were run on both 4-20% Bis-Tris, and 16% 
Tricine gels under non-reducing conditions (fig 2.4). Western blotting was carried out 
on both gel types using Mesob. tamulus antiserum (fig 2.5). Although the majority of 
peptide toxins are thought to be single chain, a recent report has identified disulphide- 
linked oligomers in Mesobuthus gibbosus venom (Ucar et al., 2004). Non-reducing 
conditions were therefore chosen in order to ensure bands corresponded to intact 
proteins.
SDS-PAGE page shows the presence of both high and low molecular weight 
components in all venom types tested. Groups of proteins ~7kDa and ~4kDa may 
correspond to long and short chain neurotoxins known to be present in scorpion 
venoms. Larger proteins may include enzymes and cellular derived components. 
Although there appear to be common, or similar components between the species in the 
97-116 kDa range, Mesob. tamulus venom would appear to have more low weight 
components (<14kDa) than that of Lqh. Differences are also apparent between Mesob. 
tamulus venoms from the different regions. Konkan venom may contain an extra protein 
in the 55kDa region. There is a clear difference between the venoms at around 14kDa, 
and a number of differing bands occur in the 3-7 kDa region.
Antigenic differences were assessed by Western blotting. As seen in ELISA, the 
antisera had a strong overall reaction with the Mesob. tamulus and Lqh venoms, whilst 
there was only slight cross reactivity with Heterometrus venom. Antigens would appear 
to fall into three groups: the high MW components (>34kDa), and two groups ~7kDa 
and ~4kDa, possibly the long and short chain toxins respectively. Results do show, 
perhaps unsurprisingly, that the higher MW (possibly enzymic components) are 
generally more antigenic than the lower (possibly neurotoxic) ones. The antivenom does 
not react with any low MW Heterometrus components that may be present, all of the 
cross reactivity occurring towards the higher mass proteins. High MW components 
(>34kDa) also account for much of the cross-reactivity seen with Lqh venom. Similar
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bands are seen in venoms from both buthoid species, perhaps suggesting shared, or 
similar, components, possibly enzymes. There is some reaction in the 4 and 7kDa 
regions, believed to represent the neurotoxins, but far less than seen with Mesob. 
tamulus venoms. It is thus likely that the high signal seen with the ELISA was due to 
reaction with non-toxic components and therefore unlikely that the antisera would 
afford much neutralization of Lqh toxicity. No significant differences were seen in 
Mesob. tamulus regional venoms in the >34kDa components. Antigenic differences do 
appear, however, in the mass ranges corresponding to the neurotoxic components.
These experiments relate to venoms from single individuals from each region. From 
ELISA it is apparent that there is much inter-specimen variability, which should be 
noted when considering the results presented. There is no indication whether the venom 
differences are qualitative or quantitative, nor the molecular identities of the proteins 
involved. To further understand the venom variability samples were analysed by mass 
spectrometry.
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Fig 2.4 SDS-PAGE Analysis of Non-Reduced Venom Samples
15 4
ug ug
30
ug
15
u g
5
u g
30 15 5
u g  u g  u g
Approx. 0.5
MW (KDa) ug
— 200
— 116— 97
200— —
— 66 116—9 7 — ——  55 66—
55 — —-
— 37
— 31 3 7 — «■»
— 22
31 —
22 —
—  14 14— —
— 6 6—
— 3.5 3.5—
0.2
u g
0.5
u g
1
U g
0.2 0.5 1
u g  u g  u g
L L K K K K K A
5 10 20 5 10 20 5 10 20 Approx. 5 10 1 5 10 1 5 10
ug ug ug ug ug ug ug ug ug MW (KDa) ug ug ug ug ug ug ug ug
—  3.5
L L L  A A A K K K  L L  A A A K K K
SDS-PAGE was performed on non-reduced regional Mesobuthus tamulus venom 
samples. Varying quantities (as determined by BCA protein assay) o f venom from a 
single Konkan scorpion K3 (K) and from an Aurangabad scorpion Al (A) were run on 
both 4-20% Bis-Tris (top) and 16% Tricine gels (bottom). Lanes containing venom 
from a commercially available L. quinquestriatus hebraeus venom (L) are shown for 
comparison. Gels were stained using a colloidal Coomassie blue protein stain (left) and 
silver staining (right).
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Fig 2.5 Western Blotting of Mesob. tamulus Venom from Different Geographical 
Regions
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Western blotting was carried out on venom from a single Konkan scorpion K3 (K) and 
from an Aurangabad scorpion Al (A). Various quantities o f venom protein were run on 
both 4-20% Bis-Tris (left) and 16% Tricine gels (right). Mesob. tamulus antivenom was 
used at a 1:2500 (Bis-Tris) or 1:1500 (Tricine) dilution, followed by a 1:2000 (Bis-Tris) 
or 1:2500 (Tricine) dilution of anti-horse-HRP. Lanes containing venom from a single 
individual of H. fulvipes (H) and commercially available L. quinquestriatus hebraeus 
(L) venom are also shown.
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2.3.3 Mass Spectrometry
Having established that there are antigenic and possibly compositional differences 
between Mesob. tamulus venoms harvested from different geographical regions, mass 
spectrometry was utilised to investigate further. Analysis was restricted to the 2000- 
lOOOODa mass range in order to exclude small peptide fragments, the larger enzymes 
and matrix interference. Although intact peptides <2kDa and enzymic components may 
play an important role in scorpion venom, the focus of this study is on the peptide 
toxins, which occur predominately in the 3000-8000Da mass range, believed to account 
for the main pharmacological properties.
2.3.3.1 SELDI -TOF Fingerprinting
Venom extracts from individual Konkan (K) and Aurangabad (A) Mesob. tamulus 
specimens, single H. fulvipes specimens and from P. imperator were examined by 
SELDI-TOF protein profiling using both hydrophobic and hydrophilic chips (fig 2.6).
Both chip types bind venom components, but it would appear that either more peptides 
bind to the hydrophobic chip or the resolution is worse with this chip. Differences in 
venom fingerprints are apparent with both chips.
The different species show clear differences in venom peptides. Masses for Mesob. 
tamulus are predominately clustered in two regions: - ~3000-4500Da and -6500- 
8000Da, perhaps corresponding to long- and short-chain toxins respectively. 
Heterometrus has some masses within these ranges but most are between 4500-5500Da, 
a distribution possibly reflecting a lower proportion of ion channel toxins, sodium 
channel toxins in particular. The masses in the Pandinus sample are of low intensity 
with less distinct mass grouping.
Despite having similar fingerprints, there are apparent differences between Mesob. 
tamulus venoms from the two regions. There would appear to be variation in the type of 
peptides represented; on the hydrophobic chips, the Aurangabad venoms have higher 
overall intensity than Konkan venoms, whereas on the hydrophilic chips the situation is 
reversed. There are several clear differences in components’ masses between the
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regions, perhaps the most obvious of which is seen in the 6500-8000Da range on the 
hydrophobic chip. There is a prominent peptide ~3000Da in the Konkan venom 
(hydrophilic chip), apparently much reduced or absent in Aurangabad venom. Although 
the SELDI profiles suggest a distinct mass fingerprint for regional Mesob. tamulus 
venoms, fingerprints of individuals within a region are not identical, showing 
qualitative, if not quantitative differences.
Since the preliminary data obtained by SELDI-TOF in Singapore showed distinct 
regional venoms for Mesob. tamulus, further experiments were carried out by LC-MS in 
Sheffield to determine more precise masses for the peptides involved.
2.3.3.2 LC-MS
SELDI-TOF data showed variation in the venom from individual scorpions. Due to 
limited mass spectrometry resources, LC-MS on several individuals was not possible. 
Individual venoms were thus pooled for each region, reducing intraregional variations. 
Different peptides ionise differently in mass spectrometry. The observed abundance of 
different ions does not therefore represent abundance in the original sample. It is, 
however, possible to compare abundances of the same ion between samples, since it 
ionises to the same extent. To eliminate run-to-run variation, absolute intensity was not 
used. Instead, data was standardised to a single reference ion species. Since venom 
protein expression may vary between regions, LC-MS samples were spiked with equal 
amounts of the peptide standard solution.
Aurangabad (A), Konkan (K) and Lqh samples were run, and differing TIC profiles 
obtained for each sample (fig 2.7). Abundances were standardised against the main 
standard-mass peak and masses present in blank and standard-only samples were 
removed. In all samples, the relative proportions of standard-peptide solution masses 
were approximately the same, validating standardisation. Masses corresponding to 
possible adducts were noted. (See appendix A-C for complete list of component 
masses). The total number of peptides identified was far greater in K (296) than in A 
(170), although this could be an experimental artefact or due to greater interindividual 
variation in the Konkan region. However, total relative area of K (8.77) was similar to 
that of A (7.311) which, despite differences in ionisation properties, suggests similar
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peptide concentrations in the mass range, comprised of differing numbers of 
components.
Differences in dominant masses determined by LC-MS are readily visible in 
standardised mass fingerprints (fig 2.8). However, species grouping is not obvious using 
this technique, possibly due to the technique itself, venom pooling or the use of a 
different reference species (Mesob. tamulus and Lqh are both dangerous buthoid 
species, whereas Heterometrus and Pandinus are more distantly related, with less potent 
venom). In contrast to SELDI-TOF, there is far more data in the lower than higher mass 
range for all three species, possibly be due to inherent differences between ionisation 
methods or to LC-MS being optimised for data in the lower range. Concentrating on the 
2500-5000Da range, the LC-MS data shows good correlation to that seen with the 
SELDI hydrophilic chip. Prominent peaks, possibly relating to 2947 (for Konkan) and 
3448 (for Aurangabad) LC-MS masses are visible in SELDI-TOF fingerprints.
Differences are also apparent in the mass distribution of components (fig 2.9). Lqh 
venom has a large proportion of lower mass peptides compared with the Indian species’ 
venom. Whether this effect is real or due to degradation is unclear, since different 
species’ venoms were derived from different sources. Again, comparison of regional 
venoms shows some similarities with the SELDI-TOF 2500-5000Da range. Using both 
techniques there is a shift towards the top of this range in the Aurangabad venom.
Standardised peak areas for each mass in Konkan venom were deducted from the 
equivalent mass in Aurangabad venom (fig 2.10), highlighting differences in expression 
levels. Table 2.1 summarises the dominant masses for each venom type. There are 
considerable regional differences in expression of the prominent masses seen in the 
venom fingerprints. Although the majority of these masses are shared, a number of 
major masses, particularly in Konkan venom, are not expressed or not detected in the 
other venom type. It would appear on initial inspection that the majority of masses are 
unique to a single region. It should be noted, however, that a large number of these are 
detected only at low levels and small differences in relative concentration may push 
them below the detection threshold.
A number of masses seen in this study appear to correspond to known venom 
components (tables 2.2 and 2.3). Two known Mesob. tamulus peptides (BTK-2, BtITx3)
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and four known Lqh peptides (LQH-IT2-44, LQHIT2-53, LQHIT5, LQH8/6) are 
represented in the top 20 detected masses. Their abundance probably accounts for their 
isolation. Importantly, the two major known Mesob. tamulus peptides are present in 
both types of venom. Masses corresponding to Tamapin, Tamapin-2 and ButalT were 
only detected in venom from a single region, however. The masses corresponding to a 
number of known peptides of both species were not found by LC-MS.
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Fig 2.6 SELDI-TOF Mass Spectrometry on Individual Mesob. tamulus Venom
Samples from Scorpions Collected in Different Regions
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Venom extracts from individual Konkan (K) and Aurangabad (A) Mesob. tamulus 
specimens were examined by protein profiling on SELDI-TOF Proteinchip System II 
(Ciphergen, USA) using H50 hydrophobic (left) and NP 20 hydrophilic chips (right) 
(Ciphergen, USA) and a sinapinic acid matrix. Samples and standards (Protein MW 
Standards Kit, Ciphergen Biosystem Inc.) were spotted onto chips before washing with 
PBS and loading into the instrument. Single specimens of another Indian species (H. 
fulvipes) (H) and the African species P. imperator (P) were also used, as comparisons.
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Fig 2.7 HC (Total Ion Current) Chromatographs of LC-MS on ‘Average’ A, K 
and LQ Venom Samples
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‘Average’ Aurangabad (A) and Konkan (K) regional Mesob. tamulus venom samples 
were created by mixing equal quantities (by protein) of individual venom samples. 6pl 
of a O.lmgml'1 A, K and LQH (Leiurus quinquestriatus hebraeus) venoms (spiked with 
O.Olmgmf1 standard peptide solution) were fractionated by reverse phase HPLC and 
analysed by in-line LC-MS. Total ion current produced over time is shown above. Peak 
containing standard peptide is shown (*).
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Fig 2.8 Relative Mass Fingerprints of LQ and ‘Average’ A and K Venoms as 
Determined by LC-MS
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LC-MS data was analysed using LC-MS peak reconstruct software for masses 2-10kDa. 
Components occurring in a peptide standard-only run were removed from venom data. 
Peak areas (ion intensity x peak volume) were standardised against that of the major 
peptide standard component to produce a relative mass fingerprint for the three venom 
types: - ‘average’ Aurangabad (A) and Konkan (K) regional Mesob. tamulus venoms, 
and L. quinquestriatus hebraeus venom (LQH). The 5 most prominent masses (by peak 
area) are labelled for each venom type.
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Fig 2.9 Venom Components Grouped by Mass.
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Masses contained within Aurangabad (top left) and Konkan (top right) regional Mesob. 
tamulus venoms, and L. quinquestriatus hebraeus venom (LQH), as detected by LC- 
MS, were grouped into 500Da classes in order to give an overall picture of venom- 
component mass distribution. Masses are plotted against the number of mass 
components contained within the class.
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Table 2.1 Major Component Masses in Mesob. tamulus Regional Venoms and in L.
quinquestriatus hebraeus Venom
Samples of L. quinquestriatus hebraeus venom, and venom from Mesob. tamulus 
collected in Aurangabad and Konkan coastal regions were analysed by LC-MS. Peak 
area (peak volume x intensity) data was standardised against that for a control peptide 
spiked into each venom sample to allow comparative analysis. The top twenty mass 
components (by relative peak area) for each venom type are shown. Mesob. tamulus 
masses are assessed for quantitative differences between the two regions.
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Mesob. tamulus Aurangabad regional venom
Rank Monoisotopic mass Relative Unique to Relative Rank Notably different
[M+H]+ area A? area in K in K quantities in A 
a n d K ? f
1 3448.1 * 1.25 - 0.055 34 +/-
2 6752.9 0.54 - 0.096 104 +
3 3795.0 * 0.39 - 0.11 17 -
4 2714.6 0.38 - 0.0011 251 +
5 3683.1 0.36 - 0.086 21 -
6 3517.1 0.28 - 0.031 47 +/-
7 4017.3 0.20 + +
8 4017.3 0.19 + +
9 3910.3 0.18 - 0.060 32 -
10 3103.7 0.17 + +
11 3969.3 0.17 - 0.043 41 -
12 6755.9 0.12 - 0.0081 118 +
13 3558.1 0.12 - 0.011 98 +
14 3306.8 0.11 - 0.10 18 -
15 2712.6 0.11 + +
16 3838.1 0.10 - 0.015 76 +
17 3912.1 0.091 - 0.0036 168 +
18 3720.1 0.080 - 0.0024 202 +
19 3509.1 0.073 - 0.033 44 -
20 3670.1 0.072 - 0.0033 176 +
Mesob. tamulus Konkan regional venom
Rank Monoisotopic mass Relative Unique to K? Relative Rank Notably different
[M+H]+ area area in A in A quantities in A 
and K ? f
1 2947.5 1.36 - 0.011 81 +
2 6657.7 0.93 + +
3 4053.1 0.49 + +
4 2986.7 0.35 - 0.068 23 +/-
5 2903.7 0.22 + +
6 2725.6 0.21 - 0.0080 93 +
7 3172.9 0.21 + +
8 3504.9 0.20 + +
9 4297.5 0.20 + +
10 3408.8 0.19 - 0.066 25 -
11 2985.4 0.18 + +
12 2843.6 0.17 + +
13 7155.1 0.16 + • +
14 2970.4 0.15 + +
15 3189.6 0.14 - 0.024 55 +
16 2947.5 0.12 + +
17 3794.9 * 0.11 - 0.39 4 -
18 3306.7 0.10 - 0.11 15 -
19 3527.0 0.10 + +
20 6694.6 0.090 4- +
* Mass corresponds to  that o f known component (see table 2.2).
* +  Ranked below 50 in other venom, and more than x5 difference in relative area. - Ranked top 50 in both venoms, and less than 
x5 difference in peak area. +/- Ranked in top 50 in both venoms, but >x5 difference in relative area.
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L. quinquestriatus hebraeus venom.
R ank Monoisotopic mass 
[M+H]+
Relative area Rank Monoisotopic mass 
[M+H]+
Relative area
1 2960.7 2.36 11 3643.9 0.29
2 6754.0 * 1.71 12 3556.0 0.29
3 3993.1 1.17 13 2922.6 0.26
4 3643.0 0.68 14 4068.4 0.26
5 3180.8 0.67 15 4163.2 * 0.26
6 4293.5 0.63 16 3673.9 0.22
7 3764.3 0.54 17 2964.6 0.21
8 6740.9 * 0.47 18 7461.4 0.16
9 6664.7 * 0.39 19 2977.6 0.15
10 3994.1 0.32 20 2999.6 0.15
♦Mass corresponds to  that o f known components (see table 2.3)
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Table 2.2 Occurrence of Known Mesobuthus tamulus Peptides in A and K Type
Venoms
SCORPION (Srinivasan et al., 2001) and SwissProt (Bairoch and Apweiler, 1996) 
databases were searched for known Mesob. tamulus venom components. Peptide masses 
of these components were obtained by submitting the sequences (after removal of any 
signal peptides) to ExPASy PeptideMass software, and adjusting the resulting masses to 
allow for disulphide bonding. Any experimentally-derived masses were also noted. 
Samples of venom from Mesob. tamulus collected in Aurangabad and Konkan coastal 
regions were analysed by LC-MS and component masses calculated using LC-MS peak 
reconstruction software. Resulting data was searched for masses potentially representing 
known venom components.
For the experimental data described in this chapter, the monoisotopic mass is based 
upon the lowest detected peak in the isotope series, and the average mass is based on the 
average mass of the neutral species. For the calculation of theoretical peptide masses, 
the monoisotopic mass was determined as the sum of the exact masses of the lightest 
stable isotope for each component atom. For calculation of the average mass, the 
average of the masses for each component atom was used.
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Table 2.2 Occurrence of Known Mesobuthus tamulus Peptides in A and K Type
Venoms
Toxin name(s) Average
mass
[M+H]+
Mono­
isotopic
mass
[M+H]+
Published 
experiment 
al mass
Corresponding 
average mass (this 
work)
Corresponding 
monoisotopic 
mass (this work)
A K A K
Iberiotoxin8
IBTX
4248.0 4244.9 - - - - -
Lepidopteran- 
selective toxin b 
ButalT 
BTChl2
3856.5 3853.7 MW=3856.7 
Method=ESIb
3855.0 3853.1
N eurotoxinc 7032.9 7028.0 - - - - -
BtITx3 d 
BTChll
3798.4 3795.5 MW=3796.5
Method=
MALDIe
3797.8 3797.7 3795.0 3794.9
Potassium
channel
inhibiting tox inf
5233.2 5229.4
Tamapin 8 3459.1 3456.7 MW=3457.9
Method=ESI
g
3460.1 3457.8
Tamapin-2 8 3433.1 3430.7 MW=3431.4
Method=ESI
g
3432.1
3433.4
3430.7
3431.1
Tamulotoxin b 4206.9 4204.0 - 4205.2 4205.3 4203.6 4203.5
Tamulustoxin 1 1
TmTX
Alpha-KTx 16.1
3946.7 3943.8 MW=3945.7
Method=ESIi
Tamulustoxin 2 1 3960.6 3957.9 - - - - -
Toxin BTK-2 J 3450.1 3447.5 MW=3452;
Method=ESI
j
3450.4
3451.9
3450.5
3454.6
3448.0
3450.0
3447.9
3450.7
a Galvez et al., 1990 
b W udayagiri et al., 2001
c Sharma, M. 2001, direct submission to  PDB database, 
d Newton, K. A. 2002, direct submission to  EMBL database, 
e Dhawan et al., 2002
f  Jcyaseelan, K. 1998, direct submission to  EMBL database, 
g Pedarzani et al., 2002 
h Escoubas et al., 1991 
i Strong e ta l., 2001 
j  Dhawan e ta l., 2003
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Table 2.3 Occurrence of Known Peptides in L. quinquestriatus hebraeus Venom
SCORPION (Srinivasan et al., 2001) and SwissProt (Bairoch and Apweiler, 1996) 
databases were searched for known L. quinquestriatus hebraeus venom components. 
Peptide masses of these components were obtained by submitting the sequences (after 
removal of any signal peptides) to ExPASy PeptideMass software, and adjusting the 
resulting masses to allow for disulphide bonding. Any experimentally derived masses 
were also noted. A sample of the venom was analysed by LC-MS, and component 
masses calculated using LC-MS peak reconstruction software. Resulting data was 
searched for masses potentially representing known venom components.
For the experimental data described in this chapter, the monoisotopic mass is based 
upon the lowest detected peak in the isotope series, and the average mass is based on the 
average mass of the neutral species. For the calculation of theoretic peptide masses, the 
monoisotopic mass was determined as the sum of the exact masses of the lightest stable 
isotope for each component atom. For calculation of the average mass, the average of 
the masses for each component atom was used.
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Table 2.3 Occurrence of Known Peptides in L. quinquestriatus hebraeus Venom
Toxin name(s) Average
mass
[M+H]+
Mono­
isotopic
mass
[M+H]+
Published
experimental
mass
Corresponding mass 
(this work)
average Mono­
isotopic
Leiurotoxin I a
LeTxI
LTX1
Scyllatoxin
ScyTx
SCTX
Alpha-KTx 5.1
3424.2 3421.6 3423.5 3421.1
Agitoxin 1 b
Leiurotoxin II
AGTX1
LeTxH
4022.9 4012.0
Agitoxin 2 b 
AGTX2
4090.9 4087.9 - 4090.5 4088.5
Agitoxin 3 b
AGTX3
4101.0 4097.9 - - -
L Q H IIC 7277.2 7272.3 - - -
Alpha-like toxin 
L Q H m c
Lqhin
Lqh3
7049.0 7044.2
Neurotoxin Lqh IV d
LqhIV
Lqh4
7212.2 7207.3 MW=7211.3
METHOD=
MALDId
Alpha-like 
neurotoxin Lqh V Ie
Lqh6
6794.8 6790.1
Charybdotoxin1
ChTX 
ChTX-Lql 
ChTx-a 
Alpha-KTx 1.1
4313.0 4309.9 4312.5 4309.5
Charybdotoxin8
ChTx-b
4270.9 4267.9 - 4268.7 4267.5
Charybdotoxin8
ChTx-c
43112.0 4309.0 - 4309.7 4309.5
LQH 18-2 h
ChTx-LQ2 
Toxin 18-2, 
Charybdotoxin 2 
ChTx-d
4353.0 4350.0 4352.7 4349.6
Chlorotoxin8
CITx-a
4053.8 4050.63 - 4053.2 4050.4
Chlorotoxin 8
CITx-b
3591.1 3587.4 - - -
Chlorotoxin 8
CITx-c
3639.3 3636.5 - - -
Chlorotoxin8
CITx-d
3704.2 3701.5 - 3705.2 3702.8
Insect neurotoxin s 
LQH IT1-A
7873.0 7867. 7 - - •
Insect neurotoxin 8 
LQH IT1-B
7931.0 7925. 7 - - "
Insect neurotoxin g 
LQH m -c 7908.1 7902.7 - -
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Insect neurotoxin 8 
LQH m - D
7965.0 7959.6 - - “
Depressant insect 
neurotoxin 8
LQH IT2-13
6637.3 6632.8
Depressant insect 
neurotoxin1
LQHIT2
LqhTT2-44
6758.6 6753.9 6758.0 6754.0
Depressant insect 
neurotoxin 8
LQH IT2-53
6744.6 6739.9 6744.1 6741.0
Insect toxin SJ
LqhTT5
6669.4 6664.8 - 6668.1 6664.7
Insect toxin alpha 6A
alpha-IT8 
LQH ALPHA 6 A
7338.3 7333.3
Insect toxin alpha 6C
ALPHA-18 
LQH alpha 6C
7431.4 7426.3
Leiuropeptide I  k 
Lpl
2948.4 2946.2 - 2948.5 2946.6
Leiuropeptide II k
LpH
3192.6 3190.3 - -
Leiuropeptide m  
LpIII
3207.6 3205.3 - 3207.0 3204.7
Potassium channel 
blocking toxin 15-11 
Lqh 15-1
4137.8 4134.9 4138.1 4136.4
Probable toxin Lqh 
8/6 m
4165.9 4162.7 MW=4165 4166.1 4163.2
h Lucchesi et al., 1989 
i Z lo tk inetal., 1991 
j  Moskowitz et al., 1998 
k  Buisine et al., 1997 
1 M arshall et al., 1994 
m Adjadj et al., 1997
a Chicci et al., 1988 
b Garcia et al., 1994 
c Sautiere et al., 1998 
d Corzo et al., 2001a 
e Hamon et al., 2002 
f  Gimenez-Gallego et al., 1988 
g Froy et al., 1999
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2.3.4 Fractionation of Mesob. tamulus Venom for Venom Profiling
Extracted commercial Mesob. tamulus venom was fractionated by size exclusion (fig 
2.11a), ion exchange (fig 2.11b) and reverse phase (fig 2.12) chromatography. The size 
exclusion profile was similar to that seen in the same venom by Pedarzani et al., 2002, 
and was crudely divided into three peaks: lead-fractions 11-18, main-fractions 19-38, 
and trailing-fractions 39-55. The lead peak, which also showed absorbance at 218nm, is 
proposed to contain high molecular weight enzymes and cellular components. The 
trailing peak had no absorbance at 218nm, is therefore non-proteinacous, and most 
likely comprised of nucleic acids. Since neither fraction is likely to contain the 
pharmacological peptides, they were not examined further. The main peak appears to be 
comprised of at least two separate subpeaks, and is likely to contain the 
pharmacological peptides. Main peak fractions were pooled and further fractionated.
Ion exchange conditions were selected to favour fractionation of basic peptides and 
hence the ion channel toxins, to which the majority of venom pharmacology has been 
attributed. 36% of protein (by A280) was recovered in fractions, and the remainder in 
the flow through. The ion exchange profile was divided into 8 sections and the fractions 
within each section pooled. These groups and the flow through were both directly 
submitted for mass spectrometry, and further fractionated.
Offline reverse-phase fractionation of ion exchange pools was carried out prior to 
SELDI-TOF analysis. The profiles clearly demonstrate that each ion exchange pool was 
comprised of many components, as were the majority of the reverse phase fractions.
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Fig 2.11 Fractionation of Mesob. tamulus Venom by Size-Exclusion and Cation- 
Exchange Chromatography
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2ml venom extracts were initially run on a 75ml Sephadex G50 size exclusion column 
in 50mM ammonium formate at a flow rate of ~40ml hr'1, and the absorbance of the 
fractions measured at 280nm (A). Fractions were pooled into ‘lead’, ‘main’ and 
‘trailing’ peaks. The ‘main’ peak was further fractionated on a Hiload 16/10 SP- 
sepharose cation exchange column, using a gradient of 0.1M NaCl in lOOmM NaAc
(B). The absorbance was followed at 280nm and the profile divided into eight sections 
as shown. Fractions within each section were pooled prior to further analysis.
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Fig 2.12 Reverse Phase HPLC on Mesob. tamulus Venom Ion Exchange Fractions
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Separation of a) groups I-IV, and b) groups V-Vin and flow through, from the ion 
exchange column, by reversed phase HPLC. 0.5mg venom protein was run on a 
Dynamax C l8, 300A, 250 x 4.6mm, 5pm column equilibrated in 0.1% TFA at 0.5ml 
min'1. Samples were eluted with a 0-50% gradient of solvent B (90% acetonitrile/ 0.1% 
TFA), and the eluent monitored at 218nm. Eluted sample was collected in 1ml fractions.
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Fig 2.12b)
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2.3.5 Mass profiling of venom fractions by MALDI-TOF and LC-MS
Venom fractions from the size exclusion, reverse phase and ion exchange columns were 
individually analysed by MALDI-TOF/MS. Size exclusion and ion exchange fractions 
were also separated and analysed online by LC-MS. As with venom fingerprinting, 
analysis was restricted to the 2000 to lOOOODa mass range, both in order to focus on 
peptide toxins and to remove matrix interference. Sample MALDI-TOF, and LC-MS 
TIC and mass profiles are shown (fig 2.13). With the less fractionated samples (e.g. 
‘main’ size exclusion fraction) MALDI analysis gave poor peak resolution making mass 
analysis impossible. Reverse phase samples however, gave good resolution, and 
reproducible masses were obtained for the majority of peaks. The mass measurement 
achieved in the LC-MS experiment was more accurate but detected fewer masses in the 
>5000Da mass range. MALDI-TOF detected more masses in this higher mass range, 
but resolution was poor and few masses were able to be determined accurately.
In MALDI and LC-MS data a large number of putative adducts were observed all of 
which were removed from the final dataset. Isomasses eluting in successive fractions 
were averaged and pooled. After analysis, 665 masses were determined in total (352 by 
MALDI-TOF and 524 by LC-MS), with a large number detected by both methods. 
These masses ranged from 2005.5, close to the lower detection threshold, to 8515.4. 
The greater separation seen in this study led to far more masses being detected than with 
the venom fingerprinting. A summary of masses of Mesob. tamulus venom components 
is given (table 2.4); full details of data from which this table was derived are given in 
appendix D. Masses similar to those of all known venom components were detected 
(table 2.5), although it should be noted that this does not confirm their identity.
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Fig 2.13 Sample Mass Spectrometry Profiles of Mesob. tamulus Venom Fractions
(A) MALDI-TOF mass spectrum of a typical venom fraction (ion exchange group 1). 
Venom fractions were analysed on a SAI LaserTOF LT1500 mass spectrometer with a 
337nm nitrogen laser. The instrument was operated in the positive-ionisation mode with 
20KV accelerating voltage and an aCHCA matrix was used.
(B) Total ion current of the same fraction, analysed by LC-MS. O.lmgml'1 protein was 
separated by reverse phase (5-42% gradient of acetonitrile in 0.1% formic acid over 80 
min) and eluate introduced directly into the electrospray ion source of an API QSTAR 
pulsarl LCMS/MS system. (+5000V, ion source gas 40V, curtain gas 25V, mass range 
500-4000m/z).
(C) Reconstructed mass profile of sample shown in (B). Data was processed using LC- 
MS peak reconstruct software (API) within the 2000-10000 mass range to calculate 
component masses.
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Fig 2.13 Sample Mass Spectrometry Profiles of Mesob. tamulus Venom Fractions 
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Table 2.4 Mass Spectrometric Analysis of Mesob. tamulus Venom
Mass data was obtained by MALDI-TOF and LC-ESI mass spectrometry for the ‘main’ 
size exclusion peak fractionated by ion exchange and reverse phase chromatography as 
described. LC-MS masses were calculated from component ions using commercial LC- 
MS mass reconstruction software. Within an ion exchange group (or the data 
corresponding to direct analysis of the ‘main’ size exclusion peak) MALDI-TOF data 
was assumed to represent a single mass if data was within 0.1% variation and was 
detected in continuous consecutive fractions, and as such were averaged. Mean 
MALDI-derived masses with >0.1% SD and those derived from <3 separate masses 
from <2 sample spots were discarded. Resulting LC-MS and MALDI-TOF data is 
shown in appendix D. Within a single group, all possible adduct masses for addition of 
matrix, Na, K and Na+K, loss of CO2, NH3 and H2O, mono- and di-oxidation, along 
with those corresponding to +74 and +104, were calculated, and any corresponding 
masses (+/- 0.1% for MALDI-TOF, +/- 0.01% for LC-MS) removed from the dataset. 
MALDI and LC-MS data was combined within a group (0.1% mass tolerance) and any 
masses only eluting in LC-MS flow-through removed. Data from all groups was 
combined (mass tolerance +/- 0.1% for MALDI-TOF, +/- 0.01% for LC-MS); assuming 
identical masses found in consecutive ion exchange fractions represented a single 
molecular species. Masses close to those of recorded venom components were noted. 
The resulting summary of the mass spectrometry data is shown. Masses detected by LC- 
MS analysis are in bold, whilst those detected by MALDI-TOF are underlined. Shaded 
masses represent those observed by direct MALDI or LC-MS analysis of the ‘main’ size 
exclusion peak. Masses similar to those expected for known venom components (refer 
to table 2.5) are noted (*).
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Table 2.4 Mass Spectrometric Analysis of Mesob. tamulus Venom
2005.5 2628.8 2940.4
2007.6 2646.7 2941.1
2014.8 2657.0 2941.5
2016.6 2669.0 2941.8
2018.5 2683.8 2951.3
2027.3 26873 2963.6
2043.5 2687.6 2969.2
20463 2690.1 2969.2
2051.6 2690.9 2969.7
2055.6 2701.4 2986.5
2065.8 27083 2988.5
2075.4 2710.5 2988.6
2079.4 2710.6 2990.4
2084.8 2711.8 2990.6
2085.4 2711.9 3006.5
2089.4 2712.1 3012.2
2105.0 2715.1 3012.7
2109.2 2716.1 3021.1
2112.7 2716.6 3021.6
2143.5 2716.7 3021.9
2144.2 2717.1 3033.4
2169.5 2718.0 3038.4
21813 27193 3038.9
2183.4 2734.5 3043.9
2191.7 2738.9 3045.7
2201.7 2754.4 30603
2216.2 2756.8 3071.6
2265.8 2764.9 3078.0
2279.6 27673 3078.8
2286.2 2773.4 3081.6
2326.1 2783.7 3087.8
2332.3 2789.8 3092.9
2335.4 2794.8 3092.9
2336.7 2795.1 30943
2340.3 2812.5 3096.6
2366.2 28143 3097.8
2374.8 2825.4 3098.6
2411.2 2828.8 3102.0
2415.6 2836.6 3105.1
2442.3 2889.5 3105.8
2462.0 2889.6 3105.9
2468.5 2890.9 3106.5
2551.6 2904.6 3112.5
2554.1 2909.5 3114.7
2557.1 2922.8 3115.7
2584.0 2925.2 3127.6
2618.2 2927.0 31383
3141.6 33453 3466.8
3150.5 3349.2 3467.4
3155.1 3351.5 3468.7
3163.9 3354.1 34693
3164.7 33653 3480.4
3166.2 33653 3482.6
3169.6 3366.2 3482.8
3176.6 33673 3483.0
3176.7 3369.8 3484.6
3176.8 3375.9 3488.9
3182.6 3376.9 3497.0
3183.9 3380.7 3501.9
3184.7 3381.0 35023
3193.9 ’33823 3502.6
3202.3 3383.6 3503.2
3205.5 3394.0 35103
3207.9 3394.4 3510.6
3208.2 3396.9 3512.0
32163 3397.9 3514.2
3222.2 3400.5 3515.6
3225.2 3401.7 35173
3226.1 3402.1 3519.0
3226.2 3402.6 3519.5
32283 3404.4 3520.0
3229.6 3406.0 3521.2
3237.0 34113 3522.2
3237.5 3412.5 3522.4
32513 3417.9 3528.2
32543 3418.7 3528.7
3286.1 3420.4 3538.7
32873 3430.5 3539.8
3288.5 3430.6 3541.8
3297.0 3431.8 3544.9
3297.6 34323 35473
3298.1 3433.2* 3552.9
33063 34343 3553.0
3310.7 3437.8 3555.0
3312.9 34403 3556.4
3313.5 3450.2* 35573
3314.0 3456.9 3560.8
3316.8 34583* 3561.8
3319.2 3459.9 3562.9
3321.2 3460.0 3563.9
3325.7 3460.5* 3564.7
3328.8 3464.2 3565.5
3336.4 3465.9 3567.8
3339.4 3466.4 35723
3573.0 3696.8 3823.6
3578.0 36983 3824.6
3579.1 3701.5 38253
3581.7 3703.0 3827.8
3591.1 37043 38293
3592.2 3706.5 3829.9
3596.9 3708.9 3834.0
3597.6 3709.7 3834.9
3601.9 3710.0 3835.6
3604.7 37103 3836.9
36073 3711.4 3840.2
3608.4 3712.0 3840.7
3608.8 3714.6 3848.2
3609.1 3716.2 38543
36093 37203 3856.8*
3615.3 3722.4 3860.2
3617.4 3723.5 3863.1
3620.6 3724.0 38663
3621.8 37243 3869.5
3631.8 3724.4 3872.6
36353 3725.5 3874.5
36353 37373 38783
3637.4 37403 3878.8
3638.4 3740.6 3881.0
3639.5 3740.7 38923
3647.5 3742.7 38923
3650.5 3745.5 3895.9
3652.5 3755.1 3898.9
3658.2 3755.3 3902.1
3665.7 3756.1 3908.3
3673.0 3756.5 3909.2
3675.6 3759.6 3909.2
3677.8 3762.1 3909.6
3679.4 3770.2 3912.8
36803 3770.5 3913.0
3684.4 3774.4 3913.7
36853 3776.2 3913.7
3685.8 3777.1 3914.7
3685.9 3780.7 39153
3686.1 3781.0 39323
3686.6 3782.7 3937.6
3686.9 3794.8 3944.8
3688.2 3798.4* 3945.5*
36913 37993* 3946.9*
3692.7 3819.7 3954.2
3693.1 3821.9 3955.5
3695.2 3822.9 3958.0
138
3960.0* 3989.1 4031.0
3963.4 3990.8 4031.6
3965.8 3992.5 4040.9
3970.8 3992.6 4041.1
3972.2 3993.9 40413
3972.4 3996.2 4042.0
3972.9 3996.9 4052.0
3973.2 3998.7 4053.7
3973.5 4000.9 4058.6
3973.6 4001.4 4061.1
3974.0 4002.4 40703
3975.8 4003.2 4078.5
39783 4005.1 4078.8
3978.7 4006.8 4081.0
3979.1 4009.6 40823
3979.9 4010.4 4083.7
3981.6 4011.2 40923
3981.7 4012.5 4097.9
3982.1 4013.7 40983
3982.7 4016.7 4100.7
3983.0 4016.9 4103.2
39843 4020.2 4106.6
3985.1 4021.0 4113.0
3985.6 40223 4123.7
3988.1 4022.5 4132.6
3988.1 40243 4133.8
3989.0 4026.2 4142.6
4148.9 4268.1 4544.8
4150.2 42763 4548.8
4153.9 4286.0 45653
4158.9 42873 4569.4
4172.2 4287.4 4584.7
4178.8 4292.0 4597.8
4189.8 4298.9 4605.4
4196.6 4300.8 4611.6
4200.0 4302.4 4637.6
4201.0 4319.2 4665.3
4201.5 4323.1 4667.4
4205.9 43293 4673.0
4206.5 4337.5 4682.1
4207.0 4338.0 4684.7
4207.5 4339.2 4727.6
4209.5* 43453 4752.9
4210.0 4355.6 4753.1
4214.5 4366.1 4780.0
4218.8 4401.5 4796.6
4224.1 4463.4 4808.8
4225.6 4464.4 4825.2
4228.8 4466.1 4876.1
42323 4468.5 4880.4
4236.1 4491.5 4881.1
4246.7 4493.7 4882.2
4247.7* 4543.7 4900.4
4262.7 4544.1 4919.5
4939.0 7004.9 75003
4951.1 7006.0 7588.6
5133.6 7007.8 7653.7
5233.4* 7017.9 7743.7
5277.7 7026.8 7814.6
5319.6 7032.8* 7815.2
5469.1 7036.8 7823.5
5522.2 7048.9 7840.8
5553.7 7055.7 7850.7
5564.2 7065.3 7918.1
5778.0 7125.4 8045.6
6181.5 7125.7 8103.0
6304.5 7139.2 8144.0
6408.7 71433 8210.1
6624.0 7159.6 8213.2
6652.8 7170.5 8226.0
6658.4 7224.6 8290.3
6678.6 7234.0 8317.2
6712.0 7255.3 8327.1
6760.6 7269.1 8357.7
6829.7 7331.0 8515.4
6850.4 7356.3
6910.0 7365.5
6919.6 7393.2
6929.2 7403.4
6988.4 7449.8
6988.4 7467.9
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Table 2.5 Occurrence of Known Mesobuthus tamulus Peptides in Venom Fractions
Toxin name(s) Average
mass
[M+H]+
Mono­
isotopic
mass
[M+H]+
Published
experimental
mass
Closest mass match 
(this work)
Ion
exchange
fractionAverage Mono­
isotopic
Iberiotoxina
IBTX
4248.0 4244.9 - 4247.6 4245.3 Group 3
Lepidopteran- 
selective toxin b 
ButalT 
BTChl2
3856.5 3853.7 MW=3856.7
Method=ESIb
3856.8 3854.1 Group 7
Neurotoxin0 7032.9 7028.0 - 7032.8 7031.2 Group 7
B trrx 3 d
BTChll
3798.4 3795.5 MW=3796.5
Method=
MALDI6
3798.4
3799.2
3798.7
3797.7
Group 1 
Group 1
Potassium
channel
inhibiting toxinf
5233.2 5229.4 5233.4 5230.4 Group 1
Tam apin8 3459.1 3456.7 MW=3457.9
Method=ESIg
3460.5
3458.3
3457.8
3457.7
Group 6 
Group 7
Tamapin-2g 3433.1 3430.7 MW=3431.4
Method=ESIg
3433.2
3433.2
3431.9
3431.9
Group 6 
Group 7
Tamulotoxin11 4206.9 4204.0 4205.9 4204.5 Group 1
Tamulustoxin 1 1 
TmTX
Alpha-KTx 16.1
3946.7 3943.8 MW=3945.7
Method=ESIi
3945.4
3946.9
3942.7
3944.2
Group 5 
Group 7
Tamulustoxin 2 1 3960.6 3957.9 - 3960.0
3960.0
3958.2
3958.2
Group 7 
Group 8
Toxin BTK-2J 3450.1 3447.5 MW=3452;
Method=ESIj
3450.2 3447.8 Group 4
a Galvez et al., 1990 f  Jeyaseelan, K. 1998, direct submission to  EMBL database,
b W udayagiri et al., 2001 g Pedarzani et al., 2002
c Shartna, M. 2001, direct submission to PDB database. h Escoubas et al., 1991
d Newton, K. A. 2002, direct submission to  EMBL database. i Strong et al., 2001
e Dhawan et al., 2002 j  Dhawan et al., 2003
SCORPION (Srinivasan et al., 2001) and SwissProt (Bairoch and Apweiler, 1996) 
databases were searched for known Mesob. tamulus venom components. Peptide masses 
of these components were obtained by submitting the sequences (after removal of any 
signal peptides) to ExPASy PeptideMass software, and adjusting the resulting masses to 
allow for disulphide bonding. Any experimentally derived masses were also noted. Data 
obtained in the mass profiling study (this work, see appendix D) was searched for 
masses potentially representing known venom components.
For the experimental data described in this chapter, the monoisotopic mass is based 
upon the lowest detected peak in the isotope series, and the average mass is based on the 
average mass of the neutral species. For the calculation of theoretic peptide masses, the 
monoisotopic mass was determined as the sum of the exact masses of the lightest stable 
isotope for each component atom. For calculation of the average mass, the average of 
the masses for each component atom was used.
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2.4 Discussion
The work presented represents the first detailed dissection of Mesob. tamulus venom 
composition. The chapter is concerned with both regional venom variation and the 
fractionation of venom components, with the identification of a large number of 
component masses.
Variation in venom composition relating to geographical region has been previously 
reported in other animals e.g. spiders (Binford, 2001), snakes (Prasad et al., 1999; Fry et 
al., 2002) and cone snails (Jones et al., 1996) but, to our knowledge, this is the first 
study in scorpions. Symptomatic and antigenic differences have been observed in 
Mesob. tamulus venom (Kankonkar et al., 1998; and Kulkami, D.G.-unpublished 
observations). The symptomatic variation could be explained by differences in 
behaviour. The two populations may inject different quantities of venom, or one 
population may be more aggressive, more readily injecting venom as opposed to 
prevenom. On the other hand, the venom itself may be more concentrated or there may 
be qualitative or quantitative differences in composition. For other scorpions, the 
protein content of venom does not appear to correlate with toxicity (Kalapothakis and 
Chavez-Olortegui, 1997; El Hafney et al., 2002,), the latter being more closely related to 
levels of individual toxins. This study therefore set out to examine antigenic and peptide 
variability between Mesob. tamulus venoms found in two geographical regions with 
distinct biotopes.
Intra- and interspecific venom variation has been studied using various techniques in 
other venomous species e.g. bees (Owen and Sloley, 1988), spiders (De Oliveira et al., 
1999; Goncalves de Andrade et al., 1999; Rash et al., 2000; Binford, 2001; Escoubas et 
al., 2002), snakes (Daltry et al., 1996; Prasad et al., 1999; Fry et al., 2002), cone snails 
(Jones et al., 1996) and scorpions (El Ayeb and Rochat, 1985; Kalapothakis and 
Chavez-Olortegui, 1997; Martin-Eauclaire, et al., 1987; Tare et al., 1992; Inceoglu et 
al., 2003). ELISA has been used previously to study scorpion venom variability 
(Kalapothakis and Chavez-Olortegui, 1997). In this chapter, analysis by ELISA 
suggested general variability between venoms from Mesob. tamulus individuals, but 
clearly showed these differences to be greater between the two geographical regions. 
However, the large degree of overlap between the two groups makes ELISA an 
ineffective identification tool. Indeed, the apparent cross-reactivity of the Mesobuthus
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antiserum with the venom from Leiurus quinquestriatus hebraeus {Lqh) shows that this 
assay is not even diagnostic for venom derived from Mesob. tamulus species. Subtle 
differences in both protein and antigenic composition of regional venoms were also 
evident by SDS page and Western blotting.
The immunological studies described also examined cross reactivity between Mesob. 
tamulus antivenom and venom from H. fulvipes (another Indian scorpion) and from Lqh 
(another Buthidae species). The results show the two regional Mesob. tamulus venoms 
to share common antigenic determinants with Lqh venom, but show very little antigenic 
cross reactivity between the Indian scorpion species. A number of previous studies have 
demonstrated antigenic similarities between venoms of related scorpion species (for 
example, Das Gupta et al., 1989 (also for references to earlier studies dating back to the 
1930s); Nishikawa et al., 1994; and Becerril et al., 1996). Antigenic cross-reactivity of 
snake, toad, bee and scorpion venoms has also been reported (Lipps and Khan, 2000), 
with scorpion venom most closely related to bee venom. Although the authors did not 
speculate, this result was likely due to similarities in the enzymic components.
Although Leiurus quinquestriatus hebraeus is a North African species of scorpion, it 
shares high venom toxicity with other Buthidae (most clinically significant species 
belong to this family) and homologous neurotoxic venom components. Conversely, the 
Asian forest black scorpion {H. fulvipes) is widely distributed in South India (and in 
Malaysia and Indonesia) but belongs to the Scorpionidae family of scorpions, which, 
although morphologically impressive, have reportedly lower toxicity than the Buthidae. 
This is likely to be due, in part, to differences in the number and levels of neurotoxins in 
the venom and a lower cross-reactivity with Mesob. tamulus antiserum would be 
expected. Indeed, immuno-gel diffusion experiments between venom o f Mesob. tamulus 
and that of another Heterometrus species (H. bengalensis) also failed to show cross- 
reactivity (Das Gupta et al., 1989). Although unlikely, it is also possible that the lower 
cross-reactivity produced with H. fulvipes venom was due to intraspecies variation, 
since venom from a single individual was used in the study.
The cross-reactivity between the venoms of the Buthidae seen in ELISA may suggest 
therapeutic applications. Western blotting, however, revealed that this activity was 
primarily directed against larger, probably enzymatic, components and, as such,
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unlikely to equate to neutralizing capability. Indeed Borges et al., 1999, showed cross­
reactivity of Tityus antivenoms to be non-neutralising.
Toxin fingerprinting is based on the idea that, within any species, individuals will 
express peptides from their venom glands which have the same sequence and hence 
molecular weight, and that these toxin sequences will differ between species. A number 
of studies have used venom mass spectrometry to aid in classification and species 
identification, (e.g. scorpions (Dyason et al., 2002), spiders (Escoubas et al., 1997, 
1998, 1999), snakes (Stocklin et al., 2000), amphibians (Steinbomer et al., 1996), and 
cone snails (Jones et al., 1996)). The SELDI-TOF and LC-MS analysis described here 
determined venom fingerprints for the two regional venoms and highlighted differences 
between them. One mass (2947 Da) in particular stands out as a potential diagnostic tool 
in distinguishing between the regional venoms. Although clear regional differences in 
this peptide’s expression are evident in all samples tested by SELDI, far more samples 
are needed before any firm conclusion can be made. A large-scale study would also aid 
in selection of other diagnostic masses, since analysis based upon a single component 
might prove unreliable.
When looking for taxonomic differences in the venome it is important to consider other 
sources of venom variability. The venom fingerprint and toxicity of a given species can 
vary between different individuals and also from the same specimen over time, although 
it is generally assumed that any intraspecific variation will predominantly manifest in 
quantitative rather than qualitative differences. The protein content and lethality of 
scorpion venoms have been shown to vary between individuals of the same species (El 
Ayeb and Rochat, 1985; Martin et al., 1987; Kalapothakis and Chavez-Olortegui, 1997; 
El Hafney et al., 2002). Kalapothakis and Chavez-Olortegui, 1997, also demonstrated 
antigenic variability of T. serrulatus in a paper that seems to show a direct correlation 
between individual variation in expression levels of the main a  and p sodium channel 
toxins and variation in venom toxicity. Previous studies have indicated variation in 
Mesob. tamulus venom. Achyuthan et al., 1982, reported batch-to-batch variation in 
enzymic activity in the venom, and there are clear differences between individuals in the 
quantity of venom produced and the protein concentration within it (K. Newton and P. 
Strong unpublished observations). The SELDI-TOF data presented shows this variation 
is also evident at the level of toxin expression.
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A number of factors may be responsible for this variation. Variation in the composition 
of animal venoms have been previously reported relating to age (Owen and Sloley, 
1988; Goncalves de Andrade et al., 1999; Escoubas et al, 2002), gender (Sheumack et 
al., 1984; Rash et al., 2000; Escoubas et al., 2002), and diet (Daltry et al., 1996). 
Observed expression levels of toxin components may also be affected by genetic 
variations, environmental conditions, season, captivity, and the venom extraction 
method.
Even within an individual, the venom composition may vary. Pimenta et al., 2003, used 
MALDI-TOF MS to examine venomic variability within T. serrulatus individuals after 
a period of starvation (fully mature venom gland production) and at subsequent repeat 
extractions. The authors reported variations due to the stage of venom maturation to be 
greater than those between individuals, particularly in the mass regions corresponding 
to the ion channel toxins. The interval between previous use of the venom gland and 
extraction of the venom used in this study is not known, and thus could be the source of 
some of the variation observed. However, since scorpions from the two regions were 
treated identically, this is unlikely to account for the observed geographical variation. 
Inceoglu et al., 2003, used mass spectrometry to look at differences between venom and 
prevenom, another source of intra-individual variation. However, the differences were 
observed using manual venom extraction techniques. Venoms used in this study were 
extracted using electrical milking techniques, which are not under the neuronal control 
of the scorpion, and produce a more complete emptying of the venom gland. This 
extraction technique was important for the study of geographical variation, since it 
proved that these regional differences were not simply due to differences in scorpion 
aggression leading to preferences for prevenom or venom production.
In order to minimise the effects of the observed variation between individuals, LC-MS 
data was obtained using venom pooled from a number of individuals from each 
geographical region. The Lqh venom used as a comparison was one that is 
commercially available, and hence represents pooled extractions from a number of 
individuals. Variation in venom concentration was eliminated by the standardisation of 
venom samples by protein concentration, focusing the study on differences in protein 
composition.
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Further examination of individual Mesob. tamulus venoms will afford a clearer picture 
of their variation and how this relates to the variation seen in the different regions. In 
particular, any putative diagnostic process for identifying the different venoms will need 
to be assessed in a large number of individuals and the effect of variation within the 
region assessed. If  non-specific variation is to be reduced in the future, ideally scorpions 
should be starved prior to milking, ensuring expression of mature venom peptides with 
fewer precursor products, and ensuring that the venom gland is full. Scorpions should 
also be standardised with respect to body length, minimising possible differences 
related to maturity. It should be noted, however, that these measures may not 
necessarily be practical.
Previous studies have analysed scorpion venom mass components to one degree or 
another in a number of species, but this is the first such report on an Asian scorpion. 
Indeed, with around 1500 scorpion species, it is likely that venomic analysis is just in its 
infancy. Pimenta et al., 2001, identified 380 different mass components in the venom of 
Tityus serrulatus and stated that to their knowledge this was the largest number of 
masses detected in venom of a single species. The profiling of Mesob. tamulus (this 
study) identified 667 venom mass components and produced a profile to aid in the 
location and purification of peptides corresponding to a specific mass of interest. Such 
data may be of particular use in verifying that sequences derived from molecular 
cloning (such as those described in chapter 3) are expressed in venom, and as an aid to 
mass-spectrometric assisted peptide purification.
Pooled commercial venom was used for the venom profiling, to get a good overall 
picture of venom composition, reducing both extraction-related and individual-related 
variation. Since ion channel toxins are the components of scorpion venom that have 
generated the most scientific interest, the profiling method described was skewed 
towards finding such peptides. This was evident both in the mass range analysed, and in 
the bias towards basic peptides seen in the fractionation (most ion channel toxins are 
basic in nature). Generally, K+ toxins have masses in the 3-4.5 KDa range, and Na+ 
channel toxins are 6.5-8 KDa. There are exceptions to this rule (the smallest K+ channel 
toxin identified is Tel (from T. cambridgei) with a mass of 2446 (Batista et al., 2000), 
and not all masses within these ranges are ion channel toxins (defensins will occur in 
the K+ channel toxin mass range, for example). A few pore forming scorpion toxins of 
around 5 KDa have also been noted. One would therefore expect to see the masses
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largely in two clusters representing toxins for the two monovalent cation channels, 
which is generally the pattern observed. Sodium channel toxin masses may be under­
represented however, a phenomenon discussed later.
An obvious progression from the venom profiling described would be to obtain 
sequence data for the peptides. In a recent study by Batista et al., 2004, mass- 
spectrometric venom fingerprinting of T. cambridgei was followed by Edman 
degradation of 26 peptide components producing partial sequences. In the future we 
hope to apply mass spectrometry for these purposes as a continuation of the profiling 
described. Initial speculative attempts at MS-MS analysis of the venom samples used in 
this study were unsuccessful. It is anticipated, however, that optimisation of the 
experimental protocol, probably including the reduction and alkylation of samples prior 
to analysis, will enable amino-acid sequencing of a large number of Mesob. tamulus 
venom peptides without the need for a proteolytic digest. This will have implications in 
the discoveiy of novel component types and in knowledge of structure and functional 
properties of existing toxin classes. MALDI-TOF MS with collision induced 
dissociation/post-source decay has already been used to sequence peptides from the 
venom of solitary wasps (Hisada et al., 2000). Although these wasp peptides are 
considerably shorter than their scorpion counterparts, it is envisaged that future studies 
will produce MS-MS sequences of at least the smaller-mass scorpion venom peptides.
Although a large number of masses were identified in the venom fingerprinting and 
venom profiling described, a number of venom components may remain undetected - a 
fact that is supported by the lack of detection of some known venom components. 
Components outside the mass range will obviously be excluded, as will any contained 
within other size exclusion fractions in the profiling data. Positive ionisation was used 
for MALDI-TOF and LC-MS, selecting for basic peptide toxins. Negatively charged 
components may not ionise sufficiently in this mode. The reverse phase conditions used 
are not necessarily suitable for all peptides (some may not bind, some may bind 
irreversibly). Other components may represent too low a proportion of venom protein to 
be detected. In MALDI and LC-MS data a large number of putative adducts were 
observed. These masses were removed from the profiling data. It is possible, however, 
that some of these removed masses represented real venom components. Co-eluting 
venom components and, in the case of mass fingerprinting, peptide-standard masses 
may cause suppression effects. With MALDI-TOF analysis, above 5000Da in
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particular, poor resolution and mass reproducibility caused many observed mass peaks 
to be rejected. In addition, the missing known toxin masses may be due to errors in 
sequencing of peptides or cDNA, errors in estimation of cleavage sites from signal 
peptides in cDNA derived sequences, differences between calculated and actual mass 
due to post transactional modifications, or low relative expression levels.
Conversely, it is likely that a number of the observed masses are artefactual. Electrical 
venom extraction is particularly prone to contamination with cellular debris, which may 
account for some of the observed masses. The more sensitive the detection method, the 
more prone it is to contamination, which may have occurred at the sample preparation 
and/or fractionation stage (although at the MS stage itself, matrix or buffer interference 
was eliminated by running sample-negative controls).
Many masses may relate to same original peptide. This study assumed different 
retention times to equate to different molecular species. It should be noted that cis/trans 
isomerisation and alternative disulphide-bond pairings, for example, can result in 
differing chromatographic behaviour of the same peptide. As demonstrated by Pimenta 
et al., 2001, in T. serrulatus venom, peptides present may be incompletely cleaved from 
the precursor, or the mature peptides cleaved by proteolytic enzymes. These may be 
released from cells disrupted during venom extraction, or could contaminate the sample 
during its preparation. The mass spectrometry conditions themselves may lead to 
peptide degradation. Collision thermal degradation is a well-known phenomenon, which 
has recently been demonstrated in the analysis of scorpion toxins (Batista et al., 2004). 
A ‘proline effect’ has been seen, both by ESI and by MALDI-TOF/MS using an 
aCHCA matrix. This results from artefactual cleavage at the N-terminal of a proline 
residue in non-disulphide bonded N-terminal segments. At the data analysis stage, 
although many putative adduct masses were identified, others may be present, fiirther 
increasing the number of artificial masses seen in this study.
MALDI-TOF and LC-MS techniques for the analysis of venoms have been compared 
previously (Escoubas et al., 1999, Pimenta et al., 2001) and the relative merits will not 
be discussed in detail here. In this particular study, the LC-ESI/MS instrument has the 
advantage of better mass resolution than the MALDI instrument. The LC-ESI/MS 
instrument will simultaneously fraction the sample and, if required, allow for the 
monitoring and fragmentation of a single ion species. However, offline separation of
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venom allowed for enrichment of less concentrated protein fractions and hence better 
sensitivity for minor components. The high sample throughput of MALDI-TOF meant it 
was the ideal instrument for analysis of the large number of samples produced by 
offline separation. It should also be stressed that, although the particular MALDI-TOF 
instrument used in this study was of relatively low resolution, advances in the 
technology (for example coupling with a quadrapole device) mean that far more 
sensitive instruments utilising MALDI technology are now available. Importantly, 
different components have different ionisation efficiencies with the different 
technologies, hence the use of both methods for mass profiling in this study maximised 
the number of components observed.
Although LC-MS proved an ideal technique for detailed analysis of the regional venom 
samples, the length of time taken to run and the complexity of the data produced may 
limit its use as a diagnostic tool. In contrast, although costly, the SELDI technique may 
prove far more suitable for this task.
One major difference between the mass spectrometric methods was that seen in the 
higher mass range. SELDI-TOF data appears to reveal far more masses above 6KDa 
than do the other two methods. This relatively low apparent abundance of Na+ channel 
toxins is surprising considering that these toxins are usually the most important 
components in terms of relative concentration (Batista et al., 2002). In MALDI-TOF 
MS peaks were often observed in the sodium channel toxin mass region but were 
generally eliminated at the data processing stage due to poor reproducibility, poor peak 
resolution, and high standard errors in mass determination. Parallel analysis using an 
alternative matrix (e.g. sinapinic acid) may result in better resolution in the higher MW 
range. Although the LC-MS parameters used gave good results in the K+ channel toxin 
range, they not have been optimal for the higher end of the mass spectrum. Ideally, the 
studies should be repeated under optimal conditions for the higher end of the 2-10KDa 
range.
To conclude, having established antigenic differences in the venoms of Mesob. tamulus 
found in two distinct biotopes, this study set out to investigate the possibility that 
differences in the type and relative concentration of peptide toxins were responsible for 
the reported clinical differences. However, as noted earlier, many other factors may 
contribute to the clinical picture. It should be noted that venoms contain a wide range of
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enzymes and non-protein components, and that the venoms may also vary with respect 
to these, perhaps a candidate for future study. Protein and venom standardisation was 
necessary for the purposes of the study described. However, the results do not 
necessarily correlate to the clinical picture, where differences in venom concentration 
and quantity may also be factors. Future studies may investigate these factors, perhaps 
utilising manual extraction techniques to give a more ‘natural’ venom sample if 
practically possible. Behaviour of the regional scorpions themselves could also be 
observed. The cause of the variation remains unclear. It is possible that there are 
underlying genetic differences between individuals in the different regions, as is often 
seen with discrete isolated populations. It is equally feasible, however, that toxin 
expression levels are influenced by external factors, e.g. environmental conditions and 
feeding behaviour (prey available in the region), which may be more significant than 
genetic variability. Indeed Bawaskar, 1999, postulated that the mortality associated with 
Mesob. tamulus sting in the Konkan region is due to differing venom characteristics 
brought about by the differing climatic and environmental conditions.
Mesob. tamulus is present in other regions of India, than the state of Maharashtra. It is 
likely that they too will show regional differences to their venome, which would be 
interesting to investigate for a clearer picture of variation in the species. What 
components are common to all geographical regions? Is there a generic Mesob. tamulus 
venom fingerprint diagnostic to the species as a whole? And if so, how does it compare 
with those of other Buthidae species? This is also the first recorded mass spectrometric 
study on Lqh venom, and although a number of toxins and putative toxins have been 
identified, very few of them have had their native mass confirmed. Further analysis of 
the data contained within this study may yield information on posttranslational 
modifications, point mutations, sequencing errors, etc.
It is now theoretically feasible to sequence the entire venome of an organism using 
modem proteomic techniques. If the techniques are perfected, this proteomic approach 
could replace that of gene cloning in the identification of novel toxins. Not only would 
it have the advantage of speed, but it would also identify only expressed sequences. 
Biological activity would still need to be examined in order to confirm pharmacology, 
however. In terms of the study presented in this chapter, it is envisaged that the focus of 
such techniques will be those masses which are unique, or upregulated, in the venom of
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Indian red scorpions found in one particular region, and that the fractionated venom 
profile may prove an aid in purifying these components.
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Chapter 3
Studies on Peptides from the Venom of the Indian Scorpion
Mesobuthus tamulus.
(i) Cloning of Chlorotoxin Gene Family Members and the Purification of
the Corresponding Gene Products 
(ii) Structure of the 3’ Untranslated Region of Tamulustoxin
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3.1 Introduction
-Chloride channels are ubiquitous and are involved in a wide range of physiological 
processes, including muscle contraction, regulation of electrical excitability, sensory 
signal transduction, volume regulation, secretion and absorption. Inherited chloride 
channel disorders include those leading to kidney stones, myotonia and cystic fibrosis. 
Chloride channels are far less well studied than their cation channel counterparts. One 
reason for this has been the lack of suitable ligands with high affinity and selectivity.
Pharmacological modulators of chloride channels included small organic molecules 
such as TEA+ (tetraethylammonium cation), and the xanthine derivatives. These 
chemical modulators are all of low affinity and have poor chloride channel specificity. 
Natural toxins active upon Cl* channels include polyamine spider toxins, e.g. 
argiotoxin-636 (Herlitzes et al., 1993), and ochratoxin A (Gekle et al., 1993). Like the 
chemical modulators, these toxins have poor affinity and selectivity for chloride 
channels.
Scorpion venom contains a family of four disulphide bridge toxins, shorter than the 
known sodium channel toxins, which are active on the nervous system of insects (see
1.5.3.1). One of these short insectotoxins has proved to be a chloride channel inhibitor 
with significant pharmacological potential.
Chlorotoxin (ChlTx) was originally isolated from Leiurus quinquestriatus 
quinquestriatus venom via its action upon mammalian chloride channels (Debin and 
Strichartz, 1991; Debin et al., 1993). It was later found to bind to glioma membranes 
and block an outwardly-rectifying calcium-dependent chloride current expressed in 
glioma cells (glioma chloride current/ channel-GCC) and absent in normal glial cells 
(Ulrich et al., 1995, Ullrich and Sontheimer, 1996, 1997; Ullrich et al., 1998). Gliomas 
account for 40% of all brain cancers, and are highly invasive with most sufferers dying 
in the year of diagnosis. Prior to the discovery of chlorotoxin, there was no antigen or 
marker in use to selectively label these cells, and treatment options were limited and 
largely unsuccessful. Not only does chlorotoxin have the potential to aid in the 
identification and diagnosis of glioma (Ullrich et al., 1998; Ullrich and Sontheimer, 
1999), but it is also reported to reduce the glioma’s ability to invade surrounding tissue 
(Soroceanu et al., 1999). The specific binding to neoplastic glial cells provides the
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opportunity to use ChlTx for drug targeting (Ullrich and Sontheimer, 1999). Clinical 
trials of the toxin are underway. Chlorotoxin has more recently been shown to bind to 
other tumours derived from the neuroectoderm, including medulloblastomas, 
neuroblastomas, ganglionomas, melanomas and small cell lung carcinomas, thus 
widening its therapeutic potential (Lyons et al., 2002).
Despite the therapeutic potential, compared with the binding of other ion channel toxins 
to their targets, the chlorotoxin-GCC interaction is of relatively low affinity. There 
would appear to be two classes of binding sites on glioma cells (Kd=4.2nM and 
Kd=660nM for binding to D-54 MG human glioma cells) and radiolabelled-chlorotoxin 
has been shown to bind a 72kDa protein, consistent with members of the C1C ion 
channel family (Soroceanu et al., 1998).
It is unlikely that the GCC is chlorotoxin’s natural target and its biological purpose in 
envenomation remains to be determined. New clues can be obtained from a recent 
report by Salbaum et al., 2004. When chlorotoxin was injected into LC (locus 
coeruleus) neurons, it had no effect upon the induction of action potentials. These action 
potentials persisted, however, when GABA was bath-applied, suggesting a reduction, 
but not total block of GABAA-induced chloride conductance. Chlorotoxin is thus able to 
reduce GABAergenic local synaptic inhibition in these neurons. This study also 
demonstrated the potential of chlorotoxin as a neurological research tool. Total block of 
GABA- and glycine- mediated chloride currents leads to neuronal cell death. 
Conversely, chlorotoxin reduces, but does not abolish, these currents. The authors were 
able to express chlorotoxin in mouse brain and study the behavioural effects of 
disinhibition.
Thus chlorotoxin would appear to be a direct or indirect modulator of specific ion 
channels, but its natural target is still undetermined. Similarly, the site of action of other 
short insectotoxins remains unknown. Do they have Cl' channel modulating activities? 
And if so, is this activity directed against alternative channel types? As mentioned 
previously, the affinity of chlorotoxin for its binding site is not as great as the affinity of 
other scorpion peptides for their targets. Other members of the short insectotoxin family 
may thus have equal, or even greater pharmacological potential.
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As the first step in a study to screen scorpion venom for peptides with chloride channel 
activity and to investigate the structure/fimction relationships of the short insectotoxins, 
one of the aims of the work described in this chapter was to identify short insectotoxins 
from the Indian red scorpion. The classical approach to the study of venom toxins is 
chromatographic separation and isolation based upon biological activity, followed by 
Edman sequencing of the purified peptide. In this chapter, a different approach was 
taken. Based upon the signal peptide sequence of Bm-12 from Buthus martensii, the 
first short insectotoxin cDNAs from Mesob. tamulus were cloned. One of these 
sequences, BtChll, was selected for further study. Based on the predicted molecular 
mass of BtChll from the cDNA sequence, a putative BtChll mature toxin was purified, 
guided by MALDI-TOFF mass spectrometry. A synthetic analogue was also produced 
and purified. These peptides will form the basis of continuing studies on short 
insectotoxins from Mesob. tamulus.
The same adaptor-ligated Mesob. tamulus cDNA library used to identify short 
insectotoxin sequences was utilized to determine the 3’UTR of tamulustoxin, a voltage 
gated potassium channel toxin. Strong et al., 2001, reported a difference between the 
observed and calculated masses of tamulustoxin of approx IDa. The same author has 
noted a resistance to carboxypeptidase digestion (P. Strong unpublished observations). 
Both of these factors suggest C-terminal amidation. Experiments were performed to 
extend the 3’ end of the known cDNA sequence to include any processed C-terminal 
residues and the 3 ’UTR. The results reveal additional translated residues consistent with 
amidation of the precursor peptide, and also slight conservative differences between the 
published cDNA sequence and that determined in this work.
During the course of investigations on the cDNA sequence of tamulustoxin, a sequence 
having homology to a long-chain potassium channel toxin signal peptide was identified 
in Mesob. tamulus. Since, within scorpion toxins, related signal peptide sequences 
generally indicate related mature peptides, and given the lack of examples of long chain 
potassium channels, this sequence may warrant further investigation.
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3.2 Materials and Methods
3.2.1 Materials
Murine Moloney leukaemia virus (MMLV) reverse transcriptase was obtained from 
Amersham Pharmacia Biotech (Amersham, UK). DNA sequencing reagents were 
obtained from Applied Biosystems (Foster City, CA). All PCR (polymerase chain 
reaction) reagents were from Perkin-Elmer, USA and all PCR reactions were carried out 
using a Perkin-Elmer Cetus thermal cycler (model 480). Oligonucleotide primers were 
produced by National University Medical Institutes Synthesis Service, National 
University of Singapore (Singapore), Oswel DNA Service (Southampton, UK) and 
Alpha DNA (Quebec, Canada). EcoRl and buffer H were supplied by Promega, and 
agarose (ultra pure grade) was obtained from BRL.
Standard PCR mix comprised: - lOx PCR buffer (500mM KC1/ lOOmM Tris-HCl 
pH8.3/ 3mM MgCfe/ lmgml'1 gelatin) (2.5pi), dNTPs (2.5pl) (175pmol each) and 
DNazyme 0.5pl (0.5 unit), for a 25pl total reaction volume. For PCR reactions, negative 
controls were carried out in absence of template DNA.
The E.coli strain used was DH5a [ supE44 A/acU 169 (O80/acZAml5) hscRLll recAl 
end A l gyrA96 thi-l relAl]. RecAl mutation reduces the frequency of homologous 
recombination that may rearrange the structure of cloned DNA inserts. The strain has a  
complementation of the P galactosidase gene (i.e. contains a deletion eliminating the 
chromosomal lacZ gene, but carries the C-terminal coding domain of the gene on an 
episome), so that recombinants appear colourless and non-insert bearing colonies appear 
blue when grown on IPTG (isopropyl p-D-thio-galactoside) and X-gal (5-bromo-4- 
chloroindol-3-yl P-D-galactopyranoside).
All centrifugation steps were carried out at 13000rpm in a Beckman microcentrifuge 
unless stated otherwise.
All reagents used in the purification of synthetic and native BtChll were of analytical 
grade or better. Pooled Mesob. tamulus venom was supplied by the Haffkine Institute, 
Mumbai, India. BtChll peptide was synthesised by Hallam Biotech, Sheffield, UK. Zip- 
tips were obtained from Millipore, UK.
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3.2.2 Identification of Putative Short Insectotoxin cDNA Sequences from Mesob. 
tamulus
3.2.2.1 Scorpions
Mesobuthus tamulus (Indian red scorpions) were collected at the end of the rainy season 
(Sept-Dee) in the state of Maharashtra, India. The scorpions were kept at the Haffkine 
Institute, Mumbai, where the telsons were removed and snap-frozen in liquid nitrogen. 
These were shipped on dry ice to Singapore and stored at -80°C until use.
3.2.2.2 Isolation of Total RNA
Three whole frozen (-80°C) telsons were pulverised under liquid nitrogen using a pestle 
and mortar. Total RNA was extracted using 1ml TRIZOL® reagent (Gibco Life 
Technologies, CA, USA) per lOOmg tissue, incubated for 5min at room temperature. 
TRIZOL is a mono-phasic solution of phenol and guanidine isothiocyanate. The RNA 
was then chloroform extracted, adding 0.2ml chloroform per lOOmg telson, shaking 
vigorously and incubating for 3min before centrifugation (15min) to separate the 
phases. The upper aqueous phase was incubated with RNase-free DNase 1 (Boehringer 
Mannheim, Germany) for 30mins at 37°C. RNA was precipitated by: adding 0.5ml 
isopropyl alcohol per lOOmg tissue, incubating lOmin at room temperature and 
centrifuging for lOmins. The pellet was washed in 1ml 75% ethanol, and air-dried at 
37°C. Purified total RNA was redissolved in lOOpl sterile H2O, heated at 60°C for 
lOmin to denature secondary structure, and stored at -70°C.
3.2.2.3 Generation of an Adaptor Ligated cDNA Library 
First Strand Synthesis
lpg (l-4gl) purified total RNA from scorpion telson and lpl (lOpM) cDNA synthesis 
primer (5’-TTCTAGAATTCAGCGGCCGC(T)30VN-3’ where V=A, C or G and N=A, 
T, C or G) were made up to final volume of 5pi with sterile H2O and mixed. After 
heating for 2min at 70°C the mixture was cooled on ice for 2min. 2pl 5x first strand
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buffer (250mM Tris pH8.3/ 30mM MgCl2/ 375mM KC1), lpl dNTP mix (lOmM each), 
lpl MMLV reverse transcriptase (lOOunit pi'1) and lpl sterile H20  were added. After 
incubating for lhr at 37°C, first strand synthesis was terminated by cooling rapidly on 
ice.
Second Strand Synthesis
The second strand synthesis reaction was made up as follows: lOpl first stand synthesis 
from above, 16pl 5x second-strand buffer (500mM KC1/ 50mM ammonium sulphate/ 
25mM M gCy 0.75mM P-NAD/ lOOmM Tris pH7.5/ O^m gml'1 BSA), 1.6pl dNTP 
mix (each at lOmM), 4pl 20x second-strand enzyme cocktail (E.coli DNA polymerase I 
(6 units p f1)/ E.coli DNA ligase (1.2 units pi'1) and E.coli RNase H (0.25 units pi'1) and 
48.8pl sterile H20. The reaction was incubated for 1.5hr at 16°C before addition of 2pl 
(10 units) T4 DNA polymerase and incubation for a further 45min at 16°C.
lOOpl phenol:chloroform:isoamyl alcohol (25:24:1) was added and mixed to an 
emulsion before being spun (lOmin) to separate phases. The aqueous layer was removed 
and extracted with lOOpl chloroform:IPA (24:1), vortexing and centrifuging (lOmin) as 
above. The aqueous layer was retained and DNA precipitated by addition of Vz volume 
4M ammonium acetate and 2.5 volumes 95% ethanol, followed by centrifugation 
(lOmin). The pellet was recovered, washed with 300pl ethanol and air dried at 37°C for 
lOmin. The double stranded (ds) cDNA pellet was dissolved in lOpl sterile H20  and 
stored at -20°C.
Adaptor Ligation
5pl ds cDNA, 2pl Marathon cDNA adaptor (lOpM, Clontech, see below for sequence), 
2pl 5x ligation buffer (250mM Tris-HCl pH7.8/ 50mM MgCl2/ 5mM DTT/ 5mM ATP/ 
25% w/v polyethylene glycol MW 8000) and lpl T4 DNA ligase (1 unit ul'1) were 
incubated overnight at 16°C. The ligase was inactivated by heating for 5min at 70°C, 
and stocks of adaptor-ligated ds cDNA were stored undiluted at -20°C. Prior to use 1/50 
and 1/250 dilutions of adaptor ligated ds cDNA were made in TBE (90mM Tris-borate/
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2mM EDTA) buffer, heated at 94°C for 2mins to denature ds cDNA, cooled on ice 
2mins, and either used immediately or stored at -20°C.
Marathon cDNA adaptor: -
5 ' -C T A M ‘ACGACTCACTATAGGGCTTCGAGCGGCCGCCCGGGCAGGT-3'
3 ' - H 2N -C C C G T C C A -P04- 5 '
3.2.2.4 Primer Design
Degenerate gene specific primers corresponding to the 5’ UTR and signal peptide 
nucleotide sequence of Buthus martensii Karsch short insectotoxin Bm-12 were 
designed as follows: - mBtCFl 5’-CCAAAACTCTATTAAAAATG-3’ and mBtCF2 
5’-TTAAAAATGAARTTYCTNTAYGG-3’ (where R= G or A, Y= T or C, N= A or T 
or C or G). These primers were tested for suitability using DNAStar (Madison, USA), 
and BLAST (NCBI public database), the latter not highlighting any other potential 
binding sites for the primers amongst other known scorpion sequences.
Adaptor primers with sequences identical to those supplied with the Marathon cDNA 
amplification kit (Clontech, USA) were used: - adaptor primer 1 (API; 27-mer) 5’- 
CCATCCTAATACGACTCACTATAGGGC-35 and nested adaptor primer 2 (AP2; 23- 
mer) 5 ’-ACTCACTATAGGGCTCGAGCGGC-3 ’.
3.2.2.5 PCR
The enzyme used for the PCR reactions (i.e. DNazyme) produces products with A 
overhangs, making them suitable for TA cloning. A number of PCR cycle conditions 
were tried using both GSP mBtCFl and mBtCF2 (sequences as above) in conjunction 
with adaptor primers API and AP2 (sequences as above) in primary and secondary 
PCR. Final PCR conditions were as follows. Standard PCR mix (see 3.2.1) was used 
with the addition of lpl adaptor ligated mBt-telson cDNA library, 2.5pi (5pmol) API, 
2.5pi (5pmol) GSP mBtCF2 and sterile H2O to a 25pl total reaction volume. Cycle 
conditions were: 30sec at 94°C/ lmin at 45°C/ 2min at 60°C for 10 cycles, then 10
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cycles of 94°C for 30sec/ 50°C for lmin/ 72°C for 2min, followed by a 7min final 
extension at 72°C.
The PCR products (5pl reaction mix) were visualised by agarose gel electrophoresis.
3.2.2.6 DNA Agarose Gel Electrophoresis and Purification of Fragments/ Bands 
from Agarose Gels
Flatbed agarose gel electrophoresis was routinely performed using 1% agarose in TBE 
(90mM Tris-base/ 90mM boric acid / 2mM EDTA) buffer. O^ugml'1 ethidium bromide 
solution was routinely included in the gel to enable visualisation of bands on a UV 
transilluminator. Gels were run in the TBE buffer for 45min at 95V. 123 base pair or 
100 base pair ladder markers were used to aid size estimation.
Fragments of interest were excised from agarose gels and immediately purified with 
QIAquick gel extraction kit (Qiagen, USA) as per manufacturer’s protocol.
3.2.2.7 Preparation of Competent Cells
Competent E. coli were produced by the calcium chloride method of Cohen et al., 1972. 
E.coli strain DH5a [supEAA A/acU169 (<D80/acZAml5) hsdR ll recAl endAl gyrA96 
thi-\ relkX\ was streaked onto a LB (Luria-Bertani broth) agar plate and grown 
overnight. A 10ml LB overnight culture was generated from a single colony and used to 
inoculate 100ml LB. The culture was grown approx 3hrs at 37°C to an ODeoo of 0.5-0.7. 
The media was transferred to 2x 50ml sterile centrifuge tubes and cooled on ice for 
lOmins prior to centrifugation (Sorvall GS3 4000rpm lOmins 4°C). The liquid was 
discarded and the pellets drained and resuspended in 20ml ice-cold 0.1M CaCh. 
Bacteria were harvested as above and the CaCL wash repeated. The drained pellets were 
resuspended in 2ml ice-cold 0.1M CaCV 40% glycerol solution, 200pl aliquots were 
dispensed into pre-chilled sterile eppendorfs and stored at -70°C. Prepared competent 
cells were checked for growth, antibiotic sensitivity and competence by plating onto LB 
plates (+/- SOugml'1 ampicillin) or transformation with empty plasmid respectively.
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3.2.2.8 Cloning PCR Fragments into pCR®4-TOPO® Vector
Purified PCR fragments were ligated into a TA cloning vector by virtue of the A 
overhang produced by DNazyme. The TOPO TA Cloning® Kit for sequencing 
(Invitrogen, CA, USA), which uses the pCR®4-TOPO® vector, was used. This vector is 
supplied linearised with 3’ T overhangs and is covalently bound to topoisomerase.
Transformations were performed by combining 4pl purified PCR product with lpl 
pCR®4-TOPO vector (lOngpf1 plasmid DNA in 50% glycerol/ 50mMTris-HCL pH7.4/ 
ImM EDTA/ 2mM DTT/ 0.1% Triton X-100/ lOOpgml'1 BSA/ 30pM phenol red). After 
5min at room temperature, lpl salt solution (1.2M NaCl/ 0.06M MgCl2) was added and 
the mixture chilled on ice. 50pl chemically competent cells (either DH5a [supE44 
A/acU169 (O80/acZAml5) hsdBAl recAl endAl gyrA96 thi-l relAl] prepared as in
3.2.2.7 above, or DH5a-tTl One Shot®, Invitrogen, CA, USA) were added. 
Transformation mixture was stored on ice for 20mins before heat shock for 120secs at 
42°C and rapid chilling in ice for 1-2 mins. The bacteria were then allowed to recover 
and express ampicillin resistance in 250pl S.O.C medium (2% tryptone/ 0.5% yeast 
extract/ lOmM NaCl/ 2.5mM KC1/ lOmM MgCl2/ 10mM MgSOV 20mM glucose) for 
lhour at 37°C on an orbital shaker.
Transformed E.coli were selected by growing overnight at 37°C on 1.3% LB agar plates 
containing SOpgmT1 ampicillin. To allow for selection of recombinant colonies by a- 
complementation of the (3-galacotsidase gene, plates were coated with 5 pi 1M IPTG 
(isopropyl (3-D-thio-galactoside)/ 20pl 40mgml'1 X-gal (5-bromo-4-chloroindol-3-yl P- 
D-galactopyranoside)/ 75pi sterile H20  prior to use.
Recombinant white (or light blue) colonies were selected at random and grown 
overnight in 1.5ml LB medium containing SOpgmf1 ampicillin.
3.2.2.9 Plasmid DNA Isolation (Mini Preps)
Plasmid DNA was isolated and purified from 1ml overnight bacterial culture samples 
by the alkaline lysis method (Sambrook et. al., 1989). Briefly, the cells were isolated by 
centrifugation (lmin) and resuspended in lOOpl TGE buffer (50mM glucose/ 25mM
Tris-Cl pH8.0/ lOmM EDTA). 200pl lysis solution (0.2M NaOH/ 1% (w/v) SDS) was 
added, and the solution mixed by inversion until the cells were fully lysed. 150pl ice- 
cold potassium acetate solution (60ml 5M potassium acetate/ 11.5ml glacial acetic acid/ 
28.5ml sterile H2O) was added, mixed vigorously to yield a white precipitate, and then 
left on ice for lOmin to precipitate further. The solution was spun (lOmin) to pellet the 
high molecular weight DNA and cell debris, and the cleared supernatant (containing 
plasmid and RNA) was transferred to a fresh microcentrifuge tube. RNA was removed 
by incubating with 3 pi lOpgml'1 RNase A (heat treated to inactivate any DNase) for 
20min at 60°C. Samples were cooled and the plasmid DNA precipitated with 
isopropanol (450pl for 15mins at -70°C) and recovered by centrifugation (20mins). The 
plasmid DNA pellet was washed in lOOpl 70% ethanol, vacuum dried in a speed vac 
and resuspended in 20pl sterile H2O.
3.2.2.10 Screening for Inserts by Restriction Digest
Samples of plasmid DNA were tested for recombination with appropriately sized PCR 
fragments by digestion with the restriction endonuclease EcoRl. Restriction digests, 
containing 0.2pl (lOunits p f1) EcoRl, lpl xlO buffer H (Promega) and approx. lpg (1- 
4pl) DNA in a total volume of 20pl, were performed overnight at 37°C. Linearised 
plasmids and any excised cDNA fragments were visualised by agarose gel 
electrophoresis as described (3.2.2.6). Plasmid DNA containing appropriately sized 
inserts was prepared for sequencing.
3.2.2.11 Stock Culture
Stock cultures of colonies of interest were prepared as follows. 1ml overnight culture 
was spun to pellet cells (lmin), the supernatant discarded and the cells gently 
resuspended in 500pl LB broth: 80% glycerol (1:1). Stocks were stored at -70°C.
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3.2.2.12 Dideoxy Sequencing
The multiple cloning site of pCR®4-TOPO contains both M l3 forward and reverse 
priming sites as well as T3/ T7 priming sites. Sanger dideoxy sequencing (Sanger et al., 
1977) was carried out using the Taq DyeDeoxy™ Terminator Cycle Sequencing Kit 
(Applied Biosystems) and either T3 (5’-ATTAACCCTCACTAAAGGGA-3’) or T7 5’- 
TAATACGACTCACTATAGGG-3’ primers. 4-6pl plasmid DNA, 4pl primer (1.0 
OD), 8 pi sequencing pre-mix and sterile H2O (to 20pl total reaction volume) were 
subjected to 25 cycles (96°C 30sec/ 50°C 15sec/ 60°C lmin) PCR.
Chloroform extraction was performed on the PCR reaction (80pl sterile water was 
added, followed by lOOpl chloroform, and the mixture was vortexed. The suspension 
was spun briefly to separate the aqueous and organic phases and the aqueous phase 
retained. The DNA was precipitated by addition of 15pi 3M sodium acetate pH4.5 and 
300pl cold 100% ethanol and the solution incubated on ice lOmin. The precipitate was 
recovered by centrifugation (lOmin) and the pellet washed in 200pl 70% ethanol before 
being vacuum dried for lOmin. The DNA was redissolved in 4pl EDTA/ formamide 
buffer, denatured for 2mins at 100°C and immediately cooled on ice.
Samples were loaded onto a 6% acrylamide/ 50% (w/v) urea sequencing gel in TBE 
buffer (90mM Tris-borate/ 2mM EDTA) and run on an automated DNA sequencer 
(Applied Biosystems USA, model 373A).
3.2.2.13 Analysis of Deduced cDNA Sequences
Sequences were translated and examined visually for consensus sequences, and also 
matched against known sequences via BLAST (NCBI public database).
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3.2.3 Mass Spectrometry-Guided Purification of a Putative Chloride Channel 
Toxin Identified by cDNA Cloning
Mass spectrometry was used to identify masses corresponding to putative BtChll gene 
products in Mesob. tamulus venom. A candidate mass was isolated by mass 
spectrometry-guided purification.
3.2.3.1 Calculation of Candidate Masses
Masses of peptides correspionding to a BtChll gene product:- having no C-terminal 
modification; and with removal of a single; and double C-terminal glycine residue were 
calculated using ExPASy PeptideMass software, and the resulting masses were adjusted 
to allow for disulphide bonding.
3.2.3.2 Chromatographic Purification of the Peptide
Mesob. tamulus venom was extracted as described in 2.2.2 and fractionated by size 
exclusion and ion exchange chromatography as described previously (see 2.2.4.1 and
2.2.4.2). Samples from all size exclusion fractions, and desalted samples from all ion 
exchange groups, were analysed by mass spectrometry (see below). The mass of interest 
was isolated from ion exchange group 1 by a combination of C18 and C8 reverse phase 
HPLC using an AKTA system (Amersham-Pharmacia) and progress followed by mass 
spectrometry. Optimal reverse phase conditions are described, lmg non-desalted ion 
exchange samples were filtered (0.45pm membrane filter) and applied to a Dynamax 
C18, 300A, 250 x 4.6mm, 5pm column at a flow rate of 0.5ml min'1 in 0.1% TFA. The 
sample was eluted using a linear gradient of 0-45% acetonitrile in 0.1% TFA over 12 
column volumes. Fractions shown by mass spectrometry to contain the mass of interest 
were pooled and dried in a rotary evaporator. The sample was reconstituted in 0.1% 
TFA and applied to a Vydac 208TP C8, 300A, 250 x 3.2mm, 5pm column at 0.5ml 
min'1. The sample was eluted using a 4.5-27% gradient of acetonitrile in 0.1% TFA over 
12 column volumes. Fractions were again analysed by mass spectrometry to detect the 
mass of interest. Purification was monitored throughout by absorbance at 280nm.
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3.2.3.3 Screening of Fractionated Venom by Mass Spectrometry
The different chromatography samples were analysed separately. Size exclusion 
samples were analysed, using MALDI-TOF mass spectrometry, by the Mass 
Spectrometry Service, National University of Singapore.
lpl desalted ion exchange fractions were diluted in lOpl matrix solution (lOmg aCHCA 
in 1ml 60% acetonitrile/ 0.3% TFA) and 0.5ml was spotted onto a MALDI-TOF target 
and air-dried. Reverse-phase samples were prepared by evaporating lOpl to near­
dryness in a rotaiy evaporator, re-suspending in the matrix solution and applying to the 
target as above. Analysis of these samples was carried out on a SAI LaserTOF LT1500 
mass spectrometer as described 2.2.4.4, but with a 4500Da focus mass.
The purified peptide was analysed by quadrupole mass spectrometry, using an API 
QSTAR pulsarl (Applied biosystems) quadrapole mass analyser with an electrospray 
ion source (Analytical Services, Sheffield Hallam University). Mass data was analysed 
using Analyst QS software (Applied Biosystems).
3.2.4 Generation of Synthetic BtChll
3.2.4.1 Peptide Synthesis
The peptide RCPPCFTTNPNMEADCRKCCGGRGYCSYQCICPG-COOH was 
synthesised using standard Fmoc chemistry by Hallam Biotech, Sheffield, UK. Product 
was supplied lyophilised and was stored at -20°C.
3.2.4.2 Peptide Purification
lmgml'1 crude peptide was resuspended in 0.1% TFA for 24hrs under nitrogen. The 
resulting suspension was clarified by centrifugation and passing through a 0.45nm 
syringe filter. The solution was subjected to MALDI-TOF mass spectrometry (see 
below) and reverse phase HPLC. 1ml samples were run on a Dynamax C l8, 300A, 250 
x 4.6mm, 5pm column at a flow rate of 0.5ml min'1 using an AKTA system
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(Amersham-Pharmacia). Samples were eluted using a 0-100% linear gradient of 90% 
acetonitrile in 0.1% TFA. The eluent was monitored at 280nm and 1ml fractions 
collected, which were analysed by mass spectrometry. The folded peptide (see below) 
was fractionated and analysed in the same way.
lml crude, and folded, peptide solutions were separated on a Vydac 208TP C8, 300A, 
250 x 3.2mm, 5pm column run at 0.5ml min'1. Samples were eluted with a 0-100% 
linear gradient of 90% acetonitrile in 0.1% TFA over 10 column volumes, monitored by 
absorbance at 280nm. lml fractions were collected and analysed as above.
Final purification conditions used the C l8 column described, but a shallower gradient of 
4.5-22.5% acetonitrile in 0.1% TFA was employed over 10 column volumes.
3.2.4.3 MALDI-TOF Mass Spectrometry
For HPLC fractions, lOOpl was evaporated to near-dryness in a rotary evaporator and 
redissolved in lOpl matrix solution (lOmg aCHCA in lml 60% acetonitrile/ 0.3% 
TFA). 0.5ml was spotted onto the target and air-dried. For analysis of the crude peptide, 
a number of sample preparation techniques were used. 1, 10 and lOOpl samples were 
evaporated and dried as above. Identical samples were prepared, desalting on a C l8 zip- 
tip according to manufacturer’s instructions. For all samples, triplicate spots were 
analysed. Crude sample preparation was repeated three times.
MALDI-TOF/ MS analysis was carried out on a SAI LaserTOF LT1500 mass 
spectrometer as described in 2.2.4.4, but with a 4500Da focus mass.
3.2.4.4 Peptide Folding
The peptide was allowed to fold according to the method of Di Luccio et al., 2002. lmg 
lyophilised crude peptide was resuspended in lml 20mM sodium phosphate, pH8.2, in a 
15ml falcon tube. The solution was agitated and allowed to oxidise under air for 94hrs. 
The resulting suspension was centrifuged and passed through a 0.42pm syringe filter.
165
3.2.3.5 Homology Modelling of BtChll and BtChI2
Automated comparative modelling was carried out using Swiss-Model (ExPASY, 
Expert protein analysis system, www.expasv.org) in the ‘first approach’ mode. Two 
suitable template structures were located in the RCSB Protein Databank (PDB, 
www.rcsb.org/pdbV that for chlorotoxin (1CHL, Lippens et al., 1995) and that for 
insectotoxin 15A (ISIS, Lomize et al., 1991). BtChll and BtChl2 were each modelled 
using 1CHL, ISIS, and 1CHL + ISIS as templates. The templates, and the resulting 
structures, were submitted to the protein structure verification program WHAT IF 
(Vriend, 1990) via the Swiss-Model server.
PDB files were displayed using Deep View/ Swiss-PDB Viewer (www.expasv.org) or 
using Protein Explorer (http://molvis.sdsc.edu/protexpl/frntdoor.htm). Molecular 
surfaces were calculated and electrostatic potentials computed and mapped to these 
surfaces using Deep View. For the calculation of electrostatic potentials, atomic partial 
charges were utilised using the coulomb computation method and illustrated with the 
following cut-offs (Lippens et al., 1995): - red=-1.6kT/e; white=O.OkT/e; blue=1.6kT/e 
(k is the Boltzmann constant, T is temperature in Kelvin and e is the charge of the 
electron. At 298K kT/e=25.6 mV).
The charybdotoxin structure used for comparison was 2CRD (PDB, Bontems et al., 
1992).
3.2.5 Analysis of the 3’ UTR of Tamulustoxin cDNA
An adaptor ligated cDNA library from Indian red scorpion telson, and a gene specific 
primer based upon the known protein sequence of tamulustoxin were used in 3’RACE. 
Purified products were cloned into E. coli using a commercial sequencing vector and the 
recombinant plasmid DNA sequenced. Methods used were identical to those used in 
short insectotoxin cloning (see 3.2.2), with the exception of primer design, PCR 
conditions and PCR fragment purification, which were as described below. Clones 
originating from two separate ligations were sequenced. All clones were sequenced 
using T7 primer and sequencing was repeated on three clones using T3 primer.
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3.2.5.1 Primer Design
The gene specific primer used for 3’RACE of tamulustoxin cDNA was one of those 
used to derive the cDNA sequence of the coding region. This primer (TmTx F) 5’ -  
CGYTGYCAYTTYGTYGTYTGYAC-3 ’ (where Y= T or C) is a degenerate primer 
based on the known protein sequence for the toxin (Strong et al., 2001). The adaptor 
primer API and the nested adaptor primer AP2 had sequences as described earlier 
(3.2.2.4).
3.2.5.2 PCR reaction
A number of PCR cycle conditions were tried using TmTx F primer (see above) in 
conjunction with adaptor primers API and AP2 (sequences as described 3.2.2.4) in 
primary and secondary PCR. The PCR conditions that produced the final sequences 
were as follows. For primary PCR, standard PCR mix (see 3.2.1) was used with the 
addition of lpl adaptor ligated mBt-telson cDNA library, 2.5pi (5pmol) Adapter primer 
1, 2.5pl (5pmol) GSP TmTx F, and sterile H2O to a 25pl total reaction volume. Cycle 
conditions were: lmin at 94°C/ 2min at 50°C/ 2min at 72°C for 30 cycles, followed by 
lOmin final extension at 68°C.
5pl primary PCR reaction, 2.5pl (5pmol) Adapter primer 2, and 2.5pl (5pmol) GSP 
TmTx F were added to standard PCR mix and made up to 25pl total reaction volume 
with sterile H2O. For secondary PCR, the annealing temperature was raised to 55°C 
with the reminder of the cycling conditions as per primary PCR.
The PCR products (5pl reaction mix) were visualised by agarose gel electrophoresis. 
The PCR products were directly purified with QIAquick gel extraction kit (Qiagen, 
USA) as per manufacturer’s protocol.
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3.2.6 Identification of a Long-Chain Potassium Channel Toxin-Like Signal Peptide 
Sequence in M esob. ta m u lu s  cDNA
In the course of studies on tamulustoxin cDNA, a sequence encoding a putative signal 
peptide was deduced. Experimental conditions were as per 3.2.5 except as detailed 
below.
3.2.6.1 Primers
The primer used to obtain the signal peptide-like sequence was a degenerate reverse 
primer (TmTx R) 5’ -  YTCYTTRCCYTTYTCYTTYTT-3, (where Y =C or T, R= G 
or A), based upon the C-terminal sequence of tamulustoxin. The adaptor primer API, 
and nested adaptor primer AP2 had sequences as described earlier (3.2.2.4).
3.2.6.2 PCR Reaction
Primary and secondary PCR conditions were identical to those described for the 
tamulustoxin 3’ sequence (3.2.6.2), with the exchange of TmTx F primer for TmTx R.
The PCR products (IO jjI reaction mix) were visualised by agarose gel electrophoresis, 
producing a lower band at approx 200bp and a higher band of approx 250bp. The lower 
bands from two identical PCR reactions were excised, combined, and purified with 
QIAquick gel extraction kit (QIAGEN, USA) as per manufacturer’s protocol.
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3.3 Results
3.3.1 Identification of Putative Short Insectotoxin cDNA Sequences from Mesob. 
tamulus
An adaptor-ligated Mesob. tamulus telson cDNA library was probed for sequences that 
may represent short insectotoxins and hence have potential chloride channel modulating 
activity.
The 5’UTRs and signal peptides of scorpion ion channel toxins displaying similar 
pharmacological properties are often well conserved between species (Bougis et al., 
1989; Zeng et al., 2001, Corona et al., 2001), showing greater homology than the 
mature toxin sequences. Very little has been published on short insectotoxin nucleotide 
sequences. The 3’UTR and signal peptide nucleotide sequence is available for Bm-12 
(Zeng et al., 2000) and its variant Bm-12b (Xu et al 2000 -  direct submission to Entrez 
database) and the signal peptide nucleotide sequence for chlorotoxin variant CITx-c has 
been published (Froy et al., 1999). These nucleotide sequences were aligned using 
ClustalW (www.ch.embnet.org) (fig 3.1). As expected, there is high homology between 
Bm-12 and Bm-12b. There is also high homology between Bm-12 and CITxl at the 
nucleotide level. This homology is slightly higher at the end of the 5’UTR and the 
signal peptide (88.9%) than in the sequence encoding mature toxins (81.9%). If one 
considers the peptide sequences (all known isoforms of all known short insectotoxins), 
which are slightly more extensive; 58.3% signal peptide residues are conserved in all 
sequences, c.f. 30.8% mature peptide residues (see fig 3.4). Primers were designed 
based upon the 5’UTR and signal peptide of Bm-12 (a putative short insectotoxin from 
Buthus martensii Karsch).
Primary- and secondary-PCR was carried out using nested adaptor-primers and one of 
two degenerate gene-specific primers based upon the 5’UTR or signal peptide sequence 
using various PCR conditions. One such experiment yielded primary PCR products of 
approx. 370 base pairs (fig 3.2a). 20pl PCR reaction was run on an agarose gel, the 
bands excised and purified on a QIAquick column (Qiagen). The DNA was ligated into 
pCR®4-TOPO® vector via its A overhangs, and transformed into competent E. coli. 
After ampicillin resistance and lac z  screening, a number of colonies were selected and
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plasmid DNA purified by miniprep. Restriction digests on minipreps from a number of 
colonies revealed inserts of approx. 370 base pairs (examples shown in fig 3.2b).
Seven clones containing inserts of interest were selected for sequencing. Sequence 
analysis and comparison with those of known short insectotoxins revealed two novel 
cDNA sequences capable of encoding scorpion short insectotoxins (fig 3.3) which were 
named BtChll and BtChl2. BtChll was encoded by four clones, whilst BtChl2 was 
isolated from a single colony. Both sequences were submitted to the Entrez database 
(BtChll = AF481880, BtChl2 = AF481881) and were the first short insectotoxin 
sequences determined in this species.
In order to determine the mature sequence, the position of cleavage of the signal peptide 
was determined by a combination of von Heijne’s rules (von Heijne, 1986) and 
comparison with known short insectotoxin sequences (see fig 3.4). Both mature toxins 
appear to have an N-terminal arginine. The locations of the C-terminals of the mature 
toxins are less clear. BtChll amino acid sequence ends with a proline followed by two 
glycine residues. It is not uncommon for scorpion toxins to be amidated via removal of 
a C-terminal glycine, although not all scorpion toxins are processed in this manner. 
Therefore, BtChll may encode a mature peptide of 34, 35 or 36 residues, with or 
without C-terminal amidation. Using known rules for scorpion toxin C-terminal 
processing, one would expect BtChl2 to be unprocessed at this end, since it does not 
terminate in a basic residue. The validity of this assumption will be addressed later.
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Fig 3.1 Homology of Short Insectotoxin Nucleotides
Bm-12   GC AAAACTCTAT TAAAAATGAA
Bm-12b TGATATTGCA ATAATATACC AAAACTCTAT TAAAAATGAA
CITxl     ATGAA
GTTCCTCTAC GGAATCGTTT TCATTGCACT TTTTCTAACT GTAATGTTCG
GTTCCTCTAC GGAATCGTTT TCATTGCACT TTTTCTAACT GTAATGTTCG
GTTCCTCTAT GGAATCGCTT TTATTGCCGT TTTTTTAA CA GTAATGATCG
CAACTCAAAC
CAACTCAAAC
TGATGGATGT
TGATGGATGT
GGGCCTTGCT
GGGCCTTGCT
TTACAACGGA
TTACAACGGA
TGCTAATATG
TGCTAATATG
CAACTCATAT TGAAGCATGT GGACCTTGCT TTACAACGGA TCGTCAAATG
GCAAGGAAAT GTAGGGAATG TTGCGGAGGT ATTGGAAAAT GCTTTGGCCC 
GCAAGGAAAT GTAGGGAATG TTGCGGAGGT AATGGAAAAT GCTTTGGCCC 
GAAGAGAAGT GTGCAGAATG TTGCGGAGGC ATTGGAAAAT GCTATGGTCC
ACAATGTCTG TGTAACCGTA TATGAATAAT TAAAAATGTA CACCTGAACA 
ACAATGTCTG TGTAACCGTG AATGAATAAT TAAAAATGTA CACCTGAACA 
ACAATGTTTG TGT CGTG GTTGA ------------------- ---------------------
GATCATTTAA TGAATAATAA ATATTAATAA GCATTAAAAA AAAAAAAAAA  
GATCATTTAA TGAATAATAA ATATTAATAA GCATTAAGAA AAAAAAAAAA
The three published short insectotoxin nucleotide sequences were aligned using 
ClustalW. Bml2 (Zeng et al., 2000) and Bml2-b (Xu et al., 2000 -  direct submission to 
Entrez database) are variants of the same toxin from Buthus martensii Karsch. CITxl is 
a chlorotoxin variant from Leiurus quinquestriatus hebraeus (Froy et al., 1999). 
Regions encoding signal peptides are underlined, whilst regions encoding the mature 
peptide are shown in bold. Areas of homology are in red.
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Fig 3.2 PCR Products and Products of Restriction Digests Observed in the Cloning 
of Putative Short Insectotoxin cDNA Sequences
(a) Primary PCR' was performed using a degenerate Bm-12 signal peptide gene-specific 
forward-primer, and a universal adaptor-specific reverse-primer on an adaptor-ligated 
Mesob. tamulus cDNA library template. PCR products are shown (lane 1) run on a 1% 
agarose gel alongside a 123bp ladder (lane2). 20jul PCR products were run on a separate 
agarose gel, excised, purified using a QIAquick column (QIAGEN, USA), ligated into 
pCR®4-TOPO® cloning vector (Invitrogen, USA) and transformed into competent E. 
coli. Lac Z screening was used to select recombinant colonies for plasmid DNA  
purification, (b) Plasmids were digested using EcoRl, products visualised by agarose 
gel electrophoresis using 123bp marker (lane 1), and a number o f colonies containing 
inserts of approx 370bp (lanes 2-8) selected for sequencing.
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Fig 3.3 Sequencing of Putative Short Insectotoxin cDNA
a )  j o i a ^ i i i i
ttaaaa ATG AAR TTY CTN TAY GG
ttaaaa ATG AAG TTT CTT TAT GGA ACC ATT TTG ATT GCT
M K F L Y G T I L I A
TTT TTC TTA ACT GTA ATG ATT GCA ACT CAT TCT GAA
F F L T V M I A T H S E
GCT CGT TGT CCT CCT TGC TTT ACA ACA AAT CCG AAT
A R C P P C F T T N P N
ATG GAA GCC GAT TGT AGG AAA TGT TGC GGG GGT AGG
M E A D C R K C C G G R
GGA TAC TGC GCT AGT TAT CAA TGT ATA TGT CCT GGA
G Y C A S Y Q C I C P G
GGA
G
TAA
STOP
tatgaatgtacccttgaactgcagcgatcatttaatgataac aaatattatatgcattactgtaaaaaaaaa
b)BtCh!2
ttaaaa ATG AAR TTY CTN TAY GG
ttaaaa ATG AAG TTC CTG TAT GGA GTT ATT TTG ATT GCT
M K F L Y G V I L I A
CTT TTC TTA ACT GTG ATG ACT GCT ACT CTG TCG GAA
L F L T V M T A T L S E
GCA AGG TGT GGT CCT TGC TTT ACA ACT GAT CCT CAA
A R C G P C F T T D P Q
ACA CAA GCC AAG TGT AGT GAG TGT TGT GGG CGA AAG
T Q A K C S E C C G R K
GGT GGA GTA TGC AAG GGC CCA CAA TGT ATC TGT GGT
G G V C K G P Q C I C G
AT A CAA TAC TGA gatgtacacgtgaacatttaaggaaaataaatattaatataagcattactaaaaaaa 
I Q Y STOP
Seven putative short insectotoxin clones were sequenced using the Sanger dideoxy 
method (Sanger et al., 1977) on an automated sequencer (model 373A, Applied 
Biosystems, USA). Five clones produced sequences, which on comparison to known 
sequences, seemed to belong to the short insectotoxin family. Four o f the sequences 
were as shown in (a). This sequence was named BtChll. A fifth clone produced the 
sequence shown in (b), which was named BtChl2. The translation o f the nucleotide 
sequence is shown in bold. Primer sequence is also shown (underlined). Potential 
polyadenylation sites are shown in red.
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3.3.2 Purification of a Putative BtChll Peptide from Mesob. tamulus Venom
Since the presence of an mRNA sequence in the telson does not prove expression'of the 
gene product in the venom, mass spectrometry was used to screen the venom for masses 
of a size corresponding to the proposed mature peptide sequences. Since there was 
uncertainty about C-terminal processing of the BtChll peptide, efforts were focussed 
upon this molecule.
Protein was extracted from crude venom, and the extract fractionated by size exclusion 
chromatography with the aim of separating low and high molecular weight molecules 
from the neurotoxic components. Particularly problematic were the 
mucopolysaccharides, which afforded high viscosity and hydroscopicity to the venom 
extract, and which it was anticipated that the size exclusion column would remove. Size 
exclusion chromatography produced three peaks as seen by A280 (fig 3.5a). Mass 
analysis of the ‘main’ central peak fractions revealed a significant component of m/z ~ 
3798 that corresponded to a BtChll expression product terminating in a single glycine 
(fig 3.5b). This initial analysis did not reveal masses relating to any of the other putative 
BtChll mature peptides. It was decided to purify this component further. Since the 
biological activity of the component was unknown, a mass-spectrometry guided 
purification approach was employed.
Fractions from the ‘main’ size exclusion peak were pooled and re-fractionated by ion 
exchange chromatography (fig 3.5c). Fractions were pooled into eight eluted groups and 
column flow through. Upon desalting and analysis by mass spectrometry (fig 3.5d), the 
mass of interest was revealed in ion exchange group 1. This fraction elutes much earlier 
than potassium channel toxins elute. This is consistent with a less basic molecule such 
as that encoded by BtChll. Group 1 was further separated by reverse phase 
chromatography (fig 3.6a), screened by mass spectrometiy and fractions containing the 
mass of interest pooled. Optimisation of this step, and of a C8 reverse phase clean up 
stage (fig 3.6b), yielded a product which appeared as two peaks in MALDI-TOF mass 
spectrometry, one of m/z 3797 +/- 0.1% and another with a m/z, approximately half of 
this (fig 3.6c). In order to confirm that these two peaks were indeed related to a single 
molecular entity and to get a more precise mass, the sample was analysed on a more 
accurate and sensitive ESI/mass spectrometer. Mass reconstruction of m/z values (fig 
3.7) revealed two dominant masses (average masses 3797.2 and 3798.2 Da) exactly one
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mass unit apart, possibly representing a single peptide in both amidated and non- 
amidated forms. The analysis also revealed a number of minor contaminants, or 
possibly variants of a single component, of masses 3800-3900.
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Fig 3.5 Size Exclusion and Ion Exchange Chromatography of Mesob. famulus 
Venom, and Mass Spectrometry of Fractions to Detect Masses Corresponding to
Putative B tChl Gene Products
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Mesob. famulus venom was extracted in acidified water and 2ml fractionated by size 
exclusion chromatography in 50mM ammonium formate on a 75ml Sephadex G50 
column. 1ml fractions were collected and the absorbance measured at 280nm (a). Upon 
analysis by mass spectrometry, a number of fractions from the central ‘main5 peak were 
shown to contain a mass of approx 3797 (e.g. b). Fractions in this ‘main’ peak (19-38 *) 
were pooled. This pool was applied to an ion exchange column in lOOmM NaAc, pH4.8 
and eluted by a segmented gradient of 0-1M NaCl in the same buffer (c). Fractions 
comprising the first peak (*) were pooled to form ‘group 15 which was shown by mass 
spectrometry to contain the mass of interest (d).
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3.3.3 Synthesis and Purification of a Synthetic BtChll
A non-amidated version of the putative mature BtChll peptide (terminating in a single 
C-terminal glycine) was synthesised ‘in house’. Two previous synthesis attempts by 
alternative commercial peptide synthesis services had failed. It was initially intended 
that the mature peptide be purified by HPLC, as followed by mass spectrometry, prior 
to folding. Initial experiments suggested, however, that the synthesis had been 
unsuccessful. Mass spectrometry on a solution of the crude peptide (fig 3.8a) failed to 
show the presence of any dominant mass. Reverse phase chromatography failed to 
indicate the presence of discrete synthesis products (fig 3.8b), and mass spectrometry on 
the resultant fractions failed to detect an appropriate discrete mass.
It was decided to attempt to fold any peptide present prior to purification. A simple 
folding procedure was undertaken, in which the crude synthetic peptide was allowed to 
gently oxidise in buffer solution. After 94hrs, a considerable amount of material was 
present as a precipitate, but some material was in solution. Separation of this folded 
solution by C l8 reverse phase chromatography produced far greater peak resolution 
than obtained previously (fig 3.8c), and mass spectrometry of the fractions indicated the 
presence of a mass of interest (fig 3.8d-f).
Although the yield was low, since this was the only material of the correct mass isolated 
from any synthesis, it was decided to purify this material in order for its biological 
activity to be assessed. Attempts to utilise a C8 column failed; neither the unfolded nor 
folded crude solutions yielded fractions containing peaks of interest (fig 3.9). Peptide- 
containing fractions from the C l8 column also gave a disappointing result when applied 
to a C8 column. Purification of the folded peptide was instead improved by further 
optimisation of the solvent gradient on the C18 column. Final conditions yielded a 
single fraction containing an appropriate mass at acceptable purity, and additional, more 
complex, fractions also containing the mass of interest (fig 3.10). The purified fractions 
from a number of experiments were pooled and stored at -20°C. Remaining fractions 
containing the peak of interest were pooled, concentrated and re-purified under identical 
conditions.
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Fig 3.8 Analysis of Crude and Folded Synthetic BtChll by Reverse Phase HPLC 
and MALDI-TOF Mass Spectrometry
a) b)
d)c) %B
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A solution of crude synthetic BtChll was analysed by MALDI-TOF/ MS (a) and lmg 
fractionated by reverse phase HPLC on a C18 column at 0.5ml min'1 (b). Samples were 
eluted with a 0-100% linear gradient of 90% acetonitrile in 0.1% TFA. The eluent was 
monitored at 280nm and 1ml fractions collected. All fractions were analysed by 
MALDI-TOF/ MS but none contained the mass of interest. The crude peptide was 
allowed to fold (lmgml'1 in 20mM NaP0 4  pH8.2, agitated under air for 94hrs), and 1ml 
fractionated as above (c). All fractions were analysed by MALDI-TOF/MS. One 
fraction showed evidence of a mass potentially representing BtChll (d-f).
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Fig 3.9 Fractionation of Crude and Folded BtChll on a C8 Reverse Phase HPLC 
Column
mAU
200i
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100
mAU
F6 F7 F8 F9 F10 F ll
ml22.08.0 16.010.0 12.0 14.0 18.0 20.0
Crude (a) and folded (b) solutions of synthetic BtChll, identical to those previously run 
on a C18 column, were fractionated by C8 reverse phase HPLC. Samples were eluted 
with a 0-100% linear gradient of 90% acetonitrile in 0.1% TFA. The eluent was 
monitored at 280nm and 1ml fractions collected. All fractions were analysed by 
MALDI-TOF/ MS but none contained the mass of interest.
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Fig 3.10 Optimised HPLC Fractionation of Folded Synthetic BtChll Analysed by 
MALDI-TOF/MS
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lml folded synthetic BtChll solution was fractionated on a C18 reverse phase column
(a). The sample was eluted at lml min'1 with a 4.5-22.5% gradient of acetonitrile in 
0.1% TFA. lml fractions were collected and analysed by mass spectrometry. MALDI- 
TOF profiles of four fractions (*) are shown. Fraction d contained a molecule of the 
predicted mass with relatively little contamination. Fractions (b, c and e) also contained 
the molecule of interest but at low purity.
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3.3.4 Homology Modelling of BtChll and BtChl2
Automated comparative modelling was carried out using Swiss-Model. BtChll and 
BtChl2 were each modelled using 1CHL (chlorotoxin), ISIS (15A) and 1CHL + ISIS as 
templates. Analysis of the parent structures by WHAT IF suggested ISIS to be the more 
reliable of the template structures. Similarly, modelling on ISIS produced apparently 
better structures than modelling on 1CHL alone or 1CHL in conjunction with ISIS. The 
structures produced with ISIS as a template were no less reliable than the parent 
structures, and it was these lSIS-derived models that were used for analysis. Structures 
obtained for BtChll and BtChl2 are shown (fig 3.11a), together with the published 
structures of insectotoxin 15 A and chlorotoxin. The new molecules share the same basic 
structure as chlorotoxin, of an a-helical region (purple) and three stretches of p-sheet 
(green) cross-linked by four disulphide bridges (yellow). The C-terminal stretch of p- 
sheet is divided into two fragments in BtChl2.
The electrostatic surfaces of the four insectotoxins were calculated, and are illustrated 
alongside that of the potassium channel blocker charybdotoxin (fig 3.11b). The surface 
charge differences between the two groups of molecules are obvious, the insectotoxins 
having far more neutral (white) and negative surfaces (red) than the potassium channel 
toxin, which has predominately positive surfaces (blue). The negative charges at the C- 
terminus (top-right) should be viewed with caution, however, since the amidation status 
of BtChll and chlorotoxin is unknown. Interestingly, the highly conserved negative 
charge at position 9 has surface effects only in chlorotoxin (bottom centre, red region in 
chlorotoxin).
184
Fig 3.11 Homology Modelling of BtChll and BtChI2 and Calculation of their 
Electrostatic Surfaces
a) Automated comparative modelling of the putative mature toxins encoded by BtChll 
and BtChl2 was carried out using Swiss-Model in the ‘first approach5 mode. The 
template structure (insectotoxin 15A, ISIS, Lomize et al., 1991) was obtained from the 
RCSB Protein Databank. The structure of chlorotoxin (1CHL, Lippens et al., 1995) is 
shown for comparison. Stereoscopic images were produced from the PDB data using 
Protein Explorer.
b) Molecular surfaces were calculated, and electrostatic potentials computed and 
mapped to these surfaces using DeepView. Potentials were calculated using the 
coulomb computation method and atomic partial charges. Cut-offs: - red=-1.6kT/e; 
white=0.0kT/e; blue=1.6kT/e (k is the Boltzmann constant, T is temperature in Kelvin, 
and e is the charge of the electron. At 298K kT/e=25.6 mV). Non-amidated forms of the 
short insectotoxins were used. Charybdotoxin (2CRD, Bontems et al., 1992) is shown 
for comparison. Orientation is as for (a), with the a-helix to the left and the C-terminus 
pointing to the top right.
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Fig 3.11a
Modelling.
Stereoscopic Images of BtChll and BtChl2 Obtained by Homology
Insectotoxin I5A
Chlorotoxin
BtChll
BtChl2
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Fig 3.11b Electrostatic Surfaces of Short Insectotoxins and Charybdotoxin
Insectotoxin I5A
BtChl2BtChll
Charybdotoxin
3.3.5 Analysis of the 3’ UTR of Tamulustoxin cDNA
There is circumstantial evidence to suggest amidation of the tamulustoxin C-terminus 
(discussed in 3.1). The same adaptor-ligated cDNA library used to generate the 
chlorotoxin-like sequences was used to examine the 3’UTR and C-terminal precursor- 
peptide sequence of tamulustoxin, with the aim of providing further evidence for C- 
terminal amidation of the toxin.
Primary- and secondary-PCR was carried out using nested adaptor-primers and a 
degenerate gene-specific primer based upon the N-terminal peptide sequence of 
tamulustoxin. After optimisation of conditions, secondary PCR yielded two bands of 
approx. 245 and 730 base pairs (fig 3.12a) as visualised by agarose gel electrophoresis. 
The PCR mixture was directly purified on a QIAquick column (Qiagen), ligated into 
pCR®4-TOPO® vector, and transformed into competent E. coli. After blue/white 
screening a number of colonies were selected and plasmid DNA purified by miniprep. 
Restriction digests on minipreps from a number of colonies revealed inserts of approx. 
245 base pairs, a size similar to the lower PCR band (examples shown in fig 3.12b).
Several positive clones were selected for sequencing. In total 12 clones were identified 
with sequences corresponding to tamulustoxin. Three clones were re-sequenced using 
an alternative sequencing primer, yielding identical results. The consensus sequence is 
shown (fig 3.13a). Some sequence discrepancies did occur between the clones, 
although, in the majority of cases, the difference occurred in a single clone. There were 
more serious discrepancies, however, but these were primarily located in the region of 
primer binding and were, in all cases, conservative. As can be seen (fig 3.13b), there is 
also slight variation between this sequence and that previously reported (Strong et al., 
2001). This would not appear to be restricted to ambiguities in the new sequence but is, 
in all cases, conservative. The translated sequence of the peptide precursor reveals a 
potential amidation site (GK) at the C-terminus.
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Fig 3.12 PCR Products and Products of Restriction Digests Observed in the
Cloning of 3’ Tamulustoxin cDNA Sequences
a)
738 bp 615 bp
246 bp 
123 bp
(a) Primary and secondary PCR reactions were performed using degenerate 
tamulustoxin gene-specific forward-, and universal adaptor-specific reverse-primers on 
an adaptor-ligated Mesob. famulus cDNA library template. Secondary PCR products are 
shown (lane 1) run on a 1% agarose gel alongside a 123bp ladder (lane2). Products were 
purified directly from the PCR reaction mixture using a QIAquick column (Qiagen, 
USA), ligated into pCR®4-TOPO® cloning vector (Invitrogen, USA) and transformed 
into competent E. coli. Lac Z screening was used to select recombinant colonies for 
plasmid DNA purification.
(b) Plasmids were digested using EcoRl, products visualised by agarose gel 
electrophoresis using 123bp marker (lane 1), and a number o f colonies containing 
inserts of approx 250bp (e.g. lane 2) selected for sequencing.
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Fig 3.13 Sequencing of Tamulustoxin cDNA to Identify Cleaved N-Terminal and 
3’UTR Sequences
a)
CGY TGY CAY TTY GTY GTY TGY AC
CGT TGT CAT TTT GT GTT TGC ACT ACT GAC TGT CGT
R C H F V V C T T D C R
CGG AAT TCT CCT GGT ACA TAC GGA GAA TGC GTA AAG
R N S P G T Y G E C V K
AAA GAA AAG GGT AAA GAA TGC GTT TGT AAA AGT GGA
K E K G K E C V C K S G
AAA TAA aattcgacgtc tccctttctt gagaaataaa aatcaatctt gattttatg tcatggtttt tcaagtgaat 
K stop 
aaagaaaatt aaaatttgaa aaaaaaaaa
b)
CGT TGT CAT TTT GTT GTT TGC ACT ACT GAC TGT CGT
R C H F V V C T T D C R
CGC TGT CAT TTC GTT GTT TGT ACT ACT GAC TGT CGT
CGG AAT TCT CCT GGT ACA TAC GGA GAA TGC GTA AAG
R N S P G T Y G E C V K
CGG AAT TCT CCT GGT ACA TAC GGA GAA TGC GTA AAA
AAA GAA AAG GGT AAA GAA TGC GTT TGT AAA AGT GGA
K E K G K E C V C K S G/stop
AAA GAA AAA GGC AAG GAA TGT GTT TGT AAA TCT TGA
AAA TAA
K/- stop/-
Putative tamulustoxin clones were sequenced using the Sanger dideoxy method (Sanger 
et al., 1977) on an automated sequencer (model 373A, Applied Biosystems, USA). 
Twelve sequences corresponding to tamulustoxin were obtained. Three of these were 
also sequenced on the second strand, confirming previous results. The consensus cDNA 
sequence is shown, together with the deduced amino acid sequence (a). Bases 
conserved in all clones sequenced are shown in black. Those in blue differed in a single 
clone, whilst those in red showed deviation from the consensus in more than one clone. 
All observed deviations were conservative. Non-translated regions are in lower case; 
putative polyadenylation signals are in green. For the amino acid sequence, residues 
present in the mature toxin are in bold. Primer sequence is underlined, (b) Shows the 
consensus cDNA sequence (top) aligned against that previously published (below, 
italics) (Strong et al., 2001). Sequence discrepancies are highlighted.
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3.3.6 Identification of a Long-Chain Potassium Channel Toxin-Like Signal Peptide 
Sequence in Mesob. tamulus cDNA
During the course of experiments utilising tamulustoxin cDNA, a sequence was 
identified which has similarity to a signal peptide for a long-chain potassium channel 
toxin.
The same adaptor-ligated cDNA library used to generate the chlorotoxin-like sequences 
was probed with primers based upon the published C-terminal amino acid sequence of 
tamulustoxin. Primary- and secondary-PCR was carried out using nested adaptor- 
primers and a degenerate tamulustoxin-specific reverse primer. Secondary PCR yielded 
two bands of approx. 200 and 350 base pairs (fig 3.14a), as visualised by agarose gel 
electrophoresis. The lower molecular weight bands from two PCR reactions were 
excised, the DNA purified on a QIAquick column (Qiagen), ligated into pCR®4-TOPO® 
vector and transformed into competent E. coli. After blue/white screening a number of 
colonies were selected, the DNA purified by miniprep and restriction digests performed. 
A single clone contained an insert of just under 200bp (fig 3.14b), which was then 
sequenced (fig 3.15).
Upon analysis by BLAST (NCBI public database) the sequence proved to be 
homologous to the 5’UTR and part of the signal peptide of BmTxK(3, a putative long- 
chain potassium channel inhibitor from Buthus martemii (Zhu et al., 1999).
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Fig 3.14 PCR Products and Products of Restriction Digests Which Yielded a
Putative Long Chain Potassium Channel Toxin Signal Peptide
(a)
400 bp 
300 bp
200 bp 
100 bp
(a) Primary and secondary PCR reactions were performed using degenerate 
tamulustoxin-specific reverse-primers and universal adaptor-specific forward-primers 
on an adaptor-ligated Mesob. tamulus cDNA library template. Primary (lane 1) and 
secondary (lanes 2) PCR products are shown run on a 1% agarose gel alongside lOObp 
ladder (lane 3). The smaller bands from secondary PCR were excised, purified using a 
QIAquick column (Qiagen, USA), ligated into pCR®4-TOPO® cloning vector 
(Invitrogen, USA) and transformed into competent E. coll Lac Z screening was used to 
select recombinant colonies for plasmid DNA purification.
(b) Plasmids were digested using EcoRl and the products visualised by agarose gel 
electrophoresis using a lOObp marker (lane 1). The colony that contained the small 
(approx 200 bp) insert (lane 2) was selected for sequencing.
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Fig 3.15 TxKp Signal Peptide-Like cDNA Sequence from Mesob. tamulus
attttacatagcccgaaagattatcaaataaacg ATG AAA CAA CAA TTC TTC TTG
M K Q Q F F LM  M K 0 0 F F L
caattttacatagccccgaagattatcggtaaatgA TG AAA CAA CAG TTC TTC TTG
TTC TTA GCA GTG ATT GTG ATG CAN NCT TCT GTC ATT
F L A V I V M ? ? S V I
F L A V I V M I s V I
TTC TTA GCG GTG ATT GTG ATG ATT TCT TCT GTC ATT
GAA AAA AGA AAA GGG CAA GGA A
E K R K G Q G
E A G R G K E M
GAG GCG GGA AGA GGC AAG GAA ATG
Mesob. tamulus telson cDNA clones were sequenced using the Sanger dideoxy method 
(Sanger et al., 1977) on an automated sequencer (model 373A, Applied Biosystems, 
USA). Upon submission to BLAST (NCBI public database) the insert o f a single clone 
had high homology to TxKp signal peptide (Zhu et al., 1999). The cloned sequence, 
together with the amino-acid translation, is shown in black above. The published TxKp 
signal peptide sequence is shown in blue italics. The region of binding o f the 
tamulustoxin reverse primer is underlined. Differences between the observed and 
published sequences are highlighted.
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3.4 Discussion
3.4.1 Short Insectotoxins
This chapter identifies the first short insectotoxin cDNA sequences to be isolated from 
Mesob. tamulus, and the most complete cDNA sequences from this scorpion to date. 
Prior to this study, only three short insectotoxin nucleotide sequences had been 
published, and two of these were isotoxins. BtChll, identified here, encodes a 60aa 
precursor consisting of a putative 24aa signal peptide and a C-terminally processed 
mature peptide. The 62aa protein encoded by BtChl2 was assumed to be a precursor for 
a 38aa mature peptide.
The site of cleavage of the signal peptide was predicted according to the method of von 
Heijne (von Heijne, 1986). This is a modification of the (-3, -1) rule which looks at the 
properties of residues in two positions, N-terminal to the possible cleavage site. The 
method uses a weighted matrix to assess the probability of a particular residue occurring 
at each position from -13 to +2 from the cleavage site. The peptide is scored using each 
of the proposed cleavage sites, the site with the highest score having the greatest 
probability of cleavage. Both of the sequences deduced from this study were subjected 
to this analysis, the results being consistent with those that would be predicted from a 
comparison with known mature insectotoxin sequences.
Although the C-terminus of BtChl2 was assumed to be a tyrosine, the C-terminus of 
BtChll was less clear. C-terminal glycine residues in unprocessed peptides are often 
utilised to produce an amidated mature protein. In scorpion toxins, however, this is 
usually only the case if the glycine is followed by one or two positive residues. If there 
are three positive residues, cleavage alone generally occurs. (See section 3.4.2 for a 
more detailed discussion of scorpion toxin amidation.) In the case of BtChll, there are 
no basic C-terminal residues and two glycines. Investigation of venom components by 
mass spectrometry, however, revealed a significant mass corresponding to the version 
terminating in a single glycine.
Since the deposition of these cDNA sequences in the database, both native toxins have 
been isolated by different groups. In the case of BtChll, the amino acid sequence 
confirms this study’s prediction as to the location of the N-terminus, and reveals that the
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precursor undergoes C-terminal processing. Dhawan et al., 2002, reported a 35mer, 
toxic to insects, which is consistent with that encoded by BtChll, with the removal o f a 
single C-terminal glycine. The amidation status of the carboxylate residue is unclear.
Wudayagiri et al, 2001, reported the purification of a short insectotoxin from Mesob. 
tamulus that had lepidopteran toxicity. This native amino acid sequence (validated by 
mass spectrometry data) is identical to that predicted by BtChl2 cDNA, but with the 
omission of the C-terminal tyrosine. Since the cDNA sequence, described here, was 
derived from a single clone, there is the possibility o f a sequencing error. However, the 
occurrence of an error that inserts a single amino acid, leaving the remaining sequence 
intact, is highly unlikely. We therefore assume this to be a real phenomenon. The 
additional tyrosine may thus either be the result of a polymorphism, or indicative of C- 
terminal processing of the insectotoxin precursor. If the observed nucleotide sequence 
was indeed the result of polymorphism, it would be interesting to examine the effect o f 
this extra residue on activity. If the native peptide is the result of C-terminal processing 
of the precursor molecule, this processing again differs from that traditionally seen with 
scorpion toxins.
All o f the chlorotoxin homologues found in L. quinquestriatus hebraeus that have had 
their precursor sequences reported (CITx-a to CITx-d) have a C-terminal glycine (Froy 
et al., 1999) and no subsequent basic residues. On comparison with native chlorotoxin, 
one would predict post-translational cleavage o f this glycine residue. Bm-12 however, 
shows no C-terminal processing (Wu et al., 2000, Zeng et al., 2000). Some other short 
insectotoxins are reported to be amidated (e.g. 15, 15A, Ovchinnikov, 1984), whilst 
others have been shown to have a free C-terminus (e.g. AmmP2, Rosso and Rochat, 
1985). The short insectotoxins may therefore demonstrate a different pattern of C- 
terminal processing from that seen in sodium channel scorpion toxins (see Possani et al., 
1999 for details on sodium channel toxin processing).
Alignment of the short insectotoxins shows this group of peptides to be highly 
homologous. Aside from chlorotoxin, which has been reasonably well studied, very 
little is known about their physiological effects. Consequently, nothing is known about 
structural requirements for blocking chloride channels or inhibiting MMP-2 activity. It 
would therefore be interesting to assess the functional properties o f BtChll and 2, and to 
assess their potential as chloride channel specific probes. This requires either the
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purification of the native molecule, the synthesis of the peptide by solid-state methods 
or the generation of a recombinant analogue.
The presence in the venom of a component of molecular mass ~3797Da (one of those 
which would be predicted from analysis of the BtChll cDNA sequence) supported the 
case for peptide BtChll being an expressed venom protein terminating in a single 
glycine residue. In the absence of a functional assay for short insectotoxins (the use of 
insect neurotoxicity as a bioassay would be hampered by the presence of more potent 
and abundant long-chain insectotoxins in the venom), it was decided to purify the 
venom peptide that had the appropriate mass. Konno et al., 2001 utilised MALDI- 
TOF/MS guided fractionation to purify peptides from wasp venom. This type of 
approach enables characterisation of the native peptide with little loss of sample, 
therefore maximising output from the purification.
ESI analysis of the purified component showed average masses of 3797.2 and 3798.2 
Da plus minor contaminants. Calculated masses for the amidated and non-amidated 
forms of BtChll (assuming peptide termination after Gly35) were 3797.4 and 3798.4 
Da respectively. Mass spectrometry analysis did not reveal the presence of masses 
corresponding to any other putative BtChll expression products (see chapter 2). This 
peptide is thus the most likely venom candidate for the expression product of BtChll 
cDNA. After confirmation of the primary sequence, this peptide will be used for studies 
on biological activity.
As previously mentioned, the native peptide sequence has since been reported (Dhawan, 
et al., 2002), confirming the proposed C-terminal processing. The native toxin has a 
similar mass to the peptide purified in this study (3796.5Da, by MALDI-TOF/MS), but 
would appear to elute from a C l8 reverse phase column at a far higher acetonitrile 
concentration. It is hoped that sequence analysis of the purified peptide will reveal its 
molecular identity, either as a short insectotoxin or as a new venom component from 
Mesob. tamulus.
The crude synthetic peptide was not of good quality or yield. However, since two 
previous synthesis attempts by outside commercial services had failed, it was decided to 
persist with purification of the peptide despite the bad quality. This poor quality meant 
that HPLC traces were of little use and the extensive use of mass spectrometry was
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crucial. Initial folding attempts yielded a peptide of the correct mass, identifiable by 
mass spectrometry, which was purified by reverse-phase HPLC. The current yield of 
purified, folded, peptide is very low. If this peptide proves biologically active, attempts 
will be made to improve yields, concentrating on optimisation of the folding process. 
The concentration of peptide used in the folding reaction is rather high, and the reaction 
yields a considerable quantity of insoluble material. Significant improvements in yield 
may be achieved by simply decreasing this concentration, therefore reducing 
intermolecular disulphide bonding. Folding of the synthetic peptide may also be 
improved by the addition of the cellular enzymes peptidylprolyl cis-trcms isomerase 
(PPIase, or FK binding protein) and/or protein disulphide isomerase (PDI) to the 
reduced peptide, as recommended in the refolding of maurotoxin (Di Luccio et al.,
2001).
The synthetic and native molecules purified in this study have similar elution times on a 
C l8 column; however, they appear to show different behaviours on a C8 column. 
Future work will sequence these peptides and look for chlorotoxin-like biological 
activity.
A number of approaches were initially considered when deciding upon the methodology 
for identification of putative chloride channel blockers in this venom, including 
biological assays based upon known properties of chlorotoxin. A molecular biology 
approach was decided upon, since, even if the venom did not contain chloride channel 
or chlorotoxin-like activity, it was likely to contain short-insectotoxin homologues. 
With so little known about such molecules, further examples of short insectotoxins 
would prove valuable, even in the absence of Cf channel activity. Now that Mesob. 
tamulus short insectotoxins have been identified, the alternative approaches may 
provide useful information on the functional properties of BtChll and BtChl2. Once 
established, these assays could also be used for further screening of venom fractions for 
components of pharmacological interest.
Based on the ability of chlorotoxin to bind to membrane receptors on glioma cells 
(Soroceanu et al., 1998) and rat colonic enterocytes (Debin and Strichartz, 1991), it 
should be possible to develop binding assays for the screening of potential chlorotoxin- 
like molecules, of venom and of venom fractions. Colonic epithelial cell membranes 
would be prepared from epithelial cell scrapings of dissected rat colons in a
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modification of the method described by Reinhardt et al., 1987 and Debin et al., 1993. 
Use of this cell preparation would also provide details of chlorotoxin binding to these 
cells. Cultured glioma cells could also be used. Binding could either be assessed 
directly, using Biacore (or similar technology), or through competition binding assays 
using radiolabelled toxin, similar to those described using radiolabelled apamin (chapter 
4). Such assays do have limitations, however, with cell binding not necessarily 
correlating with pharmacological activity.
Recently, Deshane et al., 2003 have shown chlorotoxin to be an inhibitor of MMP-2 
activity. Matrix metalloproteinases (MMPs, reviewed by Visse and Nagase, 2003) are 
involved with extracellular matrix remodelling in a number of physiological processes, 
e.g. embryogenisis, wound healing, ovulation and menstruation, as well as general 
maintenance of the matrix. MMP activity has also been associated with a number of 
pathological states, for example, atherosclerosis, and multiple sclerosis. MMP-2 (or 
gelatinase A) is primarily active against basement membrane components and has been 
implicated as a therapeutic target in obesity (Chavey et al., 2003), prevention of airway 
remodelling in asthma (Suzuki et al., 2004), rheumatoid arthritis (Jackson et al., 2001) 
and a number of cancers (John and Tuszynski, 2001) including pancreatic (Bloomston 
et al., 2002), cervical (Mitra et al., 2003), breast (Duffy et al., 2000) and skin cancers 
(Hofmann et al., 2000), and glioma (Chintala et al., 1999). (In such cancers MMP2 
contributes to angiogenesis, providing a blood supply to solid tumours, and also breaks 
down the natural barriers to cell migration and metastasis). Commercial assays are 
available for MMP-2 enzyme activity, which could easily be applied to screen venom 
components for MMP-2 inhibition.
The two assays, described above, screen for chlorotoxin-like activities and are not a 
screen for chloride channel toxins in general. A more general assay would look for 
block of chloride ion flux. Electrophysiological methods have been utilised for such 
purposes by Fuller et al., 2004. Electrophysiological studies of Cl* channels are not as 
straight forward as equivalent studies on cation channels and, without good indications 
of a positive result, are impractical. More practical would be the use of Cl* sensitive 
fluorescent dyes to visualise, or quantitate, block of Cl* flux. Such assays have been 
used, for example, to examine chloride ion movement in epithelial cells, fibroblasts 
(Woll et al., 1996), synaptosomes and brain slices (Yu and Schwartz, 1995). They have
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also been utilised by Soroceanu et al., 1999 to examine the effect of chlorotoxin on 
glioma cells.
Finally, although not suitable for use with non-purified venom components, the insect 
neurotoxicity of the purified peptides could be explored. Chlorotoxin produces 
reversible paralysis in crayfish and in cockroaches (Debin et al., 1993) and AmmP2 has 
been reported as toxic to both insects and crustaceans (blowfly, beetle, and isopod) but 
not to mice (Rosso and Rochat, 1985). Native BtChll (BtITx3, Dhawan, et al., 2002) 
and BtChl2 (ButalT, Wudagagiri et al., 2001) were both isolated through their 
lepidopteran toxicities. Locust and cockroach insect synaptosomes have been used 
previously to study insect sodium channels (Gordon et al., 1990, 1992). Similar 
preparations could be used to study native binding of the short insectotoxins.
Short insectotoxins show high sequence homology. This is concentrated in three regions 
of the primary sequence. Structural analysis enables the location of these regions in a 
3D model of the protein to be predicted. There is a highly conserved region stretching 
from residue 2 of chlorotoxin through the p-sheet to Asp9 at the base of the N-terminal 
loop. In contrast, the a-helix is a region of high variability between short insectotoxins, 
although there are a few largely conserved residues (e.g. Lysl5 and a negative residue at 
positionl8). At the top turn of the molecule (see fig 3.11a) there is a conserved CCGG 
motif. The final conserved region is located around the C -terminal p-sheet ending at 
the final Cys residue. These conserved regions are therefore concentrated on the face 
opposite the a-helix.
Given the importance of charge in ion-channel toxin binding, the electrostatic properties 
of the short insectotoxins were investigated. The net charge of the known short 
insectotoxins varies between +1 (e.g. ChlTx-b) and +5 (e.g. Bs8). BtChll and BtChl2 
both have a net charge of +2; however, the distribution of charges differs markedly in 
these two peptides. Whilst the charged residues of BtChl2 generally conform to the 
consensus, the charge positions of BtChll vary markedly. More importantly, in terms of 
proposed function, the positions of four charges are conserved between BtChl2 and 
chlorotoxin (D9, K15, E l8, and K23) and three between BtChl2 and 15A (D9, K15, and 
E l8). BtChll shares only a single charged residue with chlorotoxin (R23) or with I5A 
(R17). It has been noted (Lippens et al., 1995) that residue Lys27 is conserved between 
chlorotoxin and the K+ channel blocker charybdotoxin, but its effect is negated by the
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close proximity of the negatively charged Asp residues. This lysine residue is critical 
for the interaction of charybdotoxin with the potassium channel pore, a K27R mutant 
destabilises the SMrer-charybdotoxin interaction by 1000-fold (see Miller, 1985). The 
residue is also present in all short insectotoxins, with the exception of Bsl4 and the two 
sequences described in this chapter. Nothing is known about the structural requirements 
for the recognition of chloride channels, but, given the importance of charge distribution 
in binding of ion channel toxins, and the fact that no single charged residue is conserved 
in all short insectotoxins, it would appear likely that there is considerable variation in 
pharmacological targets between members of this family.
To get a clearer picture of the extent to which these charged residues might be involved 
in toxin-receptor interactions, the electrostatic surfaces of four short insectotoxins were 
calculated. These four short insectotoxins have very different surface charge 
distributions. The positive surface seen in the solvent-exposed side of the C-terminal 0- 
sheet in potassium channel toxins is important in charybdotoxin binding (Park and 
Miller, 1992). This basic surface is maintained in 15 A and BtChl2 but not in chlorotoxin 
or in BtChll. Differing patterns of surface charge between short insectotoxins are also 
seen on the opposite side of the molecule. Although charged residues on the solvent- 
exposed face of the a-helix are critical for the binding of SK channel toxins to their 
target, in contrast, the charge distribution in this region varies widely within the ChlTx- 
like molecules. Thus the differing overall charge distributions seen in the primary 
structures of ChlTx-like molecules produce differing surface charge distributions, 
suggesting either that the short insectotoxins are binding to differing targets, or that 
electrostatic interactions are not critical determinants in the short insectotoxins’ mode of 
action.
The long-chain toxins active on sodium channels show marked variation in their species 
selectivities. Mammalian versus invertebrate selectivity of the sodium channel toxins 
and the structural basis of these species specificities is discussed by Gordon and 
Gurevitz, 2003. Examination of the limited functional data on the chlorotoxin family 
does suggest at least minor variations in the natural targets for short insectotoxins, 
revealed by their differing toxicity profiles. Chlorotoxin and I5A are both active on 
crustaceans, with chlorotoxin also acting on cockroaches (Debin et al., 1993) and 15A 
also acting on blowfly (Ovchinnikov, 1984). AmmP2 shows blowfly and beetle toxicity 
(Rosso and Rochat, 1985). As stated previously, both of the short insectotoxins isolated
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from Mesob. tamulus are active on lepidoptera (Wudayagiri et al, 2001; Dhawan et al.,
2002). In the case of BtChl2, this toxicity is selective and the toxin has no effect on 
blowflies. None of the other toxins have been reported to be tested against lepidoptera. 
There are two regions where ChlTx and 15 A are similar and BtChll and BtChl2 also 
show electrostatic similarities. The first is at the C-terminal end of the a-helix where 
chlorotoxin and I5A show areas of negative surface charge. The second is in the N- 
terminal loop spreading to the N-terminal region of the a-helix. Arseniev et al., 1984 
notes general structural homology between the a-p fold of the long- and short-chain 
insectotoxins. By this analogy, the second region of electrostatic similarity is 
structurally comparable to part of the region of long chain insectotoxins that determines 
their specificity for insects (Froy et al., 1999a). This area is far less basic in BtChll and 
BtChl2 than in ChlTx and 15A. Could this be the region that determines the Mesob. 
tamulus toxins’ selectivity for lepidoptera? Is the fact that both short insectotoxins 
found in this species are active against lepidoptera a reflection of an evolutionary 
adaptation for a specific prey type?
Finally, in the last few years, a series of papers has raised intriguing questions as to the 
status of chlorotoxin as a chloride channel blocker. Maertens et al., 2000 report no 
action of peptide containing fractions of Leiurus quinquestriatus quinquestriatus, nor of 
chlorotoxin itself, upon volume-regulated anion channels (VRAC), nor calcium- 
activated chloride channels when applied externally or cytoplasmically. The group was 
unable to repeat the observed block of GCC by chlorotoxin reported by Ullrich et al., 
1996, and dispute GCC being a chloride current, concluding that the current is through a 
K+ channel with non-exclusive K+ permeability. The 72 kDa protein that Soroceanu et 
al., 1998 reported to be the chlorotoxin acceptor was similar in size to predicted gene 
products of the C1C family (Jentsch et al., 1995). Recently this protein was identified as 
MMP-2 (Deshane et al., 2003), throwing further confusion into the issue. Chlorotoxin 
was shown to bind to surface-expressed MMP-2 on glioma cells, inhibiting its enzymic 
activity and increasing its endocytosis by caveolae. This enzyme inhibition and 
reduction of surface expression can account for the anti-invasive action of chlorotoxin 
on these cells. Taken together, these findings would appear to discount any chloride 
channel activity of chlorotoxin.
There have, however, been three recent reports documenting electrophysiological block 
of chloride channels upon intracellular application of scorpion venom components.
201
Dalton et al., 2003, report a block of a Ca2+ activated Cl' channel which modulates the 
resting potential in a specific subpopulation of reactive astrocytes, by chlorotoxin itself 
Fuller et al., 2004, have recently reported that intracellular application of a peptide 
component of Leiurus quinquestriatus hebraeus venom inhibits CFTR C1‘ currents. This 
inhibition was not due to alteration of binding kinetics, but by block of the channel pore. 
The same group has also reported block of C1C-2 (but not C1C-0 or C1C-1) currents by 
components of the same venom (Thomposon et al., 2003). Since the venom peptides 
only act intracellularly on these channels, it is unlikely that they are the natural target 
for short insectotoxins.
Thus chlorotoxin does affect certain ion channels, although it is unclear if this action is 
a direct one. Is the action on MMP-2 responsible for these ion channel effects? Or does 
chlorotoxin have a second site of action? Soroceanu et al., 1998 detected binding of 
chlorotoxin to two distinct classes of receptor on glioma cells. Are the venom 
components that are responsible for the block of CLC-2 and CFTR ion channels 
members of the short insectotoxin family? Do other members of the short insectotoxins 
bind MMP-2? If this molecule is their natural target what is its usefulness to the 
scorpion? How do the short insectotoxins produce their neurotoxic effects in insects? 
What is the nature of their natural target, and what structural features of the toxins are 
responsible for their activity?
From a pharmacological viewpoint, if BtChll and BtChl2 are found to inhibit chloride 
currents when applied intracellularly, this may not have direct therapeutic applications, 
but will provide tools for the investigation of chloride channels. Like chlorotoxin, they 
may prove active upon MMPs, with diverse therapeutic potential. To conclude, recent 
studies on chlorotoxin have served to highlight what little we know about the short 
insectotoxins, their targets, and mode of action. The identification of novel members of 
this toxin family, as described in this chapter, can only aid in the dissection of the 
mechanism of action of these little-studied molecules, irrespective of the 
pharmacological targets of such peptides.
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3.4.2 Amidation of Tamulustoxin
C-terminal amidation is a post-translational modification common in peptides found in 
the nervous system. Approximately half of nervous and endocrine system bioactive 
peptides possess a C-terminal a-amide group, critical for correct biological activity. The 
mechanism of amidation has been reviewed by Martinez and Treston, 1996. In the 
unprocessed molecule, the amino acid to be modified (which will form the carboxy 
terminus in the mature peptide) is followed by a glycine, which provides the amide 
group. This modification is a two-step process of hydrolysis and lysis, which, in 
mammals and amphibians, is carried out by a bifunctional peptidyl-glycine a-amidating 
monooxygenase enzyme (PAM). In the first reaction step, the glycine is oxidized to 
form alpha-hydroxy-glycine via the peptidylglycine a-hydroxylating monooxygenase 
activity (PHM). The peptidyl-a-hydroxyglyeine a-amidating lysase (PAL) then cleaves 
the hydroxyglycine releasing the amidated peptide and glycoxylate. In Drosphila, 
however, these PHM and PAL activities are encoded by separate genes (Kolhekar et al., 
1997), although it is not known if this is the pattern in invertebrates in general. 
Although all amino acids can be amidated, in principal, neutral hydrophobic residues 
such as Val or Phe are preferred substrates, whilst charged residues such as Asp or Arg 
are much less reactive. Amidation is believed to take place throughout the secretory 
pathway, particularly in the secretory granules. In virtually all cases, removal of the 
amide group significantly reduces, or destroys, the peptide's biological activity. The 
addition of an amide group at the C-terminus may enhance stability and biological 
activity of peptides that are not naturally amidated.
C-terminal processing of scorpion toxins often occurs during maturation. Several rules 
for this processing have been deduced through examination of sodium channel toxin 
sequences (as summarised by PosSani et al., 1999). In the simplest case (as is seen with 
excitatory insect toxins), the nucleotides encoding the C-terminal residue of the mature 
peptide are followed directly by a stop codon and no C-terminal processing takes place. 
In other toxins, additional basic residues are processed, and in general, if the last two 
residues of the precursor peptide are basic, they are cleaved during processing. If the 
precursor has a glycine followed by one or two basic residues at the C-terminus, the 
amino group of the glycine is used for amidation of the previous amino acid, which 
forms the new terminus. If the glycine is followed by three basic residues, however, the
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amino-acids are removed, but no amidation occurs. As more toxins types are examined, 
exceptions to these rules may become evident.
The majority of scorpion toxins active on voltage-gated potassium channels appear to 
be amidated. In potassium channel toxins, amidation would appear to determine affinity 
for the acceptor. Leiurotoxin, for example, is an SK channel toxin that is present in the 
venom in both amidated and non-amidated forms. The most abundant of these is the 
amidated form, which has an increased affinity for its receptor (Sabatier et al., 1994). 
P05, another SK channel toxin, has a C-terminal carboxylate. Amidation of this toxin 
strengthens the toxin-acceptor interaction to the extent that the binding to rat brain 
synaptosomes becomes, in effect, irreversible (Sabatier et al., 1993). Interestingly, in 
both molecules, the a-amidation status had no apparent effect on mouse toxicity.
With synthetic versions (both recombinant and produced by solid state methods) of 
scorpion toxins increasingly being used in experiments as a substitute for native ones, 
there is obviously a need to confirm the amidation status of the toxin prior to synthesis. 
Our group already had circumstantial evidence of C-terminal amidation of 
tamulustoxin, and the cDNA analysis carried out in this chapter has demonstrated that 
an additional C-terminal Gly and Lys are encoded by the cDNA. Following the current 
consensus for scorpion toxin processing, one would predict amidation to occur. Taken 
with the approximately IDa discrepancy in mass of the native molecule (Strong et al., 
2001), and its resistance to carboxypeptidase (P. Strong, unpublished observation), the 
cDNA evidence strongly supports amidation of the C-terminal serine in the mature 
toxin.
Analysis of the cDNA sequences of tamulustoxin clones revealed variation between the 
deduced and the published sequences, and also between the sequences of the clones 
themselves. In all cases, the deviations are conservative, not affecting the amino-acid 
sequence, but the cause of these differences should still be addressed. Slight 
conservative deviation from native cDNA sequence is often associated with the use of 
degenerate peptide sequence-based primers, and care should be taken when analysing 
such sequences in the region of primer binding. Degenerate primers were used for 
forward amplification in the current and published studies, and for reverse amplification 
in determination of the published sequence (Strong et al., 2001). Differences between 
individual clones, and between the consensus and published sequences in the 5’ region,
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correspond to those expected from the primer sequence, and a definitive identification 
of native sequence is impossible. At the 3’ end, the primers used in this study bound 
outside the range of the published sequences. Discrepancies are therefore most likely 
due to primer-related artefacts in the original sequence. However, four sequence 
differences cannot be attributed to the use of degenerate primers. They are all 
conservative, and occurred in all clones sequenced in this study. The reason for the 
discrepancy is unclear, although since all the clones sequenced in this study were 
derived from a single PCR reaction, an error during an early round of PCR cannot be 
ruled out.
All clones sequenced corresponded to tamulustoxin-1, and therefore no inferences on 
the amidation status of the tamulustoxin-2 variant can be made.
3.4.3 A Putative Long-Chain Potassium Channel Toxin Signal Peptide
Most scorpion potassium channel toxins are short peptides of 30-40 amino acids. The 
long-chain potassium channel toxins (p-KTx) have 61-64 amino acids cross-linked by 
only three disulphide bonds and are non-amidated. To date only four members of the p- 
KTx family have been identified from three scorpion species: TsTxKp from Tityus 
serrulatus (Rogowski et al., 1994; Legros et al., 1998), AaTxKp from Androctonus 
australis (Legros et al., 1998), and BmTxKp and BmTxKp2 from Buthus martensii 
(Zhu et al., 1999). TsKxKp is active against a delayed rectifier voltage-gated potassium 
channel (Rogowski 1994). Recombinant BmTXKp reversibly inhibits the transient 
outward potassium current in rabbit atrial monocytes and significantly prolongs the 
duration of the action potential in these cells (Cao et al., 2003). Aside from this data, 
very little is known about the function, three-dimensional structure or mode of action of 
these toxins.
All p-KTx have a similar RNA structure (Zhu et al., 1999) that encodes a signal peptide,, 
propeptide and mature toxin (fig 3.16). Legros et al., 1998 suggest that these toxins may 
be related to scorpion defensins. Defensins and p-KTxs both have a propeptide in their 
precursor and a phylogenetic analysis groups them both together. The same authors also 
suggested that these toxins represent an evolutionary link between sodium and 
potassium channel toxins, speculating that the increased length paved the way for an
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increase from three to four disulphides. With so few examples of these molecules, 
however, there is little in the way of evidence to support any theory as to their 
evolutionary relationships.
During the course of studies on tamulustoxin, a cDNA fragment showing high 
homology to the signal peptide of BmTxKp was isolated. In general, signal peptide 
sequences show high homology within a scorpion toxin group. However, only four 
putative long-chain potassium channel toxin sequences have been identified and the 
signal peptides of these do not appear conserved. BmTxKp is of low nucleotide and 
amino acid sequence similarity to the other three peptides in this family, but shows the 
same cysteine pattern (C...CXXC...C...CXC), suggesting a similar cysteine pairing 
(see fig 3.16). It is therefore possible that BmTxKp, and the putative long-chain toxin 
represented by the signal-peptide identified, represent a subfamily of P-KTx, explaining 
the signal peptide homology. It should be borne in mind, however, that the sequence 
was produced from a single clone, and that a fragment of homologous sequence, 
although warranting further investigation, does not provide conclusive evidence for a p- 
KTx in this scorpion venom.
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Chapter 4
Modification of Apamin, and the Effects on its Binding Affinity for 
Acceptors on Rat Brain Synaptic Membranes
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4.1 Introduction
Monoiodoapamin has previously been used to identify apamin binding sites, and hence 
SK channels to which it binds selectively and with high specificity, on membranes, 
whole cells and cultured cell lines prepared from a wide range of both neuronal and 
non-neuronal tissues. The results of these studies, which show binding to single classes 
of molecules, are summarized in table 4.1. In general, the values for Bmax are low, 
reflecting the low abundance of the acceptor, and therefore SKca channels, in 
mammalian tissues (1-50 fmol mg'1 protein), an abundance generally one fifth that of 
the sodium channel (Hugues et al., 1982d). Affinity of apamin for its acceptor is very 
high, being in the picomolar range.
The binding of radiolabelled apamin to rat brain synaptic membranes has been well 
characterised (Hugues et al., 1982c). This chapter describes the radiolabelling of 
apamin, and preparation of rat brain synaptic plasma membranes for use in filtration 
binding studies. The binding parameters of these components were determined in order 
to confirm assay performance prior to their use in competition binding studies. Once 
characterised, the assay was used to look at the apamin-acceptor binding properties of a 
number of test substances.
Information on protein conformation can be of great importance when elucidating 
function. Dempsey et al., 2000, used apamin as a model peptide for the study of P-tum 
structures, which are poorly characterised in relation to a-helices and P-sheets. Apamin 
contains an asparagine as the first P-tum residue, which is characteristic of Asn- 
stabilised type 1 P-tums. In this toxin, the p-tum is connected to a C-terminal a-helix by 
two disulphide bridges, resulting in a highly stable, well-defined structure (see fig 1.5).
Asn2 is thought to be involved in hydrogen bonding and hence the stability of a local P- 
tum (involving Asn2, Cys3, Lys4, and Ala5) as well as the peptide in general. 
Dempsey’s group have generated synthetic apamin analogues with an Asn2 to Ala2 
substitution, which produces peptides with two different disulphide bond patterns (as 
shown in fig 4.1).
In molecular modelling of the structures, replacing Asn2 with an alanine residue (which 
has a non-polar side chain unable to contribute to hydrogen bonding) did not retain the
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P-tum conformation. This destabilized the C-terminal helix region (connected to the (3- 
tum by two disulphide bonds), and subsequently the whole peptide. This prediction was 
confirmed by NMR spectroscopy studies on the analogues themselves.
These observations confirmed previous studies linking the stability of C-terminal a- 
helices with that of N-terminal P-tums, and also showed that the hydrogen bonds 
involving the Asn2 side chain were important for stability of the entire structure. The 
experiments allowed quantification of the contribution of the P-tum structure to total 
protein stability. This motif, in combination with the disulphide bonds and electrostatic 
interactions between the glutamate and the N-terminal primary a-amine group, account 
for almost all of the thermodynamic stability of the molecule.
As a complementary study to the structural studies described above, the work described 
in this chapter looks at the functional effects of this amino acid substitution, and of the 
wrongly-paired disulphide bridge analogue (see fig 4.1), on binding of apamin to its 
acceptor on rat brain membranes.
The effective and specific labelling of ion channel proteins is critical for their 
visualisation in cell biology studies and is achieved by a variety of direct and indirect 
methods. Immunostaining is often utilised, but finding suitable antibodies to ion channel 
subtypes may be hampered by high sequence conservation, such as that seen in many 
K+ channel subfamilies (Chandy and Gutman, 1993). Antibodies to ion-channels tend to 
recognise intracellular epitopes, and sample preparation often requires permeabilisation 
and fixation of samples, making them unsuitable for real-time studies. Direct labelling 
of channels, for example by expression with a green fluorescent protein tag, overcomes 
this problem, but the channels produced are non-native.
Ion channel toxins are able to interact with native ion channels in living cells, and most 
ion channels toxins bind extracellularly. To facilitate their use in cell biology, 
fluorescently labelled toxins have been made. For example Massensini et al., 2002, used 
fluorescently labelled scorpion toxins to visualise the distribution of voltage-dependent 
sodium channels in living GH3 cells via laser scanning confocal microscopy. 
Fluorescent toxin probes have a number of potential uses, for example in flow 
cytometry or studying up-regulation of specific channel types, as often occurs in tumour 
cells. Use of differently coloured fluorophores allows for simultaneous labelling of
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different receptors in the same cell, thus providing greater flexibility than radioactive 
counterparts.
Alexa Fluor 488 is a commercially available fluorescently-labelled apamin. It has been 
used to study transfection of HEK cells with SK2 (Cingolani et al, 2002). However, the 
binding properties of Alexa Fluor apamin to SK channels has, to our knowledge, not 
been reported. Experiments were carried out to validate the use of fluorescent apamin as 
a cell biology tool.
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Table 4.1 Published Apamin Binding Parameters
Tissue Kd
(PM)
"max Hypo-/ Iso- 
osmotic?
Author
Rat synaptic membranes 2.7 42 Hypo-osmotic Wadsworth et al., 1994
Rat brain synaptic plasma membranes 3.3 47 Hypo-osmotic Wadsworth et al., 1996
Rat synaptic membranes 15-25 12.5 Hypo-osmotic Hugues et al., 1982c
Rat brain synaptic membranes 35 22 Hypo-osmotic Hugues et al., 1982b
Solubilized rat brain synaptosomes 40 17 Hypo-osmotic Seagar et al., 1987
Rat forebrain homogenate 10-25 1-3 Hypo-osmotic Habermann and 
Fischer, 1979
Canine cerebral cortex synaptic 33 17.3 Hypo-osmotic Wu et al., 1985
membranes
Neuroblastoma (Clone N1E 115) 15-22 12 Hypo-osmotic Hugues et al., 1982d
Cultured rat neonatal skeletal muscle 36-60 3.5 Hypo-osmotic Hugues et al., 1982
membranes
Guinea pig colon smooth muscle 36 30 Hypo-osmotic Hugues et al., 1982a
membranes
Guinea pig ileum smooth muscle 67 42 Hypo-osmotic Marqueze et al., 1987
Rat heart membranes 59 24 Hypo-osmotic Marqueze et al., 1987
Guinea pig liver membranes 15 43 Hypo-osmotic Marqueze et al., 1987
Guinea pig liver plasma membranes 12.6 4.2 Hypo-osmotic Strong and Evans, 1987
Rat liver plasma membranes - <0.2 Hypo-osmotic Strong and Evans, 1987
Guinea pig plasma membranes 12.6 4.2 Hypo-osmotic Strong and Evans, 
1987a
PC 12 cell membranes 5.8 23 Hypo-osmotic Wadsworth et al., 1997
Solubilized rat cortex synaptic 40-150 - Iso-osmotic Schmid-Antomarchi et
membranes al., 1984
Cultured rat embryonic neurons 60-120 3-8 Iso-osmotic Seagar et al., 1984
Cultured rat brain asterocytes 90 3 Iso-osmotic Seagar et al., 1987a
PC 12 cell membranes 350 600 Iso-osmotic Schmid-Antomarchi et 
al., 1986
Bovine adrenal medulla chromaffin cells 132 0.72*3 Iso-osmotic Lara et al., 1995
Guinea pig hepatocytes (whole cells) 390 l.l* 2 Iso-osmotic Cook and Haylett, 1985
Rat hepatocytes - 0* Iso-osmotic Cook et al., 1983; Cook
0.99*2
and Haylett, 1985
Liver (guinea pig hepatocytes) 390 Iso-osmotic Cook et al., 1983
Human erythrocytes - 01 Iso-osmotic Cook et al., 1983; Cook 
and Haylett, 1985
Rat heart cultured cells (primary cardiac 69 2.8 Iso-osmotic Marqueze et al., 1987
cells)
*] fmol/mg membrane or cell protein 
*2 fmol/mg dry weight cells 
*3 fmol/io6 cells
+ No inhibitable binding at concentrations up to 5 0 0 pM toxin.
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Fig 4.1 Diagrammatic Representation of Apamin-N2A.
a)
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Synthetic apamin-N2A is an 18 amino acid apamin homologue (a) with an Asn2 to Ala2 
substitution. The diagram illustrates the C ysl-C ysll and Cys3-Cysl5 native disulphide 
bond pairings and the positions o f the p-tum and a-helix. Apamin N2A-par (b) has 
wild-type disulphide bond pairing, with the participating cysteine residues arranged in a 
parallel fashion adopting the ‘globule’ formation. In the apamin N2A -anti isomer (c), 
these cysteines are antiparallel with Cysl-Cysl5 and Cys3-Cysll disulphide bond 
pairings resulting in a structure known as the ‘ribbon’ formation in the notation of 
Pegoraro et al., 1999.
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4.2 Materials and Methods
4.2.1 Materials
Sodium 125I-Iodide was purchased from Amersham-Pharmacia. The BCA protein assay 
kit and Iodogen were purchased from Pierce. Whole frozen rat brains were purchased 
from Charles River Laboratories. Native and synthetic apamin, and the synthetic apamin 
derivatives N2A-par and N2A-anti, were supplied by Dr Chris Dempsey (University of 
Bristol). Alexa Fluor 488 apamin was purchased from Molecular Probes. All other 
chemicals were obtained from Sigma or BDH and were AR quality or equivalent where 
available.
4.2.2 Determination of Apamin Binding Parameters
4.2.2.1 Radioiodination of Native Apamin
Radiolabelled apamin was prepared by a modification of the procedure described by 
Strong and Brewster, 1992, which uses the Iodogen method to label Hisig. 1.5ml 
microcentrifuge tubes were coated with iodogen as follows: lOmg iodogen (Pierce) was 
dissolved in 25ml dichloromethane and 80jil of this solution was transferred to a 
microcentrifuge tube. The solution was evaporated to dryness under a gentle stream of 
nitrogen.
To this tube lOOpg apamin (lOOpl, lmgrnl'1), 2mCi Na125I (20pl, lOOmCi ml"1) and 
60pl 30mM Tris-HCl (pH8.6) were added, and incubated for 20min at room 
temperature, shaking intermittently. The contents of the vial were transferred to a fresh 
microcentrifuge tube for lOmin to allow unincorporated 125I+ to revert to L.
The reaction mixture was purified on a SP-Sepharose (Pharmacia) cation exchange 
column (14 x 1cm) equilibrated with 50mM sodium phosphate pH6.0/ 160mM NaCl 
(8ml hr-1). Elution with the same buffer (1ml fractions) yielded three radioactive peaks 
when measured in a calibrated y-counter. The initial peak containing unincorporated 
Na125I, was followed by a minor di-iodo[125l2] apamin peak, after which mono-iodo[125I] 
apamin eluted. Non-radiolabelled apamin remained on the column and could be eluted
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with 50mM sodium phosphate pH6.0/ 300mM NaCl if required. Mono-iodo[125I] 
apamin (specific activity 2200Ci mmol’1) was stored at 4°C in the presence of 2mgml'1 
BSA.
4.2.2.2 Preparation of Rat Brain Synaptic Plasma Membranes
Rat brain membranes were prepared, essentially according to the method of Dodd et al., 
1981, from whole frozen (-70°C) rat brains. Sucrose solutions were buffered with 
lOmM HEPES/ 2mM Na EDTA pH7.5. All solutions were ice cold and contained the 
following protease inhibitors: - 25pgml'1 bacitracin, lOpgml’1 soybean trypsin inhibitor, 
0.2mM benzamidine and 0.1 mM PMSF (dissolved in ethanol). All manipulations were 
performed on ice. Centrifugations were performed at 4°C using a Sorval SS34 rotor in a 
Sorval RC5B centrifuge or a Beckman 45Ti rotor in a Sorval Pro 80 ultracentrifuge.
Six rat brains were homogenized using five up and down strokes of a Wheaton glass- 
perspex homogeniser (0.1- 0.15mm radial clearance) in 2 x 35ml 0.32M sucrose. The 
homogenate was spun 3700rpm (1000 x g) in a SS34 rotor for lOmin and the 
supernatant collected on ice. The pellets were resuspended, spun, and the supernatants 
collected, as above. The supernatants were pooled to give the SI fraction, which was 
spun in a 45Ti rotor for 20min at 20500rpm (33000 x g). The crude mitochondrial pellet 
(P2) was retained and the supernatant discarded. The pellet was resuspended in 130ml 
0.32M sucrose and homogenized with eight up and down strokes of the homogeniser 
above. This homogenate was layered onto 4 x 30ml cushions of 1.2M sucrose in 45Ti 
centrifuge tubes and spun for 45min at 45000rpm (150000 x g). The membrane material 
suspended at the interface of the two solutions was collected, leaving the fat behind. 
This material was diluted to 140ml final volume with the HEPES/ EDTA buffer 
described above and layered onto 4 x 30ml 0.8M sucrose solutions in 45Ti tubes. These 
tubes were centrifuged 45min at 45000rpm (150000 x g). Myelin at the sucrose 
interface was removed, as was any disturbed fat. The remaining liquid was then 
removed and discarded, leaving a synaptosome pellet. This pellet was resuspended in 
10ml lOmM KC1/ 25mM Tris, pH8.4, snap-frozen in liquid nitrogen, and stored at 
-70°C.
215
4.2.2.3 BCA Protein Assay
Proteins were quantified using a BCA (bicinchoninic acid) protein assay kit (Pierce) by 
a method based on that described by Smith et al., 1985. This assay method is highly 
sensitive, shows little protein-to-protein variation and is compatible for use with a wide 
range of substances (e.g. nonionic detergents and Tris) that normally interfere in the 
Lowry assay. BSA was used as a standard.
4.2.2.4 Saturation Binding Assays
The binding of radiolabelled apamin to rat brain membranes was performed using a 
filtration binding assay based on that described in Wadsworth et al., 1994. All 
incubations were on ice and all solutions kept ice-cold. Three such experiments were 
performed, each with triplicate samples.
Radiolabelled toxin was diluted to concentrations in the range 0.1-100pM in 950pl ice 
cold binding buffer (lOmM KC1/ 25mM Tris pH8.4 containing 0.1% BSA). Tubes were 
counted individually in a calibrated Packard Cobra y-counter (approx. 85% efficiency) 
until a 1% sigma confidence was reached (or for a maximum of 20min), to obtain 
accurate values for calculation of total toxin concentration. 50pl membrane solution 
(diluted in above buffer) was added to give a final concentration of lOOpg membrane 
protein per tube. Tubes were vortexed, and incubated on ice for 90min.
Bound ligand was separated from free using Whatman GF/B glass-fibre filters pre­
soaked for lhr at 4°C in 0.5% w/v polyethyleneimine. With this technique, introduced 
by Bruns et al., 1983, acidic membrane proteins are electrostatically retained by the 
polycation, whereas neutral or basic ligands, e.g. apamin, are not. This helps to 
dramatically reduce non-specific binding of free (basic) apamin to filters. Excess liquid 
was drained from the filter, which was placed in a Brandell cell harvester. Samples were 
rapidly filtered and washed with 5ml ice cold binding buffer. Filters were placed in the 
bottom of tubes and read in the y-counter as above.
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Non-inhibitable binding was determined by parallel incubations in the presence of 
0.1 pM native apamin and subtracted from total binding to give the inhibitable 
component.
4.2.2.5 Determination of Non-Specific Binding
^-Tubocurarine, another blocker of SKca channels, was used to ensure that the 
inhibitable binding determined by competition with excess cold apamin described above 
was due to specific and biologically relevant binding to the apamin acceptor. lOOpM 
radiolabelled apamin was. incubated with the membranes in the presence and absence of 
0.1 pM unlabelled apamin or ImM d-tubocurarine chloride and filtered as described 
above. Results were determined in triplicate experiments, each carried out with 
triplicate samples.
4.2.2.6 Time Course of Apamin Binding to Rat Brain Synaptic Membranes
50pl membrane solution was added to 900pl binding buffer (described above) to give 
lOOpg membrane protein per tube, and incubated on ice. At appropriate time intervals, 
50pl radiolabelled apamin solution was added to give a final concentration of 15pM, 
which is close to the Kd (equilibrium dissociation constant) for this reaction. Total 
incubation times with labelled toxin varied between 120min and 1.5min, which was the 
lowest practical incubation time. After incubating with radiolabelled apamin, membrane 
samples were filtered and counted in a y-counter as described (4.2.2.4).
Diluted membrane samples for assessing non-specific binding were pre-incubated with 
0.1 pM unlabelled apamin for lhr on ice, prior to the addition of labelled apamin and 
then processed as above.
For the time course experiments triplicate tubes were prepared for each sample. The 
time points used were interspaced over three individual experiments and the data 
combined to produce a single time course.
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4.2.2.7 Analysis of Binding Data *
Data from three experiments on the time course of binding using different incubation 
times were combined and plotted using Prism (Graphpad software, San Diego USA), 
and an exponential association rate curve was fitted to the data using the same software. 
Results from saturation binding experiments were analysed using Radlig (Biosoft, 
Cambridge, UK). Site modelling and non-linear curve fitting allowed for Scatchard 
analysis of the saturation binding data, and estimations of Kd, Bmax (maximum binding 
site density) and Hill coefficients were determined using the same software. Plots 
shown in the results section were produced from appropriate curve fitting algorithms 
using Prism and show typical results from three separate experiments, each with three 
replicate samples.
+ The analysis of the binding data (Hulme and Birdsall, 1 9 9 0 ; and Haylett, 19 9 6 ) assumed a simple 
bimolecular interaction, and was based upon the law of mass action:
ligand + receptor ligand:receptor
<  Koff
Free ligand (L) and receptor (R ) collide due to diffusion. If this collision is in the correct orientation and is 
of sufficient energy, binding occurs to form a receptor-ligand complex (L R ). The rate of association 
(number of binding events in a period of time) is determined by: [L] x [R] x Ron, where Kon is the on rate 
constant (M*1 mirr1)- Similarly, the rate of dissociation (number of dissociation events in a given period of 
time is determined by: [LR] x Koff, where Koff is the off rate constant (min1).
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At equilibrium, the rate of dissociation is equal to the rate of formation of new complexes, thus 
[L] x [R ] x Kon = [LR] x Koff
The relationship between the on rate and the off rate constants at equilibrium is defined by the equilibrium 
dissociation constant Kd (M ).
[L ]x [R ]_ K «
Note that when half of the receptors are occupied, the concentration of occupied is equal to the 
concentration of unoccupied receptors: [R] = [LR] therefore Kd = [L]. Thus Kd is the concentration of 
ligand that will occupy half of the receptors at equilibrium.
In the equilibrium binding studies B denotes the amount of radioligand bound, whilst Bmax denotes the 
maximum capacity.
[ r l ]  = [kjrot x — 1—-r where [R ] Tot is the concentration of bound and free receptor.
Kd 4- [LI
Therefore B = Bmax x — -i and a plot of B against [L] should produce a rectangular hyperbola.
Kd +  [L]
The top of this curve can give an estimation of Bmax, and Kd can be estimated by reading the ligand 
concentration that produces half maximal binding.
In practice, the observed binding is the result of both specific radioligand binding to the receptor and non­
specific binding. Since under ideal conditions, non-specific and specific binding are independent, for a 
given ligand concentration specific binding can be calculated by subtraction of non-specific binding from 
total binding. In the case of the apamin binding studies described in this chapter, non-specific binding is 
determined by repeating radioligand binding in the presence of excess unlabelled apamin.
In order to obtain a linear representation of the relationship, saturation binding data is often subjected to 
linear transformation. A number of transformations may be used, the most common of which is the 
Scatchard plot:
B  Bmax B  BFrom the previous equation, = ----------- , and bound/free ( y-r) is plotted against bound (B).
[L] Kd Kd [Lj
If the data is from a first order reaction, a straight line will be obtained with an x intercept of Bmax and a 
slope of -  — . Non-linear data may indicate the presence of multiple binding sites of different affinities orKd
cooperativity of binding.
A more common method for the determination of multiple binding sites or cooperativity of binding is 
transformation of data to a Hill plot. The above equation can be further rearranged:
— ——  -  -fci th e r e fo r e  lo g  f— 5 — 1 =  lo g  [ l ]  -  logKd
Bmax — B  Kd yBmax B y  L J
If data is derived from non-cooperative binding to a single class of binding sites, plotting log [ ^, Bmax B
against log [L] should yield a straight line of slope = l.
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4.2.3 Binding of Apamin-N2A Isoforms
4.2.3.1 Synthesis, Refolding and Purification of Apamin Analogues
The synthesis, purification and refolding of the apamin analogues was carried out by Dr 
Chris Dempsey, (University of Bristol).
Synthetic apamin and synthetic apamin-N2A (both with C-terminal carboxyamide) were 
synthesised using standard Fmoc chemistry 5-10mg of the crude synthetic peptides were 
purified by reverse phase HPLC using a linear gradient (0-30% acetonitrile/ 0.1% TFA 
over 35mins) on a Vydac C4 semi-preparative column with a flow rate of 2-3ml m in1. 
Correct synthesis was confirmed by a) mass spectrometry and b) 2-D NMR.
Disulphides were allowed to form by air oxidation of the synthetic apamins in aerated 
lOmM sodium phosphate pH7.0, in the presence of O.lmM EDTA (to remove trace 
metals which may bind to cysteine side chains and prevent disulphide formation). 
Disulphide formation was followed by reverse phase HPLC, which was also used to 
separate and purify the various disulphide-bonded isoforms.
4.2.3.2 Screening of Synthetic Peptides for Inhibition of Monoiodo[125I]apamin 
Binding
The various apamin-based peptides were assessed for their ability to inhibit the binding 
of radiolabelled apamin to its acceptor on rat brain membranes using a variation of the 
filtration binding assay described in 4.2.2.5. A single concentration of radiolabelled 
toxin (lOOpM) was incubated in the presence or absence of a ten-fold excess of the test 
substance.
4.2.3.3 Competition Binding Assays with Apamin Analogues
Filtration binding studies, in the presence of increasing concentrations of the peptides 
were used to construct competition binding curves. lOpM radiolabelled apamin 
solutions containing varying concentrations of putative competitor were assayed in
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triplicate for binding to rat brain synaptic membranes using the filtration binding assay 
described. The non-specific component was determined by inclusion of lOOnM cold 
native apamin in parallel incubations. As with the screening experiment above, the 
experiment was carried out in triplicate, with triplicate samples used for each 
experiment.
Competition binding data was analysed* using sigmoidal curve-fitting and Hofstee 
analysis (Radlig). Ki values were estimated for the competitors of radiolabelled native 
apamin binding.
4.2.3.4 Competition Binding Curves for the Two Halves of HPLC Peak for Apamin 
N2A-Anti
In order to determine whether or not the competitive binding shown by apamin N2A- 
anti was due to contamination with the native disulphide bridges isoform, leading and 
trailing halves of the N2A-anti isoform peak, as purified by HPLC, were collected
125separately. Competition binding studies were carried out against I-apamin as before.
fIn general, assuming non-cooperative binding to single class of receptors, if a range of unlabelled 
competitor concentrations ([i]) are incubated with the receptor in the presence of fixed amount of 
radioligand (<[Ka]) the resulting concentration of bound radioligand can be plotted against log [i] to 
produce a sigmoid curve. Inhibitors/competitors are often defined in terms of IC50 ([I] which produces 
5096 reduction in radioligand binding). The loglCso can be determined directly from this plot. The Hofstee 
plot linearises this relationship. If the 96 reduction of ligand binding is plotted against 96 reduction/ 
competitor concentration, a straight line with a slope of [IC 5 0 ]  is produced.
The relationship between inhibitor concentration [i] and specific binding in the presence of inhibitor (Bi) is 
given by the equation
Bi = Bmax X  -7 T-rr-------
Provided Kd is known for the labelled ligand, non-linear least squares analysis can be used to derive Ki (the 
equilibrium dissociation constant for the inhibitor/competitor) from the competition binding curves using 
this equation.
The equations above were taken from Haylett, 199 6  and Hulme and Birdsall, 1 9 9 0 . For further information 
on the subject, refer to these references.
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4.2.4 Binding Studies on Alexa Fluor 488 Apamin
4.2.4.1 Testing the Ability of Alexa Fluor 488 Apamin to Inhibit 
Monoiodo[12SI]apamin Binding to Rat Brain Synaptic Plasma Membranes
A single concentration of radiolabelled toxin (lOOpM) was incubated with rat brain 
membranes membranes, in the presence or absence of InM Alexa Fluor 488 apamin in 
the filtration binding assay described in 4.2.2.5.
4.2.4.2 Competition Binding Curves for Alexa Fluor 488 Apamin
Competition binding curves were created as described for the synthetic apamin 
analogues (4.2.3.3) using lOpM radiolabelled toxin and concentrations of Alexa Fluor 
apamin in the range lpM-lOOnM. Control curves were created in parallel using lOfM- 
lOOpM native apamin.
4.2.4.3 Competition Binding Curves for Alexa Fluor 488 Apamin Under 
Physiological Buffer Conditions
Competition binding curves for native and Alexa Fluor apamin were performed in 
physiological Hepes buffered saline solution (HBSS: -124mM NaCl/ 4mM KC1/ 2mM 
CaCk/ 1.2mM MgCV lOmM glucose/ 25mM Hepes, pH7.4 in the presence of 0.1% 
BSA) (Massensini et al., 2002). In order to ascertain a suitable concentration of 
radiolabelled apamin for use in the assay an approximate saturation binding curve was 
constructed. 40pM proved to be a suitable concentration of radiolabelled apamin and 
was therefore used. The concentration ranges of the native, and fluorescently labelled 
toxins used to construct competition binding curves in HBSS were lOOfM-lOnM and 
lOOfM-lOOnM respectively.
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4.2.4.4 Use of Alexa Fluor 488 Apamin to Visualise Transfected SK Channels in 
HEK Cells
Alexa Fluor apamin was used to label HEK-293 transfected with the SK2 gene 
(Cingolani et al, 2002). The same group also used the fluorescent apamin probe to 
visualise transfected SK3 in these cells (Dr Martin Stocker, University College London 
- unpublished data). Briefly, cells were incubated with 50nM Alexa Fluor apamin on a 
coverslip for lOmins. Slide was washed by three dips in PBS and embedded in 20% 
glycerol in PBS. Binding was visualised with a fluorescent microscope and images 
recorded with a CCD camera.
4.2.4.5 Electrophysiology of block of rSK2 with Alexa Fluor Apamin
Electrophysiological recordings were performed for the Alexa Fluor apamin block of 
rSK2 by Mr Dieter D’Hoedt (University College London). The recording conditions 
were as described for whole cell patch clamp on HEK293 expressing chimeric rSKl 
channels in D’Hoedt et al., 2004.
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4.3 Results
4.3.1 Radioiodination of Native Apamin
Native apamin was labelled with 125I at His 18 by the Iodogen method, and 
monoiodo[125I]apamin was purified from the reaction mixture by isocratic ion exchange 
chromatography (fig 4.2). The first peak represents unincorporated Na125I. The second 
peak contains monoiodo[125I]apamin free from unlabelled apamin, which remained on 
the column. The approximate recovery after purification was 50%, and the purity of the 
final product was >98%. Monoiodo[125I]apamin had a specific activity of2200Ci /mmol 
and was stable stored in the presence of 2mgml'1 BSA at 4°C for two months.
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Figure 4.2 Purification of Monoiodo[125I]apamin by Ion Exchange
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Native apamin was radiolabelled at Hisl8 by the Iodogen method. 
Monoiodo[125I]apamin was purified from the reaction mixture under isocratic conditions 
(50mM sodium phosphate pH6.0/ 160mM NaCl) on an SP sepharose ion exchange 
column as described (4.2.2). Fractions were quantified by reading lOpl samples in a y- 
counter. The elution profile above is typical o f that obtained from three separate 
iodinations and purifications. The first peak (fractions 9-12) contains unincorporated 
Na125I, and the second major peak (fractions 39-49) contains purified 
monoiodo[125I]apamin with a specific activity o f 2200 Ci/mmol. Unlabelled apamin was 
retained on the column, which was later discarded.
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4.3.2 Determination of Biological Relevance of Binding
Unlabelled apamin is obviously very similar in structure to the radiolabelled toxin, and 
it is therefore possible that it could displace non-biologically relevant saturable binding 
of the radiolabelled variant. J-Tubocurarine differs in basic structure to apamin, but 
contains the SK channel ‘pharmacophore’ of two positive charges l lA  apart. These 
positive charges interact with SK channels providing an additional method of displacing 
radiolabelled apamin bound specifically to its acceptor. Figure 4.3 shows the percentage 
displacement of radiolabelled apamin by d-tubocurarine chloride to be comparable to 
that displaced by native apamin and there is no significant difference between the two 
treatments (2-tail student t-test, a=0.05). The binding of the radiolabelled toxin to these 
membranes is thus both specific and biologically relevant. Displacement by native 
apamin is a suitable method for determination of non-specific binding as used in the 
experiments presented in this chapter.
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Fig 4.3 Comparison of Binding in the Presence of Cold Apamin or d-Tubocurarine
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Equilibrium binding assays were performed, incubating lOOpg rat brain membranes 
with lOOpM radiolabelled apamin. Parallel incubations were carried in the presence of 
either 0.1 pM unlabelled apamin or ImM d-tubocurarine chloride, as described in
• • 1254.2.2.5. Both treatments are effective at displacing the specific component o f I- 
apamin binding. Data shown is the mean (+/- SD) of that obtained from triplicate 
incubations and is typical o f results obtained in three separate experiments.
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4.3.3 Time Course of Apamin Binding
Rat brain membranes were prepared, and purified by sucrose density gradient 
centrifugation. A number of experiments were then performed to validate the 
methodology used and to confirm the quality of the membranes and radiolabelled toxin 
prior to use in competition binding studies.
In order to confirm that equilibrium was being reached during the incubation of the 
radiolabelled toxin and the rat brain membranes, a time course was plotted (fig 4.4). The 
results show that binding of a 15pM radiolabelled apamin solution on ice in the 
hyposmotic binding buffer used for the majority of the binding experiments is complete 
in less than 60min. No decay of binding was seen during the course of the experiment, 
and the data confirms 90min to be a suitable incubation time for binding studies. It is 
recommended for binding analysis that the concentration of bound radioligand accounts 
for no more than 10% of that added. Specific maximum binding was less than 10% in 
this experiment, and indeed throughout the studies, eliminating the need to adjust 
calculations for ligand depletion^.
f l f  used in  conjunction with data  from  e ither dissociation curves, o r  additional curves show ing tim e course o f  b in d in g  a t 
differing concentrations o f  radiolabelled toxin, the da ta  from  th e  tim e course could be  used  to  calculate th e  association 
rate  c o n stan t Since th is  has previously been de term ined for apam in binding to  ra t b ra in  synap tic m em branes (Hugues 
e t al., 1 9 8 2 c), an d  th e  purpose o f th e  above experim ent was purely validation of assay m ethodology, these  fu rther 
experim ents w ere no t undertaken.
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Figure 4.4 Time Course of Apamin Binding to Rat Brain Synaptic Membranes
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15pM radiolabelled apamin was incubated on ice in the presence o f lOOpgmf1 rat brain 
membranes (♦) or lOOpgml'1 membranes pre-incubated with 0.1pm native apamin ( a ) 
for times ranging between 1.5 and 120min as described 4.2.2.6. All incubations were 
carried out in triplicate. Points shown are mean +/- SD. Binding curves are the result of  
fitting combined data from three separate experiments utilizing different incubation 
times to a one phase exponential association equation using Prism.
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4.3.4 Saturation Binding Assays
In order to examine the effects of potential competitors on 125I-apamin binding to rat 
brain membranes, it was necessary to first characterize the binding of the radiolabelled 
native toxin itself This was effected by saturation binding analysis, measuring 
equilibrium binding of increasing concentrations of monoiodo[125I]apamin to prepared 
membranes. Bound ligand was separated from free on a cell harvester and total binding 
was quantified using a gamma counter (fig 4.5). Non-specific binding was determined 
by parallel incubations with unlabelled native toxin. There was no significant saturable 
binding of I25I-apamin to the filters themselves, and non-specific binding increased 
linearly with increasing concentrations of labelled apamin. Specific binding was 
determined by subtracting the non-specific binding from total binding. This specific 
binding is saturable, at approximately 30pM, proving that the radiolabelled apamin is 
binding to a limited number of binding sites and is therefore likely to be biologically 
relevant.
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Figure 4.5 Binding of 125I-Apamin to Rat Brain Membranes
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Equilibrium binding studies were performed as described in 4.2.2.4. Rat brain
125membranes (lOOpg) were incubated with increasing concentrations (0. l-100pM) o f I- 
apamin in the presence (■) and absence (♦) of 0.1 pM unlabelled native apamin for 
90min on ice. After rapid filtration, the membrane bound activity was quantified. 
Saturable specific binding of radiolabelled apamin to its acceptor was calculated as the 
difference between total and non-specific binding (as determined in the presence o f  
0.1 pM unlabelled apamin) (A). Data in the figure above is typical o f three separate 
experiments, each performed with triplicate incubations. In the above figure, Prism has 
been used to fit curves (—  and — ) to the measured data and a single-site binding 
curve (— ) to the data for specific binding.
231
4.3.5 Analysis of Binding Data
The ratio of bound to free radiolabelled toxin was plotted against the amount bound to 
give a linear Scatchard plot (fig 4.6). Multi-site modelling using Ligand suggests 
binding to a single class of non-interacting binding sites (correlation coefficient=0.998 
+/- 0.001) with Kd 14.8 +/- 4.1 pM and Bmax 33.8 +/- 3.5 fmol mg'1 membrane protein. 
Logio occupancy was plotted against logio unbound in a Hill plot (fig 4.7). This plot was 
linear (correlation coefficient=0.998 +/- 0.002), with a Hill coefficient nH=0.98 +/- 0.09 
thus showing no evidence for cooperativity, i.e. increasing occupancy of binding sites 
does not alter affinity of binding. The binding constants are comparable to previous 
studies suggesting both membranes and radiolabelled apamin are of high quality.
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Figure 4.6 Scatchard Plot of Saturable Binding of Radiolabelled Apamin to Rat
Brain Membranes
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Equilibrium binding studies were performed as described in 4.2.2.4. Rat brain 
membranes (lOOjig) were incubated with increasing concentrations (O.l-lOOpM) of 125I- 
apamin in the presence and absence of 0.1 pM unlabelled native apamin for 90min on 
ice. After rapid filtration the membrane bound activity was quantified. Saturable 
specific binding o f radiolabelled apamin to its acceptor was calculated as the difference 
between total and non-specific binding. This data (•) was transformed to give a 
Scatchard plot. Radlig used multi-site modelling and non-linear curve fitting to estimate 
the binding parameters. In all cases the data best fitted a single class o f non-interacting 
binding sites (— ■). The figure presented is typical o f Scatchard plots obtained from 
three separate experiments each performed with triplicate incubations. The mean 
observed IQ—14.8 +/- 4.1 pM and Bmax=33.8 +/- 3.5 fmol mg'1 membrane protein.
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Figure 4.7 Hill Plot of Saturable Binding of Radiolabelled Apamin to Rat Brain
Membranes
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Equilibrium binding studies were performed as described in 4.2.2.4. Rat brain
• • • • • 125membranes (lOOpg) were incubated with increasing concentrations (0. l-100pM) of I- 
apamin in the presence and absence o f 0.1 pM unlabelled native apamin for 90min on 
ice. After rapid filtration the membrane bound activity was quantified. Saturable 
specific binding o f radiolabelled apamin to its acceptor was calculated as the difference 
between total and non-specific binding. This data was transformed in Radlig to give a 
Hill plot (•) and non-linear curve fitting (— ) produced an estimate o f the Hill 
coefficient. In all cases a straight line was obtained with a slope of approximately one 
(nH=0.98 +/- 0.09), indicating non-cooperative binding. The figure presented is typical 
of Hill plots produced from three separate experiments each performed with triplicate 
incubations.
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43.6 Synthesis, Refolding and Purification of Apamin and the Apamin N2A 
Disulphide Analogues
Apamin and apamin-N2A (a synthetic apamin analogue with Asn-2 replaced by Ala-2) 
were synthesized using standard Fmoc chemistry, and the crude synthetic peptides purified 
by reverse phase HPLC. The resulting trace for apamin N2A is shown in figure 4.8(a). The 
largest peak (for each synthetic peptide) was assumed to be the reduced peptide having the 
correct sequence. This assumption was verified by analysis of the peptides via mass 
spectrometry and 2-D NMR.
Disulphides were allowed to form by air oxidation and the reaction followed by analytical 
HPLC. Oxidation of apamin resulted in formation of a single peptide with native disulphide 
bridge pairings. In contrast, apamin-N2A underwent oxidation to give two disulphide 
isomers. Figure 4.8(b) shows an analytical reverse-phase HPLC of the products of apamin 
N2A oxidation, the peaks being apamin N2A-par, which eluted first, followed by apamin 
N2A-antL Apamin N2A-par (parallel cys residues) has the same disulphide bond pairing as 
native apamin. Apamin N2A-anti (antiparallel cys residues) has an incorrect disulphide 
bond pairing (Cysl-Cysl 5 and Cys3-Cysl 1). Both oxidation reactions were complete after 
approx. 24hrs.
The oxidation products for synthetic apamin and the N2A analogue were purified by 
preparative reverse phase HPLC, lyophilized and stored frozen ready for use in the binding 
assays.
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Fig 4.8 Purification of Apamin N2A-Par and -Anti
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Figure a shows the purification of crude synthetic apamin-N2A by reversed phase HPLC 
with a gradient of 0-30% acetonitrile over 35min. The largest peak ❖ is the reduced peptide 
with the correct sequence.
The purified apamin N2A peptide underwent air-oxidation to give two isomers that are seen 
as two separate peaks after air oxidation is complete. Figure b shows an analytical reverse 
phase HPLC on the products of apamin N2A oxidation, o Apamin N2A-Par (disulphides 
in native conformation). <> apamin N2A-anti (non-native disulphide conformation).
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43.7 Effect of Native Apamin, Synthetic Apamin, and its N2A Analogues on Binding 
of Radiolabelled Apamin to Rat Brain Membranes
In preliminary experiments the native and synthetic peptides were assessed for their ability 
to compete with iodinated apamin for binding to the rat brain membranes. Equilibrium 
binding assays were performed as previously, incubating a single concentration of 
radiolabelled apamin with the membranes. Parallel incubations were performed containing 
a ten-fold excess of the test ligands. Non-specific binding was taken as the binding in the 
presence of InM unlabelled native toxia Fig 4.9 shows that all ligands significantly 
compete (1-tailed t-test, a=0.05), to various degrees, with the radiolabelled toxin for 
binding to the apamin acceptor. Although the inhibition of binding seen on addition of 
apamin N2A-anti was considerably less than that seen with the other peptides, there was no 
significant difference between the % total binding seen in the presence of native, synthetic, 
or N2A-par apamia
The inhibition of 125I- apamin binding was further examined using lOpM unlabelled toxin 
in the presence of increasing concentrations of the peptides (100nM-0.01pM). The data was 
corrected for non-specific binding as determined in the presence of excess (O.lmM) native 
apamin, and used to construct competition binding curves (fig 4.10). Site modeling using 
Radlig suggested competitive inhibition at a single class of binding sites for all ligands 
tested and Hoftsee analysis provided estimates of Ki for each ligand. Synthetic apamin and 
apamin N2A-par showed competitive binding of the same order as the native molecule, 
there being no significant difference (1-way ANOVA, a=0.05) between the Ki for native 
apamin (6.32 +/- 1.55pM), synthetic apamin (9.38 +/- 5.42pM) and apamin N2A-par (5.38 
+/- l.l7pM). Apamin-N2A anti was also found to competitively inhibit binding to 125I- 
apamin binding sites (Ki = 0.203 +/- 0.038nM) but with significantly less affinity than the 
native toxin (1-tailed t-test, a=0.05). The affinity constants quoted above are the mean +/- 
SD of Ki estimates obtained from three separate experiments, each containing triplicate 
samples.
It should be noted that there was a significant difference (2-tailed t-test, a=0.05) between 
the affinity constant for the native toxin as determined by competition binding, and the
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figure obtained using Scatchard analysis. Although some variation is expected due to the 
different methodology used to generate the data, this is not the cause of the approximately 
two-fold difference in affinity. The difference is in fact due to the fact that different 
molecules are being studied. The affinity constant produced by the Scatchard analysis was 
for the radiolabelled toxin, whilst the figure produced by competition binding was 
equivalent to the affinity constant for the native unmodified toxin.
The two isoforms of apamin N2A had been purified by HPLC and showed baseline 
separation, meaning that contamination of the non-wild type disulphide-paired molecule 
with its wild-type disulphide-bonded isoform was negligible. In order to confirm that the 
apamin-acceptor binding seen in the N2-anti isotype was not due to such a contamination, 
the leading and trailing halves of the HPLC peak were assayed separately. Competition
125 * *binding studies were performed against I-apamin, the data processed, and competition 
binding curves plotted as for the intact peak above (see fig 4.11). Again, the data fitted a 
model of competitive inhibitable binding to a single class of binding sites. There was no 
significant difference (2 tailed t-test, a=0.05) between the Ki for the two halves of the peak 
(leading sample Ki =0.201 +/- 0.076nM, trailing sample Ki =0.208 +/- 0.054nM), or 
between these samples and the whole peak. This suggests that the inhibition of 125I-apamin 
seen with this ligand was not due to contamination.
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Fig 4.9 Comparison of Binding in the Presence of Native Apamin, Synthetic Apamin,
Apamin N2A-Anti and Apamin N2A-Par
■  Native apamin
■  Synthetic apamin 
Apamin N2A-par
■  Apamin N2 A-anti
■ control
Equilibrium binding assays were performed, incubating lOOpg rat brain membranes with 
lOOpM radio labelled apamin. Parallel incubations were carried out in the presence of InM 
unlabelled native apamin; InM synthetic apamin; InM apamin N2A-par or InM apamin 
N2A-anti as described in 4.2.3.2. All the substances tested inhibited total binding of 
radiolabelled apamin. Data shown is the mean (+/- SD) of that obtained from triplicate 
incubations and is typical of results obtained in three separate experiments.
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Figure 4.10 Competition Binding Curves for Apamin and its Synthetic Derivatives
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The figure shows the inhibition o f binding of 125I-apamin to rat brain membranes by native 
apamin and by the synthetic analogues. Rat brain membranes (lOOpg) were incubated for 
90min on ice in the presence of 125I-apamin (lOpM) together with increasing concentrations 
of (■) native apamin, ( A )  synthetic apamin, (▼) apamin N2A-par, or (•)  apamin N2A-anti. 
Membranes were harvested by rapid filtration, and 125I-apamin binding calculated as 
percentage of total binding determined in the absence of competitors. Data was corrected 
for non-specific binding as determined in the presence of excess (0.1 pM) native apamin. 
The data presented is the mean (+/- SEM) of that obtained from triplicate incubations and is 
typical of results obtained in three separate experiments. The curves displayed are the result 
of fitting the data points to a one-site competition model using non-linear regression 
analysis (Prism).
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Figure 4.11 Competition Binding Curves for the Two Halves of the HPLC Peak
Containing Apamin N2A -anti
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The figure shows the inhibition of 125I-apamin binding to rat brain membranes by the two 
halves of the HPLC peak containing apamin N2A-anti. As in figure 4.10, rat brain 
membranes (lOOpg) were incubated for 90min on ice in the presence of 125I-apamin (lOpM) 
together with increasing concentrations of the leading (♦) and trailing (♦) halves of the
125apamin N2A-anti peak. Membranes were harvested by rapid filtration, and I-apamin 
binding calculated as percentage of total binding determined in the absence of competitors. 
Data was corrected for non-specific binding as determined in the presence of excess 
(0.1 pM) native apamin. The data presented is the mean (+/- SEM) of that obtained from 
three separate experiments each performed with triplicate incubations. Data obtained 
previously (fig 4.10) is shown for comparison. The curves displayed are the result of fitting 
the data points to a one-site competition model using non-linear regression analysis 
(Prism).
♦ N2A Anti (Leading)
• N2A Anti (Trailing) 
N2A Anti
Native 
Synthetic 
N2 A Par
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43.8 Affinity of Alexa Fluor Apamin for Apamin Binding Sites on Rat Brain
Membranes
The effectiveness of Alexa Fluor 488 apamin binding to rat brain synaptic membranes 
was tested. As an initial experiment the ability of the fluorescent derivative to 
competitively inhibit lOOpM radiolabelled apamin binding to its rat brain acceptor was 
examined as described previously. As can be seen in fig 4.12 the percentage total 
binding was significantly reduced (one-tailed t-test, a=0.05) in the presence of Alexa 
Fluor apamin. The degree of this reduction was somewhat surprising, however, when 
compared with that seen previously using a comparable concentration of apamin N2A- 
anti (see fig 4.9). This initial experiment appears to indicate Alexa Fluor apamin to have 
a considerably lower affinity than the non-wild type disulphide bonded N2A-anti 
apamin analogue. Full competition binding curves carried out with the fluorescent toxin 
confirmed these results (fig 4.13). As would be expected, site modelling using Radlig 
showed the data to fit a model for competitive inhibition at a single class of binding 
sites. The calculated Ki was 0.47 +/- 0.07 nM, which represents an approximately 70- 
fold drop in affinity when compared to native apamin (Kj=6.32pM).
From these results it appears that Alexa Fluor apamin has a considerably lower binding 
affinity than native apamin, yet immunocytochemistry experiments carried out with the 
probe (Cingolani et al., 2002) give good results. The immunocytochemistry was carried 
out under physiological buffer conditions. Both native and radioiodinated apamin show 
lower binding affinity in isosmotic buffers than under the low ionic strength conditions 
used above (as can be seen in the summary of published apamin binding parameters, 
table 4.1). Since the majority of experiments requiring the use of Alexa Fluor apamin 
would be carried out under physiological buffer conditions, binding studies were 
repeated using such buffers.
Since the change in buffer was expected to reduce the affinity of 125I-apamin binding, it 
was anticipated that the lOpM radiolabelled apamin concentration, used under low-salt 
conditions, would not produce sufficient binding to allow for the construction of 
accurate competition binding curves. In order to ensure that the physiological buffer 
experiments were carried out using a suitable concentration of radiolabelled apamin, a 
single experiment was carried out (triplicate incubations, n=l) to construct a saturation 
binding curve and give an rough approximation of K<p40pM under these conditions
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(data not shown), which is at the lower end of the range reported in the literature (see 
table 4.1). Since estimates for apamin affinity constants obtained by our research group 
(Wadsworth et al., 1994; Wadsworth et al., 1996) in low ionic strength buffer have been 
consistently at the lower end of the spectrum, this 40pM value would seem to be 
feasible, and thus 40pM radiolabelled apamin was used experimentally to determine the 
effects of higher salt on Alexa Fluor Apamin binding.
As can be seen (fig 4.14), under isosmotic conditions, there is still a significant (one 
tailed t-test, a=0.05) reduction in Alexa Fluor apamin binding (EC5o=156 +/- 6 pM) 
compared to that of the native toxin (EC50 25.7 +/- 0.8 pM), but the difference between 
the two toxins would appear to be reduced. Again, site modelling using Radlig showed 
the data to fit a model for competitive inhibition at a single class of binding sites. It is 
not possible to calculate Kd values from the existing data, and hence compare the 
binding in the two buffers directly*, but without knowledge of the mechanism leading to 
the reduction of binding seen with the Alexa Fluor apamin derivative, such 
quantification would be of little practical use.
Parallel observations on the effectiveness of Alexa Fluor apamin binding were noted by 
our collaborators at University College London. The fluorescent toxin was used to 
visualise apamin receptors on SK2 (Cingonali et al., 2002) and SK3 cell lines (Dr 
Martin Stocker) (see fig 4.15). The UCL group noted experimental difficulties due to a 
very fast off rate associated with SK2 binding. Alexa Fluor apamin binding to SK2 was 
further studied electrophysiologically (fig 4.16). There was no difference in the 
association and dissociation kinetics. The observed IC50 was 324 +/- 42 pM, indicating 
an approximately 6-fold reduction in affinity compared to the native toxin (Mr Deiter 
D’Hoedt and Dr Martin Stocker unpublished data). The UCL data is comparable to our 
data showing a reduction in membrane binding for the fluorescent versus native toxin 
under physiological salt conditions (fig 4.15).
ideally, in order to be able to directly compare binding affinities in the two buffers, the two sets of 
experiments should have been carried out using identical lOpM quantities of radiolabelled toxin. The 
differences in binding seen under the two conditions was such that lOpM radiolabelled apamin did not 
produce adequate inhibitable binding under high-salt conditions to allow for the construction of accurate 
competition binding curves. A single experiment was carried out to determine a suitable 125I-apamin
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concentration for use under these conditions, the figure of 4 0 pM being a rough estimate of binding affinity, 
produced for this purpose.
For this reason, this value was not used to determine Kd for native and fluorescent apamin in the 
competition assay described in isosmotic buffer. Determination of an accurate Kd for these compounds, 
and thus direct comparison between binding in high- and low-salt would have required construction of full 
binding curves in triplicate. Since quantitative analysis would be unlikely to shed light on the mechanism 
of this salt effect, these experiments were not undertaken.
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Fig 4.12 Radiolabelled Apamin Binding in the Presence and Absence of Alexa
Fluor Apamin
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Equilibrium binding assays were carried out, incubating lOOjug rat brain membranes 
with lOOpM radiolabelled apamin. Parallel incubations were carried out in the presence 
of InM Alexa Fluor apamin as described in 4.2.4.1. Binding o f radiolabelled apamin 
was reduced in the presence of the fluorescently labeled toxin. Data shown is the mean 
(+/-SD) of that obtained from triplicate incubations and is typical of results obtained in 
three separate experiments.
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Fig 4.13 Competition Binding Curves for Alexa Fluor Apamin
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The figure shows the inhibition of binding o f 125I-apamin to rat brain membranes by 
native apamin and by the fluorescently labelled Alexa Fluor toxin. Rat brain membranes 
(lOOpg) were incubated for 90min on ice in the presence o f 125I-apamin (lOpM) 
together with increasing concentrations o f ( A )  native apamin or Alexa Fluor apamin, 
(■). Membranes were harvested by rapid filtration, and 125I-apamin binding calculated 
as percentage of total binding determined in the absence of competitors. Data was 
corrected for non-specific binding as determined in the presence o f excess (0.1 pM) 
native apamin. The data presented is the mean (+/- SEM) of that obtained from triplicate 
incubations and is typical of results obtained in three separate experiments. The curves 
displayed are the result o f fitting the data points to a one-site competition model using 
non-linear regression analysis {Prism, GraphPad software, San Diego USA).
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Fig 4.14 Alexa Fluor Apamin Competition Binding Curves in Physiological Buffer
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The figure shows the inhibition of binding o f 125I-apamin to rat brain membranes by 
native apamin and by the fluorescently labelled Alexa Fluor toxin in physiological 
strength buffer. Rat brain membranes (lOOpg) were incubated for 90min on ice in the 
presence of 125I-apamin (lOpM) together with increasing concentrations of ( A )  native 
apamin or Alexa Fluor apamin, (■). Membranes were harvested by rapid filtration, and 
125I-apamin binding calculated as percentage of total binding determined in the absence 
of competitors. Data was corrected for non-specific binding as determined in the 
presence of excess (0.1 pM) native apamin. The data presented is the mean (+/- SEM) of 
that obtained from triplicate incubations and is typical o f results obtained in three 
separate experiments. The curves displayed are the result of fitting the data points to a 
one-site competition model using non-linear regression analysis {Prism, GraphPad 
software, San Diego USA).
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Fig 4.15 Alexa Fluor Apamin Binding to Expressed SK Channels
HEK-293 cells expressing SK2 (a and b) and SK3 (c and d) cell lines were incubated 
for lOmins with 50nM Alexa Fluor apamin on coverslips. Cells were washed by dipping 
x3 in PBS and embedded in PBS/ 20% glycerol. Images were recorded using a CCD 
camera. Images were supplied by Dr Martin Stocker, UCL.
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Fig 4.16 Electrophysiological Block of rSK2 Currents by Alexa Fluor Apamin
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Whole-cell patch clamp recordings were made in the presence of lpM [Ca24]i on HEK- 
293 cells expressing rSK2 channels. Voltage ramps of -100 to +40mV were applied 
(ramp duration 400ms) in the presence, and absence, of Alexa Fluor apamin. A 
representative experiment is shown above. (IC50=324 +/- 42pM, n=4). Data was 
provided by Mr Dieter D’hoedt and Dr Martin Stocker (UCL).
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4.4 Discussion
Prior to its use in the characterisation of potential competitors of apamin binding, 
various parameters of the apamin-binding assay were tested. The saturation binding 
studies reported in this chapter show binding of monoiodo[125I]apamin to a single class 
of acceptors on rat brain membranes with Kd=14.8 +/- 4.1 pM and Bmax=33.8 +/- 3.5 
fmol mg*1. These values are comparable to those seen in previous studies (table 4.1). 
Binding was shown to be specific and biologically relevant by carrying out assays in the 
presence of excess unlabelled apamin and also in the presence of tubocurarine (as 
described by Cook and Haylett, 1985). These results proved both membranes and 
radiolabelled apamin were of high quality and that the binding assay was functioning 
correctly.
The structure of apamin has been investigated by a number of authors, and the main 
residues critical for binding to SK channels and for toxicity have been identified. The 
compactness and high stability of apamin have led to its use as a model peptide, for 
instance in structure-antigenicity relationships (Defendini et al., 1990), testing of 
structural algorithms (Sun, 1995), analysis of disulphide linkages (Gray, 1993) and, as 
in this study, functional determination of secondary structure.
The experiments using synthetic apamin analogues described in this chapter examine 
the functional importance of the P-tum motif and the Asn 2 residue. Native apamin had 
a Ka of approximately half that for the radiolabelled toxin. This two-fold decrease in 
activity on radioiodination at Hisl8 is in agreement with the observations of Hugues et 
al., 1982a. Synthetic apamin has been shown to have full biological activity (Sandberg 
and Ragnarsson, 1978) and as would be expected the synthetic apamin peptide used in 
this study showed the same level of binding as the native, thus proving the effectiveness 
of synthesis and the validity of its use.
Apamin has a well-characterized P-tum motif that helps to stabilize the structure. NMR 
studies show that replacement of Asn2 with Ala2 destabilizes the peptide, and it was 
envisaged that this would lead to a reduction of binding activity. The data for the 
competition binding curves with apamin N2A-par show the Asn-2 amino acid and the 
P-fold to be non-critical for binding. The structural studies performed on this peptide 
(Dempsey et al., 2000, Dempsey personal communication) showed apamin N2A-par is
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only transiently unfolded, this state accounting for approx 10% of its conformation at 
any given time. Therefore 90% of the toxin would show full binding affinity, with the 
remaining 10% binding with reduced affinity. Taking into account errors in peptide 
quantification and the inherent error in the binding studies, it is likely that such a small 
decrease in affinity would not be statistically significant. It is also possible that the 
native state is stabilized on binding; thus the loss of the P-tum region would have a 
greater effect on the kinetics of binding than on the overall affinity. A third possibility is 
that despite structural changes in the molecule as a whole, spatial relationships between 
residues critical for apamin binding are maintained. Future studies using Biacore 
technology will explore the effects of the N2A substitution on binding kinetics.
Since apamin contains four cysteines, there are three possible ways that disulphides can 
form. The globule and ribbon formations (illustrated in fig 4.1) are produced by Cysl- 
Cysll, Cys3-Cysl5 and Cysl-Cysl5, Cys3-Cysll respectively. A third ‘bead’ 
conformation would be produced by Cysl-Cys3, Cysll-Cysl5 pairing, producing two 
small loops in the structure. This is thought to be highly unfavourable due to steric 
interactions. Callewaert et al., 1968, determined the disulphide pairing of apamin to be 
Cys3-Cysl5, CyslrCysll and upon air oxidation fully reduced native apamin folds 
spontaneously to give this native disulphide bond pairing (Huyghues-Despointes and 
Nelson, 1992). The apamin N2A analogue used in here, however, produces an 
additional ribbon conformer under these conditions.
Surprisingly, the molecule containing mispaired disulphide bonds showed only a 30- 
fold reduction in its ability to displace apamin from SK channels. Further experiments 
mled out the possibility of contamination with the native disulphide bridged isoform, 
and it seems that despite the incorrect disulphide bond pairing apamin N2A-anti retains 
a significant, if low, affinity for the apamin acceptor.
One disulphide-bridged intermediates are rare in the formation of apamin, but at least 
three of these intermediates are found at very low concentrations in an equilibrium 
folding mixture (Chau and Nelson, 1992). By substitution of specific cysteines with 
alanines, the properties of two of these single disulphide structures have been examined, 
namely those containing each of the native disulphide bonds (Chau and Nelson, 1992; 
Huyghues-Despointes and Nelson, 1992; Xu and Nelson, 1994). The Cys3-Cysl5 bond 
is the most stable and forms first, its formation promoting that of the second disulphide.
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CD analysis of molecules containing only this Cys3-Cysl5 linkage showed the presence 
of significantly less a-helix than those with both bonds. NMR, however, showed an 
overall structure similar to that of the native toxin with similar relative positioning of 
the a-helix and P-tum. Thus this Cys3-Cysl5 linked peptide would appear to have 
multiple conformations similar to the native and, as one might expect, the absence of 
one disulphide allows for greater flexibility. Peptides containing only the Cysl-Cysll 
disulphide show far less secondary structure; the N-terminal of the a-helix is present 
along with some secondary structure in the reverse turn region. Although Cys3-Cysl5 
appears structurally more important, the functional effects of removing this bond have 
not been investigated.
Reduced apamin and homologs equivalent to the fully-reduced peptide have been 
synthesised and studied. Reduced and alkylated apamin had been reported to have no 
neurotoxicity (Habermann, 1972; Vincent et al., 1975). These studies, however, used 
only a single dose 10 times that of the lethal dose of apamin. A later study (Labbe-Jullie 
et al., 1991) using higher concentrations of an open-chain apamin analogue, showed 
apamin-like symptoms followed by complete recovery, when l-10pg (i.e. 100-1000 
times the lethal dose of native apamin) was injected into mice. Binding studies with the 
same open-chain analogue showed that it could completely displace radiolabelled 
apamin with a K0.5 of 79nM (c.f. 0.012nM for the native toxin), suggesting that even 
without the disulphide bridges a small fraction of the molecules are in a conformation 
that allows for residual specific binding to the apamin acceptor.
Although removal of disulphide bridges may maintain some secondary structure and 
allow for greater malleability of the molecule, one would expect, however, alterations of 
the cysteine partners within the pairings to distort the molecule, preventing formation of 
a native like structure. Prior to the study by Dempsey et al., 2000, the N-terminal 
sequence had been shown to play a role in directing disulphide pairing. Deletion of the 
Lys4 produced a similar disulphide pairing to that seen with apamin N2A-anti 
(Volkman and Wemmer, 1997) and with endothelin (a powerful vasoconstrictor peptide 
which, like apamin contains a CSH motif and four cysteine residues at identical 
positions, but which naturally adopts a ribbon formation). NMR experiments, however, 
showed the 3D structure of the Lys4-deleted molecule to more strongly resemble 
apamin than endothelin, implying that the folding, and consequently the structure, is due 
more to the primary sequence than to the disulphide pairing.
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Substitution of selenocysteine for specific cysteine residues encourages apamin to fold 
with distinct disulphide bridge pairings as a consequence of differences in redox 
potential between disulphide and diselenocide bonds. In this way apamin analogues 
have been created in each of the three disulphide conformations (Pegoraro et al., 1999; 
Fiori et al., 2000) and the structures examined by CD and NMR. The different structures 
showed far more similar spatial conformations than would have been expected, with the 
a-helical region left largely intact. There was found to be a cis-trcms isomerisation of 
the Ala5-Pro6 peptide bond in all of the selenocysteine-induced structures, with the 
trans-Pro-6 isomers showing greatest structural similarity to the wild type. The 
proportions of this isomer varied however, the proportion of the c/s-isomer being 
reduced in the bead formation and increased in the ribbon formation. Incidentally, cis 
isomers are increased in the apamin N2A-anti and to a small extent in the apamin N2A- 
par molecules used in this study (Dempsey et al., 2000). In this ribbon conformation the 
P-tum is partially and totally dismpted in the trans and cis isomers respectively but the 
C-terminal a-helix is only slightly distorted. Surprisingly, the structural conformation of 
the bead analogue was closer to that of native apamin than that of the ribbon formation, 
although it demonstrated greater flexibility. Importantly, there was little perturbation of 
the a-helix, which also maintained its relative position to the N-terminal portion.
Similar experiments with tmncated apamin, using selective deprotection of the cysteines 
to promote the different disulphide pairings, showed only the globule formation to have 
significant a-helical content (Ramalingam and Snyder, 1993). The apparent difference 
between the two groups’ findings may be due to the ribbon and bead formations being 
more flexible and having more than one structure, which would show as disorder on a 
CD spectmm.
Although several authors have looked at the effects of different disulphide pairing on 
structure, the experiments presented in this chapter would appear to be the first analysis 
of their effects on function. It would be interesting to test the binding ability of the 
conformational isomers described above. Of particular interest would be those in the 
bead formation, which show unexpectedly similar structure to the native toxin, the main 
differences lying in the p-tum, which has proved non-essential for binding.
Since scorpion toxins share both the ion channel blocking properties and the structural 
CSH motif of apamin, studies carried out on scorpion toxins may also be relevant to the
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bee venom toxin. For example, maurotoxin is a four disulphide-bridged peptide from 
the scorpion Scorpio mauruspalmatus with a broad selectivity, blocking SK and Kvl.2 
and Kvl.3 channels (Kharrat et al., 1996, 1997; Carlier et al., 2000; and Avdonin et al., 
2000). It has a different disulphide pattern to that of other scorpion toxins (C1-C5, C2- 
C6, C3-C4, C7-C8), but maintains a similar 3D structure (Blanc et al., 1997) and the 
ability to bind to and interact with potassium channels. For this reason, the effect of 
maurotoxin’s disulphide bridges on folding, structure and function have been well 
studied (Fajloun et al., 2000, 2000b; Lectome et al., 2000; Carlier et al., 2001; Di 
Luccio et al., 2002). It has been shown that differential pairing of these disulphide 
bridges alters the 3D structure and hence spatial distribution of key residues, which in 
turn alters the selectivity of the toxin (Fajloun et al., 2000; Fajloun et al., 2000b; 
Lectome et al., 2000; Carlier et al., 2001). These structural alterations still tend to 
maintain the general a/p scaffold and do not necessarily destroy maurotoxin’s binding 
ability, nor significantly decrease its affinity for potassium channels. Therefore the 
disulphide arrangement has important roles and these bonds have been proposed to not 
just stabilize pre-folded structures, but to subtly determine the final 3D structure and 
hence selectivity of the toxin (Fajloun et al., 2000). Studies on other scorpion toxins 
have looked at the effects of removing single disulphide bonds and report differing 
effects on binding activity (Sabatier et al., 1996; Calabro et al. 1997; Drakopoulou et al., 
1998; Zhu et al., 2002).
One would expect the sturdy CSH backbone, which is highly conserved in ion channel 
toxins, to play an important role in stabilizing structure and hence activity. There is, 
however, increasing evidence that the basic 3D structure of the molecule is not as reliant 
on this bonding pattern as one might expect and that the oc/p fold can be maintained in 
some toxins in the absence of one or more disulphide bridges. Indeed, it has been 
suggested by Tamaoki et al., 1998, that the positions of the cysteines are more important 
in the formation of the CSH motif than the pairing of the disulphides. In the case of 
apamin N2A, a non-wild-type disulphide-bond pairing imparts less stability, and 
therefore greater flexibility upon the molecule. Although this peptide spends less time in 
a conformation compatible for binding, it may still be free to transiently form such a 
structure. The consequential loss of effective concentration of the ligand would be 
expected to decrease the Kd through a reduction in the on-rate of the peptide. The off- 
rate would be unaffected. It is hoped to study the kinetics of apamin binding in future, 
using real-time measurements on a Biacore system. It is thus proposed that in apamin
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(and possibly also scorpion toxins) the bridge pattern is not critical for the recognition 
of potassium channels, as long as structural constraints allow for the formation of the 
a/p fold and maintain a correct spatial distribution of critical residues. More subtle 
changes in structure (probably within the a-helical region) are likely to alter binding 
affinities, and also the selectivity of the molecule. The latter has not been investigated 
for the apamin analogues used in this study, but would prove interesting for future 
examination.
The resistance of native apamin to proteolytic digestion results from its tightly folded 
structure. Fully reduced apamin is readily digested by proteolytic enzymes (K. Newton, 
unpublished observations). Mice injected with a non-disulphide bridged variant of 
apamin initially showed symptoms characteristic of apamin poisoning, but subsequently 
completely recovered (Labbe-Jullie et al., 1991). It was proposed that the toxin was 
binding to its acceptor (albeit with a lower affinity) but was losing toxicity over time by 
enzymatic degradation as a consequence of the unfolded state of the molecule. It would 
be interesting to examine the resistance of the apamin analogues studied in this chapter 
to proteolytic digestion. Does the increase in flexibility of the molecule leave it more 
exposed to proteolytic attack? And therefore does the p-sheet serve to stabilize the 
molecule and impart resistance to degradation? It would also be useful to study the 
vulnerability of an apamin molecule in the ‘bead5 conformation, to frilly understand the 
role that correctly formed disulphide bridges play in the proteolytic resistance of the 
native toxin.
Despite a number of potential applications (as discussed earlier), the use of 
fluorescently-labelled ion-channel toxins has not often been reported, and only a few 
ion-channel toxins appear to have been successfully labelled with fluorescent moieties, 
including toxins active on sodium (Joe and Angelides, 1993; Darbon and Angelides, 
1984), calcium (Jones et al., 1989), and NMD A receptor (Benke et al., 1993) channels. 
As an example, a variety of fluorescent derivatives of Leiurus quinquestriatus 
quinquestriatus toxin V have been reported to retain high specificity for the voltage 
sensitive sodium channel (Angelides and Nutter, 1983) and show only 2-3 fold loss of 
activity compared to the native toxin. The technique used by a number of groups 
(Darbon and Angelides, 1984; Angelides, 1986; Jones et al., 1989; Cohen et al., 1991) 
was to incorporate fluorescent moieties via reaction with primary amines. This is not 
ideal, since we know that potassium channel toxins tend to rely on the interaction of
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positively charged amino acids with the channel for binding, and modification would 
thus be expected to lead to a loss of affinity. Experiments were designed to determine if 
this was a potential problem with the use of Alexa Fluor 488 apamin (specifically 
labelled at Lys4). The results presented indicate a greatly reduced affinity of Alexa 
Fluor 488 apamin for the rat brain membrane apamin acceptor when compared to 
native-apamin and to the radiolabelled counterpart used in the majority of experiments 
in this chapter.
At first sight it may appear that the results described here contradict those of Vincent et 
al., 1975, who saw a much smaller effect on toxicity of labelling apamin, via primary 
amines, with a fluorescein derivative. It should be noted, however, that binding does not 
necessarily directly correlate with toxicity, the former being highly dependent on ionic 
strength. The work of Albericio et al., 1984 corroborates this; modification of one of the 
two arginine residues in apamin produced a 100-fold loss of toxicity and a 
corresponding 1000-fold loss of binding.
The Lys4 residue, which is modified in Alexa Fluor apamin, is located on the opposite 
side of the toxin to the face believed to interact with the channel pore (Vergara et al., 
1998), and would appear unlikely to be involved directly with any toxin-channel 
interaction (see fig 4.17).
Although the two arginine residues have been shown to be essential for the binding and 
toxicity of apamin (Vincent et al., 1975), the affinity of apamin for its acceptor is such 
that other factors also seem to play a role. The same authors reported a 2.6-2.8 fold loss 
of activity on modification of either the e-amino group of Lys4 or the imidazole side 
chain of His 18. Combined modification of both residues, however, caused a drastic 
(>10 fold) loss of toxicity. These results could be interpreted such that these amino 
acids do not play a large role in activity individually, but rather contribute to generalised 
charge effects. The pH of the low ionic strength buffer used for the binding experiments 
described in this chapter was such that the histidine would be predominantly uncharged, 
which may mean that the electrostatic effect of altering the lysine would become more 
important. Although the modification of the lysine group of apamin will result in a 
small loss of positive charge, the effect on binding seen with the addition of the Alexa 
Fluor moiety is probably due more to the presence of the Alexa molecule itself, rather 
than lysine modification. The structure of Alexa 488 can be seen in fig 4.18. It is a large
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molecule with respect to the lysine it is modifying, with a large overall negative charge 
(-3). Modification of apamin with Alexa Fluor 488 succinimidyl ester reduces the 
overall positive charge on apamin by two, hence reducing the electrostatic interaction 
between apamin and acceptor. The positioning of the charges in native apamin creates a 
dipole moment. It has previously been suggested that the nature of this dipole moment 
contributes to the alignment of the toxin with the membrane and the precise positioning 
of the toxin in its acceptor (Ciechanowicz-Rutkowska et al., 2003). The addition of a 
highly negatively charged moiety to the molecule is likely to disrupt this charge 
distribution. The exact orientation of the Alexa Fluor substituent is unknown, but the 
increased bulk of the modified toxin may also prevent apamin from sitting tightly at the 
mouth of the pore of the SK channel, thus weakening the charge interactions between 
channel and toxin.
Cell-labelling experiments are generally carried out in physiological media (i.e. at high 
ionic strength), conditions at which apamin binding to its receptor is reduced (Hugues et 
al., 1982c). For this reason, Alexa Fluor apamin binding was also studied in high salt 
buffer. One would expect any electrostatic effects of the Alexa Fluor label to be reduced 
under such conditions, and any steric effects to remain unchanged. The results show 
that, under physiological conditions, the binding affinity of the fluorescent toxin for its 
receptor is lower than that of the native toxin. This shift in affinity appears to be less 
than that seen in low salt buffer. These results indicate that electrostatic interactions 
play a role in the loss of binding affinity seen with the fluorescently labelled toxin, but 
also suggest the involvement of additional, possibly steric factors.
Beeton et al., 2003, attached a fluorescein probe to the a-amino group of the N-terminal 
Arg residue of ShK (Stichodactyla helicmthus) toxin. This residue is located on the 
opposite face of the toxin to that believed to interact with the channel pore, and the 
modification produced a 4-fold drop in the affinity of the toxin for Kvl.3 channels. In 
contrast, the fluorescent toxin showed a 160-fold less affinity for the K vl.l subtype 
than did the native toxin, presumably due to a change in the overall electrostatic 
properties of the molecule, drastically altering the toxin’s selectivity. The work on ShK 
again demonstrates that generalised charge alterations can have profound effects on the 
affinities of modified toxins for their ion channel targets.
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Since the binding affinity of apamin to its acceptors is so high, the reduced affinity of 
Alexa Fluor apamin may be insignificant for many applications. The majority of 
applications requiring a fluorescent SK-channel probe use physiological conditions, 
where the adverse effects of Alexa Fluor labelling are less pronounced. However, this 
reduced affinity should be taken in to account when designing experiments and in 
subsequent analysis of results, since it may have significance both for quantification 
purposes and for suitable toxin concentrations required for detection of SK-channels.
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Fig 4.17 Proposed Orientation of Apamin in the Mouth of the SK2 Channel Pore
Two of the four SK2 subunits are shown in a cross section through the membrane. The 
charged residues o f apamin are illustrated: Lys4-green, Glu7-red, Arg 13-cyan, Arg 14- 
purple, and Hisl8-blue. Note the location o f Lys-4 to which the Alexa Fluor moiety of 
Alexa Fluor apamin is attached.
SK channel structure and the position o f apamin binding are taken from Vergara et al., 
1998. The structure of apamin was kindly provided by Dr Chris Dempsey (University o f  
Bristol) and is based upon the co-ordinates o f Pease and Wemmer, 1988.
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Fig 4.18 Structure of Alexa 488 (adapted from Panchuk-Voloshina, et al., 1999)
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Animal venoms are a rich source of pharmacological molecules useful as research tools 
or as clinical drugs. Scorpion venoms have yielded a number of ion channel toxins, 
principally those active upon sodium or potassium ion channels. Although many current 
studies focus on the toxins, scorpion envenomation still causes fatalities, and the 
venoms themselves still warrant investigation. This work investigates a range of aspects 
of scorpion and bee venom neurotoxins, from the level of the crude venom to structure/ 
function studies on a well-defined bee venom peptide.
The Indian red scorpion (Mesobuthus famulus) is a serious threat to life in many regions 
of India. However, the venom of the species is less well studied than that of many other 
clinically relevant scorpion species. There is anecdotal evidence for regional variation in 
the severity of Indian red scorpion envenomation. Immunological and proteomic 
analysis of Mesob. famulus venoms from two regions of the state of Maharashtra, each 
with differing biotopes, suggests quantitative and qualitative regional variation in the 
Mesob. famulus venome. A peptide of 2947Da was identified that may prove diagnostic 
between the two venom types. The different distribution of peptides in regional 
scorpions has implications for toxin research. It highlights the need to specify the region 
from which scorpions were collected when identifying new molecules, and considerably 
increases the potential number of novel pharmaceutical components in the venoms of 
this scorpion. In addition, a mass profile of fractionated Mesob. famulus venom was 
generated as an aid to future isolation of specific peptides from the venom of this 
species.
Scorpion short insectotoxins may be prove to be of clinical importance as chloride 
channel blockers and cancer-therapeutics. Little is known about these molecules and 
relatively few have been isolated. Analysis of Mesob. famulus cDNA, using RACE 
(rapid amplification of cDNA ends), and oligonucleotide primers based upon the signal 
peptide sequence of the Buthus martensii short insectotoxin Bml2, yielded two novel 
putative short insectotoxin sequences, BtChll and BtChl2. A putative BtChll 
expression product has been purified from the venom of this species based upon its 
calculated mass. Additional experiments on the Mesob. famulus telson cDNA library 
revealed evidence for the amidation of the K+-channel toxin tamulustoxin, and of the 
existence of a novel long-chain potassium channel toxin in this species.
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In contrast to the short insectotoxins, apamin, a calcium-activated potassium channel 
toxin from the honey bee Apis mellifera, has been extensively studied. The toxin has a 
well-defined structure and mode of action. The specific binding of the toxin to an 
acceptor on rat brain membranes was utilised to further study specific aspects of its 
structure and function.
Three reasons have been proposed for the existence of the Asn-stabilised P-tum motif in 
apamin. The suggestion that the presence of this structure (or at least the Asn residue 
contained within it) promotes wild-type disulphide-bond pairings was confirmed by 
structural studies (Dempsey et al., 2000). The second possibility is that the P-tum is 
required for binding. There was no reduction in binding of a synthetic apamin peptide 
upon substitution of asparagine-2 for alanine (which has previously been shown to 
dismpt the p-tum of the toxin, Dempsey et al., 2000), provided the peptide retained the 
correct disulphide pairing. An Asn2Ala-apamin isoform, which contained non-native 
disulphide bridges causing the molecule to adopt the ribbon conformation, maintained 
its ability to bind these receptors, but with a 30 fold decrease in affinity. Thus, 
promotion of correct disulphide pairing does in turn increase the affinity of apamin for 
its acceptor. The P-tum itself, however, has little effect on binding affinity, although the 
structure may yet prove to play some role in the functional block of SK channels. 
(When considering results from binding experiments, it should be borne in mind that 
binding does not necessarily constitute functional block and future studies may show 
differing effects of the Asn-substitution and non-native disulphide pairings on block of 
SK currents). The third hypothesis suggests that the presence of the p-tum imparts 
resistance to proteolytic enzymes, and will be the subject of future investigation.
Addition of a large negatively charged fluorescent moiety (Alexa 488) to Lys-4 of 
synthetic apamin, decreased the binding affinity by seventy-fold compared to the native 
toxin. This effect was considerably reduced, but not abolished, in low salt buffer, 
suggesting that most, but not all, of the decrease in affinity could be attributed to 
electrostatic effects. The results show that overall charge distribution is more important 
for binding of this toxin to rat brain membranes than the P-tum or disulphide pairings.
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Appendix A. LC-MS Data for Mesobuthus tamulus venom from Aurangabad 
region.
LC-MS was performed on Mesob. tamulus venom (Aurangabad region) and data 
analysed as described (2.2.3.4 and 2.2.3.5). Component masses and their elution 
windows were calculated using LC-MS peak reconstruction software (Applied 
biosystems) with a mass tolerance of 0.01%, signal-to-noise ratio of 10 and 2000- 
lOOOODa final mass range. Peak areas were standardised against that of a peptide 
standard and the masses corresponding to those in a standard-only sample removed. 
Masses differing by IDa were assumed products of peptide oxidation or amidation and 
their relative areas pooled. Masses occurring in venoms from both regions (same 
isotopic and average mass +/- 0.02%, same retention time +/- lmin) were averaged and 
noted. Masses suspected of representing adducted peptides were noted.
Mass (Avg) Average mass of the neutral species.
Mass (Mono) Monoisotopic mass ([M+H]4). Based upon the lowest detected peak in 
the isotope series.
Apex Mass Mass of isotope distribution at maximum intensity.
Area Integrated total intensity (counts sec"1) over the m/z range of the
contributing ions.
Relative area Area standardised against that of peptide standard.
Score Least squares correlation coefficient for fit of observed values to
calculated masses.
Evidence Type of series used for mass determination. I = isotope series, C = charge
series, IC = isotope series that is also part of a charge series.
Time Elution window of ions contributing to mass information. Time is shown
to nearest 0.5 min from initiation of data collection.
Shared Mass S  indicates mass eluting at similar time is also detected in venom of 
Mesob. tamulus from Konkan region.
Adduct * indicates possible adduct mass. Data was examined for potential
masses relating to +Na, +K, +Na+K, -C02, -NH3, -H20 , mono- and di­
oxidation, in addition, to +74, +104 (adducts previously observed in 
scorpion venom mass data (Pimenta et al., 2001)).
Mass
Avg.)
Mass
(Mono
Apex 
) Mass
Area Relativ<
Area
5 Score Series
.............
Time
(min)
..45.0-45.5
Shared
Mass?
Adduct?
2006.^X 2005.6 2005.<:3 572 0.003 1.00
2 0 0 9 .:3 2008.6 20Q9A> 3155 0.016 LOO I 27.0 - 27.5
2025.!3 2025.3 20261 406 0.002 1.00 I 28.5-29.0
2150.<) 2150.0 2151.1 300 0.002 1.00 I 50.0 - 50.5
2163.:> 2162.5 2163.f 517 0.003 1.00 I 35.0-35.5 V
2374.() 2373.5 2374.5 358 0.002 0.89 I 46.5-47.0 S
2393.S 2392.7 2393./ 798 0.004 1.00 I 41.5-42.0
2436.17 2435.7 2437.2 454 0.002 1.00 I 37.0 - 37.5 s
2521.2 2519.8 2520.8 1140 0.006 1.00 I 51.0-52.0 s
2577.5 2576.8 2577.8 768 0.004 1.00 I 45.5-46.5 s
2592.5 2591.7 2592.7 489 0.003 1.00 I 40.5-41.5 s
2645.0 2643.5 2645.0 12965 0.068 1.00 IC 47.5-48.5 s
2667.3 2666.5 2666.5 296 0.002 1.00 I 47.5-48.0
2683.2 2682.4 2682.4 1535 0.008 1.00 I 44.5 . 45.5 ❖
2714.8 2712.6 2713.6 20916 0.109 1.00 IC 44.0-44.5
i - i  f \Z/ 1 /.U 2715.4 2716.1 72369 A nnQ\ J . ~ )  /  o 1.00 mI V 48.0-49.0
2718.0 2716.2 2717.2 1710 0.009 0.94 I 54.0-55.0 *
2727.4 2725.6 2727.1 1590 0.008 1.00 IC 45.5-46.0 s
2736.4 2734.6 2736.6 499 0.003 1.00 I 44.0-44.5 *
2738.3 2736.5 2738.6 4840 0.025 1.00 IC 48.0-49.0 *
2751.8 2749.8 2750.8 603 0.003 1.00 I 44.0-44.5 s ❖
2754.3 2752.5 2753.5 3699 0.019 1.00 IC 48.0-49.0 *
2759.9 2758.5 2759.5 1182 0.006 1.00 I 48.0-49.0
2775.6 2774.5 2775.5 317 0.002 1.00 I 48.0-49.0 %•
2782.9 2781.6 2782.6 827 0.004 1.00 I 36.0-37.0
2949.5 2947.5 2948.5 2144 0.011 1.00 I 22.5 - 23.5 s
2953.2 2951.4 2953.4 3352 0.018 1.00 IC 46.5-47.0
2974.9 2973.4 2975.4 1481 0.008 1.00 I 46.5-47.0
2988.9 2986.7 2988.7 13052 0.068 1.00 rc 5.0 - 5.5 s
3021.2 3019.6 3021.1 4437 0.023 1.00 IC 5.0-5.5 s *
3060.7 3058.8 3059.7 3007 0.016 1.00 rc 41.5-42.0
3105.9 31.03.7 3104.7 32162 0.168 1.00 rc 32.0-32.5
3110.5 3108.7 3110.7 802 0.004 1.00 i 30.0-31.0 s
3145.7 3144.7 3145.7 732 0.004 1.00 r 31.5-32.5
3166.7 3164.7 3165.7 6235 0.033 1.00 rc 43.0-43.5 *
3168.5 3166.7 3168.2 1137 0.006 1.00 i 27.0 - 27.5
3183.6 3182.0 3184.0 4052 0.021 1.00 IC 43.0-44.0
3188.8 3186.7 3188.7 2606 0.014 1.00 i 43.0-43.5
3191.8 3189.7 3191.7 4689 0.024 1.00 IC 5.0 - 5.5
3204.3 3202.7 3204.7 1507 0.008 1.00 IC 43.0-43.5
3223.9 3221.8 3222.8 7982 0.042 1.00 IC 22.5-23.0 *
3251.4 3250.9 3250.9 403 0.002 1.00 i 33.5-34.0
3251.7 3249.9 :3251.9 822 0.004 1.00 i 33.5-34.0
3261.8 3260.8 :3261.8 255 0.001 1.00 i 22.5-23.0 ' *
3296.2 3293.9 :3295.9 7009 0.037 1.00 IC 32.5-33.5
3309.0 3306.8 :3308.8 20937 0.109 1.00 IC 33.0-34.0
3321.2 3318.9 :3319.9 2101 0.011 1.00 IC 23.5-24.0
i i i
Mass
Avg.)
_. Mass 
(Mono
_ Apex 
) Mass
_ Area Relative
Area
£ -Score Serieis Time
(min)
Shared
Mass?
Adduct?
3346.<? 3345.4 3346.1 2251 0.012 1.00 IC 33.0-34.0 S
3351.() 3349.0 3350.C) 2905 0.015 1.00 I 31.5-32.5
3357.!> 3355.9 3356.* 9023 0.047 1.00 IC 33.0-33.5 S
3380.C) 3379.5 3379.5 3251 0.017 0.77 I 54.5-55.0
3389.S> 3388.1 3389.6 2183 0.011 1.00
1.00
I
IC
54.0-55.0
35.0-36 0
S
3391.^ 3389.0 3391.C 3096 O.Olo
3392.* 3391.9 3391.5> 290 0.002 1.00 I 27.0 - 27.5
3392.7 3390.7 3392.7 1087 0.006 1.00 I 49.5-50.0 s -
3397.5 3395.3 3397.5 930 0.005 0.72 I 54.0-55.0
3411.2 3408.8 3410.8 12732 0.066 1.00 IC 46.0 - 46.5 s
3411.8 3410.3 3411.8 931 0.005 1.00 I 48.0-48.5 s
3418.3 3415.9 3417.9 9745 0.051 1.00 IC 26.0 - 26.5 *
3418.9 3417.9 3418.9 1023 0.005 1.00 I 29.5-30.0 *
3430.6 3429.0 3429.9 1723 0.009 0.95 I 22.5-23.0
3435.1 3433.0 3435.0 559 0.003 1.00 I 5.0 - 5.5
3449.8 3448.4 3449.4 239426 1.250 1.00 IC 40.0-46.5 V *
3460.1 3457.8 3459.8 2603 0.014 1.00 IC 27.0 - 27.5
3467.0 3465.0 3467.0 8718 0.046 1.00 IC 5.0 - 5.5 *
3472.9 3470.0 3472.0 6450 0.034 1.00 IC 5.0 - 5.5 *
3478.3 3476.4 3477.9 9189 0.048 1.00, IC 35.0-36.0 s
3484.3 3482.0 3484.1 6688 0.035 1.00 IC 5.0 - 5.5
3487.9 3486.0 3488.0 10494 0.055 1.00 IC 5.0 - 5.5 *
3493.3 3492.0 3492.0 3020 0.016 1.00 IC 5.0-5.5
3494.3 3492.0 3493.0 9101 0.048 1.00 IC 23.0 - 23.5 Hi
3500.4 3498.0 3500.1 1743 0.009 1.00 IC 5.0-5.5 *
3500.6 3498.6 3500.1 9782 0.051 1.00 IC 23.5-24.0 s
3502.4 3501.0 3502.1 1299 0.007 1.00 IC 5.0 - 5.5
3511.3 3509.1 3511.6 14005 0.073 1.00 IC 5.0 - 5.5 s
3514.0 3512.0 3512.0 672 0.004 1.00 IC 5.0-5.5
3517.2 3514.9 3516.9 5075 0.027 1.00 IC 32.0-32.5- s *
3519.2 3517.0 3519.0 53972 0.282 1.00 IC 26.0 - 26.5
3525.4 3523.9 3525.0 1110 0.006 1.00 IC 5.0 - 5.5 ❖
3535.4 3532.9 3534.9 860 0.004 1.00 I 22.5^-23.0 s
3535.5 3533.0 3535.0 13309 0.070 1.00 IC 35.0-35.5 s
3540.7 3539.0 3541.0 389 0.002 1.00 I 26.0 - 26.5
3541.0 3539.0 3541.1 1982 0.010 1.00 I 23.0-24.0
3546.9 3545.6 3547.5 938 0.005 1.00 I 5.0 - 5.5 V
3553.5 3551.1 3553.0 9470 0.049 1.00 IC 30.0-31.0
3557.1 3556.0 3557.0 429 0.002 1.00 I 26.0-26.5
3560.4 3558.1 3560.1 23683 0.124 1.00 IC 5.0-5.5 V *
3571.9 3570.0 3572.0 1845 0.010 1.00 IC 5.0 - 5.5
3576.4 3574.0 3576.1 2080 0.011 1.00 IC 5.0-5.5 Hi
3588.3 3586.5 3588.0 12250 0.064 1.00 IC 36.5-37.0 V
3593.3 3591.5 3593.0 1819 0.010 1.00 IC 5.0 - 5.5 V Hi
3595.2 3594.1 :3594.1 768 0.004 1.00 IC 5.0 - 5.5 Hi
3596.8 3596.1 :3596.1 397 0.002 1.00 I 5.0 - 5.5 *
3611.9 3611.0 :3612.1 367.2 0.002 1.00 I 5.0-5.5 Hi
3629.3 3627.0 3629.1 3981 0.021 1.00 IC 30.0-30.5
Mass
[Avg.]
- -Mass 
(Mono
Apex 
) Mass
Area _ Relatixi 
Area
e Score Seriejs. Time 
(min)
Shared
Mass?
Adduct?
3672.. 3670.6 3672.1 13768 0.072 1.00 IC 21.0-22.0 /
36842) 3682.5 3684.^> 3231 0.017 1.00 I 27.5 - 28.5 S
368525 3683.1 3685.1 68391 0.357 1.00 IC 22.5-23.0 S
3707.(3 3706.1 3707.1 1277 0.007 1.00 IC 22.4-23.0
3715.() 3713.2 3715.2 3439 0.018 1.00 IC 22.0-22.5
3722A 3720.5 3722.C 15350 0.080 1.00 IC 46.0-47.0 S *
3723/ 3721.5 3723.5 2787 0.015 1.00 IC 22.5-23.0 V *
3744.2 3743.0 3744.C 663 0.003 1.00 I 46.0 -  47.0
3754i 3752.3 3754.3 7689 0.040 1.00 IC 23.0 - 23.5 ❖
3756.3 3755.4 3755.4 1219 0.006 1.00 I 23.0 - 23,5
3760.S 3760.0 3760.Q 709 0.004 1.00 IC 46.0-47.0
3769.8 3769.1 3769.1 356 0.002 1.00 I 25.5 - 26.5
3770.9 3769.0 3770.0 11742 0.061 1.00 IC 49.0 - 49.5 S
3792.7 3791.1 3792.0 747 0.004 1.00 I 49.0-49.5 *
3797.7 3795.0 3797.5 74055 0.387 1.00 IC 26.0-27.0 /
3819.6 3816.9 3818.9 46670 0.024 1.00 IC 26.0-27.0 *
3821.8 3821.0 3820.5 o  o  r- 0.002 1.00 I 22.5-23.0 y'
3830.4 3828.2 3830.2 2329 0.012 1.00 IC 26.0-27.0
3835.3 3833.0 3834.5 5969 0.031 1.00 IC 26.0-27.0 S *
3840.5 3838.1 3840.1 19555 0.102 1.00 IC 22.5-23.0 v''
3841.3 3839.0 3841.0 1387 0.007 1.00 I 26.0-27.0 ✓ ❖
3854.7 3852.1 3854.1 5976 0.031 1.00 IC 22.0-23.0
3854.9 3854.1 3854.1 5230 0.027 1.00 IC 22.0-23.0
3895.7 3895.2 3896.3 930 0.005 1.00 I 34.0-35.0 :)<
3896.5 3895,1 3897.1 491 0.003 1.00 I 30.5-31.5
3910.6 3908.7 3910.2 5541 0.029 1.00 IC 36.5-37.0 ✓
3912.5 3911.1 3912.2 34795 0.182 1.00 IC 5.0 - 5.5
3913.0 3910.2 3912.2 776 0.004 0.88 I 5.0 - 5.5 s
3914.6 3912.0 3914.0 17392 0.091 1.00 IC 29.0 - 29.5 V *
3929.0 3928.2 3929.3 378 0.002 0.99 I 31.5-32.5 *
3932.0 3930.3 3932.2 1310 0.007 1.00 I 31.5-32.5
3932.1 3930.2 3931.2 6858 0.036 0.98 I 42.0-43.0
3934.2 3933.2 3934.2 160 0.001 1.00 I 5.0-5.5 ❖
3950.2 3948.3 3949.3 801 0.004 1.00 I 5.0 - 5.5 ❖
3951.9 3951.0 3951.0 358 0.002 1.00 I 29.0 - 29.5
3953.6 3952.0 3953.1 1398 0.007 1.00 IC 42.0-43.0
3971.7 3969.2 3971.2 32091 0.168 1,00 IC 22.0 - 22.5 v'
3986.4 3985.4 3986.3 2495 0.013 1.00 IC 42.5 -  43.0
3986.4 3984.3 3986.31 1323 0.007 1.00 I 33.5-34.5
3993.5 3991.7 3993.7 1803 0.009 1.00 IC 22.0-22.5 V *
4009.8 4007.2 1009.2 2433 0.013 1.00 IC 22.0-22.5 *
4020.0 4017.3 1019.3 38274 0.200 1.00 I 25.5 - 26.5
4020.1 4017.3 1019.3 35923 0.188 1.00 I 27.0-27.5
4029.5 4027.3 1029.2 9414 0.049 1.00 IC 22.5 - 23 S
4042.6 4041.3 1041.3 1039 0.005 0.89 I 25.5-26.0
4052.1 4049.4 *1051.5 6471 0.034 1.00 IC 28.5-29.0 *
4053.5 1052.4 t1052.4 1180 0.006 0.76 I 28.5-29.0
4061.1 1059.3 i1059.3 941 0.005 1.00 I 25.5 - 26.5
- Mass- 
;Avg.)
-Mass-
(Mono'
Apex
Mass
Area Relative
Area
Score Series Time..
(min)
Shared
Mass?
Adduct?
4114.3 4113.5 4114.4 1128 0.006 1.00 I 26.5 - 27.5
4134.4 4132.4 4134.4 10944 0.057 1.00 IC 31.0-31.5
4173.1 4170.5 4172.5 7911 0.041 1.00 IC 38.0-38.5
4205.3 4203.0 4203.0 3858 0.020 1.00 IC 5.0 - 5.5 v'
4207.3 4205.5 4207.1 755 0.004 1.00 IC 30.5-31.5 Y
4223.7 4221.3 4223.2 740 0.004 0.89 I 24.0-24.5
4226.1 4223.5 4226.5 1322 0.007 1.00 IC 32.5-33.5
4241.9 4240.5 4241.5 647 0.003 0.94 I 31.0-32.0
4303.0 4302.5 4302.5 249 0.001 1.00 I 50.0 - 50.5
4303.4 4300.5 4303.6 4762 0.025 1.00 IC 50.0 - 50.5
4339.2 4336.6 4339.6 3104 0.016 1.00 IC 23.5-24.0
4464.2 4462.5 4464.5 325 0.002 1.00 I 21.5-22.0 S
4528.6 4528.0 4529.0 379 0.002 1.00 I 54.5 -  55.0
4877.8 4876.9 4876.9 328 0.002 1.00 I 37.0 - 37.5
4930.4 4928.4 4930.4 871 0.005 1.00 I 41.0-41.5 V
5100.0 5098.2 5099.0 1716 0.009 1.00 I 54.0-55.0
5467.4 5465.3 5466.2 703 0.004 0.95 I 54.0-55.0
6706.6 6705.0 6707.0 1097 0.006 1.00 I 44.5 - 45.5
6756.3 6754.2 6755.4 102870 0.537 1.00 IC 54.0 -  55.0 V
6770.1 6777.7 6777.7 1513 0.008 0.85 I 54.0-55.0
6795.7 6793.8 6794.7 3504 0.018 0.89 I 54.5 -  55.0 *
6803.0 6801.7 6801.7 566 0.003 1.00 I 54.0-55.0
6816.3 6813.6 6816.6 1760 0.009 1.00 IC 54.0-55.0
6820.7 6819.8 6817.6 1108 0.006 1.00 IC 54.0-55.0
6991.5 6989.1 6992.1 5665 0.030 1.00 IC 54.0 . 54.5
Appendix B. LC-MS Data for Mesobuthus tamulus venom from Konkan region.
LC-MS was performed on Mesob. tamulus venom (Konkan region) and data analysed as 
described (2.2.S.4 and 2.23.5). Component masses and their elution windows were 
calculated using LC-MS peak reconstruction software (Applied biosystems) with a mass 
tolerance of 0.01%, signal-to-noise ratio of 10 and 2000-10000Da final mass range. 
Peak areas were standardised against that of a peptide standard and the masses 
corresponding to those in a standard-only sample removed. Masses differing by IDa 
were assumed products of peptide oxidation or amidation and their relative areas 
pooled. Masses occurring in venoms from both regions (same isotopic and average mass 
+/- 0.02%, same retention time +/- lmin) were averaged and noted. Masses suspected of 
representing adducted peptides were noted.
Mass (Avg) Average mass of the neutral species.
Mass (Mono) Monoisotopic mass ({M+H]4). Based upon the lowest detected peak in 
the isotope series.
Apex Mass Mass of isotope distribution at maximum intensity.
Area Integrated total intensity (counts sec"1) over the m/z range of the
contributing ions.
Relative area Area standardised against that of peptide standard.
Score Least squares correlation coefficient for fit of observed values to
calculated masses.
Evidence Type of series used for mass determination. I = isotope series, C = charge 
series, IC = isotope series that is also part of a charge series.
Time Elution window of ions contributing to mass information. Time is shown
to nearest 0.5 min from initiation of data collection.
Shared Mass S  indicates mass eluting at similar time is also detected in venom of 
Mesob. tamulus from Aurangabad region.
Adduct * indicates possible adduct mass. Data was examined for potential 
masses relating to +Na, +K, +Na+K, -CCb, -NH3, -H2O, mono- and di­
oxidation, in addition to +74, +104 (adducts previously observed in 
scorpion venom mass data (Pimenta et al., 2001)).
Mass
(Avg.]
Mass
(Mono
Apex 
) Mass Area
Relativi
Area
3 Score Series Time
(min)
Sharec
Mass?
Adduct?
2046/ 2045.4 2046/ 903 0 .002 1.00 I 58.5 - 59.5
2052.1 2051.4 2051.4 431 0 .001 1.00 I 60.0 - 60.5
2055/ 2054.4 2055.4 558 0.001 1.00 I 50.0-51.5
2094.2 2093.4 2093.4 548 0.001 1.00 I 49.5 - 50.5
2109.1 2108.3 2108.3 2967 0.006 1.00 I 5 .0-5.5
2147.S 2147.3 2148.3 517 0.001 1.00 I 5 .0-5 .5
2150.S 2150.0 2151.1 4310 0.009 1.00 IC 48.0-49.0 S
2163.5 2162.5 2163.5 2968 0.006 1.00 I 39.5-40.5 v'
2172.8 2172.4 2172.4 253 0.001 1.00 I 48.0-49.0
2180.0 2179.5 2180.5 327 0.001 1.00 I 41.0-42.0
2199.0 2198.5 2199.5 465 0.001 1.00 I 41.5-42.5
2230.9 2229.4 2230.5 3165 0.007 1.00 IC 49.0-50.0
2236.0 2234.9 2234.9 1155 0 .002 0.89 I 50.5-51.5
2238.1 2237.6 2237.6 732 0 .002 1.00 I 50.5-51.5
2246.4 2245.4 2246.4 947 0.002 1.00 I 49.5-50.0 ❖
2251.0 2249.5 Q 6 1 9y 0 .020 1.00 I 39.5-40.5
2255.0 2254.5 2254.5 907 0.002 1.00 I 39.5-40.5
2290.2 2289.6 2290.6 579 0.001 1.00 I 42.0-43.0
2293.5 2292.6 2293.6 1019 0 .002 1.00 I 42.0-43.0
2296.7 2295.6 2296.5 3104 0.007 1.00 I 41.5-42.5
2301.7 2300.6 2301.6 2167 0.005 1.00 I 44.5-42.0
2338.0 2337.6 2337.6 2018 0.004 1.00 I 42.0-43.0
2374.6 2373.5 2374.5 4899 0 .010 1.00 IC 48.5 - 49.5
2380.7 2379.5 2381.5 752 0 .002 1.00 I 48.5-49.5
2407.7 2406.6 2407.6 1325 0.003 1.00 I 42.0-43.0
2436.7 2435.7 2437.2 2500 0.005 1.00 I 41.5-42.0 S
2447.0 2445.6 2446.7 3084 0.006 1.00 I 42.0-42.5
2479.2 2477.6 2478.6 1975 0.004 1.00 I 42.0-42.5 *
2495.9 2494.6 2495.7 1813 0.004 1.00 I 42.0-42.5
2521.2 2519.8 2520.8 5775 0 .012 1.00 I 53.5-54.0 S *
2521.4 2520:8 2520.8 2929 0.006 0.89 I 53.4-54.0
2536.1 2534.7 2535.7 11440 0.024 1.00 IC 42.0-43.0
2555.2 2554.6 2555.6 324 0.001 1.00 I 42.0 - 42.5 *
2557.7 2556.6 2558.7 821 0 .002 1.00 I 42.0-42.5 *
2577.9 2576.8 2577.8 4338 0.009 1.00 I 45.5-46.0 S
2585.6 2584.5 2584.5 951 0.002 1.00 I 42.0 - 42.5
2586.5 2585.5 2585.5 336 0.001 1.00 I 47.5-48.0
2592.9 2591.7 2592.7 2509 0.005 1.00 I 42.0-42.5 S
2613.9 2613.5 2613.5 1712 0.004 1.00 I 47.5-48.0
2621.1 2619.8 2620.8 1544 0.003 1.00 I 39.5-40.0
2628.4 2627.8 2628.8 2138 0.004 1.00 I 45.0 - 45.5
2643.0 2641.7 2642.8 406 0.001 1.00 I 55.5-56.0 •J*
2645.0 2643.5 :2645.0 n o r 0.001 1.00 I 51.5-52.0 V *
2717.0 2715.4 :2716.1 508 0.001 1.00 I 50.5-60.0 S
2727.4 2725.6 ;2727.1 98630 0.207 1.00 IC 47.5-48.0 v'
2751.8 2749.8 ;2750.8 6399 0.013 1.00 IC 47.5-48.0 S2757.7 2756.6 2275 8.6 508 0.001 1.00 I 51.5-52.0 S
' v iii
-  Mass 
(Avg.]
_ .Mass. 
(Mono
Apex 
) Mass
Relative; Score Series Time
(min)
Sharec
Mass?
Adduct?
Area Area
2765.1 2763.5 2765.5 5052 0.011 1.00 IC 47.5 -  48.0 %
2771.1 2770.5 2771.5 317 0.001 1.00 I 47.5 -  48.0
2771.1 2769.5 2771.5 485 0.001 1.00 I 47.5-48.0
2792.2 2790.6 2791i 819 0 .002 1.00 I 51.5-52.0
2793.1 2791.4 2792.4 2514 0.005 1.00 IC 24.5 -  25.0 *
2802.5 2801.8 2801.c 983 0.002 0.99 I 24.5 -  25.0
2816.8 2815.7 2816.6 548 0.001 1.00 I 49.5 -  50.0
2827.6 2826.7 2827.6 738 0.002 1.00 I 49.5-50.0
2834.2 2832.7 2833.7 762 0.002 1.00 I 51.5-52.0
2845.6 2843.6 2844.6 81856 0.171 1.00 IC 49.0 -  50.0
2868.6 2865.6 2866.6 6243 0.013 1.00 IC 49.5 -  50.0
2877.2 2875.7 2876.7 818 0.002 1.00 I 51.5-52.0 *
2883.5 2881.6 2883.6 5550 0.012 1.00 IC 49.5-50.0 'T'
2887.8 2886.6 2887.7 713 0.001 1.00 I 51.5-52.0
2889.1 2887.6 2888.6 2389 0.005 1.00 I 49.5 -  50.0 ❖
2905.7 2903.7 2904.7 103973 0.218 1.00 IC 51.5-52.0 *
2917.5 2916.5 2917.5 362 0.001 1.00 I 24.5-25.0
2928.7 2927.6 2928.6 7564 0.016 1.00 IC 51.5-52.0
2931.2 2930.4 2931.5 324 0.001 1.00 I 24.5-25.0
2931.5 2929.4 2931.5 11099 0.023 1.00 IC 26.0-27.0
2933.9 2932.5 2934.5 1046 0 .002 1.00 I 24.5-25.0
2943.5 2941.6 2943:6 6538 0.014 1.00 IC 51.5-52.0 *
2949.5 2947.5 2948.5 649363 1.360 1.00 IC 24.5-25.0
2949.8 2948.6 2948.6 766 0.002 1.00 I 51.5-52.0 ❖
2963.1 2962.4 2963.4 311 0.001 1.00 I 24.5-25.0 *
2963:7 2961.7 2963.7 5152 0.011 1.00 IC 56.5-57.0 ❖
2967.1 2964.5 2969.4 6230 0.013 1.00 IC 24.5-25.0
2967.2 2965.4 2966.4 3503 0.007 1.00 IC 49.0-50.0
2969.9 2968.4 2970.4 5640 0.012 (.0 0 I 24.5-25.0
2972.1 2969.4 2971.4 7755 0.016 1.00 IC 27.0-27.5
2972.8 2970.4 2971.4 71537 0.150 1.00 IC 24.5-25.0
2979.0 2978.4 2979.4 825 0.002 1.00 I 24.5-25.0
2982.9 2980.4 2982.5 4270 0.009 1.00 IC 24.5-25.0
2987.3 2985.4 2987.4 6762 0.014 1.00 IC 27.0-27.5
2987.5 2985.4 2987.4 85057 0.178 1.00 IC 24.5-25.0 ❖
2988.9 2986.7 2988.7 168685 0.353 1.00 IC 5.0-5 .5 *
2990.1 2989.4 2989.4 22563 0.047 1.00 I 49.0-49.5
2993.4 2991.4 2992.4 14690 0.031 1.00 IC 24.0-25.0 *
3003.6 3001.4 3003.4 7323 0.015 1.00 IC 24.5-25.0 *
3005.0 3005.4 3005.4 3831 0.008 1.00 IC 24.5-25.0
3005.3 3003.8 3004.6 1364 0.003 1.00 IC 5.0-5 .5 *
3009.9 3007.4 3008.4 15012 0.031 1.00 IC 24.5-25.0 *
3010.0 3008.6 3009.6 4535 0 .010 1.00 IC 5.0-5 .5 *
3015.2 3013.4 3014.4 6307 0.013 1.00 IC 24.5-25.0 *
3018.3 3017.4 3017.4 369 0.001 1.00 I 24.5-25.0
3021.2 3019.6 :3021.1 5501 0.012 1.00 I 5 .0-5 .5 ❖
3025.2 3023.4 :3024.4 13512 0.028 1.00 IC 24.0-25.0
3026.7 3025.6 23025.6 830 0.002 0.00 I 5 .0-5 .5 *
-Mass
(Avg.]
- -Mass- 
(Moho
Apex 
) Mass Area
Relative
Area
j Score Series___.Time
(min)
Sharec
Mass?
Adduct?
3031/ 3029.4 3030/ 3565 0.007 1.00 I 24.0-25.0
3036/ 3035.4 3037/ 1767 0.004 1.00 I 24.5-25.0
3037.2 3036.7 3037/ 162 0.000 1.00 I 5.0-5.5
3039.2 3038.7 3039/ 146 0.000 1.00 I 5.0-5.5
3042.2 3040.6 3041/ 1163 0.002 1.00 I 24.0-25.0 *
3047.6 3046.5 3046/ 2877 0.006 1.00 IC 24.5-25.0 *
3053.1 3051.4 3053.4 1910 0.004 1.00 I 24.0-25.0 *
3062.6 3061.4 3061.4 810 0.002 1.00 I 24.5-25.0
3067.6 3066.9 3066.9 18630 0.039 0.99 I 41.0-42.0
3069.5 3067.4 3070.5 5460 0.011 1.00 IC 24.5-25.0 *
3080.8 3080.4 3080.4 272 0.001 1.00 I 24.5-25.0
3086.0 3084.3 3086.4 937 0.002 0.93 I 24.5-25.0
3091.6 3089.3 3091.4 1877 0.004 1.00 I 24.0-25.0 *
3107.7 3105.4 3107.4 2025 0.004 1.00 IC 24.5-25.0 *
3110.6 3108.7 3110.7 3864 0.008 1.00 IC 34.0-35.0
3114.5 3112.4 3115.5 1240 0.003 1.00 I 24.5-25.0
3156.3 3155.8 3156.8 401 0.001 1.00 I 5.0-5.5
3168.5 3166.7 3168.2 566 0.001 1.00 I 29.5-30.0 S
3173.0 3171.9 3172.9 17674 0.037 1.00 IC 5.0-5.5
3174.3 3173.9 3173.9 36626 0.077 1.00 IC 5.0-5.5
3174.7 3172.9 3173.9 98413 0.206 1.00 IC 5.0-5.5 *
3176.7 3175.8 3175.8 11801 0.025 0.94 I 5.0-5.5
3191.8 3189.7 3191.7 68603 0.144 1.00 IC 5.0-5.5 S
3207.8 3205.9 3207.8 7753 0.016 1.00 IC 5.0-5.5 *
3210.3 3207.8 3207.8 21 1 0 0.004 1.00 IC 5.0-5.5
3213.2 3211.8 3211.8 847 0.002 1.00 IC 5.0 -5 .5
3215.4 3213.6 3215.6 1603 0.003 1.00 IC 5.0-5.5
3222.4 3221.8 3222.8 340 0.001 1.00 I 5.0-5.5
3225.6 3223.8 3225.7 924 0.002 1.00 IC 5.0-5.5
3229.6 3227.6 3228.6 1899 0.004 1.00 IC 5.0-5.5 *
3272.0 3270.9 3271.9 1200 0.003 1.00 IC 5.0-5.5
3281.7 3279.7 3280.7 3453 0.007 1.00 IC 47.0 - 47.5 *
3309.0 3306.8 3308.8 48355 0.101 1.00 IC 38.0 - 38.5 v'
3331.1 3328.9 3330.9 3400 0.007 1.00 IC 31.5-32.0
3331.4 3328.7 3330.7 3200 0.007 1.00 IC 38.0-38.5 *
3332.0 3330.7 3331.7 2994 0.006 1.00 IC 38.0-38.5
3336.0 3334.9 3336.7 1173 0.002 0.99 I 50.5-51.5
3346.8 3345.8 3346.8 1179 0.002 1.00 I 27.0-28.0
3346.8 3345.7 3345.7 2162 0.005 1.00 IC 38.0 - 38.5
3346.9 3345.4 3346.1 5356 0.011 1.00 IC 38.0-38.5
3347.2 3344.9 3346.9 33243 0.070 1.00 IC 29.0-29.5 v" *
3352.8 3351.7 3353.7 485 0.001 1.00 I 37.5-38.5 v"
3352.9 3350.8 3351.8 10038 0.021 1.00 IC 50.5-51.5rJDOD.J ddo2.d _3362,3 1916 0.004 1.00 I 50.5-51.5
3368.7 3367.8 :3368.8 471 0.001 1.00 I 28.5 - 29.5 *
3369.4 3367.7 3369.8 1438 0.003 1.00 I 50.5-51.5
3380.8 3380.3 23381.3 481 0.001 1.00 I 50.5-51.5
3389.9 3388.1 23389.6 10225 0.021 1.00 IC 62.0-63,0 S *
Mass
(Avg.:
Mass 
i (Mono
Apex 
) Mass Area
Relative
Area
 ^ Score Series Time
(min)
Shared
Mass?
Adduct?
3392."1 3390.7 3392."1 2707 0.006 1.00 T 52.0-53.0 S
34.1JJ13408.8_ 3410.?\ 90343 „ 0.189 1.00 IC 48.0-49.0 V
3411.?I 3410.3 3411.?3 1999 0.004 1.00 I 50.0-50.5 S
3413.41- 3412.7 3413.7f 800 0.002 1.00 IC 62.0-63.0
3424.? 3422.9 3424.S 1706 0.004 1.00 IC 22.5 - 23.5 ❖
3428.2 3427.7 3428.7' 1026 0.002 1.00 I 62.0-63.0
3432.1 3431.1 3432.3 784 0.002 1.00 I 24.0-25.0
3432.3 3430.1 3432.1 7641 0.016 1.00 IC 22.5-23.5
3433.4 3430.7 3432.7 8789 0.018 1.00 IC 48.0-49.0 *
3436.3 3435.1 3436.C 1247 0.003 1.00 I 24.0-25.0
3449.7 3448.4 3 4 4 9 1 26295 0.055 1.00 T 48.0-49.0 S
3452.5 3451.9 3451.9 1118 0.002 0.27 I 5 .0-5 .5 S
3454.6 3452.7 3454.7 1414 0.003 1.00 I 48.0-49.0
3466.2 3463.9 3465.9 10356 0.022 1.00 IC 24.5-25.0
3471.7 3469.7 3471.7 11.14 0.002 1.00 IC 48.0-49.0 *
3476.6 3475.7 3476.7 377 0.001 1.00 I 48.0-49.0
3477.4 3476.9 3477.9 262 0.001 1.00 I 5 .0-5 .5
3478.3 3476.4 3477.9 21813 0.046 1.00 IC 40.0 - 40.5 S
3497.3 3494.8 3496.8 37933 0.079 1.00 IC 5.0-5 .5
3500.6 3498.6 3500.1 12287 0.026 LOO IC 25.5 - 26.5 S
3502.8 3501.7 3502.9 438 0.001 1.00 I 24.5-25.0
3507.3 3504.9 3506.9 95430 0.200 1.00 IC 28.0-28.5 *
3509.3 3507.9 3510.0 1948 0.004 LOO I 5.0-5 .5 *
3511.3 3509.1 3511.6 15761 0.033 1.00 IC 5.0-5 .5 S
3517.5 3514.9 3516.9 2250 0.005 1.00 IC 36.5 - 37.5
3519.2 3517.0 3519.0 14948 0.031 1.00 IC 28.5-29.0 S
3527.6 3526.5 3527.6 4647 0.010 1.00 I 40.5-41.0
3529.5 3527.0 3529.0 47969 0.100 1.00 IC 34.5 - 35.5 *
3530.2 3529.8 3530.8 4084 0.009 1.00 IC 28.0-28.5
3534.0 3531.9 3533.8 778 0.002 1.00 IC 5.0-5 .5
3535.4 3532.9 3534.9 5452 0.011 1.00 IC 40.0-40.5 S *
3545.1 3542.8 3544.8 4348 0.009 1.00 IC 28.0-28.5 *
3545.4 3542.9 3545.0 13135 0.028 1.00 IC 29.5-30.0 *
3546.9 3545.6 3547.5 1040 0.002 LOO I 5.0-5 .5
3560.4 3558.1 3560.1 5112 0.011 1.00 IC 5 .0-5 .5 s
3567.5 3565.9 3569.0 1634 0.003 1.00 IC 35.0 - 35.5
3588.3 3586.5 3588.0 875 0.002 LOO I 41.0-42.0 s
3593.3 3591.5 3593.0 1953 0.004 0.89 I 5 .0-5 .5 s
3672.5 3670.6 3672.1 1598 0.003 LOO I 22.5-23.0 s
3684.9 3682.5 3684.5 41066 0.086 1.00 IC 26.0-27.0 ■/
3685.5 3683.1 3685.1 3141 0.007 1.00 I 24.0-25.0 </
3689.6 3688.0 3689.0 1397 0.003 1.00 I 37.0-38.0
3709.7 3707.1 :3709.1 32410 0.068 1.00 IC 38.0-28.5
3711.7.3710.1 :3712.1 492 0.001 1.00 I 41.5-42.0 ❖
3722.4 3720.5 :3722.0 1148 0.002 1.00 IC 48.5-50.0
3723.4 3721.5 23723.5 1556 0.003 1.00 IC 26.0 - 26.5
3725.6 :3723.2 23725.2 8505 0.018 1.00 IC 42.0 - 42.5 *
3741.8 :3739.1 23741.1 28422 0.060 1.00 IC 41.5-42.0 *
Mass
(Avg.;
Mass
(Mono
Apex 
) Mass Area
Relative
Area
; Score Series Time
(min)
Sharec
Mass?
Adduct?
3743.i 3741.9 3742.S 6777 0.014 1.00 IC 28.5-29.0 *
3770J) 3770.0 3770.5 1348 0.003 1.00 IC 51.0-52.0
3785.( 3782.8 3784.S 2523 0.007 1.00 IC 41.5-42.0
3797.1r 3795.0 3797.1 52149 0.109 1.00 IC 29.0-29.5
3819.* 3816.9 3818.9 2139 0.004 1.00 I 29.0-29.5
3821.8 3821.0 3820.5 520 0.001 LOO I 29.0-29.5
3825.8 3823.2 3825.1 1881 0.004 1.00 I 5 .0-5.5
3825.8 3824.1 3825.1 1179 0.002 0.81 I 5.0-5.5
3835.3 3833.0 3834.5 2619 0.005 1.00 IC 29.0-29.5 *
3838.C 3836.1 3838.2 360 0.001 1.00 I 5 .0-5 .5
3840.5 3838.1 3840.1 7205 0.015 1.00 IC 24.0 - 24.5
3845.8 3844.1 3845.1 15442 0.032 1.00 IC 24.5 -  25.0
3851.6 3849.2 3851.2 4661 0 .010 1.00 IC 37.0-38.0
3852.2 3850.1 3852.2 1754 0.004 1.00 IC 39.5-40.0
3860.5 3859.0 3859.9 2632 0.006 1.00 IC 41.5-42.0
3869.7 3867.1 3869.1 3702 0.008 1.00 IC 57.5-58.0
3886.7 3884.0 3886.0 32413 0.068 1.00 IC 27.5 - 28.5
3887.9 3885.1 3887.1 23889 0.050 1.00 IC 53.5 -  54.0
3897.0 3894.2 3896.2 37126 0.078 1.00 IC 5.0-5 .5
3902.5 3900.0 3902.0 21787 0.046 1.00 IC 27.0 -  28.0 *
3908.3 3907.0 3908.0 1369 0.003 1.00 I 27.5 - 28.5
3910.6 3908.7 3910.3 751 0.002 1.00 I 41.5-42.0 S
3911.8 3911.0 3911.0 352 0.001 1.00 I 53.5 -  54.0
3912.5 3911.1 3912.2 1564 0.003 1.00 I 5 .0-5 .5 S
3913.0 3910.2 3912.2 4251 0.009 1.00 IC 5.0-5 .5 S *
3913.7 3913.0 3914.0 11365 0.024 1.00 IC 38.0-38.5
3913.8 3911.0 3913.0 29437 0.062 1.00 IC 38.0 - 38.5
3914.6 3912.0 3914.0 1740 0.004 1.00 I 32.5-33.5 S
3915.1 3912.8 3914.8 824 0 .002 0.80 I 33.0-33.5
3917.7 3916.1 3918.1 1243 0.003 1.00 I 36.5-37.0
3925.3 3924.1 3925.1 486 0.001 1.00 I 53.5-54.0
3935.5 3934.1 3934.9 432 0.001 0.99 I 38.0-38.5
3936.9 3934.2 3936.2 12397 0.026 1.00 I 24-25
3951.8 3951.0 3951.0 424 0.001 1.00 I 38.0-38.5 *
3971.7 3969.2 3971.2 20654 0.043 1.00 IC 23.5-24.5 S
3973.9 3971.4 3973.3 5676 0.012 1.00 IC 39.0-40.0 *
3974.6 3972.2 3974.2 4537 0.010 1.00 IC 26.5-27.0 *
3989.8 3988.4 3989.3 912 0 .002 1.00 I 39.0-40.0
3993.5 3992.7 3993.7 566 0.001 1.00 I 23.5-24.5 S
4004.9 4003.2 4004.2 1939 0.004 1.00 I 25.0-26.0
4005.9 4003.3 4005.3 7430 0.016 1.00 IC 34.5-35.5 *
4029.5 4027.3 4029.2 4348 0.009 1.00 IC 24.0-25.0 S
4037.8 4035.1 4038.2 5354 0.011 1.00 IC 24.0 - 24.5
4055.9 4053.1 4055.1 234241 0.491 1.00 IC 24.5-25.0
4078.3 4075.1 4078.1 8872 0.019 1.00 IC 24.5-25.0
4088.9 4087.1 '1090.1 1746 0.004 1.00 IC 24.5-25.0 *
4093.8 4091.1 *1093.1 6153 0.013 1.00 IC 24.5-25.0 *
4107.1 4106.2 t-1108.1 497 0.001 1.00 I 24.5-25.0
Mass
(Avg.1
Mass
(Mono
Apex 
) Mass Area
Relativ<
Area
3 Score Series Time
(min)
Sharec'
Mass?
Adduct?
4159.2 4157,5 4159.<: 7007 0.015 1.00 IC 5.0-5 .5
4161.2 4160.4 4160.4 449 0.001 1.00 I 23.0-24.0
4176.C 4173.4 4175.4 4019 0.008 1.00 IC 34.5 - 35.5
4176.1 4175.0 4176.1 759 0 .002 1.00 I 24.5-25.0
4205.2 4203.0 4204.C 23812 0.050 1.00 IC 5.0-5 .5
4207.3 4204.5 4207.6 13650 0.029 1.00 IC 35.0-36.0 •/
4217.3 4215.6 4215.6 7641 0.016 1.00 IC 5.0-5.5
4258.5 4257.6 4258.5 511 0.001 1.00 I 41.0-42.0
4294.3 4292.6 4292.6 4345 0.009 1.00 IC 5.0-5 .5
4298.9 4295.5 4298.6 4335 0.009 1.00 IC 5.0-5 .5
4300.5 4297.5 4299.5 94288 0.198 1.00 IC 41.5-42-5
4322.5 4320.5 4322.5 1204 0.003 LOO I 41.5-42.5
4338.3 4337.5 4337.5 1098 0 .002 1.00 I 41.5-42.5
4364.1 4362.4 4364.5 1609 0.003 1.00 IC 23.0-23.5
4455.2 4454.5 4454.5 1011 0.002 1.00 I 50.5-51.5
4627.3 4626.6 4626.6 1242 0.003 1.00 I 41.5-42.0
4634.5 4633.2 4634.0 1697 0.004 0.94 I 41.0-42.0
4713.2 4711.6 4713.7 514 0.001 1.00 I 22.5 - 23.5
4746.9 4744.9 4745.9 661 0.001 0.94 I 24.0-25.0
4930.4 4928.4 4930.4 12989 0.027 1.00 I 42.0-42.5
4952.1 4950.2 4952.2 1184 0.002 1.00 I 42.0 - 42.5
4968.1 4966.3 4967.3 2555 0.005 1.00 I 42.0 - 42.5 *
5308.8 5307.7 5308.8 592 0.001 1.00 I 24.5-25.0
5394.0 5393.3 5393.3 1021 0.002 1.00 I 52.5 -  53.5
5406.7 5405.2 5406.1 1477 0.003 0.95 I 52.5-53.5
5637.1 5636.0 5636.9 428 0.001 1.00 I 42.0 - 42.5
5758.2 5757.2 5758.2 3614 0.008 0.90 I 52.5 -  53.0
5768.9 5767.4 5769.3 782 0.002 1.00 I 41.5-42.0
5899.2 5896.8 5898.8 878 0 .002 1.00 I 24.5 -  25.0
5921.9 5917.9 5920.8 5220 0.011 1.00 I 24.5-25.0
5935.0 5933.8 5935.8 1056 0.002 1.00 I 24.5-25.0
5954.4 5953.8 5954.7 307 0.001 1.00 I 24.5-25.0
5958.4 5955.8 5958.8 1703 0.004 1.00 I 24.5-25.0
5965.0 5961.8 5964.8 2089 0 .004 1.00 I 24.5-25.0
5996.3 5994.8 5996.7 544 0.001 1.00 I 24.5-25.0
6001.3 5998.8 6002.8 787 0.002 0.94 I 24.5-25.0
6006.7 6004.7 6004.7 792 0.002 0.79 I 24.5-25.0
6660.5 6657.7 6659.7 442169 0.926 1.00 IC 50.5-51.5-
6682.9 6679.7 6681.5 35146 0.074 1.00 IC 50.5-51.5 *
6685.5 6683.7 6683.7 4913 0.010 0.85 I 50.5-51.5
6698.1 6694.6 5697.6 43183 0.090 1.00 IC 50.5-51.5
6712.5 6710.5 5712.6 2743 0.006 1.00 I 50.5-51.5
6717.9 6717.8 5717.8 12296 0.026 1.00 IC 52.5-53.0
6718.0 6715.7 5717.7 30442 0.064 1.00 IC 52.5 - 53.5
6718.4 5714.8 5717.8 23778 0.050 1.00 IC 52.5 -53.5
6722.3 5720.7 5718.6 9203 0.019 1.00 IC 50.5-51.5
6736.1 5734.5 t5735.6 1421 0.003 0.99 I 50.5-51.5
6740.1 5738.6 5739.7 1265 0.003 1.00 I 52.5 - 53.5
Mass
(Avg.)
Mass
(Mono)
Apex
Mass Area
Relative
Area
Score Series Time
(min)
Shared
Mass?
Adduct?
6741.0 6740.5 6740.5 516 0.001 0.99 I 52.5 - 53.5
6756.3 6754.2 6755.4 .4591 0.010 1.00 IC 52.5 - 53.5 Y
6766.9 6765.6 6765.6 819 0 .0 0 2 1.00 I 50.5-51.5
6780.1 6777.7 6778.7 6163 0.013 1.00 IC 50.5-51.5 S
6940.6 6937.8 6939.8 31422 0.066 1.00 IC 39.0-39.5
7143.8 7142.0 7142.0 39557 0.083 1.00 I 41.5-42.5
7157.5 7155.1 7157.2 76442 0.160 1.00 IC 41.0-42.0
7415.8 7414.4 7414.4 14946 0.031 1.00 IC 41.0-42.0
xiv
Appendix C. LC-MS Data for Leiurus quinquestriatus hebraeus venom.
LC-MS was performed on Lqh venom and data analysed as described (2.2.3.4 and 
2.2.3.5). Component masses.and their elution windows were calculated using LC-MS 
peak reconstruction software (Applied biosystems) with a mass tolerance of 0.01%, 
signal-to-noise ratio of 10 and 2000-10000Da final mass range. Peak areas were 
standardised against that of a peptide standard and the masses corresponding to those in 
a standard-only sample removed. Masses differing by IDa were assumed products of 
peptide oxidation or amidation and their relative areas pooled. Masses suspected of 
representing adducted peptides were noted
Mass (Avg) Average mass of the neutral species.
Mass (Mono) Monoisotopic mass ([M+H]4). Based upon the lowest detected peak in
f b r i  I P A i o n O  Q A r i P CU1U ipuwpv Oviivj.
Apex Mass Mass of isotope distribution at maximum intensity.
Area Integrated total intensity (counts sec'1) over the m/z range of the
contributing ions.
Relative area Area standardised against that of peptide standard.
Score Least squares correlation coefficient for fit of observed values to
calculated masses.
Evidence Type of series used for mass determination. I = isotope series, C = charge
series, IC = isotope series that is also part of a charge series.
Time Elution window of ions contributing to mass information. Time is shown
to nearest 0.5 min from initiation of data collection.
Adduct * indicates possible adduct mass. Data was examined for potential
masses relating to +Na, +K, +Na+K, -C02, -NH3, -H20 , mono- and di­
oxidation, in addition to +74, +104 (adducts previously observed in 
scorpion venom mass data (Pimenta et al., 2001)).
Mass
(Avg.)
Mass
(Mono.)
Apex
Mass
Area Relativ<
Area
eScore Evidence2 Time (min Adduct?
2003.4 2002.5 2002.5 326 0.001 1.00 I 6.0-6.5
2008,2 2007-8 2007.8 2607 0.008 1.00 I 4.5 - 5.5
2008.3 2007.2 2008.2 992 0.003 1.00 IC 35.5-36.0
2014.0 2013.4 2014.4 329 0.001 1.00 I 34.0-35.0
2019.6 2018.5 2019.5 2396 0.007 1.00 I 27.5 - 28.5
2024.6 2024.2 2024.2 856 0.003 1.00 I 35.5-36.0
2026.2 2025.7 2026.7 610 0.002 1.00 I 4.5 - 5.5
2030.8 2030.0 2030.0 1440 0.004 1.00 I 27.5 - 28.5
2046.4 2045.4 2046.4 1895 0.006 1.00 I 58.5-59.0
2049.0 2048.3 2049.4 309 0.001 1.00 I 4.5 - 5.5
2052.2 2051.3 2052.4 845 0.003 1.00 I 60.0 - 60.5 *
2055.6 2054.4 2055:4 1837 0.005 1.00 I 50.5-51.0
2057.3 2056.7 2057.7 2877 0.009 1.00 I 42.0-42.5
2060.9 2059.8 2059.8 810 0.002 1.00 I 4.5 - 5.5
2068.2 2067.4 2068.3 995 0.003 1.00 I 58.5-59.0 • *
2071.0 2Q70.4 2071.4 560 0.002 1.00 IC 50.5 -  51.0 ❖
2074.2 2073.3 2074.3 634 0.002 1.00 I 60.0 - 60.5 *
2084.2 2083.3 2083.3 641 0.002 1.00 I 58.5-59.0
2090.1 2089.3 2090.3 348 0.001 1.00 I 60.0 - 60.5 *
2094.3 2093.4 2094.4 955 0.003 1.00 I 49.5-50.0
2098.5 2097.5 2098.4 913 0.003 0.90 I 37.0-38.0
2114.0 2113.4 2114.5 468 0.001 1.00 IC 37.0-38.0
2124.4 2122.8 2123.8 911 0.003 1.00 I 4.5 - 5.5
2139.3 2137.9 2137.9 1293 0.004 1.00 I 4.5 - 5.5
2140.0 2139.3 2139.3 778 0.002 0.89 I 4.5-5.5
2141.5 2140.4 2141.4 694 0.002 1.00 I on A on r DJ.V - JJ.J
2145.0 2144.5 2145.5 535 0.002 1.00 I 42.0 - 42.5 $
2148.5 2147.3 2148.3 32427 0.097 1.00 IC 4.5 - 5.5 *
2150.5 2149.4 2150.4 16687 0.050 1.00 IC 48.0-48.5 *
2156.6 2155.2 2155.2 1131 0.003 0.29 I 4.5 - 5.5
2159.3 2158.8 2158.8 697 0.002 0.97 I 4.5'- 5.5
2161.2 2160.3 2161.2 1370 0.004 1.00 IC 4.5 - 5.5
2163.0 2162.5 2163.5 3614 0.011 1.00 I 36.5-37.02165.5 2164.6 2165.6 613 0.002 1.00 I 44.0-44.52168.4 2167.8 2167.8 8525 0.025 1.00 IC 4.5 - 5.5
2172.6 2171.4 2172.4 1725 0.005 1.00 I 48.0 - 48.5 *
2173.0 2172.5 2172.5 199 0.001. 1.00 I 6.0 - 6.52176.7 2175.3 2176.2 1398 0.004 1.00 I 4.5 - 5.52180.2 2179.3 2179.3 565 0.002 1.00 I 4.5 - 5.52180.4 2179.5 2180.5 644 0.002 1.00 I 38.0-3 8.52180.9 2180.3 2181.3 192 0.001 1.00 I 4.5 - 5.52183.9 2182.5 2183.5 693 0.002 1.00 I 36.5-37.02186.3 2185.8 2186.8 295 0.001 1.00 I 4.5 - 5.52199.7 2198.5 2199.5 1312 0.004 1.00 I 40.5-41.0 *2208.0 2207.5 2208.5 418 0.001 1.00 I 46.0 - 46.5. 2210.7 2209.5 2210.5 1483 0.004 1.00 I 29.5 - 30.5 *2213.9 2212.5 2213.5 779 0.002 1.00 I 37.0 - 37.5
xvi
Mass
(Avg.)
Mass
(Mono.)
Apex
Mass
Area Relativ
Area
eScoreEvidenceTime (min Adduct?
2214.6 2213.5 2214.5 1660 0.005 1.00 I 42.0 - 42.5
2216.0- - 2214.9 - 2215.9 - -298 .0.001 jO.89 I .. . 4.5 -5.5
2217.4 2216.5 2217.5 818 0.002 1.00 I 48.5 -  49.0
2229.5 2228.3 2229.4 477 0.001 1.00 I 4.5 - 5.5
2230.9 2229.5 2230.5 3515 0.010 1.00 I 49.0 - 49.5
2232.5 2231.5 2232.5 2546 0.008 1.00 IC 42.0 - 42.5 *
2237.4 2236.5 2237.5 426 0.001 1.00 I 38.0 - 38.5 *
2238.3 2237.5 2238.4 599 0.002 1.00 I 34.0 - 34.5
2246.5 2245.5 2246.5 2780 0.008 1.00 IC 49.0 - 49.5 *
2249.6 2248.6 2249.6 635 0.002 1.00 I 42.5-43.5 ❖
2250.7 2249.5 2250.5 3525 0.010 1.00 TX 36.5-37.0
2252.5 2251.6 2252.6 29583 0.088 0.89 I 48.0-49.0
2254.2 2253.3 2254.3 915 0.003 1.00 I 52.0 - 52.5 *
2254.7 2253.5 2254.6 1883 0.006 1.00 I 36.5-37.0 *
2255.5 2254.9 2254.9 647 0.002 0.99 I 4.5 - 5.5
2259.9 2258.4 2259.5 1097 0.003 1.00 I 48.0 - 48.5 *
2261.2 2260.9 2260.9 373 0.001 1.00 I 48.0-49.0
2263.4 2263.0 2263.9 325 0.001 0.99 I 48.0-49.0
2275.4 2274.4 2275.5 513 0.002 1.00 I 48.0-48.5 *
2276.2 2275.3 2276.3 360 0.001 1.00 I 41.5-42.0 *
2293.8 2292.6 2293.6 1586 0.005 1.00 I 52.0 - 52.5
2296.8 2295.6 2296.6 2723 0.008 1.00 I 41.5-42.0
2308.7 2307.5 2308.5 2923 0.009 1.00 IC 50.5-51.5
2318.2 2317.3 2318.4 586 0.002 1.00 I 35.5-36.0
2326.5 2325.5 2326.5 729 0.002 1.00 I 44.5-45.0 *
2331.0 2330.5 2330.5 570 0.002 1.00 I 50.5 - 51.5
2344.1 2342.6 2343.6 400 0.001 1.00 I 6.0 - 6.5 *
2344.7 2343.3 2344.3 3407 0.010 1.00 IC 4.5 - 5.5
2350.8 2349.6 2350.6 1876 0.006 1.00 I 43.0-44.0
2367.0 2365.6 2366.6 5028 0.015 1.00 I 41.5-42.0
2374.9 2373.5 2374.5 4535 0.014 1.00 IC 48.5 — 49.0
2379.6 2378.6 2379.6 447 0.001 1.00 I 51.0-51.5 *
2380.6 2379.6 2380.6 697 0.002 1.00 I 48.5-49.0
2394.4 2393.7 2393.7 2349 0.007 1.00 I 43.0 - 43.5
2396.5 2395.6 2395.6 480 0.001 1.00 I 48.5-49.0 *
2424.6 2423.6 2424.6 566 0.002 1.00 I 31.5-32.0 *
2437.0 2435.6 2436.7 3431 0.010 1.00 I 38.5 -.39.5
2447.1 2445.7 2446.7 8081 0.024 1.00 IC 42.0 - 42.5
2447.5 2445.8 2446.7 887 0.003 1.00 I 39.5 - 40.5
2447.6 2446.6 2447.7 708 0.002 1.00 I 46.0-46.52455.7 2454.6 2455.6 1306 0.004 1.00 I 44.0-45.0
2472.9 2471.6 2472.6 1763 0.005 1.00 I 40.5-41.0
2520.8 2519.8 2520.7 619 0.002 1.00 I 51.5-52.02521.0 2519.8 2520.7 1346 0.004 1.00 I 49.5 - 50.5
2521.4 2519.8 2520.8 8887 0.026 1.00 IC 53.5 -  54.0 ❖
2524.0 2522.6 2524.7 770 0.002 1.00 I 42.0 - 42.5
2524.8 2523.6 2524.6 572 0.002 1.00 I 39.5-40.5
2525.3 2524.6 2524.6 1477 0.004 1.00 I 42.0 - 42.5
xvii
Mass
(Avg.)
Mass
(Mono.)
Apex
Mass
Area Relativ
Area
eScoreEvidenceTime (min) Adduct?
2526.0 2525.6 2525.6 429 0.001 1.00 I 39.5-40.5
- 2527.7 - 2526.7- - -2526.7 ..2179_ 0.006 -1.00 J.. 42.0 - 42.5
2535.7 2534.7 ' 2535.7 1231 0.004 1.00 I 45.0-46.0
2536.5 2535.7 2535.7 288 0.001 1.00 I 6.0 - 6.5
2557.8 2556.8 2557.7 255 0.001 1.00 I 2.0 - 3.0 *
2559.0 2557.7 2558.8 869 0.003 1.00 I 53.5 -  54.0
2561.4 2560.6 2561.7 204 0.001 0.98 I 2.0-3.0
2564.6 2562.7 2563.7 595 0.002 1.00 I 2.0-3.0
2573.2 2571.0 2571.9 1348 0.004 1.00 I 4.5 - 5.5
2573.7 2572.7 2573.7 617 0.002 1.00 I 40.5 - 41.5 £
2574.4 2574.0 2574.0 C O T_?o / 0.002 1.00 TX 4.5 - 5.5
2576.2 2574.7 2575.7 455 0.001 1.00 I 2.0-3.0
2577.8 2576.7 2577.8 1896 0.006 1.00 I 45.5-46.0
2577.8 2576.8 2577.8 3054 0.009 1.00 I 46.5-47.0
2577.8 2576.8 2577.8 3945 0.012 1.00 I 47.5-48.0
2590.0 2589.6 2589.6 164 0.000 1.00 I 2 .0-3 .0
2593.1 2591.8 2592.8 2148 0.006 1.00 I 42.0 - 42.5
2593.5 2592.9 2592.9 592 0.002 1.00 I 37.5-38.0
2600.2 2598.8 2599.8 641 0.002 1.00 I 47.5 -  48.0 *
2608.3 2606.7 2607.7 399 0.001 1.00 I 2.0-3.0 *
2615.8 2614.8 2615.8 551 0.002 1.00 I 47.5 -  48.0 *
2616.6 2615.7 2615.7 322 0.001 1.00 I 2.0-3.0
2621.1 2619.8 2620.9 3102 0.009 1.00 IC 36.0 - 36.5
2624.1 2622.6 2623.7 347 0.001 0.89 I 2.0 - 3.0
2628.1 2626.8 2627.8 2275 0.007 1.00 I 44.5-45.0 *
2636.5 2634.6 2635.7 572 0.002 1.00 I 2.0 - 3.0
2643.1 2641.8 2642.8 1371 0.004 1.00 I 55.0-56.0 *
2656.7 2654.8 2655.7 500 o.oor 1.00 I 2.0-3.0
2665.2 2664.7 2665.7 185 0.001 1.00 I 2.0 - 3.0 *
2692.6 2691.7 2691.7 366 0.001 1.00 I 2.0-3.0
2697.6 2696.6 2697.7 228 0.001 1.00 I 2.0 - 3.0
2702.1 2701.7 2701.7 180 0.001 1.00 I 2.0 - 3.0
2717.2 2715.8 2716.8 1703 0.005 1.00 I 66.0 - 66.5 *
2728.5 2727.6 2727.6 319 0.001 1.00 I 2.0-3.02731.1 2730.4 2730.4 885 0.003 1.00 I 4.5 - 5.52737.3 2736.6 2737.7 129 0.000 0.99 I 2.0 - 3.02747.1 2745.5 2746.4 2217 0.007 1.00 IC 4.5 - 5.52799.6 2798.3 2800.5 598 0.002 0.99 I 4.5 - 5.52800.4 2799.4 2800.5 755 0.002 0.89 I 4.5 - 5.52806.4 2804.5 2805.6 3260 0.010 1.00 I 4.5 - 5.52810.5 2809.6 2809.6 1336 0.004 1.00 I 4.5 - 5.52813.9 2813.6 2813.6 154 0.000 0.99 I 4.5 - 5.52818.3 2816.6 2817.6 1235 0.004 1.00 I 4.5 - 5.52819.3 2818.6 2818.6 519 0.002 0.88 I 4.5 - 5.52824.5 2823.6 2823.6 299 0.001 1.00 I 2.0 - 3.02827.2 2826.5 2827.5 226 0.001 1.00 I 4.5 - 5.52829.6 2828.5 2829.6 868 0.003 1.00 I 4.5 - 5.52844.5 2843.6 2844.5 3639 0.011 1.00 IC 4.5 - 5.5
x v iii
Mass
(Avg.)
Mass
(Mono.)
Apex
Mass
Area Relativ
Area
eScorsEvidenoeTime (min; Adduct?
2846.5 2844.5 2845.6 10621 0.032 1.00 IC 4.5-5.5 *
2846,7- 2845.6- - -2846.5.. .7829 0,023. 1.00 .. IC 4.5 - 5.5
2900.2 2898.6 2901.7 408 0.001 0.87 I 4.5 - 5.5
2902.0 2900.6 2901.7 755 0.002 1.00 I 4.5-5.5
2906.6 2905.6 2906.6 496 0.001 1.00 I 4.5 - 5.5 *
2913.1 2912.6 2912.6 141 0.000 0.99 I 4.5-5.5
2917.5 2915.6 2916.7 7246 0.022 1.00 IC 4.5 - 5.5
2919.0 2918.6 2918.6 1233 0.004 1.00 I 4.5-5.5
2924.7 2922.6 2923.6 87790 0.261 1.00 IC 4.5 - 5.5
2926.7 2925.6 2925.6 1983 0.006 0.72 I 4.5 - 5.5
2932.7 2930.6 2931.7 2684 0.008 1.00 t r 4.5 - 5.5
2935.1 2933.7 2933.7 991 0.003 1.00 IC 4.5 - 5.5
2940.5 2939.5 2940.6 360 0.001 0.88 I 4.5 - 5.5
2945.3 2943.7 2945.7 9832 0.029 1.00 IC 4.5 - 5.5
2948.5 2946.6 2947.6 29385 0.087 1.00 IC 4.5 - 5.5 %
2950.6 2949.6 2949.6 5780 0.017 1.00 IC 4.5 - 5.5 *
2957.8 2956.6 2958.6 1890 0.006 1.00 IC 4.5 - 5.5
2958.7 2957.6 2959.6 2987 0.009 1.00 IC 4.5 - 5.5 *
2962.7 2960.7 2962.7 793181 2.362 1.00 IC 4.5 - 5.5
2966.2 2964.6 2965.6 71244 0.212 1.00 IC 23.0 -  24.0
2973.6 2972.6 2973.6 579 0.002 1.00 I 4.5 - 5.5 *
2979.3 2977.6 2978.6 51858 0.154 1.00 IC 4.5 - 5.5
2985.1 2982.6 2984.6 25083 0.075 1.00 IC 4.5 - 5.5
2985.7 2985.6 2985.6 4002 0.012 1.00 IC 4.5 - 5.5
2986.0 2984.6 2984.6 5452 0.016 1.00 IC 4.5 - 5.5
2990.5 2988.6 2989.7 2921 0.009 1.00 I 4.5 - 5.5
2995.9 2994.6 2995.7 27436 0.082 1.00 IC 4.5 - 5.5 ❖
2998.7 2997.7 2998.6 8293 0.025 1.00 IC 4.5 - 5.5
3001.1 2999.6 3000.6 50870 0.151 1.00 IC 4.5 - 5.5 *
3006.6 3004.6 3005.6 9497 0.028 1.00 IC 4.5 - 5.5 *
3009.5 3009.7 3010.6 1929 0.006 1.00 IC 4.5 - 5.5
3012.6 3010.7 3012.7 8293 0.025 1.00 IC 4.5-5.5 *
3015.7 3013.7 3014.6 5558 0.017 1.00 IC 4.5 - 5.5
3016.8 3017.7 3017.7 2028 0.006 1.00 IC 4.5 - 5.5 •2*
3016.8 3015.6 3015.6 2253 0.007 1.00 IC 4.5 - 5.5
3022.9 3021.6 3022.6 5596 0.017 1.00 IC 4.5-5.5 *
3024.4 3022.6 3022.6 1213 0.004 LOO IC 4.5 - 5.5 *
3027.9 3026.6 3027.6 ' 2348 0.007 1.00 IC 4.5 - 5.5
3028.2 3026.6 3027.7 4595 0.014 1.00 IC 4.5 - 5.5 *
3033.0 3030.6 3033.6 2763 0.008 1.00 IC 4.5 - 5.5
3036.2 3035.6 3036.6 752 0.002 1.00 IC 4.5 - 5.53039.0 3037.6 3038.5 4752 0.014 1.00 IC , 4.5 - 5.5
3042.2 3040.7 3040.6 1409 0.004 1.00 IC 4.5 - 5.5
3045.1 3043.6 3044.5 1296 0.004 1.00 IC 4.5 - 5.5 *
3046.5 3045.7 3045.7 307 0.001 1.00 I 4.5 - 5.5
3051.3 3049.7 3050.6 1798 0.005 1.00 IC 4.5 - 5.5
3053.0 3051.6 3051.6 416 0.001 0.30 I 4.5 - 5.5 *
3061.5 3059.7 3061.7 1627 0.005 1.00 IC 4.5 - 5.5
xix
Mass
(Avg.)
Mass
(Mono.)
Apex
Mass
Area Relative
Area
eScorieEvidenc<2 Time (min^ Adduct?
3069.2 3067.7 3069.7 781 0.002 1.00 I 4.5 - 5.5 &
3075.9 3074.6- - - 3075.6- 1229 .. Q.Q04. J.00 . IC . 4.5 - 5.5
3077.8 3077.7 ' 3078.7 1711 0.005 1.00 IC 4.5 - 5.5
3081.6 3080.6 3081.7 3818 0.011 1.00 IC 4.5-5.5
3097.4 3095.6 3095.6 664 0.002 1.00 IC 4.5 - 5.5
3136.7 3135.8 3136.8 260 0.001 1.00 I 4.5 - 5.5
3165.4 3163.7 3164.8 342 0.001 1.00 I 4.5 - 5.5 *
3166.3 3165.8 3166.8 166 0.000 1.00 I 4.5 - 5.5
3173.3 3169.7 3174.6 1057 0.003 1.00 IC 4.5-5.5
3181.3 3180.7 3181.7 6694 0.020 1.00 I 4.5 - 5.5
3183.0 3180.8 3182.7 22513$ 0.670 i nni . w tnXV/ 4.5 - 5.5
3193.8 3192.8 3192.8 9162 0.027 1.00 IC 4.5 - 5.5
, 3199.5 3197.7 3199.7 3065 0.009 1.00 IC 4.5 - 5.5
3205.4 3202.7 3203.7 3734 0.011 1.00 IC 4.5 - 5.5
3207.0 3204.8 3206.7 21954 0.065 1.00 IC 23.0-24.0
3210.6 3209.7 3209.7 318 0.001 0.88 I 4.5 - 5.5 *
3216.8 3213.8 3214.9 6280 0.019 1.00 IC 4.5 - 5.5
3217.0 3215.5 3217.5 859 0.003 1.00 I 49.0-50.0
3220.5 3218.7 3220.7 5936 0.018 1.00 IC 4.5 - 5.5
3222.1 3221.7 3221.7 916 0.003 1.00 I 4.5 - 5.5
3224.8 3223.7 3223.7 408 0.001 0.88 I 4.5 - 5.5
3227.3 3226.8 3226.8 956 0.003 1.00 IC 4.5-5.5
3231.5 3230.7 3230.7 593 0.002 1.00 I 4.5 - 5.5
3235.0 3232.7 3234.7 1142 0.003 1.00 IC 4.5 - 5.5
3281.8 3279.8 3281.7 468 0.001 1.00 I 4.5 - 5.5
3282.6 3281.7 3281.7 272 0.001 1.00 I 4.5 - 5.5
3354.9 3353.8 3355.8 1560 0.005 1.00 I 56.0 -  57.0
3359.8 3357.9 3359.8 6030 0.018 1.00 IC 31.0-31.5
3370.3 3368.4 3370.3 655 0.002 0.81 I 4.5 - 5.5
3370.9 3370.4 3371.4 390 0.001 1.00 I 4.5 - 5.5
3420.7 3419.0 3420.0 21523 0.064 1.00 IC 4.5 - 5.5
3421.4 3420.0 3420.0 2435 0.007 0.00 I 4.5 - 5.5
3422.4 3422.0 3422.0 2537 0.008 1.00 I 4.5 - 5.5
3423.5 3421.1 3423.1 33941 0.101 1.00 IC 28.0-29.0
3445.0 3443.0 3444.1 1033 0.003 1.00 I 4.5 - 5.5
3505.5 3503.0 3505.0 20968 0.062 1.00 IC 40.5-41.0
3506.5 3504.0 3506.0 6811 0.020 1.00 IC 36.5-37.0
3534.3 3533.0 3534:0 410 0.001 1.00 I 37.0 - 37.5
3541.1 3538.9 3540.9 2374 0.007 1.00 I 26.5-37.53542.4 3540.0 3542.0 •6322 0.019 1.00 IC 35.5-36.0
3543.0 3542.0 3543.0 1407 0.004 r.oo IC 40.5-41.03558.5 3556.0 3558.0 97759 0.291 1.00 IC 34.5 - 35.5 *
3574.2 3571.9 3574.0 3954 0.012 1.00 IC 34.5 - 35.5 *
3578.1 3577.0 3578.1 1022 0.003 1.00 I 40.5-41.0
3578.5 3576.0 3578.0 38456 0.115 1.00 IC 38.0-38.5
3580.8 3577.9 3578.9 7361 0.022 1.00 IC 34.5 - 35.5
3596.1 3593.9 3595.9 6210 0.018 1.00 IC 34.5 - 35.5 *
3600.3 3599.0 3600.0 1354 0.004 1.00 I 37.5 - 38.5
XX
Mass
(Avg.)
Mass
(Mono.)
Apex
Mass
Area Relative
Area
eSconeEvidencieTime (min) Adduct?
3602.1 3599.9 3601.9 1547 0.005 1.00 I 34.5-35.5
- 3616.0 3614.0- -3616.0- 1069 -0.003. -1.00 I .37-5 - 38-5
3627.0 3626.0 3627.0 547 0.002 1.00 r 24.5 - 25.5
3645.4 3643.0 3645.0 22889<5 0.682 1.00 IC 24.5 - 25.5
3646.5 3643.9 3645.9 97876 0.291 1.00 IC 28.0-290
3661.8 3660.9 3660.9 768 0.002 1.00 i 24.5-25.5
3668.1 3665.0 3666.9 11438 0.034 1.00 IC 24.5 - 25.5
3668.3 3665.8 3667.9 3601 0.011 1.00 ic 28.0-29.0
3673.7 3672.2 3673.3 1096 0.003 1.00 i 27.0-28.0
3675.4 3673.0 3674.9 15284 0.046 1.00 IC 25.0-26.0
3676.5 3o/:>.y 3675.9 74398 0.222 1.00 m 28.0-29.0 *
3682.9 3680.9 3681.9 14096 0.042 1.00 IC 25.0-26.0
3683.7 3681.8 3682.8 1362 0.004 1.00 i 28.0-29.0
3684.7 3683.8 3683.8 1913 0.006 1.00 i 28.0-29.0
3689.2 3686.9 3688.9 2485 0.007 1.00 i 24.5-25.5
3691.7 3689.3 3691.2 18353 0.055 1.00 IC 28.0-29.0
3691.9 3691.0 3692.0 642 0.002 1.00 i 25.0-26.0
3697.9 3697.0 3697.9 844 0.003 1.00 IC 25.0-26.0
3699.0 3696.8 3697.9 3726 0.011 1.00 IC 28.5 - 29.5
3705.2 3702.9 3705.9 1726 0.005 1.00 IC 24.5 ■, 25.5 *
3709.3 3708.3 3709.2 451 0.001 1.00 I 30.5-31.5
3711.0 3708.9 3711.9 1372 0.004 1.00 IC 25.0-26.0
3714.5 3712.8 3713.9 5929 0.018 LOO IC 28.5 - 29.5
3720.1 3717.8 3719.8 1403 0.004 1.00 IC 28.5-29.0 ❖
3721.9 3719.9 3720.9 1160 0.003 1.00 IC 25.0 - 25.5
3727.3 3725.9 3726.8 347 0.001 0.89 I 25.0 - 25.5
3736.7 3735.8 3735.8 222 0.001 1.00 I 28.5-29.0
3743.3 3741.9 3743.9 449 0.001 1.00 I 25.0 - 25.5 *
3752.8 3750.2 3752.3 20731 0.062 1.00 IC 25.5 - 26.5
3765.8 3763.9 3764.9 512 0.002 1.00 I 25.0-25.5
3766.8 3764.3 3766.3 182411 0.543 1.00 IC 26.5-27.0
3775.1 3774.2 3774.2 510 0.002 1.00 I 25.5 - 26.5
3788.8 3786.2 3788.2 18234 0.054 1.00 IC 26.5-27.0 *
3804.5 3802.3 3804.2 16745 0.050 1.00 IC 26.5-27.0
3810.4 3808.2 3810.2 3553 0.011 0.96 I 26.5-27.0
3831.7 3830.2 3831.2 1437 0.004 1.00 I 26.5-27.0
3842.2 3841.2 3842.2 510 0.002 1.00 I 26.5-27.0
3848.0 3846.2 3848.2 1258 0.004 1.00 IC 26.5-27.0 *
3859.6 3858.4 3858.4 1172 0.003 1.00 I 4.5-5.53859.7 3857.5 3858.4 1966 0.006 1.00 I 4.5 - 5.5
3861.8 3859.1 3861.0 13760 0.041 1.00 IC 28.5-29.0
3864.9 3864.1 3864.1 742 0.002 1.00 I 26.0-26.53865.9 3863.3 3865.4 12676 0.038 1.00 IC 27.5-28.03868.2 3867.2 3868.2 699 0.002 1.00 I 48.0-49.03873.8 3873.3 3874.3 405 0.001 1.00 I 48.0-49.03894.6 3893.2 3894.3 862 0.003 1.00 I 31.0-31.5
3897.1 3894.4 3897.5 1583 0.005 1.00 IC 4.5 - 5.5
3897.2 3895.4 3897.4 2385 0.007 1.00 IC 4.5 - 5.5
xx i
Mass
(Avg.)
Mass
(Mono.)
Apex
Mass
Area Relative
Area
3 Scon2 Evident2 Time (mini Adduct?
3914.9 3912.4 3914.4 30964 0.092 1.00 IC 4.5 - 5.5
- 3916.0- - 3915.4 -_ .3915.4 92Q2_. .0.027 .1,00___IC . 4.5 - 5.5
3921.9 3920.4 ' 3921.3 1439 0.004 1.00 I 29.5 - 30.5 *
3932.7 3931.4 3932.4 799 0.002 1.00 I 4.5 - 5.5
3934.7 3933.4 3934.4 2620 0.008 1.00 IC 4.5 - 5.5
3936.1 3934.4 3935.4 5611 0.017 1.00 IC 4.5 - 5.5
3948.7 3946.5 3947.4 688 0.002 1.00 I 4.5 - 5.5
3951.3 3949.4 3950.4 734 0.002 1.00 I 4.5 - 5.5
3958.4 3955.5 3958.5 4400 0.013 1.00 IC 4.5 - 5.5
3959.5 3958.5 3958.5 1332 0.004 1.00 IC 4.5 - 5.5
3969.8 syr\s'j-T  oj y o / . D j y Q y . j 1905 r \  n n / c 1 nnl . V V I 4.5 - 5.5 *
3977.6 3976.1 3977A 732 0.002 1.00 I 26.5 - 37.5
3995.7 3993.1 3995.1 391795r 1.167 1.00 IC 27.5 - 28.5
3996.9 3994.1 3997.1 10770C 0.321 1 .0 0 IC 30.5-31.0
4015.3 4012.4 4014.5 14855 0.044 1.00 IC 4.5 - 5.5
4018.1 4015.1 4017.0 18541 0.055 1.00 IC 27.5-28.5
4019.4 4016.0 4018.0 7489 0.022 1.00 IC 30.5-31.0
4028.4 4027.1 4028.1 1459 0.004 1.00 IC 27.5 - 28.5
4033.7 4031.0 4033.1 22042 0.066 1.00 IC 27.5 - 28.5 ❖
4034.9 4032.0 4034.0 6627 0.020 1.00 IC 30.5-31.0 *
4038.5 4036.4 4038.4 1238 0.004 0.96 I 4.5 - 5.5
4039.7 4037.0 4039.0 4719 0.014 1.00 I 27.5-28.5
4040.2 4038.0 4041.0 2055 0.006 1.00 IC 30.5-31.0
4042.9 4042.4 4043.4 397 0.001 1.00 I 4.5 - 5.5
4048.0 4047.4 4048.5 375 0.001 1.00 I 4.5-5.5
4053.2 4050.4 4053.4 4648 0.014 1.00 IC 4.5 - 5.5 %
4054.0 4051.1 4054.1 30978 0.092 1.00 IC 29.0-30.0
4054.6 4053.4 4053.4 750 0.002 0.27 I 4.5 - 5.5
4054.9 4052.0 4054.1 1390 0.004 0.94 I 32.0-33.0
4055.8 4054.0 4055.0 3829 0.011 1.00 IC 27.5 - 28.5
4061.0 4059.0 4061.0 1758 0.005 1.00 I 4.5-5.5
4065.1 4062.3 4064.3 49558 0.148 1.00 IC 31.0-31.5
4070.5 4068.4 4070.3 87546 0.261 1.00 IC 4.5-5.5 •!*
4073.4 4073.0 4073.0 308 0.001 1.00 I 27.5 - 28.5
4076.1 4075.1 4076.1 373 0.001 1.00 I 29.0-30.0
4077.2 4074.9 4078.0 1334 0.004 1.00 IC 27.5 - 28.5
4084.5 4082.3 4086.4 288 0.001 0.72 I 4.5-5.5
4085.0 4083.3 4084.3 2384 0.007 1.00 IC 4.5 - 5.5
4085.8 4084.4 4087.4 400 0.001 0.89 I 4.5 - 5.54090.5 4088.5 4089.5 13031 0.039 1.00 IC 4.5 - 5.54091.7 4089.5 4091.5 22790 0.068 1.00 IC 4.5 - 5.5 *4091.9 4091.1 4091.1 484 0.001 1.00 I 29.0-30.0 %4094.6 4092.1 4094.1 4192 0.012 1.00 IC 27.5-28.5
4102.9 4101.3 4102.3 2761 0.008 1.00 I 31.0-31.5
4105.0 4104.4 4105.4 444 0.001 1.00 I 4.5 - 5.54107.6 4105.4 4108.4 nnn  o  JDDO 0.010 1.00 IC 4.5 - 5.5 *
4114.5 4111.6 4114.6 26242 0.078 1.00 IC 4.5 - 5.54115.5 4114.6 4114.6 4853 0.014 1.00 IC 4.5 - 5.5
x x ii
Mass 
i AY g-)
Mass
(Mono.)
Apex
Mass
Area Relativ
Area
eScoreEvidenc eTime (min) Adduct?
4116.2 4114.1 4117.1 3648 0.011 1.00 IC 27.5 - 28.5
- - 4123.6 • - 4121.4 - -4124:5 - 735- - 0:002 1.00 - T 4.5-5:5 -  * -
4128.9 4127.5 4127.5 391 0.001 0.94 I 4.5 - 5.5 *
4138.1 4136.5 4138.5 18877 0.056 1.00 IC 28.0-29.0
4149.5 4147.6 4148.6 3121 0.009 1.00 IC 4.5-5.5
4166.1 4163.2 4165.3 87240 0.260 1.00 IC 30.0 - 30.5
4192.0 4190.6 4192.6 1326 0.004 1.00 IC 4.5 - 5.5
4207.0 4205.4 4207.3 594 0.002 1.00 I 24.5 - 25.5 *
4210.0 4207.5 4210.4 1392 0.004 1.00 I 4.5 - 5.5
4248.1 4246.6 4248.6 570 0.002 0.93 • I 4.5 - 5.5
4248.7 4247.6 4248.7 1150 0.003 1.00 IC 4.5 - 5.5
4268.2 4265.5 4267.5 5217 0.016 LOO IC 4.5 - 5.5
4278.9 4276.5 4277.4 1538 0.005 1.00 I 4.5 - 5.5
4296.5 4293.5 4295.5 212286 0.632 1.00 IC 4.5 - 5.5
4297.9 4296.5 4296.5 17885 0.053 0.00 I 4.5-5.5
4305.5 4305.5 'ZA'ZJ T J 0.001 1.00 I 34.0-35.0
4309.8 4309.5 4310.5 1176 0.004 1.00 IC 4.5 - 5.5
4312.5 4309.5 4312.5 12910 0.038 1.00 IC 4.5 - 5.5 *
4318.0 4315.5 4319.4 1795 0.005 1.00 IC 4.5-5.5
4319.0 4318.4 4319.5 335 0.001 1.00 I 4.5 - 5.5
4322.6 4321.5 . 4323.5 11555 0.034 1.00 IC 4.5 - 5.5 *
4329.6 4327.5 4329.5 7177 0.021 1.00 IC 4.5 - 5.5
4333.8 4333.4 4332.5 3656 0.011 1.00 IC 4.5 - 5.5
4336.6 4333.5 4335.5 48747 0.145 1.00 IC 4.5 - 5.5
4345.3 4342.5 4343.5 1697 0.005 1.00 IC 4.5 - 5.5
4346.5 4345.6 4344.6 1081 0.003 1.00 IC 4.5 - 5.5
4350.3 4348.5 4350.5 478 0.001 0.76 I 4.5 - 5.5
4352.7 4349.6 4352.5 2721 0.008 1.00 IC 4.5 - 5.5 *
4355.5 4352.5 4355.4 9367 0.028 1.00 IC 30.5-31.0
4356.0 4354.4 4354.4 3716 0.011 1.00 IC 25.0-25.5
4358.4 4355.5 4358.5 1142 0.003 1.00 IC 4.5 - 5.5
4358.9 4358.5 4358.5 237 0.001 0.99 I 4.5 - 5.5
4366.1 4364.5 4365.6 392 0.001 0.72 I 4.5 - 5.5 *
4367.4 4363.5 4365.6 991 0.003 1.00 IC 4.5 - 5.5
4372.3 4369.5 4372.4 1357 0.004 1.00 I 4.5 - 5.5 *
4412.4 4411.7 4412.7 4392 0.013 1.00 IC 4.5 - 5.5
4412.8 4409.7 4412.7 10195 0.030 1.00 IC 4.5 - 5.5
4414.5 4413.7 4413.7 2460 0.007 1.00 IC 4.5 - 5.5
4470.2 4467.5 4469.5 2681 0.008 LOO I 25 .0- 25.5
4475.9 4472.6 4475.6 21645 0.064 1.00 IC 4.5 - 5.5
4485.4 4482.5 4485.5 10333 0.031 1.00 IC 26.5-27.0
4492.1 4490.6 4492.6 617 0.002 1.00 I 4.5 - 5.5A A A '" '  A 4492.6 4492.6 A  A O  Z.0 O 0.001 1.00 I 4 .5 -5 .5
4502.2 4500.6 4500.6 255 0.001 0.75 I 4.5 - 5.5
4502.2 4499.7 4501.7 486 0.001 0.98 I 4.5 - 5.5
4513.8 4511.7 4512.7 675 0.002 1.00 I 4.5 - 5.5
4528.7 4527.7 4527.7 795 0.002 1.00 I 4 .5 -5 .5
4741.1 . 4738.8 4739.8 6470 0.019 1.00 IC 31.5-32.0
x x iii
Mass
(Avg.)
Mass
((Mono.)
Apex
Mass
Area Relative
Area
2 Score2 EvidencejTime (min) Adduct?
4819.6 4813.0 4819.9 513 0.002 1.00 I 27.5-28.0
4862.4 - -4861/8 ■' - 4862.8 -- 251- 0.001 1.00 ----------------r . . . . 23.0 -24.0 ■■ —
4889.5 4887.9 4888.9 1147 0.003 1.00 I 24.5 - 25.5
4895.5 4894.9 4896.0 299 0.001 0.99 I 4.5 - 5.5
4931.0 4929.5 4929.5 19039 0.057 1.00 I 42.0 - 42.5
4952.6 4950.4 4952.3 4885 0.015 1.00 IC 42.0 - 42.5
4968.3 4966.5 4968.4 5609 0.017 1.00 I 42.0-42.5
4974.1 4973.2 4973.2 1102 0.003 1.00 I 42.0 - 42.5
4990.3 4988.4 4990.4 1698 0.005 0.97 I 42.0 - 42.5 *
• 5006.2 5005.3 5005.3 594 0.002' 1.00 I 42.0 - 42.5
5219.8 5219.5 5219.5 2312 0.007 i 0.99 I 4.5 - 5.5
5795.7 5794.8 5794.8 354 0.001 1.00 I 48.0-49.0
5796.0 5794.5 5796.5 1118 0.003 1.00 I 42.0-42.5
5810.4 5808.3 5810.4 934 0.003 0.78 I 48.0-49.0
5887.7 5886.2 5886.2 470 0.001 0.84 I 4.5- 5.5
5947.0 5946.1 5947.2 o o o 0.001 1.00 TX 4.5 - 5.5
5948.7 5948.1 5949.1 229 0.001 1.00 I 4.5-5.5
6145.6 6142.3 6145.3 1831 0.005 1.00 I 4.5 - 5.5
6552.4 6550.8 6551.9 26640 0.079 1.00 IC 40.5-41.5
6668.1 6664.7 6667.7 129297 0.385 1.00 IC 56.0-57.0
6682.2 6680.6 6682.6 18575 0.055 0.94 I 57.5 -  58.0
6691.0 6688.7 6689.6 10783 0.032 1.00 IC 56.0-57.0
, 6705.8 6702.7 6705.6 12790 0.038 1.00 IC 56.0-57.0
6744.1 6740.9 6742.9 157653 0.469 1.00 IC 47.0 - 47.5
6758.0 6754.0 6756.9 573542 1.708 1.00 IC 48.0-49.0
6769.5 6768.0 6769.0 1538 0.005 1.00 I 48.0-49.0
6779.5 6776.8 6779.8 1952 0.006 0.90 I 48.0-49.0
6788.7 6786.9 6790.0 704 0.002 1.00 I 48.0-49.0
7259.9 7257.1 7259.1 777 0.002 0.92 I 4.5 - 5.5
7464.9 7461.4 7464.4 53690 0.160 1.00 IC 49.5-50.0
7992.8 7991.1 7991.1 2118 0.006 1.00 I 27.5 - 28.5
xx iv
Appendix D. Mass Profiling Data for Mesob. tamulus venom.
Mass data was obtained by MALDI-TOF and LC-ESI mass spectrometry for the ‘main’ 
_size_exclusionpeakifactionatedbyjQn_exchange_andj:everse_phase_chromatography^as 
described. LC-MS masses were calculated from component ions using commercial LC- 
MS mass reconstruction software (API). Within an ion exchange group (or the data 
corresponding to direct analysis of the ‘main’ size exclusion peak) MALDI-TOF data 
was assumed to represent a single mass if data was within 0.1% variation and was 
detected in continuous consecutive fractions, and as such were averaged. Mean 
MALDI-derived masses with >0.1% SD and those derived from <3 separate masses 
from <2 sample spots were discarded. Resulting LC-MS and MALDI-TOF data is 
shown in the table. Within a single group all possible adduct masses for addition of 
matrix, Na, K and Na+K, loss of CO2, NH3 and H2O, mono- and di-oxidation, along 
with those corresponding to "F74- and -tT04 were calculated, and any' corresponding 
masses (+/- 0.1% for MALDI-TOF, +A 0.01% for LC-MS) are shaded.
. Mass (Avg.) Average mass of the neutral species.
Mass (Mono.) Monoisotopic mass ({M+H]*). Based upon the lowest detected peak in 
the isotope series. (LC-MS only)
Apex Mass Mass of isotope distribution at maximum intensity. (LC-MS only)
Score Least squares correlation coefficient for fit of observed values to
calculated masses. (LC-MS only)
Evidence Type of series used for mass determination. I = isotope series, C = charge 
series, IC = isotope series that is also part of a charge series. (LC-MS 
only)
Time Elution window of ions contributing to mass information. Time is shown
to nearest 0.5 min from initiation of data collection. (LC-MS only) 
MALDI Fraction(s) from offline reverse phase HPLC in which mass was noted. 
Fraction (MALDI-TOF/ MS only).
XXV
Size exclusion ‘main’ peak
-----Mass—
(average)
----Mass---
(mono.)
- Apex Masji—  Score- Evidence-- -T im e-- -M A LM
fraction
2001.5 2000.8 2001.8 l.OO I 0-5
2005.5 2005.0 2006.0 1.00 I 35-40
2016.5 2014.8 2015.9 1.00 I 0-5
2017.4 2016.9 2017.9 1.00 I 0-5
2021.6 2020.9 2021.9 1.00 I 0-5.
2033.5 2032.8 2033.8 1.00 i 0-5
2053.5 2052.8 2053.8 1 r\r\i.UU TI 0-5
2067.8 2066,9 2067.9 l.OO I 0-5
2085.7 2084.9 2085.9 LOO I 0-5
2088.4 2086.9 2087.9 l.OO I 0-5
2121.4 2120.8 2121.8 , l.OO I 0-5
2133.9 2132.8 2133.9 l.OO I 0-5
2139.5 2138.9 2139.9 l.OO I 0-5
2152.4 2150.9 2151r9 l.OO I 0-5
2157.6 2156.9 2157.8 l.OO I 0-5
2189.5 2188.8 2189.8 l.OO I - 0-5
2203.5 2202.8 2203.8 l.OO I 0-5
2257.5 2256.8 2257.9 l.OO I 0-5
2274.1 2273.9 2273.9 l.OO I 0-5
2287.6 2286.8 2287.9 LOO I 0-5
2288.6 2286.8 2287.8 l.OO I 0-5
2292.7 2291.8 2291.8 l.OO I 0-5
2304.6 2303.8 2303.8 l.OO I 0-5
2340.4 2338.8 2339.8 l.OO I 0-5
2361.4 2360.8 2361.8 LOO I 0-5
2389.5 2388.9 2389.8 1.00 I 0-5
2408.5 2406.9 2407.8 1.00 I 0-5
2419.5 2418.8 2419.8 1.00 I 0-5
2424.4 2422.9 2423.8 LOO I 0-5
2476.2 2474.8 2475.8 1.00 I 0-5
. 2492.2 2490.8 2491.8 LOO r 0-5
2497.4 2496.8 2497.8 LOO i 0-5
2508.2 2506.9 2507.8 1.00 r 0-5or 1 /< iz j i4. l o n  o o ZJ 1D.O 'Mr 1 n o Z.D 1J.O 1.00 i 0-5
2524.4 2522.9 2523.8 LOO i 0-5
2544.4 2542.9 2543.8 1.00 i 0-5
2544.7 2543.8 2543.8 1.00 i 0-5
2560.2 2559.8 2559.8 L00 r 0-5
xxvi
Mass
(average)
Mass
(mono.)
Apex Mas;5 Score Evidence Time MALDI
fraction
2560.3 2558.8 2559.8 1.00 I 0-5
" ' '2576.4'' 2574.8 ~ “ “257538“ ■ LOTT- ------- 1 - ‘ 0-5 “ - -----------
2584.1 2583.8 2583.8 1.00 I 0-5
2592.6 2590.8 2591.8 1.00 I 0-5
2612.7 2610.8 2611.8 1.00 I 0-5
. 2622.2 2621.8 2621.8 1.00 . I 0-5
2628.3 2626.8 2627.8 1.00 I 0-5
2644.6 2642.8 2643.8 LOO I 0-5
9A 6A  A 2658.8 2659.8 1.00 T 0-5
2678.6 2676.7 2679.8 1.00 I 0-5
2688.2 2686.5 2687.5 LOO IC ‘ 35-40
2691.4 2690.8 2691.8 1.00 I 0-5
2693.5 2692.7 2693.8 1.00 I 0-5
2696.4 2694.7 2695.8 1.00 I 0-5
2712.2 2710.8 2711.8 LOO I 0-5
2714.6 2712.6 2713.6 1.00 IC 35-40
2716.7 SE main
2732.2 2730.7 2731.8 1.00 I 0-5
2758.7 2757.8 2757.8 1.00 I 0-5
2796.2 2794.8 2795.8 0.89 I 0-5
2814.4 2812.8 2813.8 i.oo I 0-5
2816.6 SE maid
2818.2 2817.8 2817.8 1.00 I 0-5
2822.7 2821.8 2821.8 LOO I 0-5
2830.2 2829.7 2829.7 0.99 I 0-5
2836.6 2835.8 2835.8 1.00 I 0-5
2848.0 2847.8 2847.8 1.00 IC 0-5
2852.9 2851.8 2852.8 1.00 I 0.5
2877.1 2875.8 2875.8 1.00 I 0-5
2884.6 2882.9 2883.8 1.00 I. 0-5
2894.4 2892.7 2895.8 0.99 I 0-5
2904.6 2903.8 2903.8 1.00 I 0-5
2908.6 2907.8 2907.8 1.00 I 0-5
- 2924:6 - 2923:8 “ 7  2924.8 1.00 IC 0-5
2936.6 2935.7 2935.7 LOO I 0-5
2941.8 2940.7 2941.7 1.00 IC 0-10
2968.7 2967.8 2967.8 1.00 I 0-5
2972.7 2971.8 2971.8 1.00 IC 0-5
2988.8 SE main
2988.8 2986.7 2987.7 LOO IC 0-10
2996.8 2995.7 2997.7 LOO I 0-5
xxv ii
Mass
(average)
Mass
(mono.)
Apex Mas*s Score Evidence Time MALDI
fraction
3056.8 3055.8 3056.7 1.00 I 0-5
" "3059.8 ~. —---------- — -  —  — — - -  —  -  - • - -  ---------------------------- • SEmain
3060.5 3058.7 3059.7 1.00 I 35-40
3093.1 3092.8 3092.8 1.00 I 0-5
3106.5 3105.7 3106.6 1.00 I 20-30
3164.0 3162.7 3164.8 1.00 I 0-5
3166.2 3164.6 3166.6 1.00 I 35-40
3183.9 3181.9 3183.0 0.98 I 35-40
3188.4 3186.7 Q157 AX U  # •. V/.  . 1 nnJ . . U V / I w* ~ / ~ r V /
3191.8 3189.7 3190.7 1.00 IC 0-10
3192.7 SE main
3236.7 3235.7 3235.7 1.00 I 0-5
3261.1 3259.7 3260.7 1.00 I 0-5
3262.2 3261.8 3261.8 1.00 I 0-5
3296.8 3295.9 3296.9 LOO I 0-10
3309.9 SE main
3332.6 3330.7 3332.8 1.00 I 0-5
3391.9 3390.9 3391.9 1.00 I 0-10
3392.0 SE main
3398.6 3397.8 3398.7 1.00 I 0-5
3399.1 3398.7 3398.7 1.00 I 0-5
3449.9 SE main
3450.5 3448.0 3450.0 1.00 IC 0-10
3464.7 3463.8 3464.7 1.00 I 0-5
3466.1 3465.1 3467.0 0.99 I 0-10
3477.8 SE main
3482.1 3481.0 3483.0 LOO -I 0-10
3500.9 3500.1 3500.1 1.00 I 20-25
3519.3 3517.0 3519.0 1.00 IC 20-25
3519.7 3518.1 3519.0 1.00 IC 0-10
3560.4 3558.1 3560.1 1.00 IC 0-10
3572.1 3570.9 3572.0 1.00 I 0-10
3578.0 3576.0 3578.0 0.83 I 0-10
3685.0 SE main
3709.7 3707.2 3709.2 1.00 IC 20-25
3722.4 3719.9 3722.0 1.00 IC 35-40
3740.8 3739.8 3740.7 1.00 I 0-5
3760.3 3759.0 3759.9 1.00 I 35-40
3775.8 3774.8 3775.7 LOO 0-5:
3782.7 3781.7 3782.7 1.00 I 0-5
3788.7 3786.6 3787.7 0.87 I 0-5
xxviii
Mass
(average)
Mass
(mono.)
Apex Mas*s Score Evidence Time MALDI
fraction
3797.8 SE main
' ”380077“ ' 3799.7 ; “3800.7 1.00- - ; r - -0-5 ' : .... ..
3804.6 3803.7 3803.7 1.00 i 0-5
3807.0 3806,7 3806.7 1.00 i 0-5
3807.8 3805.3 . 3807.3 1.00 IC 0-10
3819.1 3816.9 3818.9 1.00 i 20-25
3824.7 3822.8 3824.7 LOO i 0-5
3835.6 3833.0 3835.0 1.00 IC 20-25
3836.6 1 nnl.UU rJL V
3839.9 SE main
3842.9 3840.7 3842.8' 0.80 I 0-5
3853.9 3852.8 3854.7 0.99 I 0-5
3860.9 3859.6 3860.7 1.00 I 0-5
3866.7 3865.7 3866.8 1.00 I 0-5
3872.2 3871.6 3872.6 1.00 I 0-5
3874.8 3873.7 3875.7 1.00 I 0-5
3879,1 3876.4 3878.4 i.oo IC 0-10
3879.1 3876.7 3878.7 0.97 I 0-5
3891.2 3890.7 3890.7 1.00 I 0-5
3896.9 3895.6 3896.7 1.00 I !  S l i i l
3902.6 3901.6 3902.6 1.00 i 0-5
3908.7 3906.7 3908.6 1.00 i 0-5
3912.9 SE main
3913.0 3910.3 3912.3 1.00 IC 0-10
3920.6 3919.7 3920.7 1.00 I 0-5
3926.9 3924.8 3926.7 0.86 I 0-5
3928.9 3927.6 3929.7 1.00 I 0-5
3932.3 3930.6 3932.7 1.00 I 0-5
3937.1 3935.7 3935.7 0.75 I 0-5
3938.3 3936.7 3938.7 1.00 I 0-5
3945.1 SE main
3948.1 3945.7 3947.7 0.97 I 0-5
3957.6 3955.6 3956.7 i.oo I 0-5
3972.9 SE main
3973.8 3971.1 3973.1 1.00 IC 35-40
3974.4 3972.6 3974.7 0.74 I 0-5
3980.3 3979.7 3980.7 LOO I 0-5
3983.3 3982.7 3983.7 0.99 I 0-5
3987.6 3985.7 3986.7 1.00 I 0-5
3993.3 3991.7 3993.7 0.79 I 0-5
3996.2 3994.1 3996.1 1.00 IC 35-40
xxix
Mass
(average)
Mass
(mono.)
Apex Mas*» Score Evidence Time MALDI
fraction
3998.3 3997.7 3998.7 1.00 I 0-5
' 4002.5 3999.6 " 4001.7" “  1.00 ■ I "  " " 0-5 " ‘
JA in  n4 u iu .y  - A n n r \  rru u y .  / 4010:7 LOO I 'ft-- C-KJ-J
4011.9 4010; 1 4011.1 LOO I 35-40
4016.6 4015.7 4016.7 0.99 I 0-5
4019.0 SE main
4025.7 4023.7 4025.7 1.00 I 0-5
4029.0 4028.6 4028.6 0.99 I 0-5
4034 7 4033.7 4034.7 i nni.V/V TX 0-5
4041.0 4039.7 4040.7 . 1O0 I 0-5
4058.7 4057.7 4058.6 1.00 I 0-5
4076.7 Aft'yc £ fJ.KJ A A'T/T 'T4uao. / t Afti.uU rX 0-5
4078.8 SE main
4082.2 4081.7 4082.7 1.00 I 0-5
4082.3 4081.7 4082.7 1.00 I 0-5
4086.6 4084.6 4085.6 1.00 I 0-5
4089,1 4088,7 4088.7 LOO I 0-5
4094.3 4092.7 4094.7 0.93 rX 0-5
4096.4 4095.5 4096.5 - 1.00 W m X I m i 0-10
4100.7 4099.7 - 4100.7 LOO I I I  p i l l m i m S B
4101.0 SE main
4106.2 4105.7 4106.6 1.00 1 0-5
4109.2 41.07.6 4109.7 - LOO I 0-5
a 11 o nT U O .7 4117.6 /I110 *7 -ri ia. f 1.00. - I 0-5
4124.3 4122.8 4124.7 0.99 I - 0-5
4130.3 4129.7 4130.7 1.00 I 0-5
4131.8 4129.7 4130.7 0.95 ’I 0-5
4136.6 4135.7 4136.6 0.99 I 0-5
4142.8 4140.7 4142.7 0.82 I 0-5
4147.8 4146.6 4148.6 1.00 TX 0-5
4148.5 4146.6 4148,5 0.94 I 0-10
4152.4 4149.6 4151.7 0.96 I 0-5
4157.3 /II At x Jv .v; 4157.6 LOO I 0-5
416077" 4X59:6 4160.7 ~ LOO 1 0-5
4167.0 4164.6 4166.6 0.97 I 0-5
A1 '70 0 SE main
4190.3 4189.8 4190.7 0.98 I 0-5
4191.0 • 4189.8 4190.6 1.00 I 0-5 .
4196.3 4194.7 4196.7 LOO . I 0-5
4208.0 SE main
4213.5 4211.7 4211.7 1.00 0-5
XXX
Mass
(average)
Mass
(mono.)
Apex Masj5 Score Evidence Time MALDI
fraction
4216.2 4214.7 4214.7 0.79 I 0-5
'4226.2 ' ' ' 4225.6' 422'6.7 0.99 ' --------------------  ----- Q_5 —  . . .
4230.2 4227.6 4229.7 0.84 0-5
4237.2 4236.6 4237.6 1.00 I 0-5
4249.2 4246.7 4247.7 1.00 0-5
4263.7 4261.7 4262.6 1.00 I 0-5
4266.9 SE main
4268.7 4267.5 4268.6 1.00 I 0-5
4274.6 4273.7 4274.7 0.99 I 0-5
4281.1 4279.6 4280.7 1.00 I 0-5
4287.3 4285.7 4286.7 0.94 0-5
4292.6 4291.6 4292.6 1.00 I ■ 0-5
4325.3 4324.7 4325.7 1.00 I 0-5
4329.7 4327.7 4331.6 0.95 I 0-5
4363.9 SE main
4365.5 4363.7 4367.7 0.94 I 0-5
4381.0 4379.7 4379.7 1,00 I 0-5
4395.5 4393.7 4394.7 0.94 r 0-5
4401.3 4399.7 4400.6 0.95 i 0-5
4412.3 4410.6 4412.6 0.76 i 0-5
4419.0 4416.6 4418.7 0.96 i 0-5
4424.3 4423.6 4424.7 1.00 i 0-5
4428.7 4426.8 4427.7 0.92 i 0-5
4433.3 4432.7 4433.7 1.00 i 0-5
4437.5 4435.6 4436.7 0.93 i 0-5
4449.1 4447.7 4448.6 1.00 i 0-5
' 4467.0 -4464.6 4467.6 0.81 i 0-5
4483.1 4481.7 4481.7 1.00 i 0-5
4521.6. 4519.7 4523.7 0.74 0-5
4522.6 4520.7 4523.6 1.00 i 0-5
4550.6 4548.6 4550.6 1.00 i 0-5
4551.1 4550.7 4550.7 1.00 i 0-5
4556.7 4555.7 4555.7 1.00 i 0-5
4569.3 4567.6 4568.7 0.94 I 0-5
4588.1 SE main
4605.7 4603.7 4604.7 1.00 i 0-5
4612.6 4611.6 4613.6 1.00 i 0-5
4615.9 4613.6 4615.6 0.80 i 0-5
4637.4 4635.7. 4637.6 0.94 i 0-5
4649.2 4648.7 4649.7 1.00 i 0-5
4653.4 4651.7 4652.6 0.95 i 0-5
xxx i
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4690.4 ‘ 4687.7 4691.6 0.98 I 0-5
" “4718.7“ '4717.7 4719.6 ' ' 1.00 ' ‘ I ~ ' 0-5 ' . . . . . .
4737.2 4735.7 4737.7 1 A Ai . U U I 0-5
4740.5 4739.6 4739.6 LOO I 0-5
5564.2 SE main
6623.9 SE main
6829.7 SE main
6846.7 SE main
6986.1 SE main
7036.8 SE main
7048,9 SE main
7124.6 SE main
7156.9 | • SE main
7224.6 SE main
7345.3 SE main
7502.1 SE main
7588.6 SE main
7823.5 SE main
8103.0 SE main
8210.1 SE main
109277 SE main
11122.7 SE main j
Flow through from ion exchange column
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2411.2 H13
2644.1 HI 5-13
2670.9 12-13
2690.0 H15-I3
A a i  vl ^ HI 5-13
“ 274173—
2774.4 11-13
2781.3 16
2787.2 12
2789.8 2788.6 2790.6 1 . 0 0 TX 45-50
2813.8 H6-H7
2814.8 . 2812.6 2813.6 1 . 0 0 IC 25-30
2836.6 2835.6 2835.6 0.89 I 25-30
2842.8 12
x x x ii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2951.3 H7
2959.9 2958.9 2960.8 ------- 1.00-- - - - - - - - - - - - - - - - - - - - - - - 1 — ----- 0-5- — ..............
2968;0 H5-H9
2969.2 2968.5 2968.5 1.00 I 30-35
2969.7 2968.6 2969.6 1.00 I 20-25
2911.5 G14
2990.4 2988.5 2989.5 1.00 I 30-35
3030.7 G14
3060.5 3058.7 3060.7 0.90 I 30-35
3062.2 H11-H12
3087.8 3085.7 3086.7 0.90 T1 30-35
3089.3 . . . .  . .  .  . . - - - - -  -- - HM-H12
3097.8 3096.7 3097.7 1.00 I 30-353104.6 H6-H7
3105.9 3103.6 3105.6 1.00 IC 20-25
3111.8 H4-H5
3115.7 12-13
3127.6 3126.7 3127.6 0.99 I 20-25
31.65.7 H6-H7
3168.7 HI
3169.6 3168.7 3168.7 1.00 I 20-25
3180.0 G15
31.85.4 12-13
3191.9 3189.7 . 3191.7 1.00 I l l i J i i i W iim o m
3194.0 G8-G14
3196.8 H10-H11
3214.5 12-13
3224.3 . G15-H1
3226.2 H7
3250.9 G14-G15
3269.0 H6
3278.7 H14
3285:0 H7
3296.1 H10
3308.8 H5-H7 .
3311.1 l l i i i l i p H10-H11
3321.2 3318.9 3320.9 1.00 IC 20-25
-3322.0-... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . :  . . . . . . . . . . . . . . . . . . . ]31
3332.2 '36
391:  \ S  i. X  '  ' •  • • J ,X j+J  J L J L W  :
3374.5 35-H6
3392.5 i 38-H9
3397.7 315-12
3408.4 311-012
3411.3 31I-H14
x x x iii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3411.3 3409.8 3410.9 0.88 I 35-40
~-34-22r7- - ------------- --------... . . ----- . . . . .  _ G14--------
3426.3 ' H5-H7
3431.5 G12
3459.7 H5
3460.0 3458.7 3459.8 0.87 r 20-25
3496.1 H4
3506.8 H10
3519.0 H ll
3519.5 3517.0 3519.0 1.00 IC 20-25
3520.2 H3-H6
3521.2 111
3521.7 H1-H2
3524.6 13-15
3541.8 3541.0 3541.0 1.00 i 20-25
. 3549.4 H5-H7
3557.3 3554.9 3556.9 0.98 i 20-25
3569.2 11-12
3626.9 H6-H8
3648.5. HI 5-12
3649.0 18
3679.3 14
3691.0 17
3698.3 14
3698.3 H15
3700.4 19
3722.4 3720.0 3722.0 1.00 IC 35-40
3722.7 H ll-H I 2
3755.4 HI 5-11
3756.0 H9
3769.9 H13-H14
3770.5 3769.0 3770.0 1.00 IC 40-45
3776.9 13-14
3787.6 [4-15
3800.4 H15
3813.0 mmgmM M
3827.3 H7-H8
■ 3830,5 - ......................... — ......................................... 315 — ........
3847.2 314
3853.8 34-H6 .•5S7H 1; Uf J. H0-H11
3885.9 315
3900.9 I4-15
3906.3 314
3911.6 I110-H11
3913.7 I115-13
xxx iv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALM
fraction
3914.1 H4-H5
----- 3914:8 _■ -------------- - H7. ..
3916.6 14
3920.7 m&wmmii
3924.5 H4-H8.
3932.8 IHIO-Hll
3959.0 (Hll
3972.3 16
3973.5 3971.1 3973.1 1.00 IC 35-40
3973.6 3971.1 3973.1 1.00 IC 35-40
3973.6 3972.2 3973.1 1.00 IC 35-40
3973.7 - .... HI 1-12
3985.4 H7-H9.
4003.7 IH10-H15
4009.8 G14-H1
4011.8 - H6-H7 ;
4016.1 H8
4020.8 H5 :
4048.7 H8-H11
4076.8 H7-H10
4077.7 H2-H4
4078.8 4077.1 4079.1 1.00 IC 20-25
4081.0 12-13
410L3 12 -
4108.8 H2-H5
4111.2 III 1-112
4111.7 {h i  5 .
4133.8 4132.3 4133.3 1.00 I 20-25
4135.5 . H7-H8
4168.0 |H2.
4176.8 |I2.
4176.8 jm o-m i .
4203.0 H15
4223.9 H2-H3
4255.9 (H2-H3
4308:1 [HIS.
4319.2 HI 2-12
-  4326,3 ... ------ ----- - ■ H 7 ...........
. 4345.5 - b
4365.9 i314tJL311-H12
4825.2 I113-13
4843.3 IH I
4851.7 I115
5469.1 I10
5553.7 I9
XXXV
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
5631.5 H10-H12
- -6181.5 . . . . . . . . .  ----------------------------- - ■-  - -  — ----------------. . . . . . . . . . . . .  — H-l-5
6624.0 ' H10
6712.0 H12-H13
6746.7 [ H156841.5 H9
6859.0 H5-H10
6878.5 12
6879.5 H ll
7028.8 m o
7055.7 13-15
7065.3 H10-H11
7139.2 11-12
7159.6 HI 4-13
7255.3 H13-H14
7269.1 H15
7356.3 H14-H15
7403.4 H13-H15
,7552.5 H10-H15
7596.0 H12-H14
7622.1 HI 3-HI 5
7850.7 HI 5-12
7878.5 H10
8226.0 H14-H15
Group 1 from ion exchange column
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2018.5 A14-A15
2085.4 2084.8 2085.8 1.0 I 1-5
2087.4 B14-B15
2089.4 2088.8 2088.8 1.0 I 1-5
2121.3 2120.7 2121.7 - 1.0 . I 1-5
2215.4 2214.7 2215.7 1.0 1-5
2225.4 2224.7 2224.7 1.0 B i l l l l l m m m
2279.3 2278.7 2279.7 1.0 I 1-5
2293.8 2292.7 2292.7 1.0 I 1-5
2360.3 2358.7 2359.7 1.0 I 1-5
2407.6 2406.7 2407.7 1.0 I 1-5
2428.4 2426.7 2427.7 1.0 I 1-5
2476.0 2474.7 2475.7 0.9 I 1-5
2496.4 2494.7 2495.7 1.0 I 1-5
2544.0 2542.7 2543.6 0.9 I 1-5
2551.3 2550.7 2551.7 1.0 I 1-5
xxxv i
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2554.5 2553.7 2553.7 1.0 I 1-5
- - 2557.1- ----------------- AT0---------
2560.4 2558.7 2559.7 1.0 I 1-5
■ 2564.6 2563.7 2563.7 1.0 I 1-5
2584.0 A ll
2598.0 .2596.6 2597.6 0.9 I 1-5
2611.9 2610.7 2611.7 0.9 I 1-5
2619.2 2618.6 2619.6 1.0 I 1-5
2632.4 2630.7 2631,7 1.0 I 1-5
2680.1 2678.7 2679.7 0.9 I 1-5
' M i  o n  n  ZOO/.J 2686.7 n e o n  c  Zvo/.Q 1.0 I 1 c l-J
2687.5 - - -  -; ------------... C1-C2-------
2696.4 2694.6 2695.7 1.0 1-5
2700.6 2699.7 2699.7 1.0 I 1-5
2710.6 2709.6 2709.6 1.0 I 1-5
2715.6 C3-C6
2717.1 2715.4 2716.4 1.0 IC 45-50
2718.1 C9-C10
2732.2 2730.6 2731.6 0.9 i 1-5
2746.6 2745.7 2745.7 1.0 i 1-5
2768.4 2766.7 2767.6 1.0 i 1-5
2816.0 2814.7 2815.6 0.9 i 1-5
2826.5 2825.6 2825.6 1.0 i 1-5
2828.1 2826.4 2827.5 1.0 m x i i m il25s3QS
2832.5 2830.6 2831.7 1.0 i t i l l i f l l
2836.4 2835.6 2835.6 1.0 i 1-5
2854.0 2853.7 2853.7 1.0 i 1-5
2868.5 2867.6 2867.6 1.0 r . 1-5
2884.1 2882.7 2883.6 0.9 i 1-5
2889.6 B2-B3
2894.6 2893.6 2895.6 1.0 i 1-5
2902.3 C3
2904.6 2903.6 2903.6 1.0 i 1-5
2914.5 2913.6 2913.6 1.0 i 1-5
2925.0 2923.7 2924.7 1.0 i 1-5
2937.2 2936.7 2937.7 1.0 i 1-5
2959.2 2958.6 2959.6 1.0 i 1-5
2962.7 2960.6 2963.6 1.0 i 1-5
2968.5 2966.5 2967.6 1.0 i 1-5
2972.6 2971.6 2971.6 1.0 i 1-5
0 QQ£ nZ w y  V . u 2994.6 2996.6 1.0 i 1-5
3017.0 M3
3018.9 3017.6 3017.6 1.0 i 1-5
3040.6 3039.6 3039.6 1,0 i 1-5
3053.7 M2
3056.0 3054.5 3055.6 0.9 i 1-5
x x x v ii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALI>I
fraction
3058.4 3057.6 3057.6 1.0 I 1-5
-  3062.6 - 3061-6 - -  3061.6 - ----- -1.0 ~_; - j :-5 - ■
3064.6 3063.6 3063.6 1.0 I 1-5
3081.6 A15anCK ^ A13-A14
3098.6 3097.6 3099.6 1.0 I 1-5
3105.2 3104.7 3105.6 1.0 I 1-5
3108.0 3106.6 3107.6 1.0 I 1-5
3112.0 A12-A13
3167.3 3165.6 3167.6 0.9 I 1-5
3172.3 I C1-C2
3174.4 - — ----- - --- ------ B2...............
3176.6 3175.6 3175.6 1.0 r 1-5
3182.2 C3-C4
3194.4 3193.6 3193.6 1.0 i 1-5
3198.3 ■3197:6 7 T G 7  AX y / ,v 1 nX . V X::.. 1-5
3208.5 3207.6 3207.6 1.0 T 1-5
3219.3 B9
3240.8. . 3239.6 3239.6 1.0 1 1-5
3244.4 3243.6 3243.6 1.0 i 1-5
3251.3 3249.6 3251.7 1.0 i 30-40
3252.7 B14-B15• ;• s'-:••'■;-.jzoi.5 W im M i ^zoi.6 ;::o . 7 i i l I I tM I I
3266.4 .3265.6 3265.6 i 1-5
3272.9 3271.5 3271.5 i 1-5
3276.5 3275.6 3275.6 i 1-5
3295.6 B13-B14
3315.4 B14-C1
3317.7 B8
B3-B4
3333.0 ■3331.6 3332.6 1.0 i 1-5
3344.0 3342.6 3343.6 0.9 i 1-5
3358.6 B5
3368.5 3367.6 3367.6 1 n l.U i 1-5
3369.2 3368.1 3370.1 l.O i 1-5
3382.2 m m m * 213393.4 i  m m m 33
- -3396,6- -- - 36-C8
3397.9 3396.6 3397.6 l.O i 1-5
3400.8 jjy9./ ,3399.7 , 0.9 i 25-30
•M H 1 7 3399.6 3401.6 l.O iX 1-5
3403.9 I32
3404.8 3404.6 3404.6 l.O I 1-5
3409.3 314-B15
3412.5 3411.0 3412.9 0.9 I 1-5
3417.5 I36
x x x v iii
Mass
(average)
H/T,---itiSss
(mono.)
Apex Mass Score Evidence Time MALBI
fraction
3417.8 3415.6 3417.7 1.0 I 25-30
- - 3422.2- --------- -■---------- 1— .................... B5-----------
.3432.8 B9
3458.5 3456.5 3458.6 1,0 I . 1-5
3465.8 3463.5 3465.6 1.0 TX 1-5
3471.1 3469.6 3470.6 1.0 I 1-5
3477.2 B11-B13
3480.4 3479.5 3479.5 1.0 I 1-5
3483.8 • A15-B2
3486.2 B9O A (\£. O A14-B1
3501.3 r C2
3508.6 B12-C1
3512.0 3510.6 3511.7 1.0 I 20-25
3513.2
3514.2 ^ 1 0  i 3514.1 0.8 I 1-5 B2-B3r o JLO.d A13
3519.0 3517.5 3519.5 1.0. I 1-5
3536.6 3534.5 . 3536.6 1.0 1-5
3541.1 3539.0 3540.9 0.8 I 1-5
3544.1 3543.6 3543.6 1.0 I 1-5£ / .U 3545.5 3547.5 1.0 I 1-5
3552.5 i:::;3551S5sl 113554^ 5:1::/-': mmwm-wrn
3562.0 B11-B13 *
3562.7 3561.5 3563.5 1.0 I 1-5
3573.7 C2
3583.7 3582.3 3582.3 1.0 I 1-5''co.i /: 3583.6 O C O/l c 1 A l.U TX 1-5 -
3589.0 B15 ,
3591.1 3590.5 3591.5 1.0 I 1-5
3595.0 B3
3595.1 B14
3594.7 3596.7. \ nX  • V . m
3596.9 3595.6 3596.7 1.0 T1 20-25
3602.4 3601.6 3601.6 1.0 I 1-5
3606.3 3605.6 3605.6 1.0 . * I 1-5
3608.8 3608.6 3608.6 1.0 I 1-5
-3609.2 ........ ...................... ' ! . . .  . - . . .  . . . ^2
nJ . V / . V 3615.6 3615.6 1.0 I 1-5
**% V ' / ^ / v  * vJOZy.3 I " * / '!  “ T \  t'3y-X5 L\J
3647.5 3645.6 3647.5 1.0 1 1-5
3648.6 3648.1 3649.0 1.0 I 1-5
3651.4 3650.5 3650.5 l.O IC 1-5
3662.2 3660.5 3662.6 1.0 I 1-5
3665.7 3664.7 3666.7 1.0 I 25-30
3669.8 3667.5 3669.5 1.0 I 1-5
xxx ix
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3674.8 3672.5 3674.5 1 . 0 I 1-5
3676.3 . ; 3675.5 3675.5 i i l S l i P • 1 -5 -
3704.0 B10
3713.8 B9
3740.6 3738.5 3740.6 1 . 0 I 1-5
3765.0 3764.1 3764.9 1 . 0 I 1-5
3775.8 3774.5 3776.5 1 . 0 I 1-5
3780.7 3778.7 3779.8 1 . 0 I 25-30
. 3788.4 3787.5 3788.5 1 . 0 T 1-5
3794.9 3794.5 3794.5 1 . 0 I 1-5
3797.7 B5 -B10 .
3798.4 3796.7 3798.7 1 . 0 IC 25-30
3801,6 C9-C15
3802.9 3801.5 3802.5 1 . 0 I 1-5
3805.8 3804.6 3805.5 1 . 0 I 1-5
3809.7 3807.5 3809.5 1 . 0 I 1-5
3810.2- BS
3812.8 3812.5 3812.5 1 . 0 I 1-5
3816.0 3814.5 3815.5 1 . 0 I 1-5
3819.7 3817.6 3819.7 1 . 0 I 25-30
3819.9 3819.5 3819.5 1 . 0 tm m
3820.8 . B14-B15
3831.9 Cl
3834.9 3832.7 3834.7 1 . 0 IC 25-30
3835.8 3834.7 3835.7 1 . 0 i 25-30
3836.9 3835.7 3836.6 0.9 i 25-30
3840.5 3837.8 ' 3839.8 1 . 0 IC 20-25
3840.6 - B4-B6
3841.7 ■ . 3839.8 3840.8 I B l i B i i l r 20-25
3857; 1 3855.5 3857.5 m m m m I
3868.6 3867.5 3869.5 - 1 . 0 ■ I i l i l l l l
3873.9 3871.5 3873.5 l.O I 1-5
3878.3 3876.7 3877.7 1 . 0 IC 20-25
3879.3 3877.5 . 3878.5 I l l i l l l l ; I 1-5
3884.1 3883.5 3884.5 mmmrniMm : I 1-5
3902:2 C5
3909:3 3908.5 3908.5 1 . 0 I 1-5
3932.1 -  _ -  _  . ----------------------------------- -------------------- 38-B10
3938.6 3936.5 3938.5 1 . 0 I 1-5
3944.8 3942.5 3944.5 0.8 I 1-5
^ G / f ^  Q l \  -7  A  1 1“X t  XTt X X
3953.1 '■ I31-B2
3959.8 i U 0-A 12
3978.3 3977.5 3977.5 1 . 0 I 1-5
3982.2 I311 ■
3987.5 32
xl
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time M ALM
fraction
3989.1 3988.1 3989.0 1.0 I 1-5
— -3992.5- 3991.6 3992.5 L0 - m m im m rn -  -  -1-5— ----------------------------------- - - - - -
3994.6 B10
3998.1 3997.4 3998.5 1.0 i 1-5
4001.0 B1
4001.4 3999.4 4001.5 0.9 i 1-5
4004.8 4004.5. 4004.5 1.0 i 1-5
4009.7 4008.5 4009.5 1.0 i 1-5
4014.5 4011,5 4013.5 1.0 i 1-5
4021.5 B l l
4030.3 4028.0 4030.0 1.0 i l l ®  l i i i f 20-25
- 4 030 .6 - .  .  . A 13-B1------
4052.3 B10-B13
4059.4 4058.4 4059.4 1.0 i 1-5
4070.2 4068.5 4070.5 1.0 i 1-5
4077.7 4075.4 4077.5 1.0 i 1-5
4083.0 4080.4 4082.5 1.0 i 1-5
4088.1 4087.5 4088.5 1.0 i 1-5
4094.4 4093.4 4094.5 1.0 i 1-5
4100.3 A14-A15
4102.1 C1-C2
4113.0 4112.5 4112.5 1.0 i 1-5
4113.0 B10
4130,8 4128.5 4130.5 0.8 i l l i l i S I I I
4142.0 [B11-B13
4142.6 . 4140.5 4142.5 1.0 i 1-5
4148.7 4146.4 4148.5 0.8 i 1-5
4160.5 4159.5 4160.5 1.0 i 1-5
4172.0 ts 12-01
4172.2 • 4171.2 4172.2 1.0 r 35-40
4191.2 4189.5 4190.5 0.9 i 1-5
4195.7 4194.4 4196.5 LO i 1-5
4197.2 B14
4200.0 4197.5 4199.5 1 0.9 i 1-5
4205.9 4204.5 4205.5 0.9 i 1-5
4213.7 4212.4 4214.4 1.0 i 1-5
4218.5 4215.5 4217.4 1.0 i 1-5
4228.6 . .4227.-4- 4229.4— ................-1.0.............. .............. —  i .................. .. 1-5 .
4232.2 4230.5 4232.4 1.0 i ■ 1-5 312
4233.3
4258.6 4257.5 4259A 1.0 i 1-5
4263.0 4261.5 4263.4 1.0 i  . 1-5
4269.3 (: i
4274.9 4274.4 4274.4 1.0 i 1-5
4281.9 4279.4 4281.5 1.0 i 1-5
4287.1 4285.5 4286.4 1.0 r 1-5 -
x li
Tl/T__inass
(average)
n/r__mass
(mono.)
Ape a Mass Score Evidence Time H/T A T TXT ITl/iljlxi
fraction
4296.9 4295.4 4 2 9 5 . 4 1 ,0 I 1-5
_ __ 4313 .5 -— 43_X4_4_— 43-13 r5— 1-5
4318.5 4317.5 4319.4 1 .0 1-5
4332.7 4329.5 4331.4 1 .0 i 1-5
A O A £  c.  TJtU.U AO, A A C "tJTT. ^ AO A C  ATJfctU.fct 1 .0 i 1-5
4352.6 4350.4 4352.5 1 .0 i 1-5
4355.3 B3
4355.6 4354.1 4356.1 1 .0 i 20-25
4365.3 4363.5 4364.4 0.9 t 1-5
4375.2 B1
4395.3 4393.5 A 'JQ A A 0.9 TX 1-5
4401.7 4399.5 4400.4 - - ----- i ; 0 ---- 1-5 .
4407.1 4405.5 4407.4- 0 . 8 I * 1-5
4412.3 4411.4 4411.4 1 .0 I 1-5
4419.1 4416.4 4418.4 1 .0 I 1-5
4424.6 4422.5 4424.5 t n  _-l . \s I 1-5
4430.0 4429.4 a ah h j u A 1 .0 X 1-5
4434.3 . 4431.4 4436.4 1 .0 1-5
4463.4 4461.4 4463.4 1 .0 I 1-5
4468.9 4466.4 4469,4 1 .0 I 1-5
4474.3 4472.4 4475.4 0.9 I 1-5
A A Q f i  Q TTUO.O A A H Ci  A t t  /  y.~r 4481.4 i nJL.V I l i l i i :
4485.6 4483.4 4485.4 i.U :
4491.1 4488.4 4490.4 1 .0 I .
4498.2 B2
4499.6 4497.3 4499.4 0 .8 . I 1-5
4506.4 4504.5 4505.4 1 .0 T 1-5vtcic c*1-JiJ.J B1
4518.8 4517.4 4517.4 . 1 .0  . - I 1-5
4521.9 4521.4 4522.3 1 .0 I 1-5
4539.0 4536.3 4538.4 1 .0 I 1-5
4545.8 4543.4 4547.4 0,9 I l l l i l l l
4550.9 4 5 4 9  4 1.0 TX i-'*JL
4556.9 4554.4 4556.4 1.0 TI 1-5
4566.4 4563.3 4565.4 0.9 I 1-5 <
4580.8 4579.4 4580.4 1.0 I 1-5
4590.8 4587.4 4589.4 0.9 I 1-5
4600.3 4597.5 4601.4 0.9 I 1-5
A A V t H A~tKji.yj.-r 4614.3 A A 1 A  ATU1V/,“T . 1 .0 TX 1-5
4621.1 4619.4 4622.4 1 .0 I 1-5
4626.4 4623.4 4625.4 L0 1 1-5
4636.0 4634.4 4637.4 1.0 I 1-5
4641.0 (: i
A K A  1 9 4 5 3 0 4 4640.4 0.9 I 1-5
4672.6 4670.4 4673.4 1 .0 , I 1 ci--'
4677:9 4676.4 4679.4 0.9 I 1-5
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4683.5 4681.3 4685.4 1 .0 I 1-5
----- 4689.6-— 4687,4- _ 4691,4- ------ 1, 0 -  - --------1_------
I
. .  . 1-5-..
1-5
----------- ---- ----
4694.8 4692.3 4694.4 ' 1 .0
4699.9 4699.4 4700.4 1 .0 W S M w M 1-5
AHC\ A A t  / U-r.-r 4701.3 4706.4 0 . 8 TJL 1-5
4718.3 A7i /.^ 4717.4 1 .0 I 1-5
4740.8 4737.4 4739.4 0.9 I 1-5
4775.8 4773.3 4775.4 0.9 I 1-5
4789.3 4787.3 4787.3 1 .0 I 1-5
4802.4 4801.4 4803.3 1 .0 I 1-5
A  OA O A ‘tOUO.i 4805.4 a ono /iitOUO.‘t A O U.O TJL 1 c i - j
4815.8 4815.3 4815.3 1 .0 I 1-5
4820.4 4819.4 4820.4 1 .0 I 1-5
4825.1 4823.3 4825.4 0.7 I 1-5
4830,5 4827.4 4829.4 1 .0 I 1-5
4841.2 4838.4 4841.4 1 .0 I 1-5
4856.7 4 or 4 ^ 4856.4 0 . 8 I 1-5
4869.0 4867.5 4869.3 0 . 8 I 1-5
4876.0 4874.3 4877.4 1 .0 I 1-5
4887.9 4886.4 4889.3 1 .0 , I 1-5
4893.5 4890.3 .4893.4 1 .0 1-5
4899.1 /IOQ'7 A to > / .-r A QQQ n  - r u > o __f 1 nJ.-.U
4904.3 4903.5 4904.3 1 . 0 TI 1-5
4915.6 4914.3 4915.4 0.9 1 1-5
4920.3 4919.3 4919.3 1 . 0 I 1-5
4930.9 4928.3 4931.3 0.9 I 1-5
4937.0 4934.4 4937.3 1 . 0 I 1-5
4946.0 4944.2 4946.3 1 . 0 I 1-5
4951.3 4949.3 4952.3 -1 .0 I 1-5
4956.2 4955.4 4955.4 1 . 0 I 1-5
4961.7, 4958.3 4961.4 . L0 I 1-5
4967,0 4965.3 4967.4 1 . 0 I 1-5
4977.8 4975.4 4979.4 1 . 0 I 1-5
4996.6 4994.4 4997.3 1 . 0 I 1-5
5002.2 5000.3 5000.3 0.9 I 1-5
5006.8 5005.4 5005.4 1 . 0 I 1-5
5011.9 5009.3 5011.4 1 . 0 I !-5
5020.0 5017.4 5021.3 0.9 I 1-5
t z n n A  a“T 5023.4 T 1 n I 1-5
5029.7 5027.4 5029.4 1 .0 I 1-5
5034.7 5033.3 5033.3 1 . 0 T 1-5
5045.3 5042.3 5045.3 1 . 0 I 1-5
5059.5 5057.3 5059.3 0 . 8 I 1-5
5079.9 5077.4 5079.3 1 . 0 I 1-5
5092.3 5090.3 5093.3 1 .0 I 1-5
5097 0 5095.4 5097.3 1 . 0 I 1-5
x liii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDX
fraction
5102.2 5099:3 5102.3 1.0 1-5
_ —-5-109.3-- 5107.3 5111.3 , -  -1:0---- ------X_5 ..
5129.3 5128.2 5129.3 1.0 W m 1-5
5134.6 5132.3 5135.4 0.8 i 1-5
5148.8 5147.4 5147.4 1.0 i 1-5
5157.8 5155.3 5159.3 1.0 i 1-5
5165.7 5162.3 5165.3 1.0 x i 1-5
5173.8 5172.2 5172.2 1.0 i 1-5
5191.6 5189.3 5191.3 0.8 i 1-5
5200.9 5199.2 5201.3 0.7 i 1-5
5215.1 5212.3 5216.3 1.0 i 1-5
5227.3 5225.3 5227.4 1.0 i 1-5
5233.4 5230.4 5233.4 1.0 i 1-10
5238.7 5237.3 5237.3 1.0 i . 1-5
5249.4 5246.4 5249.3 1.0 i 1-5
5264.9 5263.3 5265.3 1.0 i 1-5
5285.2 5282.3 5285.3 1.0 i 1-5
5295.1 5293.4 5295.2 0.9 i 1-5
■ 5301.4 5298:3 5301:3 1.0 l i l i S i i 1-5
5338.9 5336.4 5339.3 1.0 wmM rnsm 1-5
5347.4 5346.4 5347.3 1.0 i 1-5
Im m sm m mWmmS rn iM m m WBmmm
5361.2 5358.3 l l i l p i l l 0.9 m m  i i i i i l l l i M I S
5369.5 5366.2 5369.3 1.0 i 1-5
5383.5 5381.3 5381.3 0.7 i . 1-5
5390.3 5388.2 5390.3 1.0 i 1-5
5397.1 5395.2 5399.4 0.9 i 1-5
. 5402.7 5400.2 5402.2 1.0 i 1-5
5409.1 5407.3 5409.3 0.9 i 1-5
5420.0 5417,2 5420.3 1.0 r 1-5
5431.0 5429.3 5431.4 0.7 i ' 1-5
5436.5 5434.3 5437.3 1.0 i 1-5
5443.4.. 5441.3 5441.3 0,8 i i s l i l S
5451.8 5451.2 5452.3 1.0 rI 1-5
5454.7 5453.2 5455.2 1.0 I 1-5
5460.9 5459.2 5461.4 1.0 I 1-5
5475.7 5475.2 5475.2 1.0 I 1-5
5488 .9 ... 5487.3. : --.5487.3. - .0 .9 ........ . .  i.. 1-5 -- ..
5498.4 5497.4 5498.3. 1.0 I . 1-5
5501.2 5500.4 5501.3 1.0 I 1-5
5505.3 5504.3 5505.2 1.0 r 1-5
5509.7 5507.3 5509.2 1.0 I 1-5
5523.1 5521.2 5523.1 1.0 I 1-5
5527.3 5526.4 5527.4 1.0 I 1-5
5533.1 5531.3 5534.3 0.8 I 1-5
5537.3 5536.2 5537.3 , 10 . I _....... 1-5
x liv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time M ALM
fraction
5556.2 5553.2 5555.2 0.8 , 1-5
--5573,-7-- W m M M 5573.3 1.0 . i n  m m M - ....-1-5- - " .
5579.3 5571.3 5577.3 0.9 i 1-5
5589.6 5587.4 5589.3 0,8 M i | 1-5
5612.8 5611.2 5611.2 0.9 I 1-5
5625.8 5624.2 5627.3 1.0 I 1-5
5634.5 5633.2 5633.2 0.9 - 1-5
5641.7 5640.2 j 5641.2 : 1.0 t i l l  i i i i s - 1-5
5778.6 5776.2 j 57?73 1.0 i 1-5
5783.9 5782.2 5783.3 0.9 i 1-5
5829.7 5828.2 5829.2 1.0 i 1-5
6760.6 C7
6797.8 C6-C8
6818.8 B10
. 6850.1 D3
6908.0 |C5 -
6960.4 . p 9
7007.6 . ' ‘ |B15-C3
7015.5 [B12-B13
7121.8 [C5
7125.7 [B10-B14
7158.0 [c2 ■
7196.0 BIG
7319.5 |B15
7604.8 |B7
7643.7 1B14-B15 .
7814.6 |C5
7839.3 Cl
7921.5 S l l l l i l l * : i  ,
8213.2 (31-C2
8357.7 I314
Group 2 from ion exchange column
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time M A LM
fraction
2007.7 2006.8 2006.8 1.0 I 0-5
2014.8 B5
2019.9 2018.8 2019.8 1.0 I 0-5
2062.5 2061.8 2061.8 1.0 I 0-5
2084.8 B12
2113.2 2112.8 2112.8 1.0 I 0-5
2144.9 2143.8 2144.7 1.0 r 0-5
2156.2 2154.8 2155.8 1.0 i 0-5
2224.1 2222.8 2223.8 1.0 i 0-5
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MAERI
fraction
2279.3 2278.8 2279.8 1-0 I 0-5
2292.1 - 2290:8- ... 2291,8 1.0 - I — -0-5--- - - - —
2334.5 2333.8 2333.8 1.0 I 0-5
2340.3 B l l
2360.0 2358.8 2359.8 1.0 I 0-5
2428.1 2426.8 2427.8 1.0 I 0-5
2564.1 2562.8 2563.8 1.0 1 0-5
2617.4 B14-B15
2618.2 2616.3 2618.3 1.0 IC 20-30
2628.8 2627.3 2628.4 1.0 I 25-30
2632.0 2630.8 2631.8 1.0 I 0-5
2639.8 . . . C 9 -----------
2643.8 C1Q
2644.7 C1-C5
2646.7 2644.4 2645.4 1.0 IC 25-30
2657.0 2656.3 2656.3 1.0 I 20-30
2669.0 2667.3 2668.3 1.0 IC 25-30
2672.1 2670.4 . . 2671.4 1.0 . I 20-30
2683.8 2682.3 2683.3 1.0 IC 25-30
2686.4 B14-C1
2689.0 2687.4 2688.4 1.0 m g m m i 20-30
2690.1 2688.4 2689.4 1.0 IC 20-30
2690.9 2690.4 2690.4 1.0 IC 25-30
2691.4 2689.4 2690.4 im m m m IC 25-30
2699.5 2698.4 2700.4 1.0 I 25-30
2700.0 2698.8 2699.8 1.0 I 0-5
2708.3 2707.4 2708.4 1.0 IC 20-25
2711.1 2709.4 2711.3 1.0 IC 20-30
2711.8 2711.3 2712.3 1.0 I 20-30
2713.1 C1-C5
2716.2 C9-C14
2716.6 2714.4 2715.4 1.0 IC 25-30 l
2718.0 2716.4 2717.4 1.0 I 25-30
2719.3 2718.4 2718.4 1.0 I 25-30
2719.8 2718.3 2719.4 1.0 I 25-30
2727.7 2726.4 2727.3 1.0 IC 20-30
2727.8 2727.3 2727.3 . 1:0 I 20-30
2731.4. 2730.3 2732.3 1.0 . I 20-30
2734.5 2733.4 2734.5 1.0 I 20-25
2735.9 2734.4 2735.4 1.0 I 25-30
2738.9 2737.4 2739.4 1.0 I 25-30
2738.9 1 4 .. ■ V ■' ■ (33-C4
2749.3 2748.3 2748.3 1.0 I 20-30
2754.4 2753.4 2754.4 1.0 IC 25-30
2756.8 2756.4 2756.4 1.0 I 25-30
2764.9 2763.3 2764.3 1.0 I 20-30
xlvi
Mass
(average)
Mass
(mono.)
Apex Mass i Score Evidence Time MALDI
fraction
2767.3 2766.3 2766.3 0.9 I 20-30
-2828.8- 2827.5 - -2827.5. - -1,0 . . .  -I--..- 20-30 - ..................
2836.0 2834.7 2835.7 ' 1.0 I 0-5
2858.0 2856.7 2857.8 0.9 I 0-5
2902.6 2901.5 2902.6 1.0 25-30
2904.1 2902.7 2903.7 1.0 i 0-5
2940:5 2939.5 2940.5 1.0 i 25-30
2941.5 2940.5 2941.5 1.0 i 15-20
2969.1 2968.2 2968.2 1.0 i 0-5
2971.6 2970.7 2971.7 1.0 i 0-5
2994.2 2992.8 2993.7 1.0 i 0-5
3019.1 A13-A14
3036.3 A13
3038.4 3036.7 3037.7 0.9 i 0-5
3052.7 A12-A13
3062.2 3060.7 3061.7 , 1.0 i 0-5
3078.0 3076.6 3078.6 1.0 i 15-20
3104.0 B2-B3
3105.1 3104.2 3104.2 1.0 i 0-5
3107.9 3106.7 , 3107.7 1.0 i 0-5
3118.7 C5
3129.7 3127.7 3128.7 1.0 i 0-5
3182.6 3181.8 3182.8 1.0 i 20-25
3184.7 3183.8 3184.8 1.0 IC 20-25
3184.9 3182.8 3184.8 1.0 IC 20-25
3198.6 3196.7 3197.7 1.0 i 0-5
3205.3 A14
3222.2 3221.7 3222.7 1.0 i 20-25
3222.8 3220.8 3221.7 1.0 . i 20-25
3223.9 - A13 ;
3236.7 A12
3242.9 3241.7 . 3243.7 1.0 I 15-25
3266.1 3264.7 3265.7 1.0 I 0-5
3318.7 B12
3319.2 3317.7 3317.7 1.0 I 15-20
3325.7 3323.8 3325.8 1.0 I 15-20
3332.4 3330.7 3332.7 1.0 I 0-5
3343.1 3341.7 334-1.7 1.0. I 0.5___ ..............  . . . . . .
3377.1 3375.7 3375.7 1.0 I 0-5
3377.4 3376.2 3376.2 1.0 I 0-5
3383.6 (37
3402.1 (38
3402.6 3400.7 3401.7 1.0 I 0-5
3402.9 39-B10
3417.7 3415.7 3417.7 1.0 IC 15-25
3418.7 U3-A14 ,
x lv ii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3422.5 C2-C3
- - -3432.5 -- .. B8
3448.3 A14
3454.0 B4-B5
. 3455.2 C4-C5
3456.9 3454.7 3456.8 1.0 I 15-25
3465.5 A13
3470.1 3468.7 3469.7 1.0 I 0-5
3478.0 A15-B1
3481.7 C8
3487.4 C9-C12
- 3494:1 - - - - -  - - - ......................- A14-A15
3495.3 C15
3507.2 ■ A13 ,
3507.7 B2
3523.6 C4-C5
3536.3 3534.7 3536.7 1.0 I 0-5
3563.9 3562.9 3563.9 1.0 I 15-20
3572.3 3569.9 3572.0 1.0 I 20-25
3576.0. B12-B14
3587.3 1 3 I8 5 P 1 3587.9 1.0 . S S S S S l i i 20-25
3603.3 3601.7 3601.7 S i l l  i l l l l I IM IB S I
3607.0 B2-B4
3614.8 3613.0 3614.2 1.0 i. 0-5
3617.4 3614.8 3616.8 1.0 IC 15-20
3620.6 3619.8 3619.8 1.0 I 15-20
3635.3 3634.8 3634.8 1.0 I 15-20
3635.3 3633.8 3634.8 1.0 I 15-20
3638.5. B3
3641.7 . B12-B14
3643.7 C2
3649.2 3647.6 3647.6 1.0 I 0-5
3649.3 3648.1 3648.1 1.0 I 0-5
3674.0 3672.7 3673.7 1.0 I 0-5
3685.3 BIO
3695.5 B13-B15
3711.9 . 27-C8
-.3721.6 . - _______ _____________________________ - - 312----------
3723.2 3720.9 3723.9 1.0 IC 15-20
3723.5 3720.9 3722.9 1.0 IC 15-20
3724.3 9 7 9 9  Q 3722.9 1.0 IC 15-20
3734.3 (38-C9
3740.3 3738.7 3740.7 1.0 I 0-5
3742.3 ■ . .....  . 313-B14
3751.3 3750.2 3750.2 1.0 I 0-5
3761.8 3760.8 . 3760.8 1.0 I 15-20
x lv iii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time T i f f  A. T  T V Tir im jl/i
fraction
3782.7 3781.9 3781.9 1.0 I 15-25
- 3800.4 - 3799r7- -3799.7 -  - I7O- . . .  j ....... 0-5 -----------■ •
3801,6 C1-C2
3801.9 B8-B10
3807.4 3805.7 3805.7 1.0 I 0-5
3824.6 3823.0 3824.0 1.0 • IC 15-20
3839.9 3838.9 3839.9 1.0 IC 15-20
3840.2 3837.9 3840.9 1.0 IC 15-20
3850.9 B4-B5
3854.3 3851.9 3853.9 1.0 IC 15-20
3854.5 3851.9 3854.9 1.0 IC 15-20
3858.2 ................. . . . B3-B4 -;
3860.2 3857.9 3858.9 1.0 IC 15-25
3875.4 3873.6 3873.6 1.0 I 0-5
3892.3 3890.8 3892.8 1.0 I 15-20
3907.5 C4-C5 :
3920.6 3919.6 3920.7 1.0 I 0-5
3944.3 3942.6 3944.6 1.0 I 0-5
3954.7 B1-B2
3954.8 3952.0 3954.0 1.0 IC 15-20
3969.9 A14-A15
3972.9 3972.0 3972.0 1.0 I 15-20
3979.3 B ll
3982.7 3980.1 3982.1 1.0 IC 20-25
3988.2 3985.6 3987.6 0.8 I 0-5
3992.6 3991.6 3991.6 1.0 I 0-5
3994.4 B ll
4011.4 4009.6 4009.6 LO I 0-5
4019.1 B5-B10
4021.4 C8-C15
4022.0 C4-C5
4022.3 4020.0 4021.0 1.0 IC 15-25
4022.9 4020:9 4022.9 1.0 ■ I 15-25
.4025.5 A14
4026.2 4025.0 4025.0 1.0 I 15-25 A14
4031.0 4028.0 4030.1 1.0 IC 15-20
4031.6 4031.0 4031.0 1.0 IC 15-20
4040,9 4038,1 4040,0 1,0 IC 15-25 .
4041.3 4039.0 4041.0 1.0 I 15-25
4042.0 4040.0 4042.0 1.0 I 15-25
4042.6
4047.7 38-B11
4052.0 4050.9 4052.9 1.0 I 15-20
4053.7 4052.2 4053.2 1.0 IC 20-25
4058.6 4058.2 4058.2 1.0 I 0-5
4070.3 4069.2 4070.2 1.0 I 15-20
x lix
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time M ALM
fraction
. 4079.4 4077.6 4077.6 1.0 I 0-5
4 1 1 6 .6 - B8-B1G
4128.0 . A14
4149.1 4146.6 4148.6 1.0 I 0-5
4155.0 B12
4172.7 B12
4179.5 Cl
4180.0 :#I111I1115
4197.2 4195.6 4196.6 0.9 0-5
4208.5 4207.6 4207.6 1.0 I 0-5
4215.4 4213.6 4213.6 1.0 I 0-5
4226.9 4226.1 4226.1 1.0 I 0-5
4229.9 4228.6 4228.6 0.8 I 0-5
. 4246:1 B12-B14
4264.5 4263.6 4263.6 1.0 I 0-5
4276.5 4275.6 4275.6 1.0 I 0-5
4283.3 4280.6 4281.6 1.0 I 0-5
4294.7 4293.5 4294.4 1.0 I 0-5
4295.9 4295.0 4295.0 1.0 I 0-5
4338.0 B9
4338.0 B9
4344.4 4343.6 4343.6 1.0 I 0-5
4363.0 4361.5 4362.6 1.0 I 0-5 )
4365.4 B1-B2
4397.0 4395.6 4396.7 0.9 I 0-5
4401.2 - 4399.6 4400.6 0.9 l i i i i l i
4407.5 B3
4413.3 4411.6 4411.6 0.9 I 0-5
4419.7 4417.6 4417.6 - L0 : 0-5
4468.5 4467.6 4467.6 1.0 I 0-5
4471.3 B9
4487.8 4485.6 4485.6 . 1.0 l l i l i i l l l
4533.4 4532.1 4533.0 1.0 I 0*5
4536.8 4535.6 4535.6 1.0 I 0-5
4584.7 C2
4584.7 02
4601.7 B13-B14
4605.4 46G3v6 4604.5 1.0 I 0-5
4616.4 4615.6 4615.6 1.0 I 0-5
4623.7 4621.6 4621.6 1.0 I 0-5
4672.5 4671.5 4671.5 1.0 I \ J ~ /
4682.1 4679.7 4680.6 1.0 IC 20-25
. 4683.0 310-B11
4684.5 4683.5 4683.5 1.0 I 0-5
4691.1 4689.5 4689.5 1.0 I 0-5
4695.6 4694.5 4694.5 1.0 I 0-5
1
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALBI
fraction
4716.5 B1-B2
- - 47-27,6 - • ---------- -------- — - -  -  — .....................-  -------- B9-B10-
4740.8 4739.5 4739.5 1.0 ' I 0-5
4751.0 B l l
4752.9 4751.5 4751.5 1.0 I 0-5
4760.8 4758.5 4758.5 1.0 I 0-5
4796.6 C2
4800.3 C l
4820.5 4819.5 4819.5 1.0 I 0-5
4827.1 4825.5 4825.5. 1.0 I 0-5
4833.3 B 12
-4861.4 -------------- ------:--------- ---------------- -------------- B 1 - ...... —
4876.9 4875.6 4875.6 0.9 I 0-5
4895.2 . 4893.5 4893.5 1.0 I , 0-5
4944.8 4943.5 4943.5 1.0 I 0-5
4956.9 4955.5 4955.5 1.0 I 0-5
5024.5 5023.5 5024.5 1.0 I 0-5
5031.2 •5027.5 5029.5 0.9 I 0-5
5080.9 5079.5' 5080.6 1.0 I 0-5
5092.5 5091.5 5093.5 1.0 I 0-5
5099.2 5097.5 5097.5 , l.Q l i l l i l l S l l i l i i l l l
5133.6 B9-B10
5148.9 5147.5 5147.5 1.0 I 0-5
5167.3 5165.5 5165.5 1.0 I 0-5
• 5228.4 5227.5 5228.4 1.0 I 0-5
5235.2 52315 5233.5 0.9 I 0-5
5285.1 5283.5 5283.5 1.0 I 0-5
;5303.2 5301.5 5301.5 1.0 I 0-5
5352.8 5351.5 5351.5 1.0 I 0-5
5364.9 5363.4 5365.5 1.0 I 0-5
5371.2 5367.4 5369.5 0.9 I 0-5
5439.1 5435.4 5437.4 0.9 I 0-5
5488.4 5487.4 5488.5 1.0 I 0-5
5507.6 ,5505.5 5505.5 1.0 I 0-5
5557.2 5555.4 5555.4 1.0 I 0-5
5568.9 5567.4 5567.4 1.0 I 0-5
5575.4 5573.4 5573.4 1.0 I 0-5
5625.8 5623.5 5624.4 ■ 0.6 - ....... -I. 0-5-.
5636.4 5635.4 5636.4 1.0 I 0-5.
5643.4 5639.4 5641.4 0.9 I 0-5
5693.2 5691.5 5691.5 0.9 I 0-5
5711.6 5709.4 5709.4 1.0 I 0-5
5760.8 5759.4 5760.4 1.0 I 0-5
5779.5 5776.4 5777.4 1.0 I 0-5
5830.1 5828.4 5829.2 0.9
5847.5 5845.4 5845.4 1.0 I 0-5
1 i
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
5915.6 5913.4 5913.4 1.0 I 0-5
- - -5964r3- - -5963.-4- - -5963.4 - - 1.0 - I - 0-5 - ------ --  . . . .
6005.0 6003.4 6003.4 0.9 I 0-5
6051.2 6049.3 6050.4 1.0 I 0-5
6119.3 6117.3 6117.3 1.0 I 0-5
6136.1 6134.3 6135.2 0.9 I 0-5
6180.9 6180.4 6181.4 1.0 I 0-5
6186.3 6183.3 6186.5 0.2 I 0-5
6278.0 6275.4 6276.5 1.0 I 0-5
6289.4 6288.0 6289.0 1.0 I 0-5
6323.8 6321.3 6323.4 1.0 I 0-5
6392.0 6389.3 6391.2 1.0 I 0-5
6413.5 6411.3 6411.3 L0 I 0-5
6481.9 6479.4 6479.4 1.0 I 0-5
6492.7 6491.3 6493.1 1.0 I 0-5
6527.1 6525.3 6527.5 0.9 I 0-5
6549.5 6547.3 6547.3 1.0 I 0-5
6597.9 6597.3 6597.3 1.0 I 0-5
6698.1 6696.8 6696.8 1.0 I 0-5
6748.5 6747.0 6747.8 1.0 I 0-5
6758.7
6784.0. C7
6801.6 C7-C8
6821.5 6819.3 6820.3 1.0 I 0-5
6845.4 C2-C4
6848.4 C12
6850.4 6848.2 6849.2 0.9 I 0-5
6859.2 Cl
6896.9 C5
6957.8 6955.3 6955.3. 1.0 I 0-5
6998.6 B8-B9
7022.3 . Cl
7025.8 7023.3 7023.3 1.0 I 0-5
7049.7 C5
7093.9 7091.2 7091.2 1.0 I 0-5
7128.0 B ll
7166.3 Cl
. -7199.7. C4-C5--------
7365.4 7363.4 7363.4 0.9 I 0-5
7392.8 313-C1
7426.0 310
7520.9. 38-B9
7569.4 7567.2 7567.2 1.0 I 0-5
7637.9 7635.2 7636.3 0.9 I 0-5
7642.8 7642.3 7643.3 1.0 I 0-5
7743.7 39
lii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
7809.4 m m S m i
7826.5- — j------------- t i i l l l S
7909.6 7907.4 7908.2 1.0 I 0-5
8014.1 B9-B10
8030.6 B5
8045.0 8043.2 8044.3 1.0 I 0-5
8045.6 8043.0 8046.9 1.0 I 15-25
8113.0 8111.1 8113.1 1.0 I 0-5
8317.2 C8
8317.9 8315.1 8316.2 1.0 I 0-5
Group 3 from ion exchange column
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2105.0 B l l
2332.3 Cl
2442.3 B15
2554.1 A10-A11
2647.6 C3
2700:6 C3
2701.4 2700.5 2700.5 0.88 I 25-30
2710.3 C6
2716.1 2715.5 2716.5 1.00 IC 25-30
.2717.5 C3-C4
2717.8, 2716.5 2717.5 1.00 IC 25-30 .
2737.9 C3
2783.7 2782.6 2784.6 0.99 I 20-25
2794.8 2793.5 2793.5 1.00 IC 20-25
2795.1 2793.5 2794.4 0.92 I 20-25
2811.5 2809.5 2810.4 1.00 IC 20-25
2812.5 2811.5 2812.5 1.00 IC 20-25
2813.0 . 2812.5 2813.5 1.00 I 20-25
2909.5 2907.5 2909.5 1.00 IC 20-25
2910.7 2908.5 2910.5 1.00 IC 20-25
2922.8 2921.5 2921.5 1.00 I 20-25
2927.0 2926.5 2926.5 1.00 I 20-25
2927.0 2925.6 2926.5 1.00 I 20-25
3018.3 A13-A15
3021.1 3021.7 3019.6 1.00 IC 20-25
3021.6 3019.6 3021.6 1.00 IC 20-25
3021.9 3019.7 3021.6 1.00 IC 20-25
3038.9 3037.7 3039.7 1.00 IC 20-25
3078.8 3078.6 3078.6 1.00 IC 20-25
3079.7 3077.6 3078.6 1.00 IC 20-25
liii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3079.9 3077.6 3079.6 1.00 IC 20-25
- 3081.6 - —3080:6- - 3080.6 - -1.0 0 - - - I - - 20-25 - —  - - - •
3092.9 3090.9 3092.9 1.00 I 20-25
3094.3 3093.6 3094.6 1.00 IC 20-25
3096.6 3095.6 3096.6 1.00 IC 20-25
3097.2 3095.7 3096.6 1.00 IC 20-25
3102.0 3101.6 3101.6 1.00 I 20-25
3112.2 3111.7 3112.6 0.99 i i i i l i l S l 20-25
3114.3 3112.7 3113.7 1.00 l l l l p l l i 20-25
3114.7 3113.7 3114.7 0.89 i 20-25
3119.9 B13
3138.3 3136.6 3137.7 0:93 i 20-25
3150.0 3149.0 3150.0 1.00 i 20-25
3205.5 3204.8 3205.8 1.00 i 20-25
3207.9 3205.8 3207.8 1.00 IC 20-25
3208.2 3205.8 3208.8 1.00 IC 20-25
3209.7 3208.8 3208.8 0.29 I 20-25.
3216.3 3215.7 3216.7 1.00 I 20-25
3218,7 3216.7 3217.7 1.00 I l l i l l l lS l l l i 20-25
3219.3 3217.7 3217.7 0.73 :w m m m 20-25
3222.6 BIO
3225.2 3223.8 3224.8 1.00 IC 20-25
3226.1 3224.8 3224.8 1.00 IC 20-25
3226.2 3225.8 3225.8 1.00 I 20-25
3228.3 3226.7 3228.8 1.00 IC 20-25
3229.6 3228.7 3228.7 1.00 I 20-25
3237.0 3234.7 3236.7 1.00 I 20-25
3256.3 B14-B15
3260.2 3258.8 3,259.8 1.00 I 25-30
3266.9 3264.7 3266.6 1.00 IC 25-30
3288.5 3287.7 3287.7 . 1.00 I 25-30
. 3289.1 3288.6 3288.6 1.00 I 25-30
3293.8 3292.8 3293:8 1.00 I 15-20
3293.9 , 329-1.8 3293.8 1.00 IC 15-20
3295.5 3293.8 . 3295.8 1.00 I 20-25
3295.6 3293.8 3294.8 1.00 IC 20-25
3310.7 3309.9 3310.9 1.00 I 20-25
3312.9- 3310.8 3312.8- - 1,00........ ■IC. 20-25.... - . _  ................
3313.5 3310.8 3312.8 1.00 IC 20-25
-3317.6 3315.8 3315.8 1.00 I 20-25
3331.4 3330.8 3331.8 1.00 I 20-25
.3334.3 315
3334.4 3333.9. 3333.9 1.00 I 15-25
3334.5 .3332.9 3334.9 1.00 I . 15-25
3336.4 3334.9 3335.9 1.00 IC 20-25
3349.2 3346.8 3348.8 1.00 I 20-25
liv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3350.2 3349.8 - 3349.8 1.00 20-25
- -3351,5 3350.9 3350-.9- -------1.00 -------i 10-20 - -  -  - -  -------
3352.0 3349.8 3351.8 1.00 ' IC 20-25
3352.8 . 3350.7 - 3352.8 - 1.00 20-25
3354.1 3350.9 3355.8 1.00 IC 20-25
3355.1 . 3353:8 3353.8 1.00 ■111! B i l l 20-25
3363.3. B13-B14
3365.0 3362.9 3363.9 1.00 w m M m m 20-25
3365.3 3362.9 3364.9 1.00 IC 20-25
3365.3 3363.9 3364.8 1.00 i 20-25
3365.3 3363.8 3364.8 1.00 i 20-25
3367.3 3364.8 3366.8 1.00 IC 20-25
3367.5 3366.8 3368.9 1.00 I I I  I f f l l l l 20-25
3369.9 3367.9 3368.9 1.00 w im m im B 20-25
3372.0 B1
3375.4 C8
3375.5 3374.7 3374.7 1.00 i 20-25
3383.5 . 3382.9 3383.9 1.00 n m m g S m 20-25.
3386.4 3384.9- 3386.8 1.00 . 20-25
3391.9 3390.7 3391.8 1.00 111 l l i l l l l r 20-25
3402.1 3399.9 3400.9 1.00 IC 20-25
. 3402.6 3400.9 ■ 3401.8 1.00 i l S i i l i l . 20-25
.3403.1 3401.8 3401.8 1.00 IC 20-25
3404.2 3403.8 3403.8 1.00 i 20-25
3404.8 C l
3407.3 ■ B9
3417.9 3416.9 3418.9 1.00 i 15-25
3420.4 3417.9 3418.9 1.00 IC 20-25
3420.5 3417.9 3419.8 1.00 IC 20-25
3421.4 3418.9 3419.8 1.00 IC 20-25
3429.7 B7-B9
3430.6 3428.8 3431,8 0.88 I 20-25
3431.8 3429.8 3431.8 1.00 IC 20-25
3432.2 3430.8 3432.8 1.00 IC 20-25
3432.3 3431.8 3432.8 1.00 I 20-25
3434.0 3432.9 3434.9 1.00 I 20-25 .
3434.0 23-C5 .
3440.3- 3439.8- - 3439.8- 1.0 0 - I 20-25- - .  - - .......- - ................. - -
3440.5 3438.8 3440.8 1.00 IC 20-25
3447.9. 33-B6
3448.5 3448.0 344go 1.00 TJL 20-25
3449,9 3447.9 3449.9 to o IC 20-25
3450.6 i\13-A14
3451.4 3448.9 3449.9 1.00 IC 20-25
3451.8 (36-C13
. 3452.1 3449.9 3450.9 1.00 I 20-25
lv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3452.4 3450.9 3451.8 1.00 IC 20-25
___ 3459.9.. 3459.0 3 4 5 9 .9 - ____ 1,0 0 - - ____I - ... - - -20-30 - ----------- —
3460.7 B1
3465.1 A12
3465.9 3463.9 3465.9 1.00 IC 15-20
3466.0 Cl 4
3466.4 3463.9 3465.9 1.00 10-15 -
3466.5 3463.9 3465.9 1.00 ^ l l i i i l l l 10-15
3466.8 3464.9 3466.9 1.00 IC 15-20
3467.1 .3465.9 3465.9 0.00 i 10-15
3467.2 3464.9 3466.9' 1.00 IC 15-20
3467.4 3464.9 3466.9 1.00 IC 15-20
3468.2 3466.9 -3467.9 1.00 IC 20-25
3468.7 3467.9 3468.9 0.60 I 15-20
3468:8 3466.9 3467.9 1.00 IC . 20-25
.3469.1 3466.9 3468.9 - - 1.00 IC 20-25
3469.3 3469:9 3469.9 1.00 IC 20-25 '
. 3473.1 3470.8 3471.8-. - 1.00 IC 20-25
3475.8. A15
3476.3 B 10-B 12
3477.5 3476.8, 3477.8 i s i s i p i
3479.8 :i i l 7 i i i 113179:8:'::;:: 1.00 W iggm sm 25-30
3480.0 3477.8 3478.8 , 1.0 0 . IC 25-30
3480.8 A ll
3481.4 B9
3481.5 C15
3482.6 3481.8 3481.8 0.75 I 25-30
3482.8 3481.9 •3482.9 1.00 IC 20-25
3484.6 3482.9 3484.9 1.00 IC 20-25
3485.3 3483.9 3485.9 1.00 IC 20-25
3488.2 3486.8 3487.8 1.00 I 10-15
3488.2 3486.8 3487.8 1.00 IC 20-25
3488.7 3487.9 3487.9 1.00 I 20-25
3488.9 3487.7 3488.8 1.00 I 20-25
3489.1 3486.8 3488.8 1.00 IC 15-20
3493.4
20-25
B15-C3
3495.0 3492.8 3493.8 1.00 I
3497.0 _3495.9 3497.9 1.00 I ._ 20-30. .
3498.3 3497.9 3497.9 - 1.00 I 20-25
3502.3 3502.8 3505.8 1.00 IC 20-25
3502.5 3501.9 3502.9 1.00 rc 20-25
3504.1 3501.9 3503.8 1.00 IC 15-20
3504.4 3501.9 3503.8 1.00 IC 15-20
3506.0 3503.9 3507.8 1.00 IC 20-25
3506,5 3503.8 3505.8 1.00 IC 20-25
3507.6 3506.8 , 3506.8 0.89 , i 15-20
lvi
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3510.2. 3508.8 3508.8 1.00 i l l  w m m :M 20-25
- 3510.3 -3507r9 - -3 5 0 9 .8 - ------1.00 ------- 1 -  - - --1-5-20- - .........  -  -
3510.6 3508.9 3509.8 ' 1.00 i 15-20
3511.1 3508.8 3509.8 1.00 IC 20-25
3515.6 3513.8 3514.8 1.00 i 20-25
3517.3 3516.7 3517.8 1.00 IC 25-30
3517.7 3515.8 3516.7 1.00 IC 25-30
3522.4 3521.9 3521.9 1.00 I 20-25
3522.4 3521.8 3522.9 1.00 IC 20-25
3525.6 3523.9 3525.8 1.00 IC 20-25
3528.2 3525.8 3528.8 1.00 IC 20-25
-3532.2 3530.8 3530.8 1.00 -------------------- 1 ------ —■2 0-25
3538.7 3536.8 3537.8 1.00 I 20-25
3542.7 3540.8 3543.8 1.00 W m m m Si 20-25
3544,9 3543.7 3545,8 1.00 i 20-25
3546.2 3544.9 3544.9 1.00 i 20-25
3548.8 3546.S 3547.8 1.00 1 20-25
3553.0 3552.0 3552.9 1.00 I 20-25
3553.1 3551.8 3551.8 1.00 I 20-25
3557.0 B 10-B11
3562.9 3562.1 3562.1 0.99 I 20-25
3563.3 BI-B3
3564.2 C14-C15
3564.6 3562.0 3563.9 1.00 m m m m 20-25
3564.7 3562.0 3564.0 1.00 IC 20-25
3565.5 3564.9 3564.9 1.00 IC 20-25
35673 3566.9 3566.9 1.00 T - 20-25
3567.7 B6
3578.3 3577.0 3579.0 1.00 IC 20-25
3578.8 ■ C13-C15
3579.1 3579.0 3580.0 1.00 IC 20-25
3579.3 A15
3581.2 C3-C6
3581.7 3580.0 3582.0 1.00 IC 20-25
3583.2 3581.9 3581.9 1.00 IC 20-25
3585.9 3583.9 3583.9 1.00 I 20-25
3590.9 B3-B4
359.7.6- 35-97.0 3598.0... 1.00.... I .......... -20-25.. ..................... - ............... -
3600.3 3599.0 3601.0 1.00 IC 20-25
3602.4 3599.9 3601.9 . 1.00 IC 20-25
3604.7 3602.9 3602.9 0.25 I 20-25
3618.5 3615.9 3617.9 1.00 IC 20-25
3621.8 3620.9 3620.9 1.00 I 20-25
3629.3 31-B2
3631.8 3629.8 3630.8 1.00 IC 20-25
3635.9 3634.9 3636.9 1.00 . I 20-25
lv ii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3639.5 3637.9 3640.9 1.00 I 20-25
-  3642.7 . - . . - ------------------r ------------------ . . „ - _ B5-B6 _•
3645A 3643.9 3644.9 - 1.00 20-25
3650.2 3648.8 3648.8 1.00 20-25
3650.5 . 3648.9 3651.9 1.00 I 20-25
3680.3 B l l
3685.8 3684.0 3685.1 1.00 I 20-25
3685.9 3685.0 3685.0 1.00 I 20-25
3685.9 3685.0 3685.0 1.00 I 20-25
3686.1 3684.0 3685.1 1.00 IC 20-25
3694.3 B4-B6
3695.2 3692.9 3694.9 1.00 ie 20-25
3703.0 3702.0 3703.1 1.00 i 20-25
3707.4 B6
3712.0 3710.1 3712.0 1.00 IC 20-25
3714.7 . - . C7
3740.3 B9 -
3798.5 B7-B10
3809.2 B9
3827.4 3826.9 3827.9 1.00 i 20-25
3827.8 3825.9 3827.0 1.00 i 20-25
3828.7 * ‘ - B4-B5
3829.3 3828.8 3828.8 1.00 i 20-25
3860.2 B13-B14
3912.8 3911.9 3911.9 1.00 i 20-25
3937.6 3937,1 3938.1 1.00 i 20-25 B5
3938.6 3936.2 3939.1 1.00 i 20-25
3938.9 B5
3954.2 3952.1 3954.1 0.75 i 20-25
3955.5 3953.1 3955.1 1.00 IC 20-25
3956.5 3956.1 3956.1 1.00 i 20-25
3970.0 A13-A15
3971.1 l l l l l l f l l l l
3972.9 3970.1 3972.1 1.00 IC 20-25
3973.2 3970.0 3972.1 l.'OO IC 20-25
3973.8 3971.1 3974.0 1.00 IC 20-25
3979.9 3978.3 3979.3 0.88 i 20-30
3981.6 397-9.3- 3981.3 L00- i 20-30- - -
3990.8 3988.1 3990.1 1.00 IC 20-25
3991.0 3989.2 3991.1 1.00 IC 20-25
3994.2 (—' A JL v/ X X-i -
3995.7 3993.0 3995.0 1.00 IC 20-25
3996.2 3995.1 3995.1 1.00 I 20-25
4006.8 4007.1 4008.1 1.00 IC 20-25
4007.1 4006.1 4007.2 1.00 I 20-25
4007.3 4005.2 4007.2 1.00 IC . 20-25
lviii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4008.4 B 5
------4009.6- - -4009.0 -- 4010:0- ------ LOO-- ------ -I - - - - -20-25  - —----------- -
4010.5 4008.1 4010.0 1.00 im im s im 20-25
4016.9 4016.0 4016.0 1.00 i 20-25
4017.6 B6-B10
4018.9 A7-A8
4019.4 B13
4022.5 4021.1 4021.1 1.00 IC 20-25
4022.7 4020.1 4022.1 1.00 IC 20-25
4024.3 4022.1 4022.1 0.00 i 20-25
4041.6 4039.1 4040.1 1.00 IC 20-25
; 4 0 6 0 .6 - -4 0 5 9 .1 - - 4061.0 - 1.00 i l l l i i l l 20-25 ,
4081.0 4078.3 4081.3 0.80 i 20-25
4081.3 B8
4081.7 4079.4 4081.3 1.00 IC 20-25
4083.7 4083.3 4083.3 1.00 I 20-25
4097.9 4096.3 4098.4 1.00 I 20-25
4132.6 B9-B10
4151.3 B12-B14
4153.9 4152.4 4154.4 1.00 I 20-25
4156.2 B8
4156.5 B3
4164.6 B5
4204.4 BH-B13
4206.5 4205.4 4206.4 1.00 IC 20-25
4209.5 4206.4 4209.4 1.00 IC 20-30
4210.0 4208.4 4210.4 1.00 IC 20-30
4228.8 4224.4 4226.4 1.00 IC 20-30
4232.3 4231.3 4232.4 1.00 I 20-30
4235.3 B14-B15
4236.1 4234.4 4236.4 1.00 IC 20-30
4245.4 4243.3 4246.3 0.88 I 20-30
4245.7 B13
4246.7 4244.4 4247.4 1.00 IC 20-30
4247.7 4245.3 4247.3 1.00 I 20-30
4268.1 4267.2 4267.2 1.00 I 20-25
4279.4 B12
- 4323.1- - 4321.3 ■ 4323.3 - - 1,00- - I 20-25 —— - -------------------- - -------------------
4323.2 4321.3 4324.3 0.76 I 20-25
4345.3 4344.4 4345.3 1.00 I 20-30
4396.6- 314
4463.4 4462.2 4463.3 1.00 I 20-25
4463.8 4463.4 4463.4 0.99 I 20-25
4466.1 4465.3 4465.3 1.00 I 20-25
4543.7 4541.5 4545.6 1.00 I 20-25
4544.1 4542.6 4544.6 1.00 I 20-25
lix
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4548.8 B12
- 4637.6- ---------------- --------------- —  --------- ...--------------- B12-B13
4808.8 4807.7 4808.7 1.00 I 25-30
4809.2 4808.7 4809.6 1.00 I 25-30
4880.4 4878.7 4879.7 1.00 IC 25-30
4880.4 4877.8 4879.7 1.00 IC 25-30
4881.1 4879.7 4879.7 1.00 , I 25-30
4882.2 4881.8 4881.8 1.00 IC 25-30
4884.0 B15
4898.3 B14
4951.1 4949.6 4950.7 1.00 I 20-25
5522.2 5521.3 5522.2 0.99 I 20-25
6658.4 B13-B14
6680!8 B14-B15
6777.0 C8
6803.1 C7-C8
6865.5 C3-C5
- 6885.3 B13
6909.1 ■. B l l
6910.0 C6
6910.0 C6
6919.6 6918.1 6919.2 1.00 i 20-30
. 6925.2 B10 ,
6988.1 6987.2 6988.2 1.00 IC 25-30
6988.4 6986.3 * 6986.3 1.00 IC 25-30
6988.4 6984.2 6988.3 1.00 IC 25-30
6988.8 C1-C3
6992.4 B15
7006.0 7004.3 7006.2 1.00 IC 20-30
7006.6 7004.3 7006.2 1.00 IC 20-30
7007.8 7007.3 7007.3 1.00 I 20-30
7026.8 7024.1 7026.2 1.00 I 20-30
7116.7 B ll
7125.4 7123.2 7124.2 1.00 I 20-25
7125.5 7123.2 7125.2 . 1.00 IC . 20-25 ■
7129.8 BIO .
7142.6 7141.2 7141.2 1.00 IC 20-30
7.143.3 7140.3. 7142.4- . 1.00 IC 20-30
7143.9 32
7163.8 31-C4
7179:0 36
7227.0 ' 32
7393.2 313
7393.2 313
7429.3 314
. 7447.1 - 315
Ix
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
7449.8 7448.1 7449.2 1.00 I 20-25
-7449.9- -  7448.-3 - - 7450.3 - - i . o o - - IC -20-25-
7467.9 7466.2 7467.3 1.00 I 20-25
.7490.6 B9-B10
7561.0 A15
8327.1 C2
Group 4 from ion exchange column
Mass
(average)
__ivxSsS
(mono.)
A riAY IViass- ~i—— -— Score Evidence Time Hff i T TVTiVJLAJLJL/JL
fraction
2051.6 2051.1 2051.1 1.00 I 25-35
2753.9 B14
2773.4 2772.4 2772.4 1.00 I 40-50
2889.5 2888.4 2889.4 1.00 I 5-10
2890.3 2888.5 2889.4 1.00 I 10-15
2890.9 2889.4 2890.4 1.00 I 5-10
2940.4 C14-C15
2940.9 B2-B3
2941.1 2939.5 2940.5 1.00 IC 20-25
2987.0 C8-C13
2988.5 .2986.5 2988.5 1.00 IC 5-15
2988.6 2986.5 2987.5 1.00 IC 5-15
2988.6 C4-C5
2989.5 2987.5 2989.5 1.00 S I  S l l l l 1111118111
2990.6 2988.5 2990.5 1.00 IC 10-15
2991.9 A11-A15
3000.8 C9-C10
3006.5 3005.6 3006.6 1.00 I 10-20
3010.5 3008.5 3009.5 1.00 IC 5-15
3012.2 3010.4 3011.4 1.00 IC 5-15
3012.7 3011.5 3011.5 1.00 I 10-15
3017.4 A12
3017.6 C9
3026.3 3024.4 3026.4 1.00 IC S i i i S i ---------- --------
3027.5 3025.4 3026.4 - 1.00 IC 5-15
3028.2 3026.4 3028.4 l'oo I 10-15
3033.4 3031.4 3032.4 1.00 I 10-15
3043.9 3042.7 3043.7 1.00 I 35-40
3044.2 3043.7 3043.7 1.00 I 35-40
3045.7 3043.7 3045.7 1.00 IC 35-40
3045:9 (21
lx i
Mass
(average)
Mass
(mono.)
Apex Massj Score Evidence Time MALDI
fraction
3049.3 3047.4 3049.4 1.00 I 10-15
- 3060.6 .......... -- ---- . ------------ C3~-
3105.8 3104.8 3104.8 1.00 I 25-35
3112.5 3111.6 3112.6 1.00 I 20-25
3141.6 3140.6 3141.6 1.00 I 25-30
3150.5 3148.8 3149.8 1.00 IC 25-30
3152.3 B8-B11
3155.1 3154.6 3154.6 1.00 I 25-30
3155.1 3154.7 3154.7 1.00 I 25-30
‘ 3177.4 B 8
3297.9 C12
3297.9 C12
3298.0 A15
3298.0 A15
3306.3 3304.7 3306.7 1.00 I 25-30 B11-B13
3309.4 B11-B13
3339.4 3337.6 3339.6 1.00 IC 30-35
3347:0 B14
3374.0 A15
3404.4 3402.7 3404.7 1.00 IC 20-25
■2/tn<r a B1-B2 .
3406.0 3404.6 3405.6 1.00 I 25-30
3450.2 3447.8 3449.8 1.00 IC 20-25
3450.9 C14
3456.5 A14-B5
3458.3 3455.9 3457.9 1.00 IC 20-25
3464.0 B ll
3464.2 3461.8 3463.8 1.00 IC 10-15
3465.8 ' O il
3467.3 A13-A15
3469.0 , C13-C14
3478.7 B9-B10
3480.0 24 .
3480.3 - : .... - ----------------- -  (3 10^ 12“
3501.9 3500.8 3501.8 1.00 IC 25-30
3501.9 35-B6
3502.6 3500.8 3501.8 1.00 I 20-30
3503.2 3502.8 3502.8 1.00 IC 25-30
3508:0 314
.3516.1 33
3521.3 3519.7 3521.7 1.00 I 5-10
Ixii
Mass
(average)
Mass
(monoO
Apex Mass Score Evidence Time MALDI
fraction
3521.3 3520.8 3521.7 1.00 I 5-10
- -3542.8 ■ - - -  ------------- " i l l i l s i r —  -  — C l5
3552.9 3550.8 3552.8 1.00 IC 25-30
3553.4 1 B9-B10
3554.3 r i i i w i ! 3553.8 1.00 25-35
3556.4 3555.8 3555.8 1.00 IC 30-35
3560.8 3558.8 3560.8 1.00 I c 20-25
3578.5 A15-C1
3581 7 B15
3583.0 C5
3587.1 C2-C4
3590:1 B1-B2 '
3592.2 3590.8 3591.8 1.00 IC 25-35
3596.8 - C3
3638.2 3636.8 3637.8 1.00 I 20-25
3684.4 3682.9 3685.8 1.00 I 25-30
3685.5 B6-B8
3688.2 3686.7 3687.7 0.94 I 25-30
3708.3 Cl 5
3708.6 B3-B5
3708.9 3708.0 3708.0 1.00 I 25-30
3710.3 3708.0 3710.0 1.00 IC 25-30
3711.0 3708.9 3711.0 1.00 IC 25-30
3711.4 3709.0 3711.0 1.00 IC 25-30
3712.4 3710.9 3711.9 1.00 I 25-30
3715J - C5 :
3750.4 B14
3910.8 A14
3911.0 B14
3913.3 ; . C ll
3913.7 3911.0 3913.0 1.00 IC 10-15
3914.7 3913.0 3915.0 1.00 IC 15-20
3928.3 37 .
3940.7 V14-AT5”
.. 3941.9 211-C12
3986.7. 35-B6
3988.1 3987.0 3989.0 1.00 I 25-30
4003.2 LU 3
4018.0 311
4022.9 35
4082.0 38-B9
lx iii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4103.2 4102.2 4104.2 1.00 I 25-35
- — 4104:7-“ .................. ... B8
4112.3 B7-B8
4156.9 B3
4224.1 BIO
' 4245.9 B9
4283.2 B l l
4303.3 B10
4307.3 B7
4390;0 B3
4464.4 4462.1 4464.1 1.00 IC 20-25
4466.9 B 1-B2
4481:3 ■ A15
4493.7 4492.2 4494.2 1.00 I 20-25
. 4501.2 B l l
4565.3 4564.3 4565.4 1.00 I 20-30
4637.5 B7-B8
4658.0 ■ A15-B1
4666.5 C13
‘4671.9 B3
4675.9 - B l l
4679.7 C l5
4863.7 B13
.4881.6 B11-B12
6304.5 B ll
6614.6 B12-B13
. 6659.1 B ll
6677.2 B14
6867.4 C2-C5
. 6931.4 B8-B9
7017.9 B14
7160.8 B15-C1
7176.3 \ t 8 Illfl(E<22 ‘ .
7191.1 . -  - - ------ — 21 -.... .....
. 7208.6 ‘ . (23-C5
7331.0 (22
7428.6 312
7497.0 314-B15
7822.6 I314
8290.3 314
lxiv
Group 5 from ion exchange column
Mass
(average)
Mass 
- (mono.)
Apex Mass Score Evidence Time MALDI 
— fraction—
2020.3 2018.9 2019.9 1.00 ' IC 0-5
2022.3 2021.4 2021.4 1.00 I 0-5
2031.2 2030.6 2031.6 1.00 I 0-5
2034.4 2033.9 2034.8 0.99 I 0-5
2041.1 2040.3 2041.2 1.00 0-5
2043.3 B5
2043.5 2042.9 2043.8 1.00 I 0-5
2049.7 2048.4 2049.4 1.00 I 0-5
2052.8 2052.3 2052.3 1.00 I 0-5
2059.3 2058:9 2058.9 1;00 . 0-5
2073.8 2073.1 2074.2 0.99 I 0-5
2079.5 2078.9 2079.9 1.00 0-5
2088.4 2087.9 2088.9 1.00 I 0-5
2100.6 2099.9 2099.9 1.00 IC 0-5
2102.8 2101.5 2102.6 0.88 I 0-5
2109.5 2109.1 .2109.1 . 1.00 0-5
2111.8/ . 2111.3 2112.2 0.99 ' 0-5
2117.3 2116.4 2117.3 1.00 . . 0-5
2128.5 2127.9 2128.8 1.00 I 0-5
2134.4 2133.0 2134.1 1.00 I 0-5
2138.6 B6-B7
2142.4 2141.7 2142.8 1.00 I 0-5
2144.2 2143.2 2144.2 1.00 I 0-5
2145.3 A15-B1
2147.9 2146.4 2147.3 1.00 I 0-5
2150.9 2149.8 2150.9 1.00 , I 0-5
2155.9 2154.9 2155.9 1.00 IC 0-5
2160.3 2159.8 2159.8 1.00 0-5
2171.1 2170.0 2171.0 0.87 I 0-5
2180.2 B7
2180.5 2179.9 2180.9 LOO . 0-5
2185:7 2184.9 2184.9 1,00 0-5- _ -----
2188.3 2187.8 2187.8 1.00 i 0-5
2200.3 2199.5 2199.5 1.00 i 0-5
2210.7 ,2209.6 ■ 2210.6 1.00 0-5
2215.5 2214:8 2215.9 1.00 0-5
2224.2 2222.9 2223.9 1.00 i 0-5
2229.3 2228.9 2228.9 1.00 i 0-5
2232.9 2232.1 2232.1 1.00 i 0-5
lxv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2236.5 2235.9 2235.9 1.00 I 0-5
-------2250:6- — 2249:8- 2249:8 '"-- 1.00 -------- -j------- ------ Q_;5 ------------------
2292.5 2290.9 2291.9 1.00 I 0-5
2335.4 2334.4 2334.4 1.00 I 0-5
2336.6 B5-B6
2336.7 D1-D2
2360.2 2358.9 2359.9 1.00 I 0-5
2372.5 2371.9 2371.9 1.00 I 0-5
. 2395.6 C5
2402.7 2402.3 2402.3 1.00 I 0-5
2428.4 2426.9 2427.9 0.97 0-5
2432.5 A10-AI1
2438.2 C8
2464.9 2463.7 2464.7, 1.00 35-45
2488.1 2486.8 2487.9 0.88 0-5
2496.2 2494.9 2495.9 1.00 I 0-5
2508.6 2507.8 2507.8 1.00 I 0-5
2564.3 2562.9 2563.8 1.00 I 0-5
2576.5 2575.8 2575.8 1.00 I 0-5
2623.9 2622.8 2623.8 0.90 I 0-5
2644.6 2643.8 2643.8 1.00 0-5
2693.5 2692.8 2693.9 1.00 I 0-5
2696.9 2694.8 2695.8 1.00 I 0-5
2704.1 2702.7 2703.8 0.87 I 0-5
2710.5 B15-C3
2710.6 C7-C9
2710.9 A10
2711.9 2710.8 2711.8 1.00 I 0-5
2715.1 2713.6 2714.6 1.00 IC 40-45
2716.3 2714.6 2715.6 1.00 IC 45-5-
2716.7 2714.6 2715.6 1.00 IC 40-45
2717.5 2715.6 2716.6 1.00 IC 45-50
2734.2 , 2732.6 2734.6 1.00 , I 35-45
2762:1 -2761:8— 2761:8 1:00-------------- r ------- ' 0-5 — ----------------- -
2769.0 2767.8 2767.8 1.00 i 0-5
2780.6 2779.8 2779.8 1.00 i 0-5
2790.3 2788.9 2789.9 1.00 i 0-5
2799.0 2797.8 2797.8 1.00 i 0-5
2825.4 u o
2829.5 2828.8 2829.8 1.00 i 0-5
2833.0 2830.8 2831.8 1.00 i 0-5
lxvi
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2839.8 2838.8 2839.8 1.00 I 0-5
-----2847.9' - '2846:9' -2847.8- ------ ItOO-- --------- 1--- -------0-5 -------------------
2858.3 2856.8 2857.8 1.00 I 0-5
2863.4 2862.8 2863.8 1.00 I 0-5
2867.1 2865.8 2865.8 0.94 I 0-5
2874.8 2873.8 2873.8 1.00 I 0-5
2895.2 B15-C1 -
2896.2 2894.8 2895.8 0.89 I 0-5
2901.5 2900.$ 2900.8 . 1.00 IC 40-45
2904.3 2902.8 2903.8 1.00 I 0-5
2916.9 2915.8 2915.8 1.00 I 0-5
2923.7 B5-B6
2923.9 D1-D3
2925.2 2923.7 2924.7 1.00 IC 20-25
2925.9 A10
2938.6 C8-D1
2939.6 B2-B3
2940.0 B10 -
2941.8 2939.6 2941.7 1.00 IC 15-20
2962.9 2961.8 2961.8 1.00 m m § m m lliilll
2963.6 2962.6 2963.6 1.00 i 15-20
2969.2 2966.9 2967.8 1.00 i 0-5
2969.6 C14
2969.8 B2
2983.5 2982.9 2983.8 1.00 i 0-5
2986.3 C8-C13
2986.4 A12-B1 .
2995.1 2992.9 2993.8 1.00 IC 0-5
3003.3 3001.8 3001.8 1.00 i 0-5
3012.2 3010.8 3011.8 0.89 i 0-5
.3029:2 A10
3043.5 3042.9 3043.8 0.99 i 0-5
3052.7 3051.8 3051.8 1.00 i 0-5
3062.2 3060:8- 306 1t8 - 1.00— i 0-5 ----------- :--------
3088.5 D1-D4
3090.9 ]39-B10
3092.9 3092.0 3093.0 1.00 i 25-35
3094.5 3093:0 3094.0 1.00 IC 25-30
3105.2 3103.3 3104.3 0.79 I 0-5
3105.3 3102.8 3103.8 1.00 I 0-5
3111.4 3110.7 3111.8 1.00 • I 0-5
lxvii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3120.1 3119.8 3119.8 1.00 I 0-5
-  3129.8 - “ 3127.-9- • -3128:9-'----- -1:00- - ------- _j.__.-_. ----- 0 _ 5 - - --------
3163.4 3162.8 3163.8 1.00 I 0-5
3165.9 3164.7 3165.8 1.00 I 0-5
3179.2 3177.8 3179.8 1.00 I 0-5
3198.2. 3196.8. 3197.8 . . 1.00 IC 0-5
3202.9 3201.8 3203.8 1.00 I 0-5
3212.0 3210.8 3212.8 1.00 I 0-5
3232.1 3231.8 3231.8 1.00 I 0-5
3234.2 dZjd. a j I dd.o 0.98 I .0-5
3237.4 3235.8 3237.8 1.00 I 0-5
3263.1 3261.8 3261.8 1.00 - I 0-5 .
3267.9 3266.8 3266.8 1.00 IC 0-5
3280.8 3279.8 3281.8 1.00 I 0-5
3301.3 . 3299.8 3301.7 0.77 I . 0-5 -
3306.0 3304.9 3306.9 - 1.00 IC . 25-30
3313.8 3312.8 3313.8 1.00 I 0-5
3316.5 B10-B12
3328.8 C7-C9
3332.4 ; 3330.8 3332.8 1.00 W im m s l i l i l l
3336.3 B13-B15
3372.9 3371.8 3373.8 1.00 i 0-5
3376.8 3374.3 3376.3 0.81 i 0-5
3383.3 3381.8 3383.8 1.00 i 0-5
3394.0 3391.9 3393.9 1.00 i 25-30
3394.4 3392.9 3394.*) 1.00 i 25-35
3402.5 3400.8 3401.8 1.00 i 0-5
3407.0 3405.8 3407.8 1.00 i 0-5
3417.3 B8
.3419.1 3417.8 3418:9- 1.00 IC 25-30
3430.5 B3-B5
343 L7 D1-D2 ,
. 3432.0 3430.1 3431.2 1.00 IC 20-25
3436.2 ;  3434.7 3435.8 : 0.88 * I . 0-5 - -
34 '55.5 35
3461.4 3459.8 3459.8 1.00 IC 0-5
3467.4 3464.8 3465.8 1.00 IC 0-5
3471.0 3470.8 3470.8 1.00 IC 0-5
3473.3 3472.7 3473.7 1.00 I 0-5
3478.7 3476.4 3478.4 0.83 I 0-5
3481.9 3481.8 3480.8 1.00 IC 0-5
Ixviii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3496.0 B 6
—“ 350S.9-- 3507:8" -  -3509:7“ -  -  l.-OO" “---------r — - 0-5 - - --------------------
3513.1 3510.8 3511.8 1.00 i 0-5
3519.0 . 3518.0 3518.0 1.00 i 5-10
3520.1 3519.0 3520.0 1.00 IC 5-15
3522.1 3520.0 3521.0 1.00 IC 5-10
3530.3 3528.8 3530.8 1.00 i 0-5
3536A 3534.8 . 3536.8 1.00 i . 0-5
3551.9 3547.8 3553.7 1.00 IC 0-5
3572.0 A15-B3
3573.0 C8-C13
3586.9 3585.0 . 3587.0 1.00 IC 20-25
3588.5 C2-C4
3603.6 3600.9 3601.8 1.00 IC 0-5
3607.3 3605.0 3607.0 1.00 IC 25-30
3609.1 3608.0 3608.0 1.00 i 25-30
3611.6 B7-B8
3615.3 3613.2 3614.4 1.00 i 0-5
.3636.3 D1-D2
3637.4 B5-B7
3637.5 ' 3635.0 3637.0 1.00 IC 30-35
3638.4 3636.0 3638.0 1.00 IC 20-25
3641.0 BIO
3649.6 3646.8 3647.8 1.00 IC 0-5
3665.0 3662.8 3663.8 1.00 i 0-5 ■
3671.1 3668.8 3669.8 1.00 r 0-5 \ r\ ~ ~
3675.6 3674.8 3674.8 0.88 i 0-5
3675.8 A10-A12
3676.1 C7-C8
3677.8 3677.1 3678.1 1.00 i 5-10
3680.3 3678.0 3679.0 1.00 IC 5-10
3686.7 3685.7 3685.7 1.00 i 0-5
3693.8 l^ illlilSlll ]B6
3696:8- 3695:8 - 3697r7—- - -1:00- ------- r  — - -0 -5 - ” --------------------
 ^ 3702.1 D1-D3
3705.7 33-B7
3707.0 3705.8 3707.7 0.99 i 0-5
3710.2 3709.8 3709.8 1.00 i 0-5
3731.1 3729.7 3730.6 1.00 i 0-5
3740.2 I35
3740.6 3738.8 3740.8 0.80 i 0-5
lxix
. Mass 
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3744.3 D2
“ 3746.7 3745.8 3746.7 1.00-v !I11B1I 0-5 V -
3/JD.D 3751.8 3753.8 - 1.00 0-5
3759.6 3757.0 3759.0 1.00 IC 25-30
3774.4 3773.1 3775.1 1.00 i 20-25
3777.1 3775.7 3775.7 1.00 i 0-5
3778.0 B8-B9
3793.3 3792.8 3793.8 1.00 i 0-5
3801.0 3800.0 3800.0 1.00 IC 10-15
3801.8 D1-D2
3802.9 3802.0 3803.0 1.00 IC 20-25
3807.5 3804.7 3805.8 1.00 I 0-5
3821.3 A12
3823.6 3819.8 3821.8 LOO IC 0-5
3826.4 3825.2 3826.3 0.87 I 0-5
3843.7 3841.8 3842.9 0.60 I 0-5
3851.0 B5
3856.8 3855.8 3857.8 1.00 I 0-5
. 3857.6 D1-D4
3858.6 B6-B8
3868.9 3867.7 3867.7 1.00 I 0-5
3874.7 3871.7 3873.8 1.00 IC 0-5
3879.0 3877.7 3877.7 1.00 I - 0-5
3891.4 3889.7 3889.7 1.00 IC 0-5
3908.0 B5-B6
3908.3 C13
3909.2 A12-A15
. 3909.2 B15
3909.6 D1-D2
3911.1 . ■ C7-C11
3913.0 3911.2 3912.2 1.00 IC 5-10
3915.2 3913.2 3915.2 1.00 IC 5-10
3927.3 ]38
3945.5' “ 3942:7" 3944.8 0.88 I------- 0-5 - .....------------------------—
3951.8 3951.2 3952.3 0.99 I 0-5
3957.1 3955.6 3957.7 1.00 IC 0-5
3962.1 3959.7 3962.8 1.00 IC 0-5
3972.2 3969.5 3971.5 1.00 IC 20-25
3978.8 . 3977.6 3979.7 0.99 I 0-5
3983.8 I36
3985.6 3984.5 3986.5 1.00 I 0-5
Ixx
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3994.2 3991.8 3992.8 1.00 . IC 0-5
- - 4004:8" - 4003.7' -4003:7“ ------ 1;00- - ------ I 0-5'-- -------- -- -
4011.5 4008.7 4009.7 1.00 I 0-5
4018.5 B5-B6
4020.4 D1-D2
4022.7 4019.7 4021.7 0.81 I 0-5
4027.3 4023.8 4025.7 1.00 IC 0-5
4030.7 4029.2 4030.3 1.00 0-5
4039.4 4037.7 4037 7 0.94 i 0-5
4047.9 4045.7 4047.5 0.84 i 0-5
4050.2 4049.2 4050.3 1.00 i 0-5
4056.5 4054.8 4057.8 1.00 i 0-5
4058.9 4054.3 4059.8 1.00 IC 0-5
4072.7 -4070.8 4071.7 1.00- - llllliilll 0-5
4079.5. 4076.7 4077.7 1.00 llllillll 0-5
4087.4 B5-B6
4091.0 4090.2 4090.2 1.00 i 0-5
4096.3 4093.7 4094.7 1.00 WeKlmi: 0-5
4098.8 D1-D4
4131.7 4129.7 4131.8 1.00 i 0-5
4134!7 4133.2 4134.2 1.00 i 0-5
4149.7 4147.2 4150.2 0.81 i 0-5
4162.4 4159.8 4161.8 1.00 IC 0-5
4174.8 BIO -
4178.8 4177.4 4178.5 1.00 i 30-35
4179.8 4178.4 4179.5 1.00 i 35-40
4183.4 4181.8 4182.7 0.73 i 0-5
4189.3 4188.8 4189.8 1.00 i 0-5
4192.6 4190.7 4190.8 - 1.00 IC 0-5
4201.0 4198.8 4198.8 0.28 I 0-5
4209.1 4207.7 4207.7 1.00 IC 0-5
4215.3 4212.6 4213.7 1.00 IC 0-5
4230.8 4227.7 4229.7 1.00 I 0-5
—424076— ------ --------- r ------ 310 ■ - -
4262.7 4261.8 4263.7 1.00 IC 0-5
■ 4263.3 : 31-D4
4265.4 36-B9
4268.0 4266.6 4267.5 1.00 IC 20-30
4271.1 37
4276.6 4274.7 4275.7 1.00 I 0-5
4283.6 4280.7 4281.7 1.00 I 0-5
lxxi
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4286.0 4284.6 4285.6 1.00 IC 35-40
- --4286:6- _-----_------ ------ — . — - — - - - - - ------ _------- A15-B1
4287.4 4286.5 4286.5 1.00 I 35-40
4288.9 C8-C13
4298.6 4296.7 4297.8 0.71 0-5
4329.3 4328.7 4328.7 1.00 IC 0-5
4331,9 B6-B8
4335.4 4332.7 4334.8 1.00 IC 0-5
4339.2 4337.6 4338.6 1.00 IC 20-25
4339.3 D1-D4
4340.1 4338.6 4339.5 1.00 I 20-30
4346.7 . 4344.8 4347.7 0.90 1ISI11II1 0-5
4355.4 B7
4364.3 B3 _ - -
4366.1 4363.8 4365.7 ' 1.00 IC 0-5
4395.4 4393.8 4396.8 1,00 i 0-5
4401.5 4398.7 4400.7 1.00 i 0-5
4404.0 . D1-D2
4412.5 4409.7 4412.7 0.85 i 0-5
4419.8 4416.7 4417.7 1.00 IC 0-5
4434.0 4431.8 4433.7 1.00 IC II1I1II1I
4438.2 4436.7 4437.8 1.00 1 0-5
4449.1 4447.8 4448.7 1.00 I. 0-5
4456.0 4454,2 4455.3 0.92 1 0-5
4461.2 4460.7 4460.7 0.98 I 0-5
4464.8 4462.9 4463.7 1.00 I 0-5
4468.3 4467.6 4467.6 1.00 IC 0-5
4480.6 4478.7 4479.7 1.00 I 0-5
4487.5 4484.7 4485.7 1.00 I 0-5
4503.3 4500.7 4503.6 0.74 I 0-5
4537.4 4535.7 4535.7 1.00 I 0-5
4542.1 4540.8 4541.7 1.00 I 0-5
4549.1 4547.7 4547.7 1.00 I 0-5
“ 45521 - -4551.7 7 4551.7 — 1700----- — I — —— 0-5-----
4557.7 4556.5 4557.4 0.99 I 0-5
4560.7 4559.0 4561.1 0.93 I 0-5
4570.4 4567.8 4569.7 1.00 I 0-5
4597.8 4596.6 4597.7 0.99 I 0-5
4598.3 314-B15
4604.9 4602.7 4604.7 1.00 IC 0-5
4616.2 4613.7 4616.7 1.00 IC 0-5
lxxii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4623.2 4619.7 4621.7 1.00 I 0-5
- -.--4638.6" - 4635.7 /- 4637.7 . . 1.00 flliiii 0-5 . . '_____ - -
4667.4 B6
4672.5 4669.8 4671.7 1.00 i 0-5
• 4678.4 D1-D3
4682.4 B4-B5
4684.4 4681.7 4683.7 1.00 i 0-5
4691.0 4687.7 4689.7 1.00 i 0-5
4696.1 4694.7 4694 7 1.00 i 0-5
4713.0 4711.9 4712.7 1.00 0-5
4728.7 4727.7 4727.7 1.00 0-5 "
4735.2 4733.7 4736.7 LOO 0-5
4740.6 4737.6 4739.7 0.84 i 0-5
4752.8 4749.6 4751.7 0.83 i 0-5
4759.2 4755.6 4757.7 1.00 i 0-5
4773.7 4770.5 4773.7 1.00 i 0-5
4779.3 4777.7 4778.7 0.94 i 0-5
4820.5 4817.7 4820.7 1.00 i 0-5
4826.9 4823.7 4825.7 - 1.00 Illollll:
4842.2 4839.7 4841.7 1.00 IlIPl
4846.8 4845.6 4846.6 0.89 i 0-5
4876.1 4873.8 4875.7 1.00 IC 0-5
4879.9 B12
4888.2 4884.7 4887.7 0.88 i 0-5
4895.0 - 4891.7 . 4893.7 1.00 0-5
4900.4 4898.7 4899.7 1.00 20-25
4910.1 4907.7 4910.7 1.00 i 0-5
4924.7 4923.6 4925.7 0.99 i 0-5
4938.7 . 4937.6 4937.6 1.00 i 0-5
4944.3 4940.6 4943.7 0.91 i 0-5
4956.9 4954.8 4955.6 1.00 i 0-5
4963.2 4959.7 4961.7 1.00 i 0-5
4977.5 4974.6 4977.6 1.00 i 0-5
” 4995.4'^ 4993.7 ...4994.6 ' 0.94 ~ _  0 _ 5  ........ — =— - — ■— -----------------
5008.3 5006.7 5009.6 1.00 i 0-5
5013.7 5010.6 5013.5 0.96 i 0-5
5023.9 5020.7 5024.7 0.91 i 0-5
5031.2 5027.6 5029.7 1.00 i 0-5
5039.1 5037.7 5039.7 1.00 i 0-5
5045.9 5042.6 5045.7 1.00 i 0-5
5071.5 )1
lxxiii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDX
fraction
5080.6 5077.7 5079.7 1.00 I 0-5
- - “ 5092.3- 5089.7 - 5091T7 -  i:oo ------T - 0-5 - -  -  -  - ......
5099.0 5095.7 5097.6 1.00 I 0-5 -
5104.1 5102.7 5102.7 1.00 I 0-5
5113.2 5112.6 5113.7 0.99 I 0-5
5133.6 5131.7 5131.7 1.00 I 0-5
. 5142.1 5141.6 514L6 1.00 I 0-5
5148.4 5144.7 5147.7 0.93 I 0-5
5161.1 5159.6 5161.6 1.00 I 0-5
5167.2 5163.6 5165.7 1.00 I 0-5
5181.5 5178.7 5181.6 1.00 I 0-5
5186.6 5185.7 5185.7 0.99 I 0-5
5197.1 5196.5 5196.5 LOO I 0-5
5217.3 5215.7 5216.7 0.75 I 0-5
5224.1 5223.5 5223:5 0.98 I 0-5
5228.5 5225.6 5228.7 1.00 I 0-5
5235.2 5231.6 5233.7 1.00 I 0-5
5244.6 5243.7 5243.7 0.99 I 0-5
5249.8 5246.6 5249.6 1.00 I 0-5
5255.7 5253.6 Slilsillt 0.81 II1III!IllllilS
5259.0 5258.7 5258.7 0.98 i 0-5
5278.8 5276.6 5279.6 1.00 i. 0-5
5284.9 5282.6 5283.6 1.00 i 0-5
5289.6 5288.7 5288.7 1.00 i 0-5
5292.1 5291.7 5291.7 0.99 i 0-5
5296.4 5293.6 5295.6 1.00 i 0-5
5303.0 5299.7 5301.6 1.00 i 0-5
5316.9 C12-C13
5319.6 5316.7 5319.5 0.97 i 0-5
5347.2 5345.7 5345.7 1.00 i 0-5
5352.8 5349.5 5351.6 1.00 i 0-5
5360.5 5359.4 5359.4 0.99 i 0-5
5364.4 5362.7 5365.6 1.00 i 0-5
5370.8 5366.6 5369:6 0.93------—  r 0-5----- ----------------
5380.2 5378.6 5381.6, 1.00 i 0-5
5385.9 5382.6 5385.5 1.00 i 0-5
5392.0 5390.7 5390.7 1.00 i 0-5
5397.8 5395.8 ' 5396.7 1.00 I 0-5
5403.7 5402.7 5403.6 0.99 i 0-5
5414.7 5412.7 5413.7 1.00 r 0-5
' 5433.2 5431.7 5432.7 1.00 i 0-5
lxxiv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
5439.2 5435.7 5437.6 1.00 I 0-5
- 5447.4 -5445:5- - 5446.4 - - -1.00- - . . .  — j .  — -- 0-5 - ........................................... ■
5454.2 5451.8 5454.5 1.00 I 0-5
5463.6 5461.7 5462.6 1.00 I 0-5
5465.0 D1-D2
5479.2 5478.7 5478.7 1.00 I 0-5
5483.6 5480.6 5483.6: 0.96 0-5
5489.9 5487.6 5488.6 1.00 I 0-5
5495.0 5493.5 5495.5 1.00 I 0-5
5500.3 5497.5 5500.6 1.00 I 0-5
5507.4 5503.7 5506.6 1.00 I 0-5
5518.9 / 5516.8 5519.7 1.00 0-5
5555.5 5552.6 5555.6 0.91 I 0-5
5569.1 5567.6 5569.5 1.00 0-5
5575.2 5571.5 5573.6 1.00 I 0-5
5583.7 5581.7 5581.7 1.00 I 0-5
5590.1 5587.7 5589.7 0.98 I 0-5
5607.2 5605.7 5605.7 1.00 0-5
5613.7 5611.7 5615.6 1.00 I 0-5
5626.0 5622.5 5625.6 0.99 lilllillillilliill
5631.9 5631.5 5631.5 1.00 1 0-5
5636.0 . 5633.5 5636.6 1.00 0-5
5643.4 5639.6 5641.6 1.00 1 0-5 •
5652.7 5651.7 5651.7 1.00 1 0-5
5658.1 5654.6 5658.6 1.00 1 .0-5
5685.9 5684.8 5686.8 1.00 1 0-5
5693.9 5691.6 5693.6 1.00 - 0-5 -
5704.8 5702.7 5705.6 1.00 0-5
5711.4 5707.7 5710.7 1.00 1 0-5
5718.6 5717.7 5717.7 1.00 0-5
5724.1 5723.6 5723.6 0.99 1 0-5
5760.3 5758.7 5761.5 1.00 0-5  :
5772.5 5770.8 5773.8 1.00 1 0-5
5778.6 5774:6 5777.6 0.86 ----------------T - 0-5----- --------------------
5795.9 5793.7 5795.6 1.00 I 0-5
5820.0 5817.5 5818.7 1.00 I 0-5
5829.9 5826.6 . 5829^5 0.76 I 0-5
5832.8 5830.7 5830.7 0.34 I 0-5
5846.9 5843.6 5846.6 0.89 I 0-5
5853.0 5852.6 5853.4 0.95 I 0-5
5855.5 5854.5 5855.7 0.99 I 0-5
lxxv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
5859.3 5858.6 5859.8 0.98 1 0-5
' '5862.8 - 5860.6 5861.6 - l.oo - - j  - 0-5 —
5897.0 5895.6 5895.6 1.00 I 0-5
5902.2 5899.7 5900.8 1.00 I 0-5
5907.8 5905.7 5909.7 1.00 I 0-5
5915.9 5913.6' 5914.6 1.00 I 0-5
6001.1 5998.1 5998.7 1.00 I 0-5
6013.1 6011.6 6012.6 1.00 I 0-5
6023.0 6020.6 6023 7 0.91 T 0-5
6050.9 6047.6 6050.6 0.89 I 0-5
6100.3 6099.8 6099.8 1.00 0-5
6107.7 6105.6 6106.7 1.00 I 0-5
6114.5 6113.5 6115.5 1.00 I 0-5
6122.2 6117.6 6123.6 1.00 0-5
6125.1 6124.6 6124.6 1.00 I 0-5
6167.5 6165.7 6168.8 1.00 . 0-5
6174.1 6172.1 6173.1 0.75 I 0-5
6188.2 6185.5 6186.4 0.92 0-5
6199.6 6197.6 6199.5 0.86 iiiiiii
6238.2 6236.5 llSiliill 1.00
6255.3 6253.7 6253.7 0,95 I • 0-5
6278.2 6275.6 6275.6 0.92 I 0-5
6324.6 6322.7 6322.7 1.00 I 0-5
6360.0 6358.6 6358.6 1.00 I 0-5
6377.1 6374.5 6376.6 0.76 I 0-5
6393.9 6393.5 6393.5 0.99 0-5
6413.8 6411.6 6411.6 1.00 I 0-5
6481.9 6479.6 6479.6 0.94 I 0-5
6490.5 6489.4 6489.4 1.00 I 0-5
6495.7 6493.6 6495.6 1.00 I 0-5
6526.6 6523.5 6526.4 1.00 I 0-5
6531.5 6530.5 6530.5 1.00 I 0-5
6552.3 6549.5 6551.5 0.99 I 0-5
6627.2 . . .  - - - 310-B12------
6635.8 33-D4
6656.8 (37-C13
. 6673.1 313-B14 -
6675.2 31
6678.6 6677.5 6678.6 1.00 I 0-5
6691.8 B15
6718.2 6716.3 6716.3 1.00 I 0-5
lxxvi
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
6736.3 6735.6 6735.6 1.00 I 0-5
---  6759.7 -6758:5- -  6758.5 - 1 .0 0 - ------ IC . . . .  0-5  -
6795.3 C4
6810.6 6809.2 6809.2 1.00 I 0-5
6821.8 6819.6 6819.6 1.00 I 0-5
6830.1 6828.6 6831.6 1.00 I 0-5
6837.2 6835.5 68355 0.94 I 0-5
6850.7 6848.5 6850.6 0.93 I 0-5
6929.2 B4-R5
6945.6 D1-D2
6995.1 §15 7
7086.1 7083.5 7087.5 0.83 I 0-5
7103.6 7101.3 7106.4 0.59 I 0-5
7170.5 C2-C3
7183.8 C5-C6
7198.7 C4
7229.7 C7 7
7234.0 7231.5 7231.5 0.56 I 0-5
7290.5 7289.4 7291.5 1.00 I 0-5
7366.2 7363.5 7364.6 1.00 I 0-5
7379.0 7377.4 7380.5 1.00 I 0-5
7416.2 BIO
7495.0 B13-B15
7561.7 7559.4 7563.4 1.00 I 0-5
7569.8 7567.5 7567.5 1.00 I 0-5
7637.9 7635.5 7636.6 0.90 I 0-5
7653.7 B15
7665.0 B10
7665.3 7663.4 7667.5 0.94 I 0-5
7689.5 7687.5 7687.5 0.94 I 0-5
7748.6 . - 7747.4 7747.4 0.87 I 0-5
7766.0 7764.4 7765.4 1.00 I 0-5
7815.2 B15
7839.3 A T3 “
7840.8 7836.5 7841.5 0.81 I 0-5
8025.6 8024.4 8026.4 1.00 I 0-5
8106.5 8105.5 8107.4 1.00 I 0-5
8129.4 8128.6 8128.6 1.00 1 I 0-5
8368.4 8366.5 8367.4 1.00 I 0-5
8453.8 8451.4 8452.5 1.00 I 0-5
8515.4 (33-C4
ixxvii
Group 6 from ion exchange column
Mass 
__ (average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2009.5 2008.8 2010.0 0.99 I 0-5
2012.0 2011.6 2011.6 1.00 I 0-5
2020.6 2018.9 2019.9 LOO IC 0-5
2029.0 2028.1 2028.1 1.00 I 0-5
2063.1 2062.0 2062.9 1.00 I 0-5
2079.4 B3
2085.5 2084.9 2084.9 1.00 I 0-5
2089.6 2088.9 2089.9 1.00 I 0-5
2101.5 2100.9 2101.9 1.00 0-5 - - - ------ -
2117.5 2116.2 2117.3 1.00 I 0-5
2131.0 2129.9 2129.9 1.00 I 0-5 -
2156.4 2154.9 2155.9 1.00 I 0-5
2168.6 2167.9 2167.9 1.00 I 0-5
2192.4 2190.9 2191.9 0.88 I 0-5
2204.4 2202.9 2203.9 0.89 0-5
2216.2 B7-B9
2225.$ 2224.9 2224.9 1.00 I 0-5
2236.6 2235.9 2235.9 1.00 I 0-5
2266.5 2265.4 2266.4 1.00 I 0-5
2283.4 2282.9 2282.9 1.00 I 0-5
2286.2 B14
2292.4 2290.9 2291.9 1.00 0-5
2296.8 2295.9 2295.9 1.00 0-5
2304.4 2302.9 2303.9 . 1.00 I 0-5
2340.3 2338.9 2339.9 . 0.89 I 0-5
2360.4 2358.9 2359.9 1.00 I 0-5
2366.2 C4-C5
2372.4. 2370.9 -2371.9 1.00 i !  s i l i
2374.8 B8-B9
2428.6 2426.9 2427.9 1.00 I 0-5
2453.6 2452.9 2453.9 1.00 I 0-5
2508.6.. _250X9__ _25Q2JL__ L00 0r5___
2519.5 2518.8 2519.9 1.00 0-5
2529.9 2528.9 2529.9 1.00 0-5
2558.0 2556.9 2557.9 LOO 0-5
2564.5 2562.9 2563.9 1.00 I 0-5
2577.5 2576.9 2577.9 0.99 I 0-5
2596.7 2594.9 2595.9 LOO 0-5
2604.7 2603.9 2603.9 1.00 I 0-5
lxxviii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2612.6 2610.9 2611.9 1.00 0-5
--2624.3-- - 26229 - - -2623.9 - 0.89 - ■ I - ---- -  0-5 - -
2632.6 2631.9 2631.9 1.00 I 0-5
2642.8 C2
2644.6 2642.9 2643.9 1.00 I 0-5
2649.2 2647.9 2647.9 1.00 IC 0-5
2664.7 2662.9 2663.9 1.00 I 0-5
2690.6 2688.8 2689.8 1.00 I 0-5
2696.7 2694.8 2695.9 . 1.00 I 0-5
2699.2 2698.4 2698.4 0.99 I 0-5
2700.8 2699.9 2699.9 1.00 I 0-5
2704.7 2703.9 2703.9 1.00 I 0-5
2710.4 C1-C2
2711.5 C7-C8
2712.4 2710.8 2711.9 - 1.00\ . 0-5
2740.7 2739.9 2739.9 1.00 I 0-5
2748.6 2746.9 2747.9 1.00 - I 0-5
2768.7 2767.9 2767.9 1.00 I 0-5
2780.8 2778.8 2779.9 . 1.00 . i l i l l l l l
2790.7 -2789.8 2789.8 l l l i i i l l l
2800.5 - 2798.9- 27999 1.00 I .0-5
2816.2 2815.0 2815.8 0.90 - 0-5
2829.5 2828.8 2829:8 - 1.00 I 0-5.
2833.4 2831.3 2832.4 0.88 0-5
2836.9 2835.8 2835.8 1.00 I 0-5
2840.1 2839.9 2839.9 1.00 I 0-5
2847.8 2847.8 2847.8 1.00 0-5
2854.5 2852.8 2853.9 1.00 I 0-5
2858.6 2857.9 2857.9 1.00 I 0-5
2862.2 2861.9 2861.9 1.00 0-5
2873.5 2872.9 2873.9 1.00 I 0-5
2876.4 2874.9 2875.8 1.00 I - 0-5 .
2884.3 2882.9 2883.9 0.89 I 0-5
2894:8 2893:8 2893.8 1.00 0-5
-2906.5 2904.9 2905.8 1.00 . 0-5
2920.6 2918.9 2919.8 1.00 I 0-5
2926.7 2925.8 2925.8 ; 1.00 0-5 .
2937.4 2936.8 2937.8 1.00 I 0-5
2952.3 2950.9 2951.8 1.00 I 0-5
2962.6 2961.8 2961.8 1.00 0-5
2965.5 2964.8 2965.8 1.00 I 0-5
lxxix
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2968.9 2967.3 2968.4 0.87 I 0-5
' 2972.8 2971.8 -2971.8 1.00 - - i  --- 0-5 '
2976.1 2975.8 2975.8 1.00 I 0-5
2984.1 2983.8 2983.8 1.00 I 0-5
2988.1 A12-A13
2990.7 2988.9- 2989.9 1.00 0-5
2994.9 2993.9 2993.9 1.00 .0-5
2999.5 2998.8 2999.8 1.00 I 0-5
3006.5 30048 3005.8 1.00 0-5
3012.3 3011.0 3011.8 0.99 0-5
3020.3 3018.9 3019.8 0.90 0-5
3030.2 3029.8 3029.8 1.00 I 0-5
3051.7 3050.9 3051.9 1.00 I 0-5
3058.7 3056.9 - 3057:9 1.00 IC 0-5
3063.1 3061.9 3061.9 1.00 I 0-5
3071.6 3070.4 3070.4 0.99 0-5
3091.5 B14-C1
3099.4 3098.8 3099.8 1.00 I 0-5
3101.4 3100.8 3101.8 1.00 0-5
3104.9 3103.3 3104.4 0.87 I 0-5
3108.9 3107.8 3107.8 1.00 l l l l p l l
3156.2 3154.8 3155.8 0.89 0-5
3165.5 3163.8 3165.8 0.76 I 0-5
3194.7 3192.9 3193.9 1.00 0-5
3199.1 3197.9 3197.9 1.00 I 0-5
3212.6 3210.8 3212.9 1.00 I 0-5
3240.7 3239.8 3239.8 . 1.00 I 0-5
3244.9 3243.8 3243.8 1.00 0-5
3257.6 3255.9 3257.9 0.94 I 0-5
3262.7 3260.8 3261.9 1.00 0-5
3267.1 3265.8 3265.8 1.Q0 0-5
3279.4 3277.9 - - 3277.9 1.0Q IC 0-5
3283.6 3281.8 3283.8 1.00 I 0-5
3286.1 3283:9 ' 3285:9 - t o o ------ IC - 20-30— --------------------
3287.3 3285.8 3286.8 1.00 IC 25-30
3295.0 D2-D3
3297.0 3294.9 3296.9 1.00 IC 10-15
3298.1: iU 5-B 1
3298.1 3295.9 3297.9 1.00 IC 15-20
3303.1 3301.9 3303.8 1.00 . I 25-30
3315.8 3313.9 3314.9 1.00 IC 20-30
Ixxx
Mass
(average)
Mass
(mono.)
Apex Massi Score Evidence Time MALDI
fraction
3316.8 3315.8 3316.9 1.00 I 25-30
- - 3319.3 " fS ’ISMPP --- 7  7 B8-C1
3319.7 3317.8 3319.8 1.00 I 15-20
3327.2 3325.8 - 3326:8 1.00 I 0-5
3332.6 3330.9 3332.9 1.00 m m s i i 0-5■; o r 7^ " JDDJ. 1 . o 3335.8 1.00 i 15-20
3344.0 C2
3345.3 3343.9 3344.9 1.00 i 0-5
3345.3 B9
3348.2 3346.0 3348.0 1.00 l l l l i f l i l 15-20
3353.3 * ■ ........ - ' ..................— B12
3354.9 3353.9 3355.0. 1,00 1 !  W mSSm 25-30
3376.9 3374.7 3375.8 1.00 i 0-5
. 3378.1 _ C7-C8
3383.3 3381.8 3383.8. 1.00 i 0-5
3392.6 3391.8 3392.9 1.00 i 0-5
3398.7 3396.8 3397.9 TOO I 0-5
3402.5 3401.9 3401.9 1.00 i 0-5
3405.0 3404.9 3404.9 1.00 i 0-5
3411.8 3407.8 3409.8 1.00 IC 0-5
3418.5 3417.8 3416.9 1.00 I l lS i l iS iS 0-5
3433.2 3431.9 3433.0 1.00 I 20-25
3433.9 B4
3434.2 3432.9 3434.0 1.00 IC 20-30
3460.5 3457.9 3459.8 0.83 i 0-5
3461.3 B3
3466.7 3464.8 3465.8 1.00 i 0-5
3471.1 3469.8 3469.8 1.00 i 0-5
3476.5 B10-B11
3482.6 3481.8 3482.9 1.00 i 0-5
3495.9 3493.9 3495.9 1.00 IC 20-25
3501.3 B15
3504.7 3503.3 3505.2 1.00 . i . 0-5
- '3506:7 “ 3505.8 “ 3505.8 71.00 — r— 0-5 " - -  - -  ---------
3512.9 3510.6 3511.8 0.95 i 0-5
3518.0 210
3518.5 <314-C15
3519.6 U1-A13
3520.0 3519.0 3520.0 1.00 i 10-15
3521.2 3519.0 3520.1 1.00 IC 5-10
3521.2 3519.0 3521.0 0.98 i 10-15
lxxxi
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3522.2 3520.0 3521.0 1.00 IC 5-10
- 3526.6 f - - l i p i l l l i l l l B1-B4----- "
3530.8 3528.8 3530.8 1.00 I 0-5
• 3534.5 B5-B6
3536.7 . 3534.8 3536.9 0.80 I 0-5
3543.8 3543.0 3543.0 1.00 W M & i S . 20-30
3544.3 C4-C5
3547.3 3543.8 3545.8 1.00 IC 0-5
3550.6- A15
3555.7 3553.8 3555.8 1.00 0-5
3557.0 - " --“ “ C7-D3
3559.9 B1-B4
3561.1 3560.1 3561.1 1.00 IC 10-15
3567.6 C3
3567.8 3565.8 3567.8 0.94 I 1 0-5
3589.9 3589.1 3589.1 1.00 I 20-30
3597.9 3595.8 3596,8 1.00 IC 0-5
3602.9 3600.8 3601.9 1.00 IC 0-5
3606.5 3605.8 3605.8 1.00 I 0-5
3609.0 3608.9 3608.9 1.00 I 0-5
3615.6 3614.8 3614.8 1.00 I 0-5
3620.4 3618.8 3620.8 1.00 I 0-5
3642.8 3641.8 3641.8 0.99 I 0-5
3653.4 3651.8 3653.8 0.94 I 0-5
3664.3 3661.8 3665.8 1.00 I 0-5
3671.2 3668.8 3669.8 1.00 I 0-5
3676.1 . .3674.8 3674.8 0.97 I 0-5
3685.3 3683.1 3685.1 1.00 IC 20-25
3686.9 3685.1 3687.1 1.00 IC 20-25
3692.2 B5-B6
3701.5 C8-D3
3703.3 3701.2 3703.2 1.00 IC 20-30
3711.0 ■ B9
37-11.1 3710.2 3711.2 1:00 IC 25-30 . --------------
3714.6 3713.2 3714.1 1.00 IC 20-25
3715.7 35
3720.3 3719.2 3719.2 0.72 I 0-5
3723.2 37-B8
3724.5 . ■ 14
3734.9 3732.8 3734.8 1.00 I 0-5
3740.7 3738.8 3740.9 1.00 IC 0-5
lxxxii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3752.8 3750.9 3750.9 1.00 IC 0-5
3755.1 -3754:2" - 3754:2- 1.00 •■ - T ' -  20-25 . _  .
3761.1 3759.2 3761.1 0.94 . I 0-5
3765.2 B7
3776.2 3773.8 3776.8 1.00 IC 0-5
3779.8 B7-B9
3782.8 3781.8 3782.9 1.00 I 0-5
3788.2 3786.8 3788.8 1.00 ;111S1ISSI 0-5
3791.6 3789.8 3791.8 1.00 I 0-5
3800.8 3799.8 3800.8 1.00 I 0-5
3806.7 3804.8 3805.8 1.00 I 0-5
3811.4 3809.8 3809.8 1.00 I 0-5
3818.1 3816.8 3818.8 1.00 I 0-5
3821.0 3819.8 3821.8 1.00 fSllftNSli 0-5
3825.5 3824.8 3824.8 1.00 i 0-5
3830.0 B ll
3834.0 B7
3844.4 3843.8 3845.0 0.97 i 0-5
3847.9 3845.8 3847.8 0.94 i 0-5
3853.1 A13-A14
. 3854.1 D1--D2
3856.9 3855.8 3857.8 1.00 iisiiliiilii - 0-5
3861,1 - 3859.8 3860.8 1.00 i ■ 0-5
3868.9 3867.8 3869.8 1.00 i 0-5
3874.5 3871.8 3873.8 1.00 i 0-5
3875.5 B4-B7 -
3879.4- 3877.8 3877.8 1.00 i 0-5
3884.6 3883.8- 3884.8 1,00 i 0-5
3890.7 3888.8 3890.8 1.00 i 0-5
3903.9 B6
3911.2 D1-D2
3911.6 3909.8 3911.8 1.00 i 0-5
3911.7 uA14-A15
3925.2 3923.8 3923:8 1.00 i 0-5 . -
3939.0 3936.8 3939.8 1.00 IC 0-5
3944.8 3942.8 3944.8 0.79 i 0-5
3956.3 3955.7 3956.8 1.00 IC 0-5
3961.2 3959.8 3959.8 1.00 IC 0-5
3963.9 3962.8 3962.8 1.00 IC 0-5
3980.1 3978.8 3980.8 1.00 I , 0-5
3982.5 34
lxxxiii
Mass
(average)
Mass
(mono.)
Apex Massi Score Evidence Time MALDI
fraction
3987.0 3985.9 3986.9 1.00 I 0-5
- -  3993.6 -- -399.1:8- --3992.8- 1.00— — IC -  0-5 “
- 3998.3 B11-B12
4000.9 3999.7 4001.8 1.00 I 0-5
4004.9 4003.8 4004.8 1.00 I 0-5
4010.4 4007.8 4009.8 1.00 I 0-5
4011.0 B12
4015.5 4013.8 4013.8 1.00 I 0-5
4020^9 4019.8 4019.8. 1,00 ilBSSIil!!! . 0-5
4026.9 4023.8 4025.8 1.00 0-5
4059.5 4057.8 4061.8 1.00 IC 0-5
4064.5 4062.7 4064.8 0.93 i 0-5
4072.7. 4069.8 4073.8 0.84 i 0-5
4078.5 4075.8 4077.8 1.00 0-5
4083.4 4081.8 4081.8 1.00 i 0-5
4088.4 4087.8 4088.8 1.00 0-5
4091.1 4089,8 4091.8 1.00 0-5
4094.2 4092.7 4094.8 1.00 IC 0-5
4114.2 4113.8 4113.8 0.99 i 0-5
4129.0 4125.8 4127.8 1.00 i 0-5
4134.2 4132.7 4133.8 1.00 i 0-5
4140.9 4137.7 4139.8 0.83 i 0-5
4144.3 4143.8 4143.8 1.00 i 0-5
4148.4 B3
4148.9 4146.7 4148.8 0.79 i 0-5
4150!3 4147.6 4149.6 1.00 20-25
4154.8 iP
4161.8 4158.7 4160.8 1.00 i 0-5
4166.2 4164.6 4165.6 1.00 IC 20-25
4173.3 B4
4176.5 . 4173.8 -4175.8 . 111113111: -I 0-5
4182.6 4181.8 4181.8 1.00 0-5
4191.2 4189.8 4190.8 . . 1.00 I 0-5
4196.7 4194.7 “4196.8'"— 1.00 ----------J- ------- 0-5 __— --------- _
4202.7. \15
4203.7 D1-D3 ,
4208.8 4206.7 .4207.8 1.00 .. 0-5
4214.4 4211.8 4213.8 1.00 0-5
4219.3 4217.8 4217.8 1.00 I 0-5
4225.2 4224.7 4225.7 1.00 I 0-5
4225.7 311
Ixxxiv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4228.9 A15
- 4230.4 : 4227/8 . 4229.8 /  1.00 ....0=5 _
4235.5 4233.8 4235.8 1.00 S l i 0-5 .
4247.0 B8-B10
4263.1 4260.8 4263.8 1.00 I 0-5
4268.7 4266.7 . 4268.8 1.00 0-5
4276.7 4274.8 4277.7 1.00 I 0-5
. 4282.5 4279.8 4281.8 1.00 I 0-5
4287.8 4285.8 4285.8 1.00 0-5
4298.8 4296.7 4298.8 1.00 0-5 * - .
4317.6 B12
4318.9 4317.7 4319.7 1.00 I 0-5
4322.6 4320.8 4322.8 0.74 0-5
4328.2 4326.7 4329.8 0.86 I 0-5
4335.5 4332.8 4334.8 1.00 I 0-5
4346.9 4344.8 4346.8 1.00 I 0-5
. 4365.8 4362.6 4367.7 1.00 I 0-5
4370.4 4369.8 4370.8 1.00 I 0-5
4375.1 4372.7 4373.8 0.90 I 0-5
4382.7 B14
4386.1 4383.7 IlSlliill 1,00 I 11111181
4401.9 4398.8 4400.8 LOO lilSilll
4412.3 4409.7 4412.8 1.00 I 0-5
4418.4 4415.8 4417.8 1.00 0-5
4423.4 4421.8 4421.8 1,00 0-5
4425.4 B6-B9 .
4434.8/ 4431.7 4433.8 ’ . 1.00 0-5
4435.3 B10
4468.8 4465.8 4467.8 1.00 I 0-5
4473.2 4472.7 4472.7 0.99 0-5
4480.1 4477.8 4479.7 1.00 I 0-5
4486.5 4483.8 4485.8 1.00 0-5
4491.5 4489.8 4489.8 1.00 I 0-5
4494.8 - :.....r" ] 37- - ~
4503.5 4500.7 4502.8 1.00 I 0-5
4509.0 4507.8 4507.8 0.79 I 0-5
.’ 4523.5 . 4521.7 4523.7 1.00 0-5
4531.2 4527.7 4531.8 0.21 I 0-5
4539.6 4536.7 4538.8 1.00 I 0-5
4549.2 4545.7 4547.7 0.86 I 0-5
4557.5 4554.7 4556.8 0.84 I 0-5
lxxxv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4564.5 4562.7 4562.7 1.00 I 0-5
. .4567.31 ^1111111111: ■B13-B15 —
4570.0 4567.8 4568.7 1.00 I 0-5
4576.0 4573.8 4574.7 0.98 I 0-5
-4584.6 4581.6 4583.8 1.00 .. 11 0-5
4585.9. B9-B10
4593.7 4590.8 4592.7 1.00 I 0-5
4609.6 B13
4611.6 4610.7 4610.7 1.00 I 0-5
4616.5 4613.7 4616.8 0.84 0-5
4622.9 4619,7 .462L8 1.00 W lm m iim 0-5 - ...
4628.3 . 4626.7 4626.7 1.00 i . 0-5
4633.0 4631.7 4631.7 1.00 i 0-5
4638.7 4635.7 4637.8 . 1.00 0-5
4642.8 B7
4673.0 4670.7 4673.7 1.00 i 0-5
4676.6 B6-B7
4684.7 4682.8 4685.7 1.00 i 0-5
4686.3 B ll
4691.1 4687.8 4689.7 1.00 i 0-5
4696.2 . 4694.8 4694.8 1.00 0-5
4703.0 4701.8 4703.7 1.00 i 0-5
4706.9 4704.7 4707.6 1.00 0-5
4713.2 4711.9 4711.9 0.80 i 0-5
4725.6 B8
. 4726.6 4723.9 4727.7 1.00 x 0-5-
4741.4 4737.7 4739.7 1.00 i 0-5
4749.8 B8-B10
4753.1 4751.7 4751.7 1.00 i 0-5
4759.3 4755.8 4757.8 1.00 i 0-5
4773.8 4770.6 4772.7 1.00 i 0-5
4779.9 38
4780.0 4777.7 4781.7 1.00 i 0-5
“ "4793:6----“ 4790:7“ 4793:7 — 0:91-— j --------- — 0 - 5 ------ ------ - ----------
4800.2 4799.7 4799.7 1.00 i 0-5
4803.9 4801.8 4805.8 , 1.00 i 0-5
4809.5 4806.7 4808.8 1.00 . 0-5
4815.5 4814.7 4814.7 1.00 i 0-5
4820.4 4817.7. 4820.7 - 1.00 .0-5
4826.4 4823.7 . 4825.8 1.00 i 0-5
4831.6 4829.7 4829.7 1.00 i 0-5
lxxxvi
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4841.8 4838.7 4841.8 1.00 U Sm SW B 0-5
- -4850.7 . -  - ------- B4 - - -
/  4856.7 4855.8 - 4856.7 0.99 I W m & M 0-5
4871.7 4870.8 4871.7 0.99 I 0-5
4876.7 4873.8 4877.7 1.00 I 0-5
4883.2 4880.8 . 4883.7 . 1.00 ■ 0-5
4888.7 4886.7 4889.7 1.00 I 0-5
4894.5 . 4891.7 4893.7 1.00 I 0-5
4899.6 4897.7 4897.7 1.00 I 0-5
4911.2 4908.7 4910.7 0.96 I 0-5
4916.7 B12-B14
4919.5 4917.8 4917.8 0.73 I 0-5
4930.8 4929,7 4931.7 1.00 0-5 .
4934.7 . 4932.6 ,4934.7 1.00 0-5
4944.9 4941.7 4943.8 1.00 i 0-5
4952.0 4949.7 4952.7 1.00 i 0-5
4958.8 4956.8 4958,7 1,00 i 0-5
4966.7 4964.7 4964.7 1.00 r 0-5
4978.1 4975.8 4977.7 1.00 i 0-5
4983.1 4981.8 4982.7 1.00 i 0-5
4987.1 4985.7 4985.7 1.00 i 0-5
4999.9 4997.7 5000.8 1.00 i 0-5
5013.9 5010:6 5012.7 1.00 0-5
5018.2 5017.8 5017.8 0.99 i 0-5
5024.4 5021.7 5024.7 1.00 i 0-5
5030.9 5027.7 5029.7 1.00 i 0-5
5036.3 5034.7 5034.7 1.00 i 0-5
5040.5 - 5039.7 5039.7 1.00 0-5
5045.9 5042.6 5045.7 1.00 i 0-5
5050.2. 5049.7 5049.7 0.99 0-5
5052.5 5051.7 5051.7 1.00 i 0-5
5080.8 5077.8 5079.7 1.00 i 0-5
5086.3 5084.7 5087.7 1.00 i 0-5
5091.9 5088.8 5091.7“ — 1:00---------------j--------- — 0-5----- --------------------
5099.0 5095.7 5097.7 -1.00 i 0-5
5104.2 5102.7 5102.7 1.00 i 0-5
5108.6 5107.7 5107.7 1.00 i 0-5 \
5113.4 5112.7 5113.8 0.99 i 0-5
5127.4 5125.7 5127.6 0.77 i 0-5
5136.1 5133.6 5135.7 1.00 i 0-5
5143:8 a 5142:6 5144.7 0.99 i 0-5
lxxxvii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
5149.0 5145.6 5147.7 1.00 I 0-5
5156.1 5154.5 5156.6- - 1.00 - - j - ----- 0-5- “
5161.2 5159.7 5159.7 1.00 I 0-5
5167.3 5163.6 5165.7 1.00 I 0-5
5181.6 5178.7 5180.7 1.00 I 0-5
5186.3 5185.7 5186.7 1.00 I 0-5
5190.2 5187.6 5189.7 0.93 I 0-5
5204.3 5202.8 5204.6 1.00 I 0-5
5209.7 5207.7 5207.7 1.00 0-5
5217.2 5213.7 5216.7 1.00 I 0-5
5228.3 5225.7 522877 1.00 llllllil 0-5
5234.9 5231.7 5233.7 1.00 0-5
5249.9 5246.6 5249.7 1.00 i 0-5
5277.3 C5
5277.7 5276.7 5276.7 1.00 i 0-5
5280.1 5279.7 5279.7 0.95 i 0-5
5284,7 5281.7 5284,7 1.00 i 0-5
5291.9 5289.7 5291.8 0.80 i 0-5
5296.6 5294.7 5297.7 1.00 i 0-5
5303.0 5299.7 5301.7 1,00 l l l o l l i i
5307.9 , 5306.7 5306.7 1.00. lillllSIS51Ii#l
5316.1 5313.6 5317.7 0.87 0-5
5323.8 CIO
5329.2 5328.7 5328.7 1.00 i 0-5
5337.9 5335.8 :.W,J335;8;S7 0.84 . i isiiiii
5346.4 5344.8 5345.8 1.00 i 0-5
5353.9 5352.6 5353.6 0.88 0-5
5358.6 5356.8 5357.7 1.00 i 0-5
5364.8 5362.8 5363.7 1.00 i 0-5
5371.0 5367.7 5369.7 1.00 i 0-5
5386.2 5383.7 5384.7 0.98 0-5
5409.9 5408.5 5409.6 0.86 i 0-5
5414.6 5413.6 5414.7 1.00 i 0-5
5418.8 ‘ 5417.7 5419:8 ---- 1700----- ------ T --- 0-5 --------------------
5423.2 5420.7 5420.7 1.00 I 0-5
5428.5 5427.6 5427.6 1.00 I 0-5
5432.7 5431.7 5433.6 1.00 I 0-5
5438.1 5434.7 5437.7 1.00 I 0-5
5445.3 5442.7 5444.7 1.00 I 0-5
5453.7 5450.7 5453.6 1.00 0-5
5469.2 5467.7 5470.8 1.00 I 0-5
lxxxviii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
5483.2 5481.8 5483.7 1.00 0-5
- - 5489.0 - -5486.7 - '  - 5487.7 - ..... 1.00 - -------  j - - - .....0-5 “ — -------  .
5494.7 5493.6 5495.7 1.00 I 0-5
5500.6 5498.6 5499.6 1.00 I 0-5
5506.9 5503.7 5505.7 1.00 I 0-5
5516.2 5515.7 5515.7 1.00 0-5
5518.8 5517.7 55197 LOO I 0-5
5524.1 5521.6 5523.6 0.94 I 0-5
5535.6 5532.7 5535.7 0.85 I 0-5
5557.0 5555.7 5555.7. 1.00 0-5
5562.7 5560.9 5561.7 1.00 0-5
5568.8 5567.7 5569:8 , 1.00 0-5 ,
5574.7 5570.7 5573.7 0.86 I 0-5
5580.7 5579.7 5579.7 0.86 0-5
5589.0 5586.5 5587.6 1.00 I 0-5
5632.1 5631.6 5631.6 0.98 I 0-5
5637.1 56347. 5636.7 0.97 I 0-5
5644.9 5642.7 5642.7 0.91 I 0-5
5650.7 5649.6 5650.5 0.91 0-5
5658.1 5656.6 5657.6 1.00 I 0-5
5674.6 5672.8 5675.7 1.00 0-5
5680.4 5678.7 5678.7 1.00 I 0-5
5692.3 5690.7 5692.9 1.00 I 0-5
. 5696.2 5694.6 , 5694.6 0.71 I 0-5
5699.2 .5698:7 5699.7 1.00 I 0-5
5703.6 5700.6 5702.7 0.95 I 0-5
5711.6 57087 5709.6. 1.00 0-5
5716.0 5715.6 5715.6 0.98 I 0-5
5727.5 5725.7 5726.7 0.73 I 0-5
5737.4 5733.7 5735.7 1.00 IC 0-5
5763.3 5761.9 5761.9 1.00 I 0-5
5773.3 5772.7 5772.7 0,99 0-5
5776.0 B14
"“ 5782:5 “5780:8““ 5780:8 — 0:93------------- j — — 0-5 --------------------
5794.0 5791.9 5792.8 1.00 I 0-5
5847.7 5844.5 5846.7 1.00 I 0-5
5861.9 5859.9 5860.8 0.99 I 0-5
5868.9 5866.7 5867.6 0.94 I 0-5
5881.8 5879.6 5881.5 0.85 I 0-5
5915.1 5912.7 5913.7 1.00 I 0-5
5920.1 5918.8 5919.6 0.99 0-5
Ixxxix
Mass
(average)
Mass
(mono.)
Apex Mass} Score Evidence Time MALDI
fraction
5929.9 5928.6 5929.6 0.91 0-5
~ 5936’6“ “ "5934:9“ '  5934:9T - - n  00 T •----0-5 " -----
5964.5 5961.8 5963.8 0.75 I 0-5
5971.1 5969.7 5970.6 1.00 I 0-5
5978.0 5975.7 5979.9 1.00 I 0-5
6024.7 6023.8 6024.7 0.99 I 0-5
6034.4 6031.4 6033.5 0.90 0-5
. 6045.7 6043.8 6045.6 1.00 I 0-5
6051.3 6049.7 6049.7 0.95 I 0-5
6065.1 6064.6 6065.6 1.00 I 0-5
6119.8 6117.7 6119.7 0.96 I 0-5
6134.0 6131.5 6135.6 1.00 I 0-5
6148.3 6145.9 6147.0 1.00 I 0-5
6227.5 6225.3 6227.1 0.84 I 0-5
6239.9 6238.2 6238.2 0.92 I 0-5
6281.8 6277.6 6279.7 1.00 IC 0-5
6291.2 6288.7 6291.6 1.00 IC 0-5
6338.0 6335.5 6338.4 0.91 I 0-5
6408.7 C6
6553.1 6550.6 6552.8 0.68 I 0-5
6596.0 6593.6 6593.6 0.98 I 0-5
6635.9 B12-C1
6657.0 6654.5 6655.6. 0.91 I 0-5
6677.9 <22
6691.1 C 6 /.
6707.0 B13-B14
; 6736.6 B8
6758.3 6756.7 6759.7 0.78 I 0-5
6767.7 C7-C8
6918.8 B3-B4
7004.9 B14-B15
7087.5 - 24-C5
7098.5 7096.7 7096.7 0.35 I 0-5
7101.2 7098.5 7098.5 0.37 T 0-5----- ------ ------------ —
7116.4 <25
7118.5 32
7134.3 <23
7174.7 7173.1 7173.1 0.26 I 0-5
7184.5 lililt32-C5
7280.3 7278.4 7278.4 1.00 I . 0,5
7297.9 7295.7 7297.7 1.00 I 0-5
xc
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
7355.6 B7-B8 .
'  7390.0— — - -------- -. ------------------ — ..................... -  ■ m m m m m
7394.2 C2
7500.3 7497.5 7500.5 0.90 I 0-5
7536.2 ’ Cl
7559.2 B8-B9
7583.2 7580.6 7583.5 0.82 I 0-5
7628.6 7627.6 7627.6 1.00 I 0-5
o/ w  t , y B i t
7773.3 7770.5 7771.6 1.00 I 0-5
‘7778.0 7777.6 7777.6 0.99 I 0-5
7809.9 7807.4 7811.5 0.81 I 0-5
7918.1 C5-C6
7993.6 -  t * C6-G7 -
8072.0 B15
Group 7 from ion exchange column
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2008.7 2006.8 2007.8 1.00 IC 0-5
2011.5 2010.8 2010.8 1.00 IC 0-5
2018.9 2018.5 2018.5 1.00 I 0-5
2021.9 2020.8 2020.8 1.00 I 0-5
2034.7 2033.8 2033.8 1.00 I 0-5
2036.6 2036.1 2037.1 1.00 I 0-5
2041.5 , 2041.1 2041.1 1.00 I 0-5
2045.5 2044.1 2045.1 1.00 I 0-5
2046.6 2045.8 2045.8 1.00 I 0-5
2049.3 2048.8 i l S l i i 1.00 l l i l i !
2053.5 2052.8 2053.8 LOO i  m m im B w m m m
2058.6 2058.1 2059.1 1.00 . i i l ; o l i l i
2075:1 2074:7 2075:7 1:00 i e 0-5 - - ............ -  .... -
2085.5 ; 2084.8 2085.8 LOO ic 0-5
2089.4 2088.8 2088.8 LOO i 0-5
2097.6 2097.8 2097.8 1.00 IC 0-5
2101.5 2100.8 2101.8 1.00 i 0-5
2112.7 2112.2 2113.2 LOO i 15-25
2137.8 2136.7 2137.8 1.00 i 0-5
2142.9 B12-B14
xci
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2143.4 2142.8 2143.7 1.00 I 0-5
----- 2147:3- " 2146.8 “ 2147.8 ----- 1.00 - --------r ... ----- 0-5 - . . _ — ----
2157.9 2156.8 2156.8 1.00 I 0-5
2163.5 2162.8- 2163.8 1.00 I 0-5
2166.0 2165.8 2165.8 1.00 I 0-5
2190.1 2188.7 2189.7 1.00 n S I I S l l i l 0-5
2198.6 2197.7 2197.7 1.00 I 0-5
2204.4 2202.8 2203.7 1.00 I 0-5
2225.4 2224.8 2224.8 1.00 I 0-5
2234.0 2233.8 2233.8 1.00 I 0-5
2236.8 2235.8 -2235.8 1.00 i ; 0-5
2241.5 2240.8 2241.7 1.00 i 0-5
2265.8 B5
2272.3 2270.8 2271.8 1.00 i 0-5
2279.4 2278.7 2279.7 1.00 i 0-5
2283.3 2282.8 2283.8 1.00 i 0-5
2292.4 2290.8 2291.8 1.00 i 0-5
2296.6 2295.7 2295.7 - 1.00 . i 0-5
2326.1 2324.8 2325.7 1.00 i 0-5
2332.4 ; i 2 3 3 l l l l l i l i f f l l ! 1.00 I l i P I I l l l i l l l l i l
2340.3 2338.8 2339.8 1.00 I 0-5
2351.4 2350.8 2351.7 1.00 I . 0-5.
,2372.5 2370.8 2371.7 - 1.00 I 0-5
2395.5 2394.8 2395.7 1.00 I 0-5
2408.1 2406.8 2407.7 1.00 I 0-5
2414.6 2413.7 2413.7 1.00 I 0-5
2419.3 2418.8 2419.7 1.00 I 0-5
2428.4 2426.8 2427.7 1.00 I 0-5
2432.0 2431.7 2431.7 1.00 I 0-5
2441.4 2440.7 . 2441.7 1.00 I 0-5. .
2462.1 2460.7 2461.7 1.00 I 0-5
2467.3 B5
2468.5 2467.7 2467.7 1.00 I 0-5
- 2476.3 2474.8 2475.7“ - - -1:00— - I 0-5
2482.6 2481.7 2481.7 1.00 I 0-5
2487.4 2486.7 2487.7 1.00 I 0-5
2500.1 2498.7 2499.7 0.89 I 0-5
2506.6 2505.7 25.05.7 1.00 I 0-5 .
2523.5 2522.8 2523.7 1.00 I 0-5
2528.7 ... 2527,7 2527.7 1.00 I 0-5
2551.3 2550.7 2551.7 1.00 I 0-5
xcii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2554.5 2552.7 2553.7 1.00 I 0-5
'2564:4 ' 2562.7 ' - 2563.7 ~— 1 00 j------ - 0 - 5 - —  ..............
2568.6 2567.7 2567.7 1.00 I 0-5
2574.0 2573.7 2573.7 1.00 I 0-5
2598.4 2596.7 2597.7 1.00 I 0-5
2604.5 2603.7 2603.7 1.00 I 0-5
2612.1 2610.7 2611.7 1.00 I 0-5
2616.7 2614.7 2615.7 0.89 I 0-5
2632.6 2631.7 2631.7 1.00 I 0-5
2636.6 2635.7 . 2635.7 0.76 r 0-5
2644.5 2642.7 2643.7 1.00 i 0-5
2650.2- 2648.7 2649.7 1.00 i 0-5
2654.4 . 2653.7 . . 2654.7 1.00 i 0-5
2659.5 2658.7 2659.7 1.00 I 0-5
2664.4 2663.7 2663.7 1.00 i 0-5
2678.7 267Z7 2677.7 - 1,00 • i 0-5 ,
2690.6 ,2688.7 2689.7 1.00 i 0-5
2696.5 2694.7 2695.7 1.00 i 0-5
2700.7 2699.7. 2699.7 1:00 l l l l l l l l l l W g m iS i
2704.6 2703.7 2703.7 1.00 i 0-5
2712.1 2710.7 2711.7 0.89 i 0-5
2713.9 C1-C2
2732.7 2731.7 2731.7 1.00 i 0-5
2740.5 2739.7 2739.7 1.00 i 0-5
2746.8 2745.7 2745.7 1.00 i 0-5
2755.4 2754.7 2755.7 1.00 i 0-5
- 2758.6 27577 275.7.7 1.00 i 0-5
2768.6. 2767.7 2767.7 1.00 i 0-5 -
2784.4 2782.7 2783.7 1.00 i 0-5
2790.9 2789.7 2789.7 1.00 IC 0-5
2800.5 2799.7 2799:7 1.00 i 0-5
2826.5 2824.7 2825.7 1.00 i 0-5
2832.5 2830.6 2831.7 1.00 i 0-5
'283677 ~~2835.7 2835.7 1.00 - i ------ 0-5 --
2847.8 2846.7 2847.7 1.00 IC ,0-5
2854.3 2852:6 2853.7 1.00 I 0-5
2858.5 . 2857.7 2857.7 1.00 I 0-5
2868.8 2867.7 2867.7 1.00 I 0-5
2882.6 2881.7 2881.7 1.00 I 0-5
2888.7 2886.7 2887.7 0.89 I 0-5
2894.6 2893.7 2893.7 . 1 . 0 0 I 0-5 ,
xciii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2904.6 2903.7 . 2903.7 1.00 I 0-5
' '  2916:6'' '  2 9 i4 :r ■""291576“ ----too—------------------------ T ------------------- ---------------- 0 _ 5  -
2927.3 2926.7 2927.7 1.00 I 0-5
2930.3 2928.6 2929.7 0.88 0-5
2937.2 2936.7 2937.7 1.00 I 0-5
2952.0 2950.8 2951.7 0.91 0-5
2962.5. 2961.7 2961,7 1.00 I 0-5
2968.6 2966.7 2967-7 1.00 I 0-5
2972.8 2971.7 2971.7 1.00 . 0-5
2979.2 2977.6 2978.7 1.00 I 0-5
2986.5 A12
2990.5 2988.7, 2989.7 1.00 0-5
2994.9 2993.7 2993.7 1.00 . 0-5
3004.8 3003.7 3003.7 1.00 0-5
3012.0 3010.7 .3011.6 0.89 - 0-5
3018.6 3017.7 3017.7 1.00 I 0-5
3032.1 3030.7 3031.6 0.89 I 0-5
3039.2 3038.7 3038.7 1.00 I 0-5
3051.2 3049.6 3050.7 1.00 I 0-5'
3058.4 3056.7 3057.7 1.00 I 0-5
3063.4 3061.7 3061.7 1.00 IC 0-5
3071.5 A12
3071.6 3071.7 3071.7 1.00 IC 0-5
3095.9 3095.6 3095.6 1.00 IC 0-5
3106.4 - 3104.7 3105.7 1.00 I 0-5 ^
3120.1 3118,7 3119.6 0.89 0-5
3140.4 3139.6 3139.6 1.00 I 0-5
3146.3 3144.6 3147.7 0.87 I 0-5
3156.0 3154.7 3155.6 0.90 I 0-5
3163.9 3161.7 3162.6 1.00 IC 10-15
3164.7 3163.4 3165.4 1.00 I 20-25
3173.2 A4.12-B1
3176.8 3174.7 3176.7 1.00 IC 5-15
3183.3 318276' 3182.6 1.00' 0-5 --------------------------------- . . .
3188.5 3187.7 3188.7 1.00 I 0-5
3194.5 3192.7 3193.7 1.00 I 0-5
3198.4 3197.7 3197.7 1.00 I 0-5
3201.1 3200.7 3200.7 1.00 I 0-5
3231.9. 3230.6 3231.6 0.87 I 0-5
3235.5 3234.7 3235.6 1.00 I 0-5
3237.5 E110
xc iv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3241.3 3239.6 3239.6 1.00 IC 0-5
' 3246; 8“ ----- _------------- - l i l l S i i i i i i l l i i g i i i l i ) A14---------
3254.3 3253.6 3254.6 1.00 i 0-5
3255.6 A12-B1
3257.4 3255.6 3257.7; 0.94 - 0-5
3262.4 3260.6 3261.7 1.00 i 0-5
3267.1 3265.7 3265.7 1.00 i 0-5
3272.2 .3271.6 3272.6 1.00 i 0-5
3278.4 3277.6 3277.6 1.00 i 0-5
3297.6 3296.6 3297.6 1.00 i 0-5
3298.7 A ll-A  12
’ 3327.4 o n n r  s 3327.6 0.94 .0-5
3332.6 3330.6 3332.7 1.00 i 0-5
3368.0 3366.6 3368.6 1.00 i 0-5
3373.6 B10
3375.9 3373.7 3375.6 1.00 IC 0-5
3380.7 3379.7 3380.7 1.00 i 0-5
3387.3 3386.6 3386.6 1.00 i 0-5
3392.4 3391.6 3392.6 1.00 i 0-5
3398.5 3396.7 3397.7 1.00 i 0-5
3400.5 3398.8 3400.8 1.00 IC 20-25
3401.8 ■< 3399.8 3400.8 ‘ 1.00 20-25
3402.4 3401.6 3401.6 . 1.00 0-5
3404.8 3404.6 3404.6 1.00 I 0-5
3412.5 341L6 3411.6 1.00 I 0-5
3418.7 3416,8 3418.8 1.00 I 15-25
3423.9 3423.6 3423.6 1.00 I 0-5
3426.1 3425.6 3425.6 0.99 I 0-5
3433.2 3431.9 3431.9 0.94 I 15-25
3437.8 3436.8 3438.7 1.00 I 15-25
3438.6 B10-B11
3447.7 3445.7 3447.7 0.76 I 0-5
3450.2 3449.6 3449.6 1.00 0-5
345873“  ~ 3457.7 3458.6 1.00 T . 0-5— -----.
■ 3461.4 3459.6 3461.6 LOO ■ 0-5
3464.8 \14
3466.4 3464.6 3465.6 1.00 I 0-5
3471.1 3469.6 3469.6 1.00 0-5
. 3476.5 3475.6 ,3476.6 1.00 I 0-5
3479.0 I38-B11
3482.3 3480.6 3482.6 1.00 I 0-5
xcv
Mass
(average)
Mass
(mono.)
Apex Masi Score Evidence Time MALDI
fraction
3491.3 B7-B9
" 3492.9 349171 3492.1 - . l;00 ' -------- -IC - 20-25 \ -  —
3502.2 ■ B9-B11
3503.1 3501.6 3503.6 , 1.00 I 0-5
3512.1 3509.6 3511.6 0.80 I 0-5
3519.3 B8-B11
3521.8 3519.6, 3521.6 0.81 1 0-5
3522.3 A12
3528.7 B3
3530.2 C3
3539.8 3537.6 3539.6 0.84 I 0-5
3543,3 B1
3548.8 3547.6 3548.6 1.00 I 0-5
3552.9 B9-B11
3555.0 3553.6 3555.6 1.00 I 0-5
3555.9 B2-B3
3561.8 3560.9 3560,9 1,00 I 15-25
,3571.1 3569.6 3569.6 1.00 I 0-5
3584.5 B2-B3.
3584.7 3583.6 l l l i i l i l l 1.00 l i l i i i i t i i a i i s
3590.5 3588.6 3590.6 1.00 i 0-5
3596.5 3595.6 3596.6 1.00 i 0-5
3601.9 3600.9 3600.9 1.00 IC 15-25
3606.3 3605:6 3605.6 1.00 I 0-5
3617.5 3615.6 3617.6 0.82 I 0-5
3627.3 B9-B11
3648.1 3645.6 3647.6 0.79 I 0-5
3652.5 3650.9 3652.9 1.00 IC 15-25
3658.2 3656.1 3658.1 1.00 IC 15-20
3665.4 3663.6 3665.6 0.95 I 0-5
3668.3 3666.9 3669.0 1.00 - I. 15-25
3670.5 3668.5 3669.6 1.00 I 0-5
. 3673.3 3670.9 3672.9 1.00 IC 15-25
3674.9 ' -------- - ------  — ------------------ ---------------- -------------} 32-B3---------
3675.0 3673.6 3673.6 1.00 I * 0-5 '
3679.4 3677.6 3679.6 0.76 I 0-5
3681.3 , (32-C6
3682.9 I32-B5
3684.5 3683.9 3684.9. 1.00 . I 15-25
3685.7 (:8-C15
3686.6 3685.9 3686.9 1.00 IC 15-25
xcvi
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3690.1 3687.9 3690.0 LOO IC 15-25
36913“ 3690.0' 3690.0 ' .--_._i_oo.__ ------- 1------ '20-25-
3692.7 3690.9 3690.9 1.00 IC 15-25
3693.1 3692.6 3692.6 1.00 I 0-5
3694.0 C8-C9
3695.5 C6-C7
3697.7 3695.9 3695.9 . 1.00 IC 15-25
3699.8 B6-B7
3701.5 3700.9 3701.9 1.00 IC 15-25
3702.7 C4
3704.3 3702.9 3704.9 1.00 IC 15-25
3705.3 B2-B4
3706.5 3705.9 3706.9 1.00 I 15-25
3710.0 3708.0 3709.9 LOO IC 15-25
3716.2 3714.8 3715.8 1.00 I 15-25
3726.6 3724.9 3727.9 LOO IC ' 15-25
3731.7 3729.8 3731.8 LOO I 15-25
3743.6 3741.6 3743.6 0.85 I 0-5
3747.7 lllitlll 3747.9 1.00 immmsm111111
,3753.7/- 3751.6 llffllll!filliillISlliilSIIjllillll
3768.1 Cl
3770.2 3769.5 3770.5 LOO i 0-5
3773.9 3771.6 3773.6 1.00 i 0-5
3776.8 3776:6 3776.6 1.00 i 0-5
3782.2 3779.6 3779.6 LOO IC 0-5
3788.5 3786.6 3788.6 1.00 IC 0-5
3793.1 3792.5 3793.6 1.00 . I . 0-5'
3801.2 3800,6 3800.6 LOO I 0-5
3806.5 3804.6 3805.6 LOO I 0-5
3808.3 3808.0 3809.1 LOO IC 15-25
3810.3 3809.6 3809.6 1.00 I . 0-5
3811.8 3811.1 3811.1 LOO IC 15-25
3817.1 3815.6 3815.6 LOO I 0-5
3822.1 --------  - _ _ -------  - ]32
3822.9 3822.6 3824.5 1.00 IC 15-25
3824.5 3822.0 3824.1 1.00 I 0-5
3829.0 3828.6 3828.6 LOO . I 15-25
3846.7 . I37-B8
3848.2 3846.1 3848.1 LOO IC 15-25
3856.9 3854.1 3856.1 1.00 IC 0-5
3864.5 3861.5 3863.5 0.85 I 0-5
xcv ii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
3866.2 3864.1 3866.1 1.00 IC 15-25
----- 3869.2 - — - * *_ . C3-C4:
3869.5 ' 3867.6 3869.6 1.00 I 0-5
3872.6 3871.0 3872.0 1.00 i 15-25
3873.7 3872.1 3873.1 0.74 i 15-25
3879.2 3877.5 3877.5 1.00 i 0-5
. 3879.7 , C6-C8
3881.0 B5-B6
3881.0 3878.2 3880.2 1.00 IC 15-25
3884.5 3883,5 3884.5 . 1.00 IC . 0-5,
7 3890.4 3888.6 " 3890.5 " 1.00 i 0-5 -  - - —  -
3892.6 3892.1 3893.1 1.00 i 15-25
3898.9 3896.2 3899.2 1.00 IC 15-25
3902.1 3901.2 onm o JWi.Z 1.00 tr*it-/ 15-25
3911.6 A14
3912.8 3912.2 3913.1 1.00 I 15-25
3914.8 3914.2 3915.2 1.00 - I .15-25
3917.5 llilil 3917.2 1.00 1J1IHII1I 15-25
3920.9 3921.1 3921.1 1.00 . liiiffliiiii1111111!
3930.0 B7
3932.3 3931.1 3933.1 1.00 i 15-25
3936.9 . 3934.2 1.00 IC 15-25
. 3939.2 3938.6 3938.6 1.00 I 0-5
3943.2 B3-B4
3946.9 3944.2 3947.2 1.00 IC 15-25
3951.3 B6-B7
3954.1 3952.2 : 3954.2 1.00 I 15-25 , .
3960.0 3958.2 3960.2 1.00 IC 15-25
3960.7 - C14-C15
3965.8. 3963.3 3965.2 1.00 IC 15-25
3972.1 B7
3972.4 3969.5 3971.5 0.84 I 0-5
3974.2 3973.2 3975.1 1.00 I 15-25
3979:1 3977.2 3978.2 - 1:00----- IC------ 15-25 - ----------- - -------
3982.1 3981.2 3981.2 1.00 I 15-25
3983.7 . 38-B.ll
3984.3 3982.2 3982.2 0.64 I 15-25
3986.8 3985.6 3986.6 1.00 I 0-5
3993.7 3992.2 3992.2 0.73 I 15-25
3996.7 3995.2 3996.2 1.00 I 15-25
4003.2 4002.2 4002.2 1.00 I 15-25
xcv iii
Mass
(average
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4006.9 4005.5 4007.5 1.00 I 0-5
------4010.3 - - —4008:6 - -4009.6- ------ 1.00 ------ IC -. 0-5 —
4014.3 4013.6 4013.6 1.00 I ; 0 -5
4019.3 B3
4021.8 4020.5 4022.5 , 1.00 f l l S S i l l l l 0-5
4024.7 4023.6. 4025.5 1.00 ,1 l i l l i l l i l i l 0-5
4028.3 4026.5 4028.5 0.94. . i '. 6-5
4032.1 4031.5 4031.5 1.00 i i i i s f i i i l t 0-5
4045.3 4043.6 ' 4Q45.6 0.76 0-5
- 4045.6 A14-A15
4047.8 B7-B11
4059.2 4058.1 4058.1 1.00 i 0-5
4061 ;2 4059.6 4061.5 1.00 IC 0-5
4065.0 4064.5 4064.5 1.00 T1 0-5
4069.0 4068.5 4069.5 1.00 I 0-5
4072.9 4071.5 4073.5 1.00 I 0-5
4077.3 B3
4078.5 4075.5 4077.6. 1.00 IC 0-5
, 4083;3 4081.5 4081.5 1.00 l l l l l l l l l l l l l l l l p i p l
4086.8 w s im U ,
4088.1 4087.5 4088.5 1.00 I . l l l l l l l l
: 4089.2, B11-B15
4092.3 4089.5 4091.5 1.00 I 0-5
4095.9 4095.5 4095.5 0.99 I 0-5
4097.7 4095.3 4097.3. 1.00 IC - 15-25
4099.4 B10-B11
4106.6 4104.7 4106.5 1.00 I 0-5
4108.0 B3-B4
4110.3 B10 .
4111.9 4111.3 4112.2 1.00 I 15-25
4112.1 . jA.14 -
4113.1 4111.3 4113.3 1.00 IC 15-25
4114.6 4112.3 4114.3. 1.00 IC 15-25
-41-23:1 23-C4
4123.7 4122.5 4124.5 1.00 I 0-5
4128.9 4125.6 4127.5 1.00 I 0-5
4132.3 4131.3 4132.3 1.00 I 15-25 "
413718 32-C3
4142.6 4140.6 4142.5 1.00 I 0-5
. -4143.5 33
4149.3 4148.6 . 4148.6 1.00 I 0-5
xcix
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4150.2 4147.4 4149.3 1.00 IC 15-25
----- 4156.0 ----------------------------------------- -----------------------------------— ----------------------------------------------- B11-B12. :
4157.4 B3
4158.9 4155.5 4157.5 0.88 I 0-5
4163.2 4162.6 4163.5 1.00 I 0-5
4167.3 4164.5 4166.5 0.96 I 0-5
4176.0 B15
4181.0 B10-B11
4182.7 .4179.5 4181.5 1.00 I 0-5
4189.7 B12-B14
4189.8 4188.5 4190.5 1.00 I 0-5
4192.7 4191.5 4193.5 1.00 I 0-5
4196.6 4194.5 4196.5 1.00 I 0-5A A A4 iy/ .3 C3
4201.0 A15
4201.5 B13
4202.5 B1
4207.7 4206.4 4208.6 1.00 I 0-5
4210.8 4209.5 4211.5 1.00 I 0-5
4214.5 4212.5 4213.5 1.00 I 0-5
4218.3 C ll
4219.2 4217.5 mMrtsm 1.00 lllillll
4225.6 4223.3 4225.4 1.00 I 15-25
4225.7 4223.4 4225.3 1.00 IC 15-25
4229.2 4228.5 4229.5 1.00 I 0-5
4233.4 4230.5 4232.5 1.00 I 0-5
4259.9 4258.6 4259.5 1.00 I 0-5
4264.8 4262.5 4265.5 1.00 I 0-5
4268.8 4268.5 4268.5 0.99 I 0-5
4273.1 B11-B12
4276.3 4273.4 4277.5 0.82 I 0-5
4282.2 4279.5 4281.5 1.00 I 0-5
4287.3 L JA45-B1
4287.3 -4285:5- -4285:5- - 1:00- I ' -  0-5- - . . . .  . . —
4288.4 312
4292.0 4291.5 4292.5 1.00 I 0-5
4294.7 4293.5 4295.5 1.00 I 0-5
4297.8 . 4296.5 4298.5 1.00 IC 0-5
4305.3 311-B14
4309.7 4308.6 4310.5 1.00 0-5
4314.2 4311.5 4313.5 0.85 I 0-5
c
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4319.2 4317.5 4319.5 1.00 I 0-5
-  . 4319.8 ; ® A K - ^. ----- -------------— ----- B12-B14
4328.3 4326.5 4328.5 1.00 I 0-5 '
4337.4 B12-B14
4337.5 4335.5 4337.5 1.00 I 0-5
4346.6 4344.5 4346.5 1.00 I 0-5
4353.3 4352.5 4352.5 1.00 I 0-5
4362.9 4359.4 4361.5 0.87 I 0-5
4368.9 4366.5 4367.5 1.00 0-5
4380.1 . 4377.4 4379.5 1.00 . 0-5
4386.8 4383.5 4385.5 1.00 0-5 ‘
4394.7 4392.4 4395.5 0.86 I 0-5
4401.3 4398.4 4400.5 1.00 0-5
4412.5 4410.4 4412.5 1.00 IO i
4418.1 4415.5 -' 4417.5 1.00 I 0-5 .
4423.2 4421.5 4421.5 1.00 0-5 -■
4423.3 B7-B11
4434.3 4431.6 . 4433.5 1.00 IliiillllPi 0-5 .
4439.9 4438.6 4439.5 0.99 i 0-5
4448.8 4447.5 4448.5 1.00 i 0-5
4463.5 4462.6 1.00 lllillllll 0-5
4468.5 4465.6 4469.5 1.00 i 0-5
4476.3 4473.5 4475.5 0.87 i 0-5
4480.8 4479.5 4481.5 1.00 i . 0t5
4486.2 4483.5 4485.5 1.00 i 0-5
4491.4 4489.5 4489.5 1.00 i 0-5
4500.3 4497.4 , 4499.5 1.00 0-5
4520.6 B5-B7
4523.3 4521.5 4523:5 1,00 i IliiSS
4536.7 4533.5 4535.5 1.00 11II1S1I:
4542.8 B6
4544.8 4542.4 4544.5 0.90 i .0-5
4551.2 4549A - 4551.5 0.75 0-5
...4557:4 -4554-4- ■4559:5 0:84------— j_— — 0-5----- ---------------------
4569.4 4566.4 4568.5 1.00 i 0-5
4570.7 1314
4575.7 4573.4 4574.5 1.00 i 0-5
4580.0 4579.4 4580.5 1.00 i 0-5
4584.0 4581.4 4583.5 1.00 i 0-5
4599.1 4597.5 4599.5 0.79 i 0-5
4604.3 4601.5 4604.5 1.00 i 0-5
ci
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4615.3 B13
-  4615.9 : 4613.5 -46155 -- . -100 - ' 0-5 . . —
4622.1 4619.5 4621.5 1.00 0-5.
4627.2 4625.5 46255 1.00 0-5
4636.5 46335 46375 1.00 I 0-5
4652.6 4650.4 4652.5 1.00 I 0-5
4667.5 4666.5 4667.5 0.99 I 0-5
4672.5 4669.5 4671.4 1.00 I 0-5
4684.3 46815 4685.4 0.87 I 0-5
4690.2 46875 46895 1.00 0-5
4695.3 4693.5 46935 1.00 I 0-5
4705.9 4703.4 47065 1.00 I , 0-5 -
4726.4 4723.4 47275 1.00 0-5
4734.1 4731.3 4735.5 0.12 I 0-5
4740.7 4737.4 47395 1.00 0-5
4753.6 4752.4 4754.4 1.00 I 0-5
4759.0 4755.4 47575 0.96 I 0-5
4763.7 4763.5 4763.5 0.99 I 0-5
4773.3 .4770.3 4772.5 1.00 I 0-5
4779.6 4777.4 4778.4 0.93 lllilil
4784.1 4783.6 4784.4 0.97 I 0-5
4788.4 4785.5 4787.4 1.00 .0-5
4795.1 4792.6 47965 1.00 0-5 - -
4801.5 4799.4 48025 1.00 - I 0-5 .
. 4808.3 48055 48085 1.00 I 0-5
4820.5 4818.4 48205 1.00 I 0-5
4826.0 4823.5 4825.5 1.00 0-5 *■
4831.2 4829.5 48295 1.00 I 0-5
4841.4 48385 4841.4 1.00 I 0-5
4856.6 4854.4 4856.4 1.00 I 0-5
4869.0 48675 4868.4 1.00 - I 0-5
4876.5 4873.3 4875.5 1.00 I 0-5
4894.2 4891.5 4893.4 1.00 I 0-5
4898.7 4897.5 48975— 1.00— ------- j --------- 0-5 • -.............. - -
4907.2 4904.5 4907.4 1.00 I 0-5
4930.8 4928.4 4931.4 1.00 I - 0-5
4931.4 37
4939.0 35
4944.6 4941.4 4943.5 1.00 I 0-5
4950.4 4949.4 4949.4 1.00 I 0-5
4955.0 4952.4 4955.4 1.00 I ’ 0-5
c ii
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4962.7 4959.4 4961.4 1.00 I 0-5
------4967:5 — --------- --------- - 1 - - -'.... B6-B7
4968.4 4966.4 4967.4 1.00 I 0-5 -
4975.8 4973.4 4973.4 1.00 I 0-5
4985.4 4983.4 4985.4 1.00 I 0-5
4999.1 4996.5 4999.4 1.00 I 0-5
5005.9 5003.4 5006.4 1.00 I 0-5
5012.3 5009.4 5012.4 1.00 I 0-5
5030.1 5027.4 5029.5 1.00 I 0-5
5034.8 5033.4 5033.4 1.00 I 0-5
5045.3 5043.4 5044.4 : 1.00 0-5
5051.6 5048.4 5051.4 0.89 I 0-5
5057.5 . 5055.6 5057.4, 0.99 0-5
5074.9 5072.4 7C c 1 nn i.vy 0-5
5081.3 -5078.5 5081.4 l.00 0-5
5092.0 5089.5 5091.4 l.00 I 0-5
5098.2 5095.4 5097.4 l.00 I 0-5
5103.4 5101.5 5101.5 l.OO r 0-5
5111.2 5108.4 5111.4 . 1.00 l l l O i i i l !
5129.2 5126.5 5129.4 1.00 1I10I11I1
5133.8 5133.4 5133.4 1.00 I 0-5
5142.8 5141.4 5141.4 1.00 I 0-5
5148.6 5145.4 5147.4 1.00 I 0-5
5160.9 5159.4 5159.4 1.00 I 0-5
5166.6 5163.4 5165.4 . 0.96 0-5
5171.2 5170.4 5171.4 1.00 I 0-5
5179.8 5177.4 5177.4 1.00 I 0-5
5184.9 5183.4 5183.4 1.00 I 0-5
5187.8 5187.4 5187.4 0.96 I 0-5
5192.4 5190.3 5192.4 1.00 I 0-5
5197.5 5196.6 5198.4 0.99 I 0-5
5203.4 5200.5 5203.5. 1.00 I 0-5
5207.8 .5207.4 5207.4. 0.99 0-5
-5211.9 5210:4 - -521-3.4 1.00— I 0-5 ---------------------
5217.5 5214.4 5216.4 1.00 0-5
5234.5 5231.4 5233.4 1.00 I 0-5
5239.8 5238.4 5239.4 1.00 I 0-5
5249.3 5246.4 5249.4 1.00 0-5
5255.7 5253.4 5255.4 1.00 I 0-5
5264.6 5262.3 5265.4 0.87 I 0-5
5278.9 5277.4 5279.5 1.00 I 0-5
ciii
Mass
(average)
Mass
(mono.)
Apex Masjs Score Evidence Time MALDI
fraction
5284.5 5281.5 5283.4 1.00 0-5
------ 5290.-5-- -5289.4- - —5291.4—------ 1t 0 0 — -------- j ----- ----- 0-5—----------------
5294.7 5292.4 5295.3 0.97 I 0-5
5301.8 5298.4 5301.4 1.00 0-5
5307.4 5305.5 5305.5 1.00 I 0-5
5312.3 5311.4 5311.4 0.99 I 0-5
5317.2 5314.5 5318.4 LOO I 0-5
5327.5 5326.5 5328.4 0.99 I 0-5
5338.3 5335.4 5339.4 1.00 0-5
5342.8 5342.4 5342.4 0.98 I 0-5
5351.9 5348.4 5351.4 0.93 I 0-5
5357.5 5355.4 5357.4 0.81 I 0-5
5364.4 5362.5 5365.4 1.00 0-5
*rrJD / U . / 5369.4 n nl . V V 0-5
5378.2 5376.4 5376.4 1.00 I 0-5
5387.7 5385.3 5385.3 :■ LOO - 0-5
5397.5 5395,5 5397,4 1.00 I 0-5
5401.9 5400.2 . 5402.3. 0.75 0-5.
5407.4 5405.4 ‘ 5408.4 1.00 IlillBllllI 0-5
5413.5 5411,4 5414.4 0.96 l l l i l l l l l
5421.4 5418.4 l l l p i l i ! 1.00 l i i i i l i l l i i l l
5427.8 5427.3 5427.3 LOO i 0-5
5431.5 5429.4 5433.4 1.00 . 0-5
5437.6 5434.3 5437.4 LOO 0-5
5444.0 , 5441.4 5441.4 LOO i 0-5
5453.3 5450.4 5453.4 . 0.86 - i 0-5
5459.6 5457.5 5459.4 0.94 i 0-5;
5464.4 5463.4 5465.4 1.00 i 0-5
5483.4 5481.3 5483.4 LOO 0-5
5489.6 5486.4 5487.4 1.00 i 0-5
5499.9. 5498.3 5501.4 1.00 0-5 -
5505.7 5502.3 5505.4 1.00 i . 0-5
5511.4 5509.3 5509.3 LOO i 0-5 .
5516.9 -5515:5 - -5515.5 - -0.80 0-5- - --
5524.2 5522.4 5523.3 1.00 0-5
5535.3 5533.4 5533.4 1.00 0-5
5542.8 5541.4 5543,4 1.00 0-5
5547.4 5546.4 5548.4 0.99 r 0-5
' 5550.3. 5549.4 5551.2 0.98 0-5
5556.9 5553.3 5555.4 0.87 0-5
5563.4 5562.2 5563.1 0.88 i 0-5
civ
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
5567.9 5566.3 5567.3 l.OO I 0-5
----- 5574.0—— 5570.3----- -5573-4—------0:92- — --------- j ------- ----- 0-5— - ---------------
5583.9 5582.4 5583.5 l.OO 0-5
5588.3 5586.3 5588.3 l.OO I 0-5
5595.1 - 5593.4 5595.3 0.94 0-5
5601.2 5599.5 5601.3 0.94 I 0-5
5606.3 5604.3 5606.4 l.OO il 1| 1| 1 1 : | |1 | 0-5
5611.8 5609.3 5612.4 l.OO 0-5
5617.3 5615.3 5619.2 l.OO 0-5.
5624.4 5621.4 5625.3 0.98 I 0-5
5636.7 5635.3 5635.3 l.OO I 0-5
5642.8 5639.3 5642.3 l.OO I 0-5
5648.3 5647.3 5647.3 l.OO I 0-5
5651.0 r /cn  f ctr ^ i  £-J O J J L . J ' 1 nn l.UU I 0-5
5656.3 5654.3 5657.4 l.OO I 0-5
5661.9 5660.4 5663.3 l.OO I 0-5
5682.9 5682.5 5682.5 l.OO 0-5
5686.9 5685.3 5687.4 l.OO 0-5
5692.8 5689.1 5691.3 l.OO I 0-5
5704.1 5702.3 5703.3 0.90 I 0-5
5710.4 5708.4 5709.3 l.OO . llllilll
5714.7 5713.3 5713.3 ■ 0.93 I 0-5
5739.4 5737.2 5740.3 l.OO I 0-5
5746.7 57453 5745.3 l.0 0 r 0-5
5749.8 5749.3 5749.3 0.99 I 0-5
5754.1 5751.3 5753.4 0.83 I 0-5
5760.8 5759.4 5759.4 -1.00 I 0-5
5767.7 5765.3 5765.3 . 0.89 I 0-5
5772.3 5771.3 5772:4 0.99 0-5 -
5778.0 5774.2 5777.4 0.91 I 0-5
5782.8 B13-B14
5787.9 5787.4 5788.3 0.99 I 0-5
5792.1 5789.3 5791.2 1.00 I 0-5
- 5809.9 : 5809.3 - 5810.3 1.00 I ..................-
5813.5 5811.3 5813.3 0.96
5820.9 5819.4 5821.4 1.00 0-5
5834.8 5834.3 5835.2 1.00 I 0-5
5838.9 5837.3 5839.4 1.00 I 0-5
5842.4 5841.2. 5843.3. 1.00 I 0-5
5847.3 5844.3 5845.4 1.00 I 0-5
5852.8 5851.3 5851.3 0.73 0-5
cv
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
5860.3 5858.2 5859.1 0.89 I 0-5
----- 5873-5- 587-l-r3-—  -5873.2-------0,94 — --------1----- - -0-5— -----------------
5887.8 5886.3 5886.3 1.00 I 0-5
5892.7 5891.4 5891.4 0.99 0-5
5901.5 5899.5 5903.4 1.00 I 0-5
5909.9 5908.5 5909.3 1:00 0-5
5914.8 5912.2 5917.3 0.96 I 0-5
5926.9 5925.2 5926.4 0.99 0-5
5966.8 5965.4 5965.4 1.00 0-5
5974.2 5972.3 5972.3 0.88 . 11IS1S11 0-5 - I . . .
5982.1 5979.3 5982.3 1.00 I 0-5
5994.1 5991.2 5994.1 0.85 0-5
6024.7 6023.1 6026.1 1.00 I 0-5
6043.8 6043.3 6044.3 1.00 0-5
6048.0 6045.3 6049.3 1.00 I 0-5
6055.3 6053.3 6057.4 0.88 I 0-5
6064.0 6062.2 6064.2 0.95 I 0-5
6072.2 6070.4 6071.4 0.89 I 0-5
6096.2 6093.2 6095.3 1.00 I 0-5
6115,3 6113.2 6117.3 1.00- - 0-5
6131.7 6130.3 6130.3 0.86 I 0-5
6167.4 6165.2 6168.3 1.00 I 0-5
6172.8 6170.3 6173.3 0.65 I 0-5
6186.8 6183.4 6185.3 0.88 I 0-5
6191.6 . 6190.3 6191.3 0.94 0-5
6203.0 6201.2 6201.2 0.96 I 0-5
6236.9 6233.9 6238.1 0.97 0-5
6242.3 6241.0 6241.0 0.99 I 0-5
6250.7 6248.3 6249.4 1.00 I 0-5
6254.8 6254.3 6254.3 0.99 I 0-5
6270.4 6268.4 6269.4 1.00 I 0-5
6327.7 6325.5 6326.4 0.95 I 0-5
6339.8 6338.4 6338.4 1.00 I 0-5
—6390.6 - ~63-87t2— —6390rl— 0.76----- -------1--------- 0-5----- --------------------
6583.0 6580.4 6583.3 0.92 I 0-5
6652.8 312-B13
6674.3 312-B13
6721.0 6719.2 6719.2 1.00 I 0-5
7032.8 7031.2 7031.2 0.94 I 0-10
.7064.2 7063.3 .7063.3 1.00 I 0-5
7096.9 7095.2 7095.2 1.00 I . 0-5
evi
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
7191.5 7190.0 7191.1 0.99 I 0-5
- -7365.5— --------------- ----------------- ------------------ ----------------- --------------- B 5--------------
7387.8 B5 ■'
: 7547.9 Cl
7624.9 7624.2 7625.3 0.99 I 0-5-
7629.9 7627.1 7631.2 1.00 I 0-5
8028.3 8027.0 8027.9 1.00 I 0-5
8144.0 B13
Group 8 from ion exchange column
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
2005.5 2005.1 2005.1 1.00 I 15-20
2007.6 2006.8 2007.8 1.00 I 5-10
2016.6 2015.8 2015.8 1.00 5-10
2027.3 2026.8 2026.8 1.00 5-10
2046.3 2045.8 2045.8 1.00 I 5-10
2055.6 2054.8 2055.7 1.00 5-10
2065.8 2064.8 2065.8 1.00 I 5-10
2075.4 2074.8 2075.8 1.00 I 5-10
2085.4 2084.8 2085.8 1.00 I 5-10
2109.2 2108.8 2108.8 1.00 I 15-20
2143.5 2142.8 2143.8 1.00 I 5-10
2169.5 B3
2181.3 2180.9 2181.8 0.98 I 5-10
2183.4 2182.8 2183.7 1.00 I 5-10
2191.7 2190.7 2191.7 1.00 I 5-10
2201.7 2200.7 2201.7 1.00 I 5-10
2279.6 2278.8 2279.8 1.00 I 5-10
2326.1 2325.7 2325.7 1.00 I 5-10
2415.6 2414.8 2415.7 1.00 I 5-10
2462.0 2461.6 2461.6 1.00 I 5-10
2551.6 2550.7 ' 2551.7 TOO 5-10 -...................................... ......... - -  -
2687.6 2686.7 2687.7 1.00 I 5-10
3176.7 3175.8 3176.8 1.00 I 15-20
3193.9 A 11-A13
3202.3 B1
3314.0 3313.6 3313.6 1.00 I 5-10
3366.2 3310
Mass
(average)
Mass
(mono.)
Apex Masss Score Evidence Time MALDI
fraction
3369.8 A12-A13
------3380.7- - -3379r8- — 3380r8—------1.00— ------- 10----- -15-25- ----------- --------
3381.0 3379.8 3380.8 1.00 IC 15-25
3382.2 3381.8 3381.8 1.00 I 15-25
3396.9 3395.8 3396.8 1.00 IC 15-25
3483.0 A13
3608.4 3607.1 3609.1 1.00 I 15-20
3609.2 3607.1 3609.1 1.00 IC 15-20
3615.3 B10-B12
3634.7 B10-B13
3636.6 3636.1 3636.1 1.00 I 15-20
3637.4 3636.1 3637.1 1.00 JC 15-20
3673.0 3671.0 3672.0 1.00 IC 15-20
3705,9' B5-B6
3724.0 3722.2 3724.2 1.00 IC 15-20
3724.4 3722.2 3724.2 1.00 IC 15-20
3725.5 3725.1 3725,1 1,00 I 15-20
3725.8 3725.2 3725.2 0.89 I 15-20
3737.3 3736.2 3738.2 1.00 I 15-20
3740.7 3740.2 3741.2 1.00 I 15-20
3741.8 3739.2 3741.2 1.00 IC 15-20
3742.7 3741.1 3743.2 1.00 IC 15-20
3744.3 3743.1 3743.1 0.76 I 15-20
3745.5 3744.1 3744.1 1.00 I 15-20
3755.3 BIO
3756.1 3755.2 3756.2 1.00 I 15-20
3756.5 3754.1 3755.2 1.00 IC 15-20
3761.6 3761.1 3762.1 1.00 I 15-20
3762.1 3760.1 3761.1 1.00 I 15-20
3781.0 3780.2 3780.2 1.00 I 15-20
3808.6 .3806.1 3808.1 1.00 IC 15-20
3821.9 3821.1 3822.1 1.00 I 15-20
3825.3 3823.1 .3825.1 1.00 IC 15-20
3829:9 -3829:0 - 3829:0---- 1:00----- — I 15-20 -------------------
3838.2 131-B4
3840.7 3839.1 3841.1 1.00 I 15-20
3863.1 3862.1 3863.1 1.00 I 15-20
3878.8 3877.2 3878.2 1.00 IC 15-20
3880.5 I36
3892.3 3891.2 3892.2 1.00 IC 15-20
3895.9 3894.2 3895.2 1.00 IC 15-20
cviii
Mass
(average)
Mass
(mono.)
Apex Masi Score Evidence Time MALDI
fraction
3947.1 B5-B8
- - 3 9 4 7 ,4  - -3944,3----- 39463- ------l.OO - i i i Q I i I — T5--20- ----------- r ----------
3958.0 B8-B14
3959.6 A7-A9
3960.6 3958.3 3961.3 l.OO IC 15-20
3963.4 B11-B12
3965.8 3963.3 3965.3 l.OO IC 15-20
3970.8 3969.2 3969.2 l.OO IC 15-20 >
3974.0 3972.2 3975.2 l.OO IC 15-20
3975.8 3975.2 3976.2 l.OO I 15-20
3978.7 3976.3 3979.2 l.OO IC 15-20
3981.7 3981.2 3981.2 l.OO I 15-20
3982.3 B9-B10
3983.0 3981.3 0A01 Ooy QL.D l.OO IC 15-20
3985.1 3983.2 3985.2 l.OO IC 15-20
3988.1 3987.1 3987.1 l.OO I 15-20
3989.0 A14-B1
3992.5 3992.2 3992.2 l.OO IC 15-20
3993.9 3993.3 3994.3 l.OO I 15-20
3996.9 3994.3 3997.3 l.OO IC 15-20
3998.7 3998.2 3999.2 l.OO I 15-20
4002.4 4001.2 4003.2 l.OO IC 15-20
4005.1 4004.2 4004.2 l.OO I 15-20
4011.2 4009.4 4009.4 l.OO I 15-20
4012.5
4013.7 4013.2 4014.2 l.OO I 15-20
4016.7 4014.2 4017.2 l.OO IC 15-20
4020.2 ■ B6
4021.0 4019.2 4019.2 l.OO I 15-20
4041.1 4040.2 4040.2 l.OO I 15-20
4058.6 i4.14-A15
4061.1 4060.2 4061.2 l.OO I 15-20
4082.5 4081.1 4082.2 l.OO I 15-20
- 4098.2 -4097:2- 4099:2 - 1.00 - ....I ... • 15-20 ---------- --—
4ll0.3 34-B5
4155.4 312-B13
4163.0 U5-B1
4205.6 4204.5 4206.4 1.00 IC 15-20
4207.0 4206.5 4207.4 1.00 I 15-20
4207.5 4206.4 4208.4 1.00 I 15-20 ,
4216.5 11
cix
Mass
(average)
Mass
(mono.)
Apex Mass Score Evidence Time MALDI
fraction
4218.8 4217.5 4219.5 1.00 IC 15-20
-—421-9,0— -4 2 4 6 5 - - —4249:5— -----1.Q0----- ------- IC------- --45-20— -----------------
4230.8 B1
4287.8 B3
4298.9 4297.4 4299.4 1.00 I 15-20
4300.8 4299.5 4300.5 1.00 IC 15-20
4302.4 4300.5 4301.5 0.98 I 15-20
4329.5 B3
4342.0 B4
4938.7 B5
7901.3 -  -  - B7
7922.2 B8
